<SEC-DOCUMENT>0001513162-17-000027.txt : 20170127
<SEC-HEADER>0001513162-17-000027.hdr.sgml : 20170127
<ACCEPTANCE-DATETIME>20170127171858
ACCESSION NUMBER:		0001513162-17-000027
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		54
FILED AS OF DATE:		20170127
DATE AS OF CHANGE:		20170127

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ITUS Corp
		CENTRAL INDEX KEY:			0000715446
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		IRS NUMBER:				112622630
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-215799
		FILM NUMBER:		17554706

	BUSINESS ADDRESS:	
		STREET 1:		12100 WILSHIRE BOULEVARD
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		31044845200

	MAIL ADDRESS:	
		STREET 1:		12100 WILSHIRE BOULEVARD
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COPYTELE INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>forms1.htm
<DESCRIPTION>FORM S-1
<TEXT>
<HTML>
<head><title>Form S-1</title> </head> <body vlink=#954f72 link=blue lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>As filed with the Securities and Exchange Commission on </font></b><b>January 27, 2017</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Registration No. 333-</font></b><b>_________</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>UNITED STATES</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>SECURITIES AND EXCHANGE COMMISSION</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Washington,&nbsp;D.C. 20549</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:14pt; COLOR:black">Form S-1</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:12pt; COLOR:black">REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:14pt; COLOR:black">ITUS CORPORATION</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><i><font style=COLOR:black>(Exact Name of Registrant as Specified in its Charter)</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt' align=center>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:12.4pt> <td width=179 style="HEIGHT:12.4pt; WIDTH:134pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Delaware</font></b></p></td> <td width=183 style="HEIGHT:12.4pt; WIDTH:137.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>6794</font></b></p></td> <td width=178 style="HEIGHT:12.4pt; WIDTH:133.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>11-2622630</font></b></p></td></tr> <tr style=HEIGHT:24.75pt> <td width=179 style="HEIGHT:24.75pt; WIDTH:134pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(State or other jurisdiction of</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>incorporation or organization)</font></p></td> <td width=183 style="HEIGHT:24.75pt; WIDTH:137.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Primary Standard Industrial</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Classification Code Number)</font></p></td> <td width=178 style="HEIGHT:24.75pt; WIDTH:133.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(I.R.S. Employer</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Identification No.)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>12100 Wilshire Boulevard, Suite 1275</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Los Angeles, CA 90025</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Telephone: (310) 484-5200</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><i><font style=COLOR:black>(Address, including zip code, and telephone number,</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><i><font style=COLOR:black>including area code, of principal executive offices)</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Mr. Robert A. Berman</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>President and Chief Executive Officer</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>ITUS Corporation</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>12100 Wilshire Boulevard, Suite 1275</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Los Angeles, CA 90025</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Telephone: (310) 484-5200</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><i><font style=COLOR:black>(Address, including zip code, and telephone number,</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><i><font style=COLOR:black>1including area code, of agent for service)</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Copies to:</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Barry I. Grossman, Esq.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Ellenoff Grossman &amp; Schole LLP</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>1345 Avenue of the Americas, 11</font></b><b><sup><font style="FONT-SIZE:8pt; COLOR:black">th</font></sup><font style=COLOR:black>&nbsp;Floor</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>New York, New York 10105</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Telephone: (212) 370-1300</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Fax Number: (212) 370-7889</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Approximate date of proposed sale to public:&nbsp;As soon as practicable on or after the effective date of this registration statement.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box.</font><font style="FONT-FAMILY:Wingdings; COLOR:black">&#168;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.</font><font style="FONT-FAMILY:Wingdings; COLOR:black">&#168;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.</font><font style="FONT-FAMILY:Wingdings; COLOR:black">&#168;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.</font><font style="FONT-FAMILY:Wingdings; COLOR:black">&#168;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; and &#147;smaller reporting company&#148; in Rule 12b-2 of the Exchange Act. (Check one):</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div align=center> <table width=60% bordercolor=transparent style=WIDTH:60% cellpadding=0 cellspacing=0> <tr style=HEIGHT:12.4pt> <td width=45% style="HEIGHT:12.4pt; WIDTH:500pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Large accelerated filer [&nbsp;&nbsp;]</font></p></td> <td width=45% style="HEIGHT:12.4pt; WIDTH:45%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Accelerated filer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;[&nbsp; ]</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=45% style="HEIGHT:12.4pt; WIDTH:45%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Non-accelerated filer&nbsp;&nbsp; [&nbsp;&nbsp;]</font></p></td> <td width=45% style="HEIGHT:12.4pt; WIDTH:45%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Smaller reporting company&nbsp;&nbsp; &nbsp;[x]</font></p></td></tr> <tr> <td width=45% style="HEIGHT:12.4pt; WIDTH:45%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>(Do not check if a smaller reporting company)</font></p></td> <td width=45% style="HEIGHT:12.4pt; WIDTH:45%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'></p></td></tr></table></div> <div align=center>&nbsp;</div> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 8pt; LINE-HEIGHT:107%; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 8pt; LINE-HEIGHT:107%; TEXT-AUTOSPACE:ideograph-numeric'><b><font style=COLOR:black><br><br></font></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>CALCULATION OF REGISTRATION FEE</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:49.5pt> <td width=180 style="BORDER-TOP:0px; HEIGHT:49.5pt; BORDER-RIGHT:0px; WIDTH:135pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Title&nbsp;of&nbsp;Each&nbsp;Class&nbsp;of&nbsp;</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>&nbsp;Securities&nbsp;to&nbsp;Be&nbsp;Registered</font></b></p></td> <td width=18 style="HEIGHT:49.5pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=85 style="BORDER-TOP:0px; HEIGHT:49.5pt; BORDER-RIGHT:0px; WIDTH:63.9pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 1.1pt 0pt 0in; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Amount&nbsp;to&nbsp;Be</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>&nbsp;Registered</font></b><sup><font style=COLOR:black>(1)</font></sup></p></td> <td width=18 style="HEIGHT:49.5pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=90 colspan=2 style="BORDER-TOP:0px; HEIGHT:49.5pt; BORDER-RIGHT:0px; WIDTH:67.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 1.1pt 0pt 0in; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Proposed</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>&nbsp;Maximum</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>&nbsp;Offering&nbsp;Price</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>&nbsp;per&nbsp;Share</font></b></p></td> <td width=18 style="HEIGHT:49.5pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=102 colspan=2 style="BORDER-TOP:0px; HEIGHT:49.5pt; BORDER-RIGHT:0px; WIDTH:76.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 1.1pt 0pt 0in; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Proposed</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>&nbsp;Maximum</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>&nbsp;Aggregate</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>&nbsp;Offering&nbsp;Price</font></b></p></td> <td width=18 style="HEIGHT:49.5pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=94 colspan=2 style="BORDER-TOP:0px; HEIGHT:49.5pt; BORDER-RIGHT:0px; WIDTH:70.35pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 1.1pt 0pt 0in; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Amount&nbsp;of</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>&nbsp;Registration</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>&nbsp;Fee</font></b></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=180 style="HEIGHT:12.4pt; WIDTH:135pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Shares of common stock<sup>(2)</sup></font></p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=85 style="HEIGHT:12.4pt; WIDTH:63.9pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>947,606</font></p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=21 style="HEIGHT:12.4pt; WIDTH:16pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=69 style="HEIGHT:12.4pt; WIDTH:51.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5.04</font></p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=24 style="HEIGHT:12.4pt; WIDTH:0.25in; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=78 style="HEIGHT:12.4pt; WIDTH:58.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,775,934.24</font></p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=76 style="HEIGHT:12.4pt; WIDTH:56.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>553.53</font></p></td></tr> <tr> <td width=212 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=21 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=100 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=21 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=25 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=81 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=21 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=28 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=92 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=21 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=21 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=89 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:29.25pt> <td width=19 style="HEIGHT:29.25pt; WIDTH:14.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=36 style="HEIGHT:29.25pt; WIDTH:26.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>(1)</font></p></td> <td width=569 style="HEIGHT:29.25pt; WIDTH:427.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Pursuant to Rule 416 of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), the shares of common stock offered hereby also include such presently indeterminate number of shares of the registrant&#146;s common stock as a result of stock splits, stock dividends or similar transactions.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:3.65pt> <td width=19 style="HEIGHT:3.65pt; WIDTH:14.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=36 style="HEIGHT:3.65pt; WIDTH:26.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>(2)</font></p></td> <td width=569 style="HEIGHT:3.65pt; WIDTH:427.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="BACKGROUND:white; COLOR:black">The maximum offering price is being computed in accordance with Rule 457(a) of the Securities Act. The shares of common stock are being issued by the registrant in accordance with a right held by the registration pursuant to the terms of a patent acquisition agreement at a price per share of $5.04.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act or until this Registration Statement shall become effective on such date as the Securities and Exchange Commission acting pursuant to said Section&nbsp;8(a) may determine.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:red>The information in this prospectus is not complete and may be changed. We may not sell these securities until the Securities and Exchange Commission declares our registration statement effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:red>Subject to Completion, dated January 27, 2017</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Prospectus</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>ITUS CORPORATION</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>947,606 Shares of Common Stock</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>This prospectus relates to the issuance by ITUS Corporation (&#147;we,&#148; &#147;us,&#148; &#147;our,&#148; the &#147;Company,&#148; or &#147;ITUS&#148;) of 947,606 shares of common stock, par value $0.01 per share, to Meetrix Communications, Inc. (&#147;Meetrix&#148;).&nbsp; The Company is issuing the shares in satisfaction of an obligation owed by the Company to Meetrix in the amount of $4,775,934 pursuant to the terms of that certain Patent Acquisition Agreement, dated November 11, 2013, by and between the Company and Meetrix (the &#147;Patent Acquisition Agreement&#148;).&nbsp; The Company&#146;s obligation to Meetrix is being satisfied at a price per share of $5.04. For more information regarding the issuance price, see &#147;Determination of Offering Price&#148; beginning on page 20.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our common stock is listed on the Nasdaq Capital Market under the symbol &#147;ITUS.&#148; On January 26, 2017, the last reported sale price of our common stock was $5.05 per share.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Upon issuance of the shares to Meetrix, the shares issued will not be &#147;restricted&#148; shares and Meetrix may offer all or part of the shares for sale from time to time through public or private transactions, at either prevailing market prices or at privately negotiated prices. With regard only to the shares issued hereunder that it sells for its own behalf, Meetrix may be an &#147;underwriter&#148; within the meaning of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Investing in our common stock involves a high degree of risk. See &#147;Risk Factors&#148; beginning on page&nbsp;10 to read about factors you should consider before investing in shares of our common stock.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. &nbsp;Any representation to the contrary is a criminal offense.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>The date of this prospectus is _________, 2017.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>3</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><b><font style=COLOR:black>You should rely only on the information contained in this prospectus. We have not authorized any other person to provide you with information different from or in addition to that contained in this prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. We are not making an offer to sell these securities in any jurisdiction where an offer or sale is not permitted. You should assume that the information appearing in this prospectus is accurate only as of the date on the front cover of this prospectus. Our business, financial condition, results of operations and prospects may have changed since that date.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=TC>TABLE OF CONTENTS</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt' align=center>&nbsp;</p> <div align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Page</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#1>Cautionary Note Regarding Forward-Looking Statements </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>5</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#2>Prospectus Summary </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>6</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#3>Risk Factors </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>10</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#4>Use of Proceeds </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>20</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#5>Dividend Policy </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>20</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#6>Determination of Offering Price </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>20</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#8>Plan of Distribution </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>21</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#9>Description of Securities to be Registered </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>23</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#10>Information with Respect to Registrant </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>24</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#12>Market For Common Equity and Related Stockholder Matters </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>30</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#11>Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>31</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#13>Management </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>36</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#14>Compensation of Directors and Executive Officers </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>39</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><font style=COLOR:black><a href=#15>Transactions with Related Persons </a></font></p></font></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>44</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#16>Beneficial Ownership of Principal Stockholders, Officers and Directors </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>45</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#17>Experts </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>47</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#18>Legal Matters </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>47</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#19>Disclosure of Commission Position of Indemnification For Securities Act Liabilities </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>47</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#20>Where You Can Find Additional Information </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>47</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=90% nowrap style="HEIGHT:15pt; WIDTH:90%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#INDEX>Index to Financial Statements </a></font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>49</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><font style=COLOR:black>&nbsp;In this prospectus, we rely on and refer to information and statistics regarding our industry. We obtained this statistical, market and other industry data and forecasts from publicly available information. While we believe that the statistical data, market data and other industry data and forecasts are reliable, we have not independently verified the data.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><sup><font size=+0></font></sup>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>4</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p 13.2pt; left; 0in text-align: roman?,?serif?; new margin: style="FONT-SIZE:10pt; FONT-FAMILY:" text-autospace:? times align=left><a href=#TC>Table of Contents</a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 13.2pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=1>CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 13.2pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><font style=COLOR:black>This prospectus contains forward looking statements that involve risks and uncertainties.&nbsp; All statements other than statements of historical fact contained in this prospectus, including statements regarding future events, our future financial performance, business strategy, and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including &#147;anticipates,&#148; &#147;believes,&#148; &#147;can,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimates,&#148; &#147;expects,&#148; &#147;intends,&#148; &#147;may,&#148; &#147;plans,&#148; &#147;potential,&#148; &#147;predicts,&#148; &#147;should,&#148; or &#147;will&#148; or the negative of these terms or other comparable terminology. Although we do not make forward looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks outlined under &#147;Risk Factors&#148; or elsewhere in this prospectus, which may cause our or our industry&#146;s actual results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Moreover, we operate in a highly regulated, very competitive, and rapidly changing environment. New risks emerge from time to time and it is not possible for us to predict all risk factors, nor can we address the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause our actual results to differ materially from those contained in any forward-looking statements.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 13.2pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><font style=COLOR:black>We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short term and long term business operations, and financial needs. These forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from those reflected in the forward looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this prospectus, and in particular, the risks discussed below and under the heading &#147;Risk Factors&#148; and those discussed in other documents we file with the SEC. The following discussion should be read in conjunction with the consolidated financial statements for the fiscal years ended October 31, 2016 and 2015 and notes incorporated by reference therein. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this prospectus may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statement.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 13.2pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><font style=COLOR:black>You should not place undue reliance on any forward-looking statement, each of which applies only as of the date of this prospectus. You should be aware that the occurrence of the events described in the section entitled &#147;Risk Factors&#148; and elsewhere in this prospectus could negatively affect our business, operating results, financial condition and stock price. Except as required by law, we undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this prospectus to conform our statements to actual results or changed expectations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 13.2pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>5</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 13.2pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt color=#0066cc><a href=#TC>Table of Contents</a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=2>PROSPECTUS SUMMARY</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 5.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i><font style=COLOR:black>This summary highlights selected information contained elsewhere in this prospectus.&nbsp;&nbsp;This summary does not contain all the information that you should consider before investing in the common stock.&nbsp;&nbsp;You should carefully read the entire prospectus. In particular, attention should be directed to our &#147;Risk Factors,&#148; &#147;Information With Respect to the Company,&#148; &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and the financial statements and related notes thereto contained herein before making an investment decision.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Unless otherwise indicated, all references in this prospectus to &#147;dollars&#148; or &#147;$&#148; refer to US dollars.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Business Overview</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We were incorporated on November 5, 1982 under the laws of the State of Delaware. From inception through October 2012, our primary operations involved the development of patented technologies in the areas of thin-film displays and encryption.&nbsp; Beginning in October of 2012 under the leadership of a new management team, we recapitalized the Company, unencumbered the Company&#146;s assets, changed the Company&#146;s name and ticker symbol, relocated the Company&#146;s headquarters, and modernized its systems. In July of 2015, the Company&#146;s stock was accepted for listing and began trading on the NASDAQ Capital Market.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In June of 2015, the Company announced the formation of a new subsidiary, Anixa Diagnostics Corporation (&#147;Anixa&#148;), to develop a platform for non-invasive blood tests for the early detection of cancer. That platform is called Cchek&#153;.&nbsp; In July of 2015, ITUS announced a collaborative research agreement with The Wistar Institute (&#147;Wistar&#148;), the nation&#146;s first independent biomedical research institute and a leading National Cancer Institute designated cancer research center, for the purpose of validating our cancer detection methodologies and establishing protocols for identifying certain biomarkers in the blood which we identified and which are known to be associated with malignancies. In August of 2016 ITUS announced the renewal and expansion of our relationship with Wistar. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In October of 2015, ITUS and Wistar announced favorable results from initial testing of a small group of Breast Cancer patients and healthy controls. One hundred percent (100%) of the blood samples tested from patients with varying stages of breast cancer showed the presence of the biomarkers we identified, and none of the healthy patient blood samples contained the biomarkers. Breast Cancer is the second most common cancer in the United States and throughout the world.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In April of 2016, ITUS announced that we had demonstrated the efficacy of our Cchek&#153; early cancer detection platform with Lung Cancer.&nbsp; Lung cancer is the leading cause of death among cancers in the U.S. and throughout the world, accounting for approximately 27% of all cancer related deaths in the U.S. and 19% worldwide. In September of 2016, ITUS announced that we had demonstrated the efficacy of our Cchek&#153; early cancer detection platform with Colon Cancer. Colon Cancer is the third most common cancer in men and the second most common cancer in woman worldwide, with approximately 1.4 million new cases diagnosed each year, and approximately 700,000 deaths. At the end of September 2016 through the end of October 2016, the Company made similar announcements with respect to the efficacy of our Cchek&#153; early cancer detection platform for Melanoma, Ovarian Cancer, Liver Cancer, Thyroid Cancer, and Pancreatic Cancer. On November 15, 2016, ITUS announced that we had demonstrated the efficacy of our Cchek&#153; early cancer detection platform with six additional cancer types including Appendiceal Cancer (cancer of the appendix), Uterine Cancer, Osteosarcoma (cancer of the bone), Leiomyosarcoma (cancer of the soft tissue), Liposarcoma (cancer of the connective tissue), and Vulvar Cancer (cancer of the vulva), bringing the number of cancer types for which the efficacy of Cchek&#153; has been validated thus far to fourteen.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our Cchek&#153; cancer detection platform measures a patient's immune response to a malignancy by detecting the presence, absence, and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. These types of cells and the tumor micro-environment have been the focus of recent ground breaking published and reported research in immuno-oncology, enabling the development of revolutionary immunotherapies used for treating certain cancer types. Instead of seeking to alter or boost the body's immune system and its ability to destroy cancer cells, as is the case with immunotherapy drugs, we have developed proprietary techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Specifically, we seek to identify a subset of myeloid cells that we believe are diagnostic. These cells, often referred to as Myeloid Derived Suppressor Cells (MDSCs), are identified by specific surface proteins enabling characterization. We generally refer to MDSC&#146;s and other cells of the immune system which we believe can be diagnostic in nature as biomarkers.&nbsp; Through our proprietary protocols, we have had early success and have demonstrated accuracy in detecting these biomarkers in the peripheral blood of biopsy verified cancer patients, and in distinguishing the blood of healthy patients from the blood of cancer patients. The goal is to establish Cchek&#153; as a non-invasive, inexpensive, cancer diagnostic blood test that can reduce or eliminate the need for traditionally expensive, invasive, painful, and often inaccurate cancer diagnostic procedures which are currently in use. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>6</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p text-autospace: 0in text-align: 0pt; roman?,?serif?; ; text-indent: new margin: 0in? style="FONT-SIZE:10pt; FONT-FAMILY:" justify; times><a href=#TC><font color=#0066cc>Table of Contents</font></a></p><br> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In each instance where ITUS has demonstrated the efficacy of its cancer detection platform, fresh (utilized within 48 hours) blood samples from biopsy verified cancer patients have been tested at Wistar using a variety of experimental methodologies and protocols. Such un-blinded, non-uniform testing is common during the initial development stage of new technologies and diagnostic tests. Blood samples from patients with differing severities of cancers (with some cancers such as Breast Cancer stage 0 to stage 4) have been tested, including samples from both pre-treatment and post-treatment patients. In addition, Wistar has also tested blood from healthy donors. A critical aspect of any cancer diagnostic is the ability to accurately distinguish patients with cancer from healthy patients. Based upon our encouraging early results, our scientists are working with Wistar to finalize protocols and methodologies for identifying and classifying the immunologic biomarkers that are the foundation for our Cchek&#153; early cancer detection platform. Although our scientists, working in collaboration with Wistar, will continue to improve our processes and methodologies to achieve maximum performance, we expect our testing to become more uniform over time, and to eventually test patient samples in a double blinded manner. While studies comparing biopsy verified cancer patients have been compared to healthy donors, we have not yet evaluated benign conditions such as non-malignant neoplasias, systemic inflammatory conditions, infections, and other potential conditions that impact or may impact the immune system. Such testing will be necessary for regulatory approval.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Based upon and following the results of the more extensive clinical study, we will determine what further studies are necessary and whether and when to begin the process of seeking regulatory approval for a cancer screening test or confirmatory diagnostic test based upon our Cchek&#153; technology. One manner of seeking regulatory approval is to have a lab certified to run our cancer tests pursuant to </font><font style=COLOR:black>The Clinical Laboratory Improvement Act of 1967 and the Clinical Laboratory Improvement Amendments of 1988 </font><font style=COLOR:black>(collectively, &#147;CLIA&#148;). Among other things, CLIA requires clinical laboratories that perform diagnostic testing to be certified by the state in which the lab is located, as well as the Center for Medicare and Medicaid Services. If we seek regulatory approval pursuant to CLIA, only those laboratories that are certified under CLIA to run our diagnostic test would be able to process test samples. CLIA certification may or may not require additional studies. We could seek to establish our own CLIA certified laboratory to run the diagnostic tests, or we could potentially contract with an existing CLIA certified lab, and seek to have that laboratory certified to run our diagnostic test.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Another manner of obtaining regulatory approval would be to seek to have Cchek&#153; approved by The Food and Drug Administration (&#147;FDA&#148;) pursuant to what are commonly referred to as either the 510(K) process, or the Premarket Application (&#147;PMA&#148;) process. The appropriate pathway for FDA approval would depend upon a variety of factors, including the intended use of the test, and the risks associated with such use. FDA approval can take several years and would entail additional clinical studies.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The decision of whether and when to seek CLIA certification or FDA approval of a diagnostic test or tests utilizing our Cchek&#153; technology will be dependent on a variety of factors, including the results from more extensive clinical studies, the capital requirements of each approval process, the landscape for competitive diagnostic testing, and the time and resources required by each approval process. It is possible that we may seek to have one or more diagnostic tests approved via CLIA certification, and other diagnostic test or tests approved by the FDA, or that we may seek simultaneous FDA approval and CLIA certification of a particular diagnostic test or tests.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Over the next several quarters, we expect Cchek&#153; to be the primary focus of the Company. As part of our legacy operations, the Company remains engaged in limited patent licensing activities in the area of encrypted audio/video conference calling. We do not expect these activities to be a significant part of the Company&#146;s ongoing operations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>7</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><a href=#TC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><br>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Over the past several quarters, our revenue has been derived from technology licensing and the sale of patented technologies, including in connection with the settlement of litigation. In addition to Anixa, the Company may make investments in and form new companies to develop additional emerging technologies.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><b><font style="FONT-SIZE:10pt; COLOR:black">Patent Acquisition Agreement</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On November 11, 2013, the Company entered into the Patent Acquisition Agreement with Meetrix.&nbsp; Pursuant to the terms of the Patent Acquisition Agreement, which was entered into by the Company in connection with its former business operations involving the development of patented technologies in the areas of thin-film displays and encryption, the Company purchased from Meetrix its right, title and interest in four U.S. patents (Meetrix maintained a limited license to continue to use the patents). In consideration for its purchase of the patents, the Company issued to Meetrix 40,000 shares of common stock (the &#147;Meetrix Shares&#148;), granted Meetrix a continuing royalty in the net proceeds earned by the Company relating to the patents (the &#147;Meetrix Royalty&#148;) and agreed to pay to Meetrix, on no later than the fourth anniversary of the effective date of the Patent Acquisition Agreement, $5,000,000 (less the value of the Meetrix Shares and any Meetrix Royalty payments) (the &#147;Meetrix Obligation&#148;). Pursuant to the terms of the Patent Acquisition Agreement, the Company could elect to pay the Meetrix Obligation using stock of the Company, with a value given to the stock equal to ninety percent (90%) of the weighted average closing prices for the thirty (30) day period prior to such election. On December 27, 2016, the Company provided notice to Meetrix of its intention to issue shares of common stock to satisfy the Meetrix Obligation, which as of the date of such notice was $4,775,934. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><b><font style="FONT-SIZE:10pt; COLOR:black">Corporate Information</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><font style=COLOR:black>Our principal executive offices are located at 12100 Wilshire Boulevard, Suite 1275, Los Angeles, CA 90025, our telephone number is (310) 484-5200, and our Internet website address is <u>http://www.ITUScorp.com</u>. &nbsp;The information on our website is not a part of, or incorporated in, this prospectus supplement.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 8pt; LINE-HEIGHT:107%; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 8pt; LINE-HEIGHT:107%; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>8</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 8pt; LINE-HEIGHT:107%; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p left; 0in text-align: roman?,?serif?; new margin: 0pt? style="FONT-SIZE:10pt; FONT-FAMILY:" times align=left><a href=#TC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:24.75pt> <td width=733 colspan=2 style="HEIGHT:24.75pt; WIDTH:550pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>The Issuance</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:24.75pt> <td width=296 style="HEIGHT:24.75pt; WIDTH:222.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 11pt; TEXT-AUTOSPACE:; TEXT-INDENT:-11pt'><b><font style=COLOR:black>Common stock being issued:</font></b></p></td> <td width=437 style="HEIGHT:24.75pt; WIDTH:327.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>947,606&nbsp;shares</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:24.75pt> <td width=296 style="HEIGHT:24.75pt; WIDTH:222.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Common stock outstanding before the issuance to Meetrix: (1)</font></b><font style=COLOR:black>&nbsp;&nbsp;&nbsp;</font></p></td> <td width=437 style="HEIGHT:24.75pt; WIDTH:327.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>8,754,587 shares</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:24.75pt> <td width=296 style="HEIGHT:24.75pt; WIDTH:222.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Common stock to be outstanding after the issuance to Meetrix: (1)</font></b></p></td> <td width=437 style="HEIGHT:24.75pt; WIDTH:327.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>9,702,193 shares</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:24.75pt> <td width=296 style="HEIGHT:24.75pt; WIDTH:222.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>The Issuance:</font></b></p></td> <td width=437 style="HEIGHT:24.75pt; WIDTH:327.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>The Company is issuing the shares in satisfaction of the Meetrix Obligation pursuant to the terms of the Patent Acquisition Agreement. The Meetrix Obligation is being satisfied at a price per share of $5.04. The Company will issue the shares on or about March 27, 2017. See &#147;Prospectus Summary &#150; Patent Acquisition Agreement&#148; for more details.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr> <td valign=top> <p style="MARGIN:0in 0in 0pt"><a name=_DV_C1><b><font style="TEXT-DECORATION:none; COLOR:windowtext; text-underline:none"><font size=2>Meetrix Ownership:</font></font></b></a><b></b></p></td> <td valign=top> <p style="BACKGROUND:white; MARGIN:0in 0in 0pt" align=justify><a name=_DV_C2><font style="TEXT-DECORATION:none; COLOR:windowtext; text-underline:none"><font size=2 style=FONT-SIZE:10pt>Giving effect to the issuance, Meetrix will own approximately 9.7% of our common stock following the issuance assuming that Meetrix does not hold any other shares of common stock.</font></font></a></p> <p style="BACKGROUND:white; MARGIN:0in 0in 0pt" align=justify>&nbsp;</p></td></tr> <tr style=HEIGHT:8.1pt> <td width=296 style="HEIGHT:8.1pt; WIDTH:222.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 11pt; TEXT-AUTOSPACE:; TEXT-INDENT:-11pt'><b><font style=COLOR:black>Use of Proceeds:</font></b></p></td> <td width=437 style="HEIGHT:8.1pt; WIDTH:327.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>We will not receive any proceeds from the issuance of the common stock to Meetrix. See &#147;Use of Proceeds.&#148;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr> <td valign=top> <p style="MARGIN:0in 0in 0pt"><a name=_DV_C3><b><font style="TEXT-DECORATION:none; COLOR:windowtext; text-underline:none"><font size=2>Rights Offering:</font></font></b></a><font style="TEXT-DECORATION:none; COLOR:windowtext; text-underline:none"></font></p></td> <td valign=top> <p style="BACKGROUND:white; MARGIN:0in 0in 0pt" align=justify><a name=_DV_C4><font style="TEXT-DECORATION:none; COLOR:windowtext; text-underline:none"><font style=FONT-SIZE:10pt><font size=2>On January 19, 2017, the Company announced that its board of directors has approved a rights offering for its stockholders of up to $12,000,000. The rights offering will include the non-transferable right to purchase one (1) share of our common stock, at a discount, for each share of our common stock owned by stockholders on the ownership day of Friday, February 10, 2017.&nbsp; </font><font size=2>In the event that the issuance has not occurred prior to February 10, 2017, Meetrix will not receive any rights in connection with the shares being issued hereunder.</font></font></font></a></p> <p style="BACKGROUND:white; MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr style=HEIGHT:0.3in> <td width=296 style="HEIGHT:0.3in; WIDTH:222.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 11pt; TEXT-AUTOSPACE:; TEXT-INDENT:-11pt'><b><font style=COLOR:black>Listing of common stock:</font></b></p></td> <td width=437 style="HEIGHT:0.3in; WIDTH:327.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Our common stock is listed on the Nasdaq Capital Market under the symbol &#147;ITUS.&#148;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:0.45in> <td width=296 style="HEIGHT:0.45in; WIDTH:222.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 11pt; TEXT-AUTOSPACE:; TEXT-INDENT:-11pt'><b><font style=COLOR:black>Dividend policy:</font></b></p></td> <td width=437 style="HEIGHT:0.45in; WIDTH:327.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>We currently intend to retain any future earnings to fund the development and growth of our business. Therefore, we do not currently anticipate paying cash dividends on our common stock.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:40.5pt> <td width=296 style="HEIGHT:40.5pt; WIDTH:222.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 11pt; TEXT-AUTOSPACE:; TEXT-INDENT:-11pt'><b><font style=COLOR:black>Risk Factors:</font></b></p></td> <td width=437 style="HEIGHT:40.5pt; WIDTH:327.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>An investment in our Company is highly speculative and involves a significant degree of risk.&nbsp;&nbsp;See &#147;Risk Factors&#148; and other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in shares of our common stock.</font></p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 5.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The number of shares of common stock shown above to be outstanding before and after this issuance is based on the 8,754,587 shares outstanding as of January 26, 2017 and excludes as of such date: </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <table width=80% bordercolor=transparent style=WIDTH:80% cellpadding=0 cellspacing=0> <tr> <td width=4% style="WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&#149;</font></b></p></td> <td width=1% style="WIDTH:1.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td style="PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>1,186,872 shares of our common stock issuable upon exercise of stock options outstanding under our 2010 Share Incentive Plan, 476,322 of which are not currently exercisable, which have a weighted average exercise price of $3.29 per share and 195,400 shares of our common stock issuable upon exercise of stock options outstanding under our 2003 Share Incentive Plan which have a weighted average exercise price of $19.05 per share<font style=COLOR:black>;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=4% style="WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&#149;</font></b></p></td> <td width=1% style="WIDTH:1.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td style="PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>764,000 <font style=COLOR:black>shares of our common stock reserved for future issuance under our 2010 Share Incentive Plan;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=4% style="WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;</font></p></td> <td width=2% nowrap style="WIDTH:2.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&#149;</font></b></p></td> <td width=1% style="WIDTH:1.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td style="PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>1,780,000 shares of our common stock issuable upon the exercise of stock options outstanding pursuant to stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan which have a weighted average exercise price of $2.70 per share; and</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=4% style="WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&#149;</font></b></p></td> <td width=1% style="WIDTH:1.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td style="PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>337,400 shares of our common stock issuable upon exercise of our outstanding warrants which have a weighted average exercise price of $10.02 (excluding the 500,000 shares of common stock issuable upon exercise of the warrant issued pursuant to the Redemption Agreement).</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>9</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><a href=#TC><font color=#0066cc>Table of Contents</font></a><br><br clear=all></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=3>RISK FACTORS</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><i><font style=COLOR:black>An investment in our common stock involves a high degree of risk. &nbsp;You should carefully consider the risks described below, together with all of the other information included in this prospectus, before making an investment decision with regard to our securities. The statements contained in this prospectus that are not historic facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. If any of the following risks actually occurs, our business, financial condition or results of operations could suffer. &nbsp;In that case, the trading price of our common stock could decline, and you may lose all or part of your investment.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><b><u><font style=COLOR:black>Risks Related to Our Financial Condition and Operations</font></u></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We have a history of losses and may incur additional losses in the future</font></i></b><b><font style=COLOR:black>.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>On a cumulative basis we have sustained substantial losses and negative cash flows from operations since our inception.&nbsp; As of October 31, 2016, our accumulated deficit was approximately $151,165,000.&nbsp; As of October 31, 2016, we had approximately $3,238,000 in cash and cash equivalents and short-term investments, and working capital of approximately $2,932,000. We incurred losses of approximately $5,016,000 in fiscal year 2016. We expect to incur material research and development expenses and to continue incurring significant legal and general and administrative expenses in connection with our operations.&nbsp; As a result, we anticipate that we will incur losses in the future.&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>As a result of our current lack of financial liquidity, our independent registered public accounting firm (&#147;auditors&#148;) has expressed substantial doubt regarding our ability to continue as a &#147;going concern.&#148;</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>As a result of our limited working capital, historical losses and our current burn rate, our auditors&#146; report for our financial statements for the year ended October 31, 2016, which&nbsp;is included as part of this prospectus, contains a statement expressing substantial doubt concerning our ability to continue as a &#147;going concern&#148;. Potential sources of capital include debt and the sale of the Company&#146;s equity securities. Many factors impact our ability to generate capital including the results of our ongoing clinical trials, the price of our stock, the liquidity of our stock, factors that influence the capital markets, and the overall health of the U.S. and world economies.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Because Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;is at early stages of development, it is not likely that we will generate revenue from operations for the foreseeable future. In the event that we are unable to raise additional capital, the ongoing development of Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;would be materially and adversely impacted as would the continuing viability of the Company.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>The accompanying financial statements have been prepared assuming that we will continue as a going concern.&nbsp; In order for us to have sufficient capital to execute our business plan, fund our operations and meet our debt obligations over the next 12 months, we will need to raise additional capital.&nbsp; Although we have been successful in the past in raising capital, we cannot provide any assurance that we will be successful in doing so in the future to the extent necessary to be able to fund our operating activities and debt obligations over the next 12 months, which raises substantial doubt about our ability to continue as a going concern.&nbsp; Our financial statements do not include any adjustments that might result from the outcome of this uncertainty.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We will need additional funding in the future which may not be available on acceptable terms, or at all, and, if available, may result in dilution to our stockholders.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Based on currently available information as of January 26, 2017, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows from operations&nbsp;will not be sufficient to fund our activities and debt obligations for the next 12 months.&nbsp;To date, we have relied primarily upon cash from the public and private sale of equity and debt securities, as well as net proceeds from the December 2014 settlement with AUO Optronics Corporation (&#147;AUO&#148;), to generate the working capital needed to finance our operations and to repay the Redemption Debenture (as defined below).&nbsp;&nbsp;If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, we will be required to obtain more working capital.&nbsp; We may seek to obtain working capital through sales of our equity securities,&nbsp;including through our proposed rights offering,&nbsp;or through bank credit facilities or public or private debt from various financial institutions where possible which would be junior to our existing Redemption Debenture.&nbsp;We cannot be certain that additional funding will be available on acceptable terms, or at all.&nbsp; If we do identify sources for additional funding,&nbsp;the sale of additional equity securities or convertible debt could result in dilution to our stockholders. Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities. &nbsp;We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all.&nbsp;&nbsp;If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.&nbsp; Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>10</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><a href=#TC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Failure to pay our secured debt holder may result in a foreclosure.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>On September 9, 2014, we issued 140 shares of Series A Preferred Stock having an aggregate value of $3,500,000&nbsp; (the "Series A Preferred") and a warrant to purchase 370,000 shares of the Company&#146;s common stock (the &#147;September 2014 Warrant&#148;). The September 2014 Warrant expired on November 11, 2016.&nbsp; Holders of our Series A Preferred had a one-time right to require the Company to redeem the Series A Preferred shares, which right was set to expire on November 11, 2016 (the "Redemption Date"). Under its terms, the Series A Preferred could only be redeemed from the proceeds of the sale of the Company&#146;s equity securities.&nbsp; On November 11, 2016 the holder of all of our outstanding Series A Preferred exercised its right of redemption. On December 6, 2016, we entered into an agreement with the holder of the Series A Preferred setting forth the terms under which such redemption would take place (the &#147;Redemption Agreement&#148;) in lieu of paying the redemption from proceeds of the sale of equity securities. Pursuant to the Redemption Agreement, at closing the holder of the Series A Preferred received (i) $500,000 in cash,&nbsp;(ii) a 12% secured debenture evidencing the remaining $3,000,000 amount to be redeemed, $1,000,000 of which is due on or before June 1, 2017 and the remainder of which is due November 11, 2017 (the &#147;Redemption Debenture&#148;), and (iii) a 5 year warrant to purchase 500,000 shares of the Company&#146;s common stock with substantially the same terms as the expired September 2014 Warrant at an&nbsp;exercise price equal to 10% below the thirty (30) day volume weighted average closing price of our common stock at closing. The Redemption Debenture is secured by a lien on the Company&#146;s assets and prohibits the Company from incurring any senior indebtedness&nbsp;other than equipment financing in connection with the Company&#146;s business.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>If we default under the Redemption Debenture, the creditor may seek to obtain a judgment against the Company for the remaining balance of the Redemption Debenture and attempt to foreclose on assets of the Company sufficient to repay the remaining balance of the Redemption Debenture. In the event of a default, if the Company is unable to re-negotiate the terms of the Redemption Debenture or raise sufficient capital to repay the remaining balance of the Redemption Debenture, such default would have a material adverse impact on the ongoing operations of the Company.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>The terms set forth in the Redemption Debenture may make it difficult for us to borrow additional funds in the future.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Other than trade debt, the terms of the Redemption Debenture prohibit us from incurring indebtedness that is senior to the Redemption Debenture.&nbsp; This restriction may make it difficult for us to borrow additional funds from third parties. Additionally, the Redemption Debenture is secured by a lien on the assets of the Company which may prevent us from incurring additional secured debt.&nbsp;If we are unable to raise additional capital through the issuance of debt&nbsp;such failure could have a material adverse impact on our business, results of operations and financial condition.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Failure to effectively manage our potential growth could place strains on our managerial, operational and financial resources and could adversely affect our business and operating results</font></i></b><b><font style=COLOR:black>.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Our business strategy and potential growth may place a strain on managerial, operational and financial resources and systems.&nbsp; Although we may not grow as we expect, if we fail to manage our growth effectively or to develop and expand our managerial, operational and financial resources and systems, our business and financial results will be materially harmed.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>11</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p text-autospace: 0in white; ideograph-numeric; text-align: 0pt; roman?,?serif?; text-indent: new margin: 0in? style="FONT-SIZE:10pt; FONT-FAMILY:" background: justify; times><a href=#TC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><u><font style=COLOR:black>Risks Related to </font></u></b><b><u><font style=COLOR:black>Cchek</font></u></b><b><u><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font></u></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Our cancer diagnostic business is&nbsp;pre-revenue, and subject to the risks of an early stage biotechnology company.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Since the Company&#146;s primary focus for the foreseeable future will likely be our cancer diagnostics business, shareholders should understand that we are primarily an early stage biotechnology company with no history of revenue-generating operations, and our only assets consist of our proprietary technologies and the know-how of our officers. Therefore we are subject to all the risks and uncertainties inherent in a new business, in particular new businesses engaged in the early detection of certain cancers.&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;is in its early stages of development, and we&nbsp;still must establish and implement many important functions necessary to commercialize the technology.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Accordingly, you should consider the Company&#146;s prospects in light of the costs, uncertainties, delays and difficulties frequently encountered by companies in their pre-revenue generating stages, particularly those in the biotechnology field. Shareholders should carefully consider the risks and uncertainties that a business with no operating history will face. In particular, shareholders should consider that there is a significant risk that we will not be able to:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>demonstrate the effectiveness of Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>implement or execute our current business plan, or that our current business plan is sound;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>raise sufficient funds in the capital markets or otherwise to fully effectuate our business plan;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>maintain our management team, including the members of our scientific advisory board;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>determine that the processes and technologies that we have developed or will develop are commercially viable; and/or</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>attract, enter into or maintain contracts with potential commercial partners such as licensors of technology and suppliers.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:24.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Any of the foregoing risks may adversely affect the Company and&nbsp;result in the failure of our business. In addition, we expect to encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors. At some point, we&nbsp;will need to transition from a company with a research and development focus to a company capable of supporting commercial activities. We may not be able to reach such achievements, which would have a material adverse effect on our Company.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We may have difficulty in raising capital for our cancer diagnostic business and may consume resources faster than expected.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:24.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We currently do not generate any revenue from Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;or otherwise and as of October 31, 2016, the Company had $3,238,000 in cash, cash equivalents and short-term investments. Therefore, we have a limited source of cash to meet our future capital requirements, which will include the repayment of the Redemption Debenture and may include the expensive process of obtaining FDA approval for Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>for each type of cancer for which we desire to launch a diagnostic test. We do not expect to generate revenues for the foreseeable future, and we may not be able to raise funds in the future, which would leave us without resources to continue our operations and force us to resort to the Company raising additional capital in the form of equity or debt financings, which may not be available to us. We may have difficulty raising needed capital in the near or longer term as a result of, among other factors, the very early stage of&nbsp;our diagnostic business and our lack of revenues as well as the inherent business risks associated with an early stage, biotechnology company and present and future market conditions. Also, we may consume available resources more rapidly than currently anticipated, resulting in the need for additional funding sooner than anticipated. Our inability to raise funds could lead to decreases in the price of our common stock and the failure of our cancer diagnostic business which would have a material adverse effect on the Company.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>12</font></p><font style=COLOR:black><strong> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center> <hr> <p style="page-break-after:always;"></p></strong></p></div> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=left>&nbsp;</div> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:left; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=left><a href=#TC><font color=#0066cc>Table of Contents</font></a></div> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=left><br>&nbsp;</div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>While our&nbsp;</font></i></b><b><i><font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;&nbsp; </font></i></b><b><i><font style=COLOR:black>diagnostic technology has shown favorable results from initial testing, we cannot guarantee that these results will be replicated in future testing nor can we guarantee the success of the technology at all.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We have initially used&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;to test the blood of small groups of individuals consisting of cancer patients and healthy patients and have reported sensitivity of 92% and specificity of 92%. While these preliminary results far exceed existing diagnostic testing, there is no guarantee that these results will be replicable when we test a larger group of patients or at all. If we are unable to consistently attain results that are necessary for commercialization of&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; ,</font><font style=COLOR:black>&nbsp;our diagnostic technology will not have any monetary value and we will be unable to generate any revenue from this technology.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Even if we are able to attain results necessary for the commercialization of&nbsp;</font></i></b><b><i><font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font></i></b><b><i><font style=COLOR:black>, our ability to commercialize the technology in the future will depend on our ability to provide evidence of clinical utility.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Our ability to successfully commercialize&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>will depend on numerous factors, including whether health care providers believe that&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>provides sufficient incremental clinical utility; whether the medical community accepts that&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;has&nbsp;sufficient sensitivity (there are no or very few false positives), specificity (detects the cancer the test is supposed to detect) and predictive value to be meaningful in patient care and treatment decisions; whether the cost of the test is reasonably priced and commercially viable; and whether health insurers, government health programs and other third-party payers will cover and pay for&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>and the amount that they will reimburse for such tests. These factors may present obstacles to commercial acceptance of&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>.&nbsp;&nbsp;To the extent these obstacles arise, we will need to devote substantial time and resources to overcome these obstacles, and we might not be successful. Failure to achieve widespread market acceptance of&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>would materially harm our business, financial condition and results of operations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We are unable to give any assurance that we will be successful in providing sufficient evidence of clinical utility or any assurance that we will have adequate managerial, technical or financial resources to support the studies necessary to provide sufficient evidence of clinical utility of&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;or to adequately differentiate our test from other diagnostic products in the manner, timeframe or cost parameters we anticipate, if at all. If we are unable to provide evidence of clinical utility and differentiate&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>, we will not be able to generate the revenues and market growth that we seek. Our failure to generate revenue from the sale of our products would materially adversely impact our business, financial condition, results of operations and prospects.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Diagnostic test development involves a lengthy and complex process, and we may be unable to commercialize&nbsp;</font></i></b><b><i><font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font></i></b><b><i><font style=COLOR:black>&nbsp; on a timely basis, or at all.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We have begun to devote considerable resources to research and development for&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>, however there can be no assurance that&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>&nbsp;will be capable of reliably predicting the occurrence or recurrence of any cancers with the sensitivity and specificity necessary to be clinically and commercially useful, or, even if such technology is clinically and commercially useful, that it will result in commercially successful products. In addition, before we can fully develop&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;and commercialize any new products, we will need to:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>conduct substantial research and development;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>conduct validation studies;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>expend significant funds;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>enter into agreements and maintain relationships with third party vendors to provide third party blood samples;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>obtain regulatory approval (either CLIA, FDA or both); and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>establish or contract with the owner of a CLIA certified laboratory to process test samples.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Accordingly, our product development process involves a high degree of risk and may take several years, especially if the Company seeks FDA approval for each of its diagnostic tests. If&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>&nbsp;should fail at the research or development stage, not produce sufficient clinical validation data to support the effectiveness of the product or not gain regulatory approval or if we should run out of cash to devote towards the commercialization of the technology or fail to establish agreements with necessary third party vendors, we will not make it to commercialization and we will not generate any revenue from the technology.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>13</font></p><font style=COLOR:black> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><strong> <hr> <p style="page-break-after:always;"></p></strong></p></div> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=left><a href=#TC><font color=#0066cc>Table of Contents</font></a></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>If we fail to obtain, or if there are delays in obtaining, required regulatory approvals, we will not be able to commercialize our&nbsp;</font></i></b><b><i><font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font></i></b><b><i><font style=COLOR:black>&nbsp; technology, and our ability to generate revenue and the viability of our Company will be materially impaired.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Commercialization of&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;will require that we obtain either CLIA certification, FDA approval or both. If we are unable to obtain regulatory approval for&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>, we will be unable to commercialize and generate revenue from the technology which would have a material adverse effect on our business, financial condition and results of operations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Unless we obtain FDA approval for&nbsp;</font></i></b><b><i><font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font></i></b><b><i><font style=COLOR:black>, we will be dependent on laboratory contractors for testing of patient samples that are essential to the development and validation of&nbsp;</font></i></b><b><i><font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font></i></b><b><i><font style=COLOR:black>.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>To pursue the development and validation of&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>, we will require access to test results obtained from patient blood samples. We have currently contracted with Wistar to provide these services. Unless and until&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;receives FDA approval, we may elect to seek CLIA certification for one or more of our&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;tests. Failure to receive FDA approval or CLIA certification would have a material adverse effect on our ability to develop and validate&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>.&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We will be dependent on third parties for the patient samples that are essential to the development and validation of </font></i></b><b><i><font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font></i></b><b><i><font style=COLOR:black>.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>To pursue our development and validation of&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>, we are likely to need access, over time, to patient blood samples and such patients will need to consent to the use of their blood. As a result, we have made arrangements with Wistar and neighboring hospitals and medical practices to give us access to patient samples for the development and validation of&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>.&nbsp;In the event that we are unable to obtain patient samples, or access to patient samples becomes more limited due to changes in privacy laws governing the use and disclosure of medical information or due to changes in the laws restricting our ability to obtain patient samples and associated information, our ability to pursue the development of&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;may be slowed or halted, which could have a material adverse effect on our business, financial condition and results of operations</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Our business could be harmed from the loss or suspension of a license or imposition of a fine or penalties under, or future changes in, or changing interpretations of, the law or regulations of the Clinical Laboratory Improvement Act of 1967, the Clinical Laboratory Improvement Amendments of 1988, or the FDA or other federal, state or local agencies.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>ITUS will need to seek regulatory approval in order to market&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>.&nbsp;The clinical laboratory testing industry is subject to extensive federal and state regulation, and many of these statutes and regulations have not been interpreted by the courts. The Clinical Laboratory Improvement Act of 1967 and the Clinical Laboratory Improvement Amendments of 1988 are federal regulatory standards that apply to virtually all clinical laboratories (regardless of the location, size or type of laboratory), including those operated by physicians in their offices, by requiring that they be certified under federal law. CLIA does not pre-empt state law, which in some cases may be more stringent than federal law and require additional personnel qualifications, quality control, record maintenance and proficiency testing. The sanction for failure to comply with CLIA and state requirements may be suspension, revocation or limitation of a laboratory&#146;s CLIA certificate, which is necessary to conduct business, as well as significant fines and/or criminal penalties. Several states have similar laws and we may be subject to similar penalties. The FDA regulates diagnostic products and periodically inspects and reviews their manufacturing processes and product performance. We may choose to seek FDA approval for one or more&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;tests, opposed to seeking CLIA certification.&nbsp;We cannot assure that applicable statutes and regulations will not be interpreted or applied by a prosecutorial, regulatory or judicial authority in a manner that would adversely affect our business. Potential sanctions for violation of these statutes and regulations include significant fines and the suspension or loss of various licenses, certificates and authorizations, which could have a material adverse effect on our business. In addition, compliance with future legislation could impose additional requirements on us, which may be costly, including FDA regulation of laboratory developed tests.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>14</font></p><font style=COLOR:black> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><strong> <hr> <p style="page-break-after:always;"></p></strong></p></div> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</div> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:left; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=left><a href=#TC><font color=#0066cc>Table of Contents</font></a><br></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Health insurers and other third-party payers may decide not to reimburse our&nbsp;</font></i></b><b><i><font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font></i></b><b><i><font style=COLOR:black>diagnostic testing or may provide inadequate reimbursement, which could jeopardize our commercial prospects and require customers to pay for the tests out of pocket.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>In the United States, the regulatory process that allows diagnostic tests to be marketed is independent of any coverage determinations made by third-party payers. For new diagnostic tests, private and government payers decide whether to cover the test, the reimbursement amount for a covered test and the specific conditions for reimbursement. Physicians may order diagnostic tests that are not reimbursed by third-party payers, but coverage determinations and reimbursement levels and conditions are critical to the commercial success of a diagnostic product. Each third-party payer makes its own decision about which tests it will cover and how much it will pay, although many payers will follow the lead of Medicare. As a result, the coverage determination process will be a time-consuming and costly process that requires us to provide scientific, clinical and economic support for the use of&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;diagnostic testing to each payer separately, with no assurance that approval will be obtained. If third-party payers decide not to cover&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;or if they offer inadequate payment amounts, our ability to generate revenue from&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp; could be limited since patients who want to take the diagnostic tests would have to pay for it out of pocket. Even if one or more third-party payers decide to reimburse for&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;diagnostic testing, a third-party payer may stop or lower payment at any time, which could reduce revenue. We cannot predict whether third-party payers will cover&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;diagnostic testing&nbsp;or offer adequate reimbursement. We also cannot predict the timing of such decisions. In addition, physicians or patients may decide not to order&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;tests if third-party payments are inadequate, especially if ordering the test could result in financial liability for the patient.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Whether or not health insurers and other third-party payers decide to reimburse&nbsp;</font></i></b><b><i><font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font></i></b><b><i><font style=COLOR:black>, the technology may cost patients more than we anticipate.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We believe that our&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;diagnostic testing&nbsp;will significantly reduce the cost to patients of screening and confirmatory testing for certain types of cancer. If, however, the cost to utilize Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;is more expensive than we anticipate, many patients and third-party payers may elect not to utilize the technology which would significantly impact our ability to generate revenue from the technology.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We operate in a competitive market and expect to face intense competition, often from companies with greater resources and experience than us.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>The clinical diagnostics industry is highly competitive and subject to rapid change. We are aware of many different types of diagnostic tests available to detect cancer that are currently in use or being developed and many more types of diagnostic tests may be developed in the future. If we are able to successfully commercialize&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>, all of these tests will compete with our product. If &nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp; is more expensive than and/or does not have sufficient specificity, sensitivity or predictive value to compete with tests that are currently on the market, or if any other diagnostic tests that are under development, once successfully developed and commercialized, have greater specificity, sensitivity or predictive value and/or are cheaper than our technology, we may be unable to compete successfully with such products which would have a material adverse effect on our business, financial condition and results of operations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Furthermore, as the industry continues to expand and evolve, an increasing number of competitors and potential competitors may enter the market. Many of these competitors and potential competitors have substantially greater financial, technological, managerial and research and development resources and experience than we do. Some of these competitors and potential competitors have more experience than we do in the development of diagnostic products, including validation procedures and regulatory matters. In addition,&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>will compete with product offerings from large and well established companies that have greater marketing and sales experience and capabilities than we do. If we are unable to compete successfully, we may be unable to sustain and grow our revenue.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>15</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;<a href=#TC><font color=#0066cc>Table of Contents</font></a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>If we are unable to obtain and maintain intellectual property protection, our competitive position will be harmed.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Our ability to compete and to achieve sustained profitability will be impacted by our ability to protect our&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;cancer diagnostic technologies and other&nbsp;proprietary discoveries and technologies. We expect to rely on a combination of patent protection, copyrights, trademarks, trade secrets, know-how, and regulatory approvals to protect&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;and any of our other technologies.&nbsp;Our intellectual property strategy is intended to help develop and maintain our competitive position. However, there is no assurance that we will be able to obtain patent protection for&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>and any other technologies, nor can we be certain that the steps we will have taken will prevent the misappropriation and unauthorized use of our technologies. If we are not able to obtain and maintain patent protection our competitive position may be harmed.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 8pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black lang=EN>Third parties may initiate legal proceedings alleging that we are infringing their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of our business.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black lang=EN>Our commercial success depends upon our ability to develop, manufacture, market and sell our&nbsp;</font><font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;cancer diagnostic technologies and other&nbsp;proprietary discoveries and technologies</font><font style=COLOR:black lang=EN>&nbsp;without infringing, misappropriating or otherwise violating the proprietary rights or intellectual property of third parties. We may become party to, or be threatened with, future adversarial proceedings or litigation regarding intellectual property rights with respect to our&nbsp;</font><font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;cancer diagnostic technologies and other&nbsp;proprietary discoveries and technologies</font><font style=COLOR:black lang=EN>. Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future. If we are found to infringe a third-party's intellectual property rights, we could be required to obtain a license from such third-party to continue developing our&nbsp;</font><font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;cancer diagnostic technologies and other&nbsp;proprietary discoveries and technologies</font><font style=COLOR:black lang=EN>. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. We could be forced, including by court order, to cease developing the infringing technology or product. In addition, we could be found liable for monetary damages. Claims that we have misappropriated the confidential information or trade secrets of third parties can have a similar negative impact on our business.</font><font style=COLOR:black>&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We are dependent upon a few key personnel and the loss of their services could adversely affect us.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Our future success of developing&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;will depend on the efforts of our Executive Chairman of the Board Dr. Amit Kumar. We do not maintain &#147;key person&#148; life insurance on Dr. Kumar. The loss of the services of Dr. Kumar could have a material adverse effect on our business and operating results.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><u><font style=COLOR:black>Risks Related to Legacy Patent Licensing Activities</font></u></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>In connection with our legacy patent licensing activities, we may not be able to license our patent portfolios which may have an adverse impact on our future operations.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We may generate revenues and related cash flows from the licensing and enforcement of patents that we currently own, from technologies that we develop and from the rights to license and enforce additional patents we have obtained, and may obtain in the future, from third parties.&nbsp; However, we can give no assurances that we will be able to identify opportunities to exploit such patents or that such opportunities, even if identified, will generate sufficient revenues to sustain future operations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We, in certain circumstances, rely on representations, warranties and opinions made by third parties that, if determined to be false or inaccurate, may expose us to certain material liabilities.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>From time to time, we may rely upon the opinions of purported experts.&nbsp;&nbsp;In certain instances, we may not have the opportunity to independently investigate and verify the facts upon which such opinions are made. By relying on these opinions, we may be exposed to liabilities in connection with the licensing and enforcement of certain patents and patent rights which could have a material adverse effect on our operating results and financial condition.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>16</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;<a href=#TC><font color=#0066cc>Table of Contents</font></a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>In connection with patent licensing activities conducted by certain of our subsidiaries, a court that has ruled unfavorably against us may also impose sanctions or award attorney&#146;s fees, exposing us and our operating subsidiaries to certain material liabilities.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>In connection with any of our patent licensing activities, it is possible that a court that has ruled against us may also impose sanctions or award attorney&#146;s fees to defendants, exposing us or our operating subsidiaries to material liabilities, which could materially harm our operating results and our financial condition.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Our patented technologies have an uncertain market value.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Many of our patents and technologies are in the early stages of adoption in the commercial and consumer markets. Demand for some of these technologies is untested and is subject to fluctuation based upon the rate at which our licensees will adopt our patents and technologies in their products and services.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><u><font style=COLOR:black>Risks Related to Our Common Stock</font></u></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>The issuance or sale of shares in the future to raise money or for strategic purposes could reduce the market price of our common stock.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>In the future, we may issue securities, including&nbsp;issuing securities in connection with our proposed rights offering, to raise cash for operations, to pay down existing or then existing indebtedness, as consideration for the acquisition of assets (as we did with Meetrix), to pay for the development of our&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;platform and for acquisitions of companies. We have and in the future may issue securities convertible into our common stock. Any of these events may dilute stockholders' ownership interests in our company and have an adverse impact on the price of our common stock.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>In addition, sales of a substantial amount of our common stock in the public market, or the perception that these sales may occur, could reduce the market price of our common stock. This could also impair our ability to raise additional capital through the sale of our securities.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Any actual or anticipated sales of shares by our stockholders may cause the trading price of our common stock to decline.&nbsp;The sale of a substantial number of shares of our common stock by our stockholders, or anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <h3 style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i><font style="FONT-SIZE:10pt; COLOR:black">Meetrix will experience immediate and substantial dilution as a result of this issuance.</font></i></h3> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Meetrix will incur immediate and substantial dilution as a result of the issuance of the shares pursuant to this registration statement. After giving effect to the issuance by us of 947,606 shares of common stock at a price of $5.04 per share, Meetrix can expect an immediate dilution of $4.73 per share, or 94%. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Delaware law and our charter documents contain provisions that could discourage or prevent a potential takeover of our company that might otherwise result in our stockholders receiving a premium over the market price of their shares.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Provisions of Delaware General Corporation Law (&#147;DGCL&#148;) and our certificate of incorporation, as amended (the &#147;Certificate of Incorporation&#148;) and by-laws (&#147;By-Laws&#148;) could make the acquisition of our company by means of a tender offer, proxy contest or otherwise, and the removal of incumbent officers and directors, more difficult. These provisions include:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; LINE-HEIGHT:13.8pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>Section 203 of the DGCL, which prohibits a merger with a 15%-or-greater stockholder, such as a party that has completed a successful tender offer, until three years after that party became a 15%-or-greater stockholder;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>17</font></p> <hr> <p style="page-break-after:always;"></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><a href=#TC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; LINE-HEIGHT:13.8pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>The authorization in our Certificate of Incorporation of undesignated preferred stock, which could be issued without stockholder approval in a manner designed to prevent or discourage a takeover; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; LINE-HEIGHT:13.8pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>Provisions in our By-Laws regarding stockholders' rights to call a special meeting of stockholders limit such rights to stockholders holding together at least a majority of shares of the Company entitled to vote at the meeting, which could make it more difficult for stockholders to wage a proxy contest for control of our Board of Directors or to vote to repeal any of the anti-takeover provisions contained in our Certificate of Incorporation and By-Laws.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Together, these provisions may make the removal of management more difficult and may discourage transactions that could otherwise involve payment of a premium over prevailing market prices for our common stock.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We may fail to meet market expectations because of fluctuations in quarterly operating results, which could cause the price of our common stock to decline.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Our reported revenues and operating results have fluctuated in the past and may continue to fluctuate significantly from quarter to quarter in the future, specifically as we continue to devote more of our resources towards our&nbsp;Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>&nbsp;diagnostic technology. It is likely that in future periods, we will have no revenue or, in any event, revenues could fall below the expectations of securities analysts or investors, which could cause the market price of our common stock to decline. The following are among the factors that could cause our operating results to fluctuate significantly from period to period:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; LINE-HEIGHT:13.8pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>clinical trial results relating to our diagnostic technology;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; LINE-HEIGHT:13.8pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>progress with regulatory authorities towards the certification/approval of our diagnostic technology;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; LINE-HEIGHT:13.8pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>costs related to acquisitions, alliances and licenses.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Biotechnology company stock prices are especially volatile, and this volatility may depress the price of our common stock.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>The stock market has experienced significant price and volume fluctuations, and the market prices of biotechnology companies have been highly volatile. We believe that various factors may cause the market price of our common stock to fluctuate, perhaps substantially, including, among others, the following:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>announcements of developments in the cancer diagnostic testing industry;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>developments in relationships with third party vendors and laboratories;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>announcements of developments in our remaining patent enforcement actions;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>developments or disputes concerning our patents and other intellectual property;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>our or our competitors' technological innovations;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>variations in our quarterly operating results;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>our failure to meet or exceed securities analysts' expectations of our financial results;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>a change in financial estimates or securities analysts' recommendations;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>changes in management's or securities analysts' estimates of our financial performance;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>announcements by us or our competitors of significant contracts, acquisitions, strategic partnerships, joint ventures, capital commitments, new technologies, or patents; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>the timing of or our failure to complete significant transactions.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>In addition, we believe that fluctuations in our stock price during applicable periods can also be impacted by changes in governmental regulations in the diagnostic testing industry and/or court rulings and/or other developments in our remaining patent licensing and enforcement actions. For example, if government regulators no longer allow for the use of diagnostic technology that has not been granted FDA approval (e.g. denying products that have only received CLIA certification), the time and cost to bring our technology to market will increase which will likely have an adverse impact on our stock price.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>18</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;&nbsp;<a href=#TC><font color=#0066cc>Table of Contents</font></a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>In the past, companies that have experienced volatility in the market price of their stock have been the objects of securities class action litigation. If our common stock was the object of securities class action litigation, it could result in substantial costs and a diversion of management's attention and resources, which could materially harm our business and financial results.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Our common stock is currently listed on NASDAQ Capital Market, however if our common stock is delisted for any reason, it will become subject to the SEC&#146;s penny stock rules which may make our shares more difficult to sell.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>If our common stock is delisted from NASDAQ Capital Market, our common stock will then fit the definition of a penny stock and therefore would be subject to the rules adopted by the SEC regulating broker-dealer practices in connection with transactions in penny stocks.&nbsp; The SEC rules may have the effect of reducing trading activity in our common stock making it more difficult for investors to sell their shares.&nbsp; The SEC&#146;s rules require a broker or dealer proposing to effect a transaction in a penny stock to deliver the customer a risk disclosure document that provides certain information prescribed by the SEC, including, but not limited to, the nature and level of risks in the penny stock market.&nbsp; The broker or dealer must also disclose the aggregate amount of any compensation received or receivable by him in connection with such transaction prior to consummating the transaction.&nbsp; In addition, the SEC&#146;s rules also require a broker or dealer to make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser&#146;s written agreement to the transaction before completion of the transaction.&nbsp; The existence of the SEC&#146;s rules may result in a lower trading volume of our common stock and lower trading prices.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We do not anticipate declaring any cash dividends on our common stock which may adversely impact the market price of our stock.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We have never declared or paid cash dividends on our common stock and do not plan to pay any cash dividends in the near future. Our current policy is to retain all funds and any earnings for use in the operation and expansion of our business. If we do not pay dividends, our stock may be less valuable to you because a return on your investment will only occur if our stock price appreciates.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>19</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;&nbsp;<a href=#TC><font color=#0066cc>Table of Contents</font></a></font></p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all></font></b> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=4>USE OF PROCEEDS</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We will not receive any proceeds from the issuance of shares to Meetrix.</font> <font style=COLOR:black>The Company is issuing the shares in satisfaction of the $4,775,934 Meetrix Obligation.&nbsp; Pursuant to the terms of the Patent Acquisition Agreement, the Meetrix Obligation is being satisfied at a price per share of $5.04.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=5>DIVIDEND POLICY</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We have not declared any dividends and do not anticipate that we will declare dividends in the foreseeable future; rather, we intend to retain any future earnings for the development of the business. Payment of future cash dividends, if any, will be at the discretion of our Board of Directors after taking into account various factors, including our financial condition, operating results, current and anticipated cash needs, outstanding indebtedness and plans for expansion and restrictions imposed by lenders, if any.&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=6>DETERMINATION OF OFFERING PRICE</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The Company is issuing the shares in satisfaction of the $4,775,934 Meetrix Obligation.&nbsp; Pursuant to the terms of the Patent Acquisition Agreement, the Company&#146;s obligation is being satisfied at a price per share of $5.04 which is equal to ninety percent (90%) of the weighted average closing prices of our common stock on the Nasdaq Capital Market for the thirty day period prior to December 27, 2016, the date on which the Company provided notice to Meetrix of the Company&#146;s decision to satisfy the Meetrix Obligation in shares of common stock.&nbsp; The price per share at which the Meetrix Obligation is being satisfied does not otherwise bear any relationship to our book value, assets, past operating results, financial condition or any other established criteria of value.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Upon issuance of the shares to Meetrix, the shares issued will not be &#147;restricted&#148; shares and Meetrix may offer all or part of the shares for sale from time to time through public or private transactions, at either prevailing market prices or at privately negotiated prices. The offering price of our common stock does not necessarily bear any relationship to our book value, assets, past operating results, financial condition or any other established criteria of value. There is no assurance that our common stock will trade at market prices in excess of the issuance price as prices for common stock in any public market will be determined in the marketplace and may be influenced by many factors, including the volume and liquidity.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>20</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;&nbsp;<a href=#TC><font color=#0066cc>Table of Contents</font></a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">DILUTION</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Upon issuance of the shares to Meetrix pursuant to this prospectus, Meetrix&#146;s interest will be diluted immediately to the extent of the difference between the issuance price of $5.04&nbsp;per share and the as adjusted net tangible book value per share of our common stock immediately following this issuance.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Our net tangible book value as of October 31, 2016 was approximately $(1,084,000), or approximately $(0.12) per share. Net tangible book value per share represents our total tangible assets less total&nbsp; liabilities, divided by the number of shares of common stock outstanding as of October 31, 2016. Net tangible book value dilution per share to new investors represents the difference between the amount per share that the shares were issued for and the as adjusted net tangible book value per share of common stock immediately after completion of the issuance.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Assuming the issuance is at a price of $5.04&nbsp;per share, and after deducting estimated issuance expenses, our as adjusted net tangible book value as of October 31, 2016 would have been approximately $3,054,000, or $0.31&nbsp;per share. This represents an immediate increase in net tangible book value of $0.43&nbsp;per share to existing stockholders and an immediate dilution in net tangible book value of $4.73&nbsp;per share to Meetrix for the shares issued herein.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:24.5pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">The following table illustrates the dilution to Meetrix of the common stock in this issuance. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BACKGROUND:white; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=86% style="WIDTH:86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr> <td width=86% style="WIDTH:86%; BORDER-BOTTOM:medium none; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:medium none; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <tr> <td width=86% style="WIDTH:86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt'><font style=FONT-SIZE:10pt>Issuance price per share</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>$</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0.04in 0pt 0in; PADDING-RIGHT:0px; TEXT-AUTOSPACE:' align=right>5.04&nbsp;</p></td></tr> <tr> <td width=86% style="WIDTH:86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt'><font style=FONT-SIZE:10pt>Net tangible book value per share as of October 31, 2016</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>$</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>(0.12)&nbsp;</p></td></tr> <tr> <td width=86% style="WIDTH:86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt'><font style=FONT-SIZE:10pt>Increase in net tangible book value per share attributable to<br>&nbsp;satisfaction of the Meetrix Obligation in this issuance</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>$</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0.04in 0pt 0in; PADDING-RIGHT:0px; TEXT-AUTOSPACE:' align=right>0.43&nbsp;</p></td></tr> <tr> <td width=86% style="WIDTH:86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt'><font style=FONT-SIZE:10pt>Adjusted net tangible book value per share as of October 31, <br>2016, after giving effect to the issuance</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>$</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0.04in 0pt 0in; PADDING-RIGHT:0px; TEXT-AUTOSPACE:' align=right>0.31</p></td></tr> <tr> <td width=86% style="WIDTH:86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt'><font style=FONT-SIZE:10pt>Dilution per share to Meetrix in the issuance</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>$</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0.04in 0pt 0in; PADDING-RIGHT:0px; TEXT-AUTOSPACE:' align=right>4.73</p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-INDENT:24.5pt'><font style="FONT-SIZE:10pt; COLOR:black">The foregoing does not take into account:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt'>&nbsp;</p> <table width=80% bordercolor=transparent style=WIDTH:80% cellpadding=0 cellspacing=0> <tr> <td width=4% style="WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&#149;</font></b></p></td> <td width=1% style="WIDTH:1.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td style="PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>1,150,872 shares of our common stock issuable upon exercise of stock options outstanding under our 2010 Share Incentive Plan, 491,433 of which are not currently exercisable, which have a weighted average exercise price of $3.22 per share and 225,600 shares of our common stock issuable upon exercise of stock options outstanding under our 2003 Share Incentive Plan which have a weighted average exercise price of $18.69 per share<font style=COLOR:black>;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=4% style="WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&#149;</font></b></p></td> <td width=1% style="WIDTH:1.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td style="PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>361,956 <font style=COLOR:black>shares of our common stock reserved for future issuance under our 2010 Share Incentive Plan;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=4% style="WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;</font></p></td> <td width=2% nowrap style="WIDTH:2.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&#149;</font></b></p></td> <td width=1% style="WIDTH:1.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td style="PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>1,780,000 shares of our common stock issuable upon the exercise of stock options outstanding pursuant to stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan which have a weighted average exercise price of $2.70 per share; and</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=4% style="WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&#149;</font></b></p></td> <td width=1% style="WIDTH:1.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td style="PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:1pt; PADDING-RIGHT:1pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>707,379 shares of our common stock issuable upon exercise of our outstanding warrants which have a weighted average exercise price of $8.83 (excluding the 500,000 shares of common stock issuable upon exercise of the warrant issued pursuant to the Redemption Agreement).</p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u></u>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:8pt>&nbsp;</font><font style=COLOR:black>21</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TC><font color=#0066cc>Table of Contents</font></a></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=8>PLAN OF DISTRIBUTION</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We will issue the shares to Meetrix on or about March 27, 2017. The Company is issuing the shares in satisfaction of the $4,775,934 Meetrix Obligation.&nbsp; Pursuant to the terms of the Patent Acquisition Agreement, the Meetrix Obligation is being satisfied at a price per share of $5.04&nbsp; </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Once issued to Meetrix, the common stock held by Meetrix may be resold or distributed from time to time by Meetrix directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be changed on any stock exchange, market or trading facility on which the shares are traded or in private transactions. The sale by Meetrix may be effected in one or more of the following methods:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>transactions involving cross or block trades;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>an exchange distribution in accordance with the rules of the applicable exchange;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>in privately negotiated transactions;</font></p>&nbsp; <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>short sales after the registration statement, of which this prospectus forms a part, becomes effective;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>broker-dealers may agree with Meetrix to sell a specified number of such shares at a stipulated price per share;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>&nbsp;&#147;at the market&#148; into an existing market for the common stock;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>through the writing of options on the shares;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>a combination of any such methods of sale; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>any other method permitted pursuant to applicable law.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>If Meetrix is an &#147;affiliate&#148; of the Company, as such term is defined under Rule 405 under the Securities Act, and the shares issued to Meetrix pursuant to this registration statement have not be registered for resale by Meetrix, Meetrix shall comply with Rule 144 under the Securities Act when selling its shares.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Meetrix may also sell the shares directly to market makers acting as principals and/or broker-dealers acting as agents for themselves or their customers. Such broker-dealers may receive compensation in the form of discounts, concessions or commissions from Meetrix and/or the purchasers of shares for whom such broker-dealers may act as agents or to whom they sell as principal or both, which compensation as to a particular broker-dealer might be in excess of customary commissions. Market makers and block purchasers purchasing the shares will do so for their own account and at their own risk. It is possible that Meetrix will attempt to sell shares of common stock in block transactions to market makers or other purchasers at a price per share which may be below the then market price.&nbsp; Meetrix may agree to indemnify any agent, dealer or broker-dealer that participates in transactions involving sales of the shares if liabilities are imposed on that person under the Securities Act.&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>With regard only to the shares it sells for its own behalf, Meetrix may be an &#147;underwriter&#148; within the meaning of the Securities Act. The Company will not pay any of the selling commissions, brokerage fees and related expenses.&nbsp; If Meetrix does sell any of the shares issued pursuant to this prospectus, Meetrix will be subject to the prospectus delivery requirements of the Securities Act.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>22</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TC><font color=#0066cc>Table of Contents</font></a><br></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=9>DESCRIPTION OF SECURITIES&nbsp;TO BE REGISTERED</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>General</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><font style=COLOR:black>Our authorized share capital consists of 24,000,000 shares of common stock, $0.01 par value per share, of which 8,754,587 shares of common stock are issued and outstanding as of January 26, 2017 and 20,000 shares of preferred stock, $0.01 par value per share, of which 140 shares have been designated as Series A Convertible Preferred Stock, none of which are issued and outstanding. We are a Delaware corporation and our affairs are governed by our Certificate of Incorporation and By-laws. The following are summaries of material provisions of our Certificate of Incorporation and By-laws insofar as they relate to the material terms of our common shares. Complete copies of our Certificate of Incorporation and By-laws are filed as exhibits to our public filings.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><i><font style=COLOR:black>Common Stock</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Our common stock is listed on the Nasdaq Capital Market under the symbol &#147;ITUS&#148;.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All outstanding shares of common stock are of the same class and have equal rights and attributes. The holders of common stock are entitled to one vote per share on all matters submitted to a vote of stockholders of the Company. All stockholders are entitled to share equally in dividends, if any, as may be declared from time to time by the Board of Directors out of funds legally available. In the event of liquidation, the holders of common stock are entitled to share ratably in all assets remaining after payment of all liabilities. The stockholders do not have cumulative or preemptive rights.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></b><i><font style=COLOR:black>Dividend Rights</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Holders of the common stock may receive dividends when, as and if declared by our Board of Directors out of the assets legally available for that purpose and subject to the preferential dividend rights of any other classes or series of stock of our Company.&nbsp; We have never paid, and have no plans to pay, any dividends on our shares of common stock.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></b><i><font style=COLOR:black>Voting Rights</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Holders of the common stock are entitled to one vote per share in all matters as to which holders of common stock are entitled to vote. Holders of not less than a majority of the outstanding shares of common stock entitled to vote at any meeting of stockholders constitute a quorum unless otherwise required by law.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></b><i><font style=COLOR:black>Election of Directors</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Directors hold office until the next annual meeting of stockholders and are eligible for reelection at such meeting. Directors are elected by a plurality of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors. There is no cumulative voting for directors.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></b><i><font style=COLOR:black>Liquidation&nbsp;&nbsp;</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In the event of any liquidation, dissolution or winding up of the Company, holders of the common stock have the right to receive ratably and equally all of the assets remaining after payment of liabilities and liquidation preferences of any preferred stock then outstanding.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></b><i><font style=COLOR:black>Redemption&nbsp;&nbsp;</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The common stock is not redeemable or convertible and does not have any sinking fund provisions.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></b><i><font style=COLOR:black>Preemptive Rights</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Holders of the common stock do not have preemptive rights.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><i><font style=COLOR:black>&nbsp;&nbsp; Other Rights</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><i><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></i><font style=COLOR:black>Our common stock is not liable to calls or to assessment by the registrant and for liabilities of the registrant imposed on its stockholders under state statutes.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>23</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TC><font color=#0066cc>Table of Contents</font></a></p><u><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all></font></u> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=10>INFORMATION WITH RESPECT TO THE REGISTRANT</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Description of Business</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <h5 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'><font style=COLOR:black>Overview</font></h5> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We were incorporated on November 5, 1982 under the laws of the State of Delaware. From inception through October 2012, our primary operations involved the development of patented technologies in the areas of thin-film displays and encryption. &nbsp;Beginning in October of 2012 under the leadership of a new management team, we recapitalized the Company, unencumbered the Company&#146;s assets, changed the Company&#146;s name and ticker symbol, relocated the Company&#146;s headquarters, and modernized its systems. In July of 2015, the Company&#146;s stock was accepted for listing and began trading on the NASDAQ Capital Market.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>In June of 2015, the Company announced the formation of a new subsidiary, Anixa, to develop a platform for non-invasive blood tests for the early detection of cancer. That platform is called Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>.&nbsp; In July of 2015, ITUS announced a collaborative research agreement with Wistar, the nation&#146;s first independent biomedical research institute and a leading National Cancer Institute designated cancer research center, for the purpose of validating our cancer detection methodologies and establishing protocols for identifying certain biomarkers in the blood which we identified and which are known to be associated with malignancies. In August of 2016 ITUS announced the renewal and expansion of our relationship with Wistar.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In October of 2015, ITUS and Wistar announced favorable results from initial testing of a small group of Breast Cancer patients and healthy controls. One hundred percent (100%) of the blood samples tested from patients with varying stages of breast cancer showed the presence of the biomarkers we identified, and none of the healthy patient blood samples contained the biomarkers. Breast Cancer is the second most common cancer in the United States and throughout the world.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In April of 2016, ITUS announced that we had demonstrated the efficacy of our </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style="FONT-SIZE:10pt; COLOR:black">early cancer detection platform with Lung Cancer.&nbsp; Lung cancer is the leading cause of death among cancers in the U.S. and throughout the world, accounting for approximately 27% of all cancer related deaths in the U.S. and 19% worldwide. In September of 2016, ITUS announced that we had demonstrated the efficacy of our </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">early cancer detection platform with Colon Cancer. Colon Cancer is the third most common cancer in men and the second most common cancer in woman worldwide, with approximately 1.4 million new cases diagnosed each year, and approximately 700,000 deaths. At the end of September 2016 through the end of October 2016, the Company made similar announcements with respect to the efficacy of our </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">early cancer detection platform for Melanoma, Ovarian Cancer, Liver Cancer, Thyroid Cancer, and Pancreatic Cancer. On November 15, 2016, ITUS announced that we had demonstrated the efficacy of our </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">early cancer detection platform with six additional cancer types including<font size=+0>&nbsp;</font></font><font style="FONT-SIZE:10pt; COLOR:black" lang=EN>Appendiceal Cancer (cancer of the appendix), Uterine Cancer, Osteosarcoma (cancer of the bone), Leiomyosarcoma (cancer of the soft tissue), Liposarcoma (cancer of the connective tissue), and Vulvar Cancer (cancer of the vulva), bringing the number of cancer types for which the efficacy of<font size=+0>&nbsp;</font></font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">has been validated thus far to fourteen.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Our </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">cancer detection platform measures a patient's immune response to a malignancy by detecting the presence, absence, and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. These types of cells and the tumor micro-environment have been the focus of recent ground breaking published and reported research in immuno-oncology, enabling the development of revolutionary immunotherapies used for treating certain cancer types. Instead of seeking to alter or boost the body's immune system and its ability to destroy cancer cells, as is the case with immunotherapy drugs, we have developed proprietary techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Specifically, we seek to identify a subset of myeloid cells that we believe are diagnostic.&nbsp;These cells, often referred to as Myeloid Derived Suppressor Cells (MDSCs), are identified by specific surface proteins enabling characterization.&nbsp;We generally refer to MDSC&#146;s and other cells of the immune system which we believe can be diagnostic in nature as biomarkers.&nbsp; Through our proprietary protocols, we have had early success and have demonstrated accuracy in detecting these biomarkers in the peripheral blood of biopsy verified cancer patients, and in distinguishing the blood of healthy patients from the blood of cancer patients. The goal is to establish Cchek&#153; as a non-invasive, inexpensive, cancer diagnostic blood test that can reduce or eliminate the need for traditionally expensive, invasive, painful, and often inaccurate cancer diagnostic procedures which are currently in use.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>24</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><br><a href=#TC><font color=#0066cc>Table of Contents</font></a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In each instance where ITUS has demonstrated the efficacy of its cancer detection platform, fresh (utilized within 48 hours) blood samples from biopsy verified cancer patients have been tested at Wistar using a variety of experimental methodologies and protocols. Such un-blinded, non-uniform testing is common during the initial development stage of new technologies and diagnostic tests. Blood samples from patients with differing severities of cancers (with some cancers such as Breast Cancer stage 0 to stage 4) have been tested, including samples from both pre-treatment and post-treatment patients. In addition, Wistar has also tested blood from healthy donors. A critical aspect of any cancer diagnostic is the ability to accurately distinguish patients with cancer from healthy patients. Based upon our encouraging early results, our scientists are working with Wistar to finalize protocols and methodologies for identifying and classifying the immunologic biomarkers that are the foundation for our </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">early cancer detection platform. Although our scientists, working in collaboration with Wistar, will continue to improve our processes and methodologies to achieve maximum performance, we expect our testing to become more uniform over time, and to eventually test patient samples in a double blinded manner.&nbsp;While studies comparing biopsy verified cancer patients have been compared to healthy donors, we have not yet evaluated benign conditions such as non-malignant neoplasias, systemic inflammatory conditions, infections, and other potential conditions that impact or may impact the immune system. Such testing will be necessary for regulatory approval.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Based upon and following the results of the more extensive clinical study, we will determine what further studies are necessary and whether and when to begin the process of seeking regulatory approval for a cancer screening test or confirmatory diagnostic test based upon our </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">technology. One manner of seeking regulatory approval is to have a lab certified to run our cancer tests pursuant to CLIA. Among other things, CLIA requires clinical laboratories that perform diagnostic testing to be certified by the state in which the lab is located, as well as the Center for Medicare and Medicaid Services. If we seek regulatory approval pursuant to CLIA, only those laboratories that are certified under CLIA to run our diagnostic test would be able to process test samples. CLIA certification may or may not require additional studies. We could seek to establish our own CLIA certified laboratory to run the diagnostic tests, or we could potentially contract with an existing CLIA certified lab, and seek to have that laboratory certified to run our diagnostic test.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Another manner of obtaining regulatory approval would be to seek to have Cchek&#153; approved by the FDA pursuant to what are commonly referred to as either the 510(K) process, or the PMA process. The appropriate pathway for FDA approval would depend upon a variety of factors, including the intended use of the test, and the risks associated with such use. FDA approval can take several years and would entail additional clinical studies.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">The decision of whether and when to seek CLIA certification or FDA approval of a diagnostic test or tests utilizing our </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">technology will be dependent on a variety of factors, including the results from more extensive clinical studies, the capital requirements of each approval process, the landscape for competitive diagnostic testing, and the time and resources required by each approval process. It is possible that we may seek to have one or more&nbsp;diagnostic tests approved via CLIA certification, and other diagnostic test or tests approved by the FDA, or that we may seek simultaneous FDA approval and CLIA certification of a particular diagnostic test or tests.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Over the next several quarters, we expect Cchek&#153; to be the primary focus of the Company. As part of our legacy operations, the Company remains engaged in limited patent licensing activities in the area of encrypted audio/video conference calling. We do not expect these activities to be a significant part of the Company&#146;s ongoing operations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Over the past several quarters, our revenue has been derived from technology licensing and the sale of patented technologies, including in connection with the settlement of litigation. In addition to Anixa, the Company may make investments in and form new companies to develop additional emerging technologies.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><b><u><font style="FONT-SIZE:10pt; COLOR:black">Preliminary Biomarker Results</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">On December 7, 2016 we announced the<font size=+0>&nbsp;</font></font><font style="FONT-SIZE:10pt; COLOR:black" lang=EN>preliminary results from our </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black" lang=EN>&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black" lang=EN>cancer patient efficacy study. Using our most recent protocols and methods for measuring a patients&#146; immunological response to a malignancy, the Company achieved Sensitivity of 92% and Specificity of 92% for 88 patient samples, including 54 samples from patients with multiple types and severities of cancer, and 34 healthy patients.&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">During the initial phase of the study, which involved multiple experimental protocols and techniques for measuring immunological responses, the Company reviewed and analyzed data from a total of 315 patient samples, including 228 patients with varying stages of cancer, as well as blood samples from 87 healthy donors.&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>25</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#TC>Table of Contents</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black" lang=EN>Patient samples representing 14 different types of cancer including<font size=+0>&nbsp;</font></font><font style="FONT-SIZE:10pt; COLOR:black">Breast Cancer, Lung Cancer, Colon Cancer, Melanoma, Ovarian Cancer, Liver Cancer, Thyroid Cancer, Pancreatic Cancer,&nbsp;Appendiceal Cancer (cancer of the appendix), Uterine Cancer, Osteosarcoma (cancer of the bone), Leiomyosarcoma (cancer of the soft tissue), Liposarcoma (cancer of the connective tissue), and Vulvar Cancer (cancer of the Vulva) </font><font style="FONT-SIZE:10pt; COLOR:black" lang=EN>were included in the study. The study included samples from patients with early and late stage, biopsy-verified, drug-na&#239;ve (before therapy) tumors, as well as biopsy-verified, refractory (unresponsive to attempted chemotherapy) tumors.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black" lang=EN>Sensitivity and specificity are scientific measurements commonly used to determine the accuracy of a diagnostic test, where sensitivity measures how good a test is at identifying people with a particular disease, and specificity measures how good a test is at identifying people without the disease. Although published results vary widely,&nbsp; established diagnostic tests such as Low Dose Computed Tomography (LDCT) , which is used by other companies to screen for Lung Cancer, has sensitivity of approximately 93% and specificity of approximately 73%, the Prostate Specific Antigen (&#147;PSA&#148;) test, which is used by other companies to screen for prostate cancer, has sensitivity of approximately 21% and specificity of approximately 91%, and Mammography, used by other companies to screen for breast cancer and considered to be the &#147;gold standard&#148; for breast cancer screening, has reported sensitivity as low as approximately 68% and specificity as low as approximately&nbsp;75%. As these results indicate, current diagnostic testing is hampered by low sensitivity, low specificity or both, meaning that the tests miss a substantial portion of the cancers they are supposed to detect, or miss-diagnose a large number of healthy patients as having cancer. There is currently no inexpensive, non-invasive, diagnostic test that excels in both sensitivity and specificity.&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">Our preliminary results, while extremely promising, will have to be confirmed in blinded clinical studies of sufficient size before we can seek marketing approval for<font size=+0>&nbsp;</font></font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">from the FDA.&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black" lang=EN>Initial samples in&nbsp;our study were tested utilizing immunostaining and fluorescent microscopic imaging. While results were promising, subjectivity in interpreting the imaging results together with labor intensive and time consuming sample processing hampered the commercial viability of this approach. Subsequently, patient samples were analyzed using flow cytometry, enabling more efficient processing and analysis.&nbsp;In addition, ITUS is developing a software application using a proprietary neural network, which currently relies on up to 13 quantitative parameters to analyze test results.&nbsp;This approach, which is highly data intensive and requires substantial computer processing power to develop, results in a test which can be performed&nbsp;using a desktop computer.&nbsp;&nbsp;An initial version of our neural network, which was trained to distinguish between the immunological responses from cancer patients and healthy patients, was responsible for the sensitivity and specificity results reported above.&nbsp;The Company&nbsp;expects to&nbsp;continue to improve its protocols, continue to upgrade its neural network-software by increasing the number of patient samples used to train the software and expanding the range of markers, increasing the data resolution, and enhancing the architecture of the software, which may enable better results.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black" lang=EN>Related to our collaborative research agreement, the Company and/or Wistar currently have collaborations with doctors from University of Pennsylvania Abramson Cancer Center, The Helen F. Graham Cancer Center and Research Institute at Christiana Hospital in Wilmington, Delaware, and Virtua Health System in southern New Jersey. In most cases, patients from participating doctors at these healthcare institutions who are beginning or in some cases, continuing cancer treatment are asked to consent to have an additional tube of blood drawn for the purpose of participating in the<font size=+0>&nbsp;</font></font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">patients efficacy trials. Because the number of cancer patients treated by these hospitals varies over time, and the decision whether to participate in the </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">patient studies is ultimately at the discretion of the patient, it is difficult to predict the number of patient samples that we will receive in any given week, or during any given month. ITUS is currently in discussions with additional doctors and healthcare providers about providing blood samples for our patient efficacy trials, and the Company has capacity available to process an additional quantity of samples.&nbsp;With the addition of these new sources of patient samples, the Company expects to process enough samples and generate enough data to begin its regulatory discussions in the next 6 to 12 month period.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>26</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#TC>Table of Contents</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><u><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The Market</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">There are four primary markets for a cancer diagnostic test: screening, confirmatory testing, treatment monitoring, and recurrence testing.&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">Screening occurs when asymptomatic people are tested for indications of cancer. Examples of existing screening tests include the mammogram for Breast Cancer, Low Dose Tomography testing for Lung Cancer, and colonoscopy for Colon Cancer. All screening tests have their strengths and weaknesses, and for many cancers there are currently no recommended screening tests available.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">Confirmatory testing is used to confirm the results of a screening test. In certain instances, existing confirmatory testing can be invasive, painful, expensive, and have relatively high risks of complications. For example, a positive mammogram is often followed up with additional imaging, which can lead to a biopsy during which a needle is inserted into the breast to sample suspicious tissue or lesions. For Lung Cancer, existing confirmatory diagnostics include bronchoscopies, during which a flexible tube is inserted through the nose or mouth and into the lung, and needle biopsies, during which a long needle is inserted between the ribs and into the lung. One potential side effect a lung biopsy is a pneumothorax (commonly referred to as a &#147;collapsed lung&#148;), which has been reported to occur in approximately fifteen percent (15%) of needle biopsies of the lung. A pneumothorax can lead to other complications and sometimes requires extended hospitalization.&nbsp; In addition to the potential side effects, biopsies of any sort can be extremely painful for the patient.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">Treatment monitoring includes follow-on testing to monitor the effectiveness of a specific regimen of treatment. For example, diagnostic monitoring testing may be used to monitor the effectiveness of a particular type of chemotherapy, to determine how the cancer is responding and whether such treatment should be continued.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">Finally, recurrence diagnostic testing is used for cancer survivors to test for cancer recurrence. According to statistics published by the American Cancer Society, there are currently approximately fifteen million cancer survivors in the U.S., sixty-seven (67%) of which were diagnosed with cancer five or more years ago. Most cancer survivors live in fear of recurrence, and limitations of existing diagnostics, including repeated exposure to radiation from imaging tests, and invasiveness and costs and pain from tests such as traditional biopsies, prevent cancer survivors from being tested as often as they would like.&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">ITUS&#146;s long term vision is to have one or more tests based upon the </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">platform to serve each of the markets identified above. At this stage, it is most likely that </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">will begin as a confirmatory diagnostic test for one particular type of cancer, but our strategy for entering the market place will not be finalized until we have completed our developmental testing and analyzed all of our preliminary data.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><u><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">Competition</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><b><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">Background</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">Continuing scientific advances and discoveries, the ability to more quickly process and analyze large amounts of scientific data, and decreases in the cost of sophisticated equipment and technologies, have resulted in the potential for significant advances in cancer treatment, and in particular, cancer diagnostics. Cancer statistics gathered over the past several decades provide overwhelming evidence that the earlier that cancers are detected, the greater the survival rates. Up until now,&nbsp;doctors have primarily relied upon technologies such as imaging (x-rays, mammograms, CT Scans, MRI&#146;s, PET Scans, Ultrasounds) and biopsies and other invasive procedures for cancer detection and cancer diagnoses. In many cases, these diagnostic procedures were performed after patients exhibited one or more symptoms of cancer, at which point the cancer may likely no longer be at an early stage. Existing diagnostic technologies such as imaging have gotten better, and invasive diagnostic procedures such as colonoscopies have become more accurate and less risky, and we expect these types of traditional diagnostic tools to continue to predominate the cancer diagnostic market for the foreseeable future.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">We believe that with advancing medical knowledge, improvements in equipment and technologies, and reduction in costs of new technologies, new types of cancer diagnostics will be created and new types of cancer diagnostic testing that will outperform many of the traditional diagnostic tests, eliminate many of the negative consequences of existing diagnostic testing, and ultimately predominate the cancer diagnostic market. &nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>27</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#TC>Table of Contents</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">We have identified a class and subclasses of biomarkers that we believe are present in the blood of patients with malignancies, and are perfecting a process and methodology for detecting those biomarkers. The goal is to create a platform, </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">, that can be used to launch a series of simple and affordable blood tests that can be used to detect and monitor many of the most deadly forms of cancer, including lung cancer, breast cancer, ovarian cancer, colon cancer, pancreatic cancer, and others. It is unlikely that the Company will initially simultaneously launch tests for each of the cancers identified above, and that specific and individual cancer tests for each of the four markets identified above (screening, confirmatory testing, treatment monitoring, recurrence) &nbsp;will be launched over time.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Statistics from The American Cancer Society indicate that one out of every two males, and one out of every three females that are born today, will develop some form of cancer during their lifetimes. With approximately 200 million adults in the United States alone, we believe that the market for new, non-invasive cancer diagnostic technologies and testing will be enormous, and that there will be sufficient demand to support many different technologies and tests.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><b><font style="FONT-SIZE:10pt; COLOR:black">Cancer Diagnostic Technologies</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">If successful, we believe </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">will have several advantages over existing diagnostic technologies. For example, repeated exposure to radiation from x-ray technologies, such as mammograms, has become an increasing concern for the medical community, causing authorities to re-evaluate the recommended frequency of such x-ray based tests. &nbsp;Traditional biopsies are often impossible for some tumor based cancers depending on the location of the tumor, and are invasive, expensive, and painful enough to warrant only limited use for other cancers even when the tumor can be accessed. In addition, such biopsies are limited in their inability to detect the heterogeneity of many cancerous tumors, and the ongoing mutations that are often evident as the tumor progresses. False positives in existing testing such as the PSA test, result in otherwise healthy patients being misdiagnosed, and subject to unnecessary follow-on treatments and medical procedures. &nbsp;Patient inconvenience, risk of side effects from anesthesia, and risk of other complications result in low patient compliance with otherwise effective cancer screening tests such as the colonoscopy. &nbsp;These are just a few examples of the challenges with traditional diagnostic tests that we seek to eliminate with </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">. &nbsp;This will be the foundation for the competitive advantages that we expect to have over existing diagnostic testing.&nbsp;We expect </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;&nbsp; </font><font style="FONT-SIZE:10pt; COLOR:black">will be utilized as a component of multiple diagnostic technologies and patient background information to diagnose and manage the patient&#146;s condition.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Many public and private companies have announced plans and ongoing research efforts to launch non-invasive cancer diagnostic tests and tools that can be used for non-invasive cancer testing. These companies include well established, and successful biotech companies, start-ups, and companies of all sizes. &nbsp;Almost every bodily fluid, including blood, plasma, urine, saliva, and excrement, are being studied for biomarkers or indicators of one or more types of cancer. The term that has been used to describe the category of this type of non-invasive cancer diagnostic testing is&nbsp;&#147;Liquid Biopsy&#148;. &nbsp;In general, most of these companies are focused on identifying and analyzing one of three types of biomarkers: circulating tumor cells (&#147;CTC&#146;s&#148;), circulating tumor DNA (&#147;ctDNA&#148;), and Exosomes. Each of these types of biomarkers has their advantages and disadvantages, and we expect that tests incorporating these and other biomarkers will make their way into the cancer diagnostic marketplace.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">ITUS believes that its </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">diagnostic platform has the potential for at least three distinct advantages over the types of biomarker tests referred to above. First, it appears that the biomarkers that we are using may be present in multiple types of and varying severities of cancers. As a result, we anticipate that </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">will become a platform from which multiple tests could be launched for multiple types of cancers. Most biomarkers are associated with and useful for only one type or sub-type of cancer. Second, it appears that the biomarkers utilized by </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">may be present in both advanced, and early stages of cancers. Third, we expect </font><font style="FONT-SIZE:10pt; COLOR:black">Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style="FONT-SIZE:10pt; COLOR:black">to be significantly less expensive than the technologies commonly used for tests based on CTC&#146;s, ctDNA, and Exosomes.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><u><font style="FONT-SIZE:10pt; COLOR:black">Employees</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">As of October 31, 2016, on a consolidated basis, we had seven full-time employees.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>28</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#TC>Table of Contents</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><u><font style="FONT-SIZE:10pt; COLOR:black">Other</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Our principal executive offices are located at 12100 Wilshire Boulevard, Suite 1275, Los Angeles, California 90025, our telephone number is 310-484-5200 and our Internet website address is www.ITUScorp.com. &nbsp;We make available free of charge on or through our Internet website our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements on Schedule 14A, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such materials with, or furnish them to, the Securities and Exchange Commission (the&nbsp;&#147;SEC&#148;). &nbsp;Alternatively, you may also access our reports at the SEC&#146;s website at www.sec.gov. You may also read and copy any document we file with the SEC at the SEC&#146;s public reference room located at 100 F Street, NE, Washington, DC 20549, on official business days during the hours of 10:00 a.m. and 3:00 p.m. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference room.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 27.5pt 0pt 0in; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Description of Properties</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 27.5pt 0pt 0in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 27.5pt 0pt 0in; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We lease approximately 3,000 square feet of office space at 12100 Wilshire Boulevard, Los Angeles, California (our principal executive offices) from an unrelated party pursuant to a lease that expires May 31, 2019.&nbsp; Our base rent is approximately $11,000 per month and the lease provides for annual increases of approximately 3% and an escalation clause for increases in certain operating costs.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 27.5pt 0pt 0in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 27.5pt 0pt 0in; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Legal Proceedings<i> &nbsp;</i></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 27.5pt 0pt 0in; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 27.5pt 0pt 0in; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Other than suits we bring to enforce our patent rights we are not a party to any material pending legal proceedings other than that which arise in the ordinary course of business. &nbsp;We believe that any liability that may ultimately result from the resolution of these matters will not, individually or in the aggregate, have a material adverse effect on our financial position or results of operations.&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>29</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><a href=#TC><font color=#0066cc>Table of Contents</font></a></p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all></font></b> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=12>MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><font style=COLOR:black>Since July 2015, our common stock has traded on the Nasdaq Capital Market under the symbol &#147;ITUS&#148;.&nbsp; Prior to July 2015, our common stock traded on the OTCQB. The high and low sales prices as reported by the Nasdaq Capital Market and OTCQB for each quarterly fiscal period during our fiscal years ended October 31, 2016 and 2015 is as follows (all sales prices below reflect our one-for-twenty-five reverse stock split which was effected in June 2015):</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:1pt> <td width=39% nowrap style="HEIGHT:1pt; WIDTH:39%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=30% nowrap style="HEIGHT:1pt; WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=30% nowrap style="HEIGHT:1pt; WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:1pt> <td width=39% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:39%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Fiscal Period</font></p></td> <td width=30% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">High</font></p></td> <td width=30% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Low</font></p></td></tr> <tr style=HEIGHT:1pt> <td width=39% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:39%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;4th quarter 2016</font></p></td> <td width=30% nowrap style="HEIGHT:1pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$6.82</font></p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.85</font></p></td></tr> <tr style=HEIGHT:1pt> <td width=39% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:39%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;3rd quarter 2016</font></p></td> <td width=30% nowrap style="HEIGHT:1pt; WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">3.70</font></p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">2.55</font></p></td></tr> <tr style=HEIGHT:1pt> <td width=39% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:39%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">2nd quarter 2016</font></p></td> <td width=30% nowrap style="HEIGHT:1pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">3.31</font></p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">1.88</font></p></td></tr> <tr style=HEIGHT:1pt> <td width=39% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:39%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;1st quarter 2016</font></p></td> <td width=30% nowrap style="HEIGHT:1pt; WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">4.85</font></p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">2.01</font></p></td></tr> <tr style=HEIGHT:1pt> <td width=39% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:39%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:0px; WIDTH:30%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:1pt> <td width=39% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:39%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;4th quarter 2015</font></p></td> <td width=30% nowrap style="HEIGHT:1pt; WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$6.00</font></p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$3.50</font></p></td></tr> <tr style=HEIGHT:1pt> <td width=39% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:39%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;3rd quarter 2015</font></p></td> <td width=30% nowrap style="HEIGHT:1pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">6.40</font></p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">1.75</font></p></td></tr> <tr style=HEIGHT:1pt> <td width=39% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:39%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">2nd quarter 2015</font></p></td> <td width=30% nowrap style="HEIGHT:1pt; WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">4.10</font></p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">1.39</font></p></td></tr> <tr style=HEIGHT:1pt> <td width=39% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:39%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;1st quarter 2015</font></p></td> <td width=30% nowrap style="HEIGHT:1pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">5.53</font></p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">2.25</font></p></td></tr> <tr style=HEIGHT:1pt> <td width=39% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:39%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:1pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">As of January 26, 2017, the approximate number of record holders of our common stock was 302 and the closing price of our common stock was $5.05 per share.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><i><font style=COLOR:black>Securities Authorized for Issuance Under Equity Compensation Plans</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><font style=COLOR:black>See &#147;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.&#148;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><i><font style=COLOR:black>Dividend Policy</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><font style=COLOR:black>No cash dividends have been paid on our common stock since our inception. &nbsp;We have no present intention to pay any cash dividends in the foreseeable future.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>30</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><a href=#TC><font color=#0066cc>Table of Contents</font></a><br clear=all></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=11>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <h4 style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'><font style="FONT-SIZE:10pt; COLOR:black">General</font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In reviewing Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations, you should refer to our Consolidated Financial Statements and the notes related thereto.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <h4 style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'><font style="FONT-SIZE:10pt; COLOR:black">Results of Operations</font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in -9pt 0pt 0in'><b><font style="FONT-SIZE:10pt; COLOR:black">Fiscal Year ended October 31, 2016 compared with Fiscal Year ended October 31, 2015</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 0.5in'><b><i><font style="FONT-SIZE:10pt; COLOR:black">Revenue from Licensing Activities</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In fiscal year 2016, we recorded revenue from licensing activities of $300,000 from two license agreements. In fiscal year 2015, we recorded revenue from licensing activities of $255,000 from six license agreements and $9,000,000 from AUO as described below. The license agreements provided for one-time, non-recurring, lump sum payments in exchange for non-exclusive retroactive and future licenses, and/or covenants not to sue. Accordingly, the earnings process from these licenses was complete and 100% of the revenue was recognized upon execution of the license agreements.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 0.5in'><b><i><font style="FONT-SIZE:10pt; COLOR:black">Revenue from Settlement with AU Optronics Corporation</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">We did not record any revenue from the settlement with AUO during the fiscal year 2016.&nbsp; Revenue from the settlement with AUO was $9,000,000 in fiscal year 2015.&nbsp; On December 29, 2014, the Company<font size=+0>&nbsp;</font>and AUO entered into a Settlement Agreement (the &#147;AUO Settlement Agreement&#148;) and a Patent Assignment Agreement (the &#147;AUO Patent Assignment Agreement&#148;) pursuant to which the Company received an aggregate of $9,000,000 from AUO.&nbsp; The AUO Settlement Agreement and the AUO Patent Assignment Agreement were entered into to resolve a lawsuit filed by the Company against AUO in January of 2013, in connection with the joint development and commercialization of two of the Company&#146;s thin-film display technologies.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><b><i><font style="FONT-SIZE:10pt; COLOR:black">Inventor Royalties and Contingent Legal Fees</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Inventor royalties and contingent legal fees decreased by approximately $36,000 in fiscal year 2016, to approximately $111,000, from approximately $148,000 in fiscal year 2015. The decrease was due to the decrease in revenue from licensing activities.&nbsp; Inventor royalties and contingent legal fees are expensed in the period that the related revenues are recognized.&nbsp; The economic terms of patent agreements and contingent legal fee arrangements vary across the patent portfolios owned or controlled by the Company.&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><b><i><font style="FONT-SIZE:10pt; COLOR:black">Litigation and Licensing Expenses</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Litigation and licensing expenses decreased by approximately $3,395,000 to approximately $106,000 in fiscal year 2016, from approximately $3,501,000 in fiscal year 2015. Litigation and licensing expenses included approximately $3,298,000 of legal fees and litigation costs in fiscal year 2015, related to the settlement with AUO.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><b><i><font style="FONT-SIZE:10pt; COLOR:black">Amortization of Patents</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Amortization of patents was approximately $325,000 in fiscal years 2016 and 2015. We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life.&nbsp;During fiscal year 2016, we did not capitalize any patents or patent rights.&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 0.5in'><b><i><font style="FONT-SIZE:10pt; COLOR:black">Research and Development Expenses</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Research and development expenses increased by approximately $845,000 to approximately $1,556,000 in fiscal year 2016, from approximately $711,000 in fiscal 2015. The increase in research and development expenses was primarily due to an increase in costs in connection with the development of<font size=+0>&nbsp;</font>Cchek</font><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style="FONT-SIZE:10pt; COLOR:black">, including increased<font size=+0>&nbsp;</font>employee compensation and related costs, other than stock option expense, of approximately $626,000 and increased costs related to our collaboration with Wistar of approximately $121,000.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>31</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#TC>Table of Contents</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 0.5in'><b><i><font style="FONT-SIZE:10pt; COLOR:black">Marketing, General and Administrative Expenses</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Marketing, general and administrative expenses decreased by approximately $2,805,000 to approximately $2,710,000 in fiscal year 2016, from approximately $5,515,000 in fiscal 2015. The decrease in marketing, general and administrative expenses was principally due to a decrease in employee stock option expense of approximately $1,272,000, a decrease in employee compensation and related costs, other than stock option expense, of approximately $552,000, a decrease in consultant stock option expense of approximately $484,000, a decrease in consulting and outside services expense other than stock option expenses of approximately $276,000, and a decrease in legal and accounting fees of approximately $224,000, offset by an increase in investor relations and public relations expense of approximately $198,000.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><b><i><font style="FONT-SIZE:10pt; COLOR:black">Interest Expense</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Interest expense increased by approximately $68,000 to approximately $520,000 in fiscal year 2016, from approximately $452,000 in fiscal 2015. Interest expense in fiscal years 2016 and 2015 consisted of accreted interest on our patent acquisition obligation.&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><b><i><font style="FONT-SIZE:10pt; COLOR:black">Interest Income</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Interest income decreased to approximately $13,000 in fiscal year 2016 compared to approximately $18,000 in fiscal year 2015, due to a decrease in funds available for short-term investments.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt'><b><font style="FONT-SIZE:10pt; COLOR:black">Liquidity and Capital Resources</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Our primary sources of liquidity are cash, cash equivalents and short term investments.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Based on currently available information as of January 26, 2017, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows from operations will not be sufficient to fund our activities and debt obligations for the next 12 months.&nbsp; Our basic monthly overhead expenses are approximately $300,000, excluding payments of principal and interest due on our Redemption Debenture in 2017.<font size=+0>&nbsp;</font>To date, we have relied primarily upon cash from the public and private sale of equity and debt securities, as well as net proceeds from the December 2014 AUO settlement, to generate the working capital needed to finance our operations.&nbsp;<font size=+0>&nbsp;</font>If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, we will be required to obtain more working capital.&nbsp; We may seek to obtain working capital through sales of our equity securities or through bank credit facilities or public or private debt from various financial institutions where possible and as permitted pursuant to the Redemption Debenture which<font size=+0>&nbsp;</font>prohibits the Company from incurring any senior indebtedness<font size=+0>&nbsp;</font>other than equipment financing in connection with the Company&#146;s business.&nbsp; We cannot be certain that additional funding will be available on acceptable terms, or at all.&nbsp; If we do identify sources for additional funding, the sale of additional equity securities or convertible debt could result in dilution to our stockholders.&nbsp; Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities.&nbsp; We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all.&nbsp;<font size=+0>&nbsp;</font>If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.&nbsp; Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The accompanying financial statements have been prepared assuming that we will continue as a going concern.&nbsp; In order for us to have sufficient capital to execute our business plan, fund our operations and meet our debt obligations over the next 12 months, we&nbsp;will need to raise additional capital.&nbsp; Although we have been successful in the past in raising capital, we cannot provide any assurance that we will be successful in doing so in the future to the extent necessary to be able to fund our operating activities and debt obligations over the next 12 months, which raises substantial doubt about our ability to continue as a going concern.&nbsp; Our financial statements do not include any adjustments that might result from the outcome of this uncertainty.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>32</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#TC>Table of Contents</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">During the year ended October 31, 2016, cash used in operating activities was approximately $3,382,000.&nbsp; Cash provided by investing activities was approximately $1,503,000, which resulted from the proceeds on maturity&nbsp;of certificates of deposit totaling $3,550,000 which was offset by the purchase of certificates of deposit totaling $1,900,000 and the purchase of property and equipment of approximately $147,000.&nbsp; Our cash used in financing activities was approximately $3,000, which resulted from a royalty payment of approximately $36,000 applied to the patent acquisition obligation liability, offset by the proceeds from exercise of stock options of approximately $34,000. As a result, our cash, cash equivalents, and short-term investments at October 31, 2016 decreased approximately $3,531,000 to approximately $3,238,000 from approximately $6,769,000 at the end of fiscal year 2015.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In October 2015, the Company entered into an At Market Issuance Sales Agreement (the<font size=+0>&nbsp;</font>&#147;Sales<font size=+0>&nbsp;</font>Agreement&#148;) with National Securities Corporation (&#147;National&#148;) to create an at-the-market equity program under which the company could sell up to $10,000,000 worth of its common stock (the<font size=+0>&nbsp;</font>&#147;Shares&#148;) from time to time through National, as sales agent.<font size=+0>&nbsp;</font>On December 2, 2016, the Company terminated the Agreement with National.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>On December 9, 2016, we issued the Redemption Debenture in the amount of $3,000,000, of which $1,000,000 is due on or before June 1, 2017 and the remainder is due November 11, 2017.&nbsp; The Redemption Debenture is secured by a lien on the Company&#146;s assets and prohibits the Company from incurring any senior indebtedness&nbsp;other than equipment financing in connection with the Company&#146;s business.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-INDENT:0.5in"><a name=_DV_C28><font style='FONT-SIZE:10pt; TEXT-DECORATION:none; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; LINE-HEIGHT:115%; text-underline:none'>On January 19, 2017, we announced that our board of directors has approved a rights offering for our stockholders of up to $12,000,000. The rights offering will include the non-transferable right to purchase one (1) share of common stock, at a discount, for each share of common stock owned by stockholders on the ownership day of Friday, February 10, 2017.&nbsp; The discounted price will be the lesser of (i) twenty-five percent (25%) discount to the volume weighted average price for our common stock for the five (5) trading day period through and including Wednesday, February 15, 2017, subject to board approval and (ii) fifteen percent (15%) discount to the volume weighted average price for our common stock for the five (5) trading day period through and including Friday, March 10, 2017. </font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">The issuance of the shares in fulfilment of the Meetrix Obligation will reduce liabilities by approximately $4,172,000.</font></p> <h5 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</h5> <h5 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'><font style=COLOR:black>Off-Balance Sheet Arrangements</font></h5> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">We have no variable interest entities or other off-balance sheet obligation arrangements.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><b><font style="FONT-SIZE:10pt; COLOR:black">Critical Accounting Policies</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">The Company&#146;s consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America.&nbsp;In preparing these financial statements, we make assumptions, judgments and estimates that can have a significant impact on amounts reported in our consolidated financial statements. We base our assumptions, judgments and estimates on historical experience and various other factors that we believe to be reasonable under the&nbsp;circumstances. Actual results could differ materially from these estimates under different assumptions or conditions. On a regular basis, we evaluate our assumptions, judgments and estimates and make changes accordingly.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">We believe that, of the significant accounting policies discussed in Note&nbsp;3&nbsp;&nbsp;to our consolidated financial statements, the following accounting policies require our most difficult, subjective or complex judgments:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">Revenue Recognition; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">Stock-Based Compensation</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><b><font style="FONT-SIZE:10pt; COLOR:black">Revenue Recognition</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>33</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#TC>Table of Contents</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><u><font style="FONT-SIZE:10pt; COLOR:black">Patent Licensing</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In certain instances, our past revenue arrangements have provided for the payment of contractually determined fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&nbsp;&nbsp;These arrangements typically include some combination of the following:&nbsp;&nbsp;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&nbsp;&nbsp;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&nbsp;&nbsp;Pursuant to the terms of these agreements, we have no further obligations. &nbsp;As such, the earnings process was complete and revenue has been recognized upon the execution of the agreement, when collectability was reasonably assured, and when all other revenue recognition criteria were met.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><b><font style="FONT-SIZE:10pt; COLOR:black">Stock-Based Compensation</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">We account for stock options granted to employees and directors using the accounting guidance in ASC 718.&nbsp; We recognize compensation expense for stock option awards over the requisite or implied service period of the grant.&nbsp; We recorded stock-based compensation expense, related to stock options granted to employees and directors, of approximately $874,000 and $2,192,000 during the years ended October 31, 2016 and 2015, respectively.&nbsp; We account for stock options granted to consultants using the accounting guidance under ASC 505-50.&nbsp; We recognized stock-based compensation expense for stock options granted to non-employee consultants during the years ended October 31, 2016 and 2015, of approximately $-0- and $484,000, respectively.&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">As of October 31, 2016, there was unrecognized compensation cost related to non-vested share-based compensation arrangements for stock options granted to employees and directors of approximately $1,139,000, which will be recognized in future periods upon vesting of the stock options. &nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Determining the appropriate fair value model and calculating the fair value of stock-based awards requires judgment, including estimating stock price volatility, forfeiture rates and expected term.&nbsp; If factors change and we employ different assumptions in the application of ASC 718 and ASC 505-50 in future periods, the compensation expense that we record may differ significantly from what we have recorded in the current period.&nbsp; See Note 3 to the consolidated financial statements for additional information.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <h5 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'><font style=COLOR:black>Effect of Recent Accounting Pronouncements</font></h5> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2014-09 (&#147;ASU 2014-09&#148;), Revenue from Contracts with Customers. This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &nbsp;This standard update is effective for&nbsp;interim and annual&nbsp;reporting periods beginning after December 15,&nbsp;2016, and are to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. &nbsp;In July 2015, a one-year deferral of the effective date of the new guidance was approved. &nbsp;We are currently evaluating the impact ASU 2014-09 will have on our consolidated financial statements&nbsp;and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In June 2014, the FASB issued Accounting Standards Update 2014-12 (&#147;ASU 2014-12&#148;), Compensation &#150; Stock Compensation. This amendment requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. We do not expect this update to have a significant impact on our consolidated financial statements and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In August 2014, the FASB issued Accounting Standards Update 2014-15 (&#147;ASU 2014-15&#148;). This amendment requires management to assess an entity&#146;s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods ending after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption. We do not expect this update to have a significant impact on our consolidated financial statements and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>34</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#TC>Table of Contents</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In April 2015, the FASB issued Accounting Standards Update 2015-03 (&#147;ASU 2015-03&#148;) to simplify the presentation of debt issuance costs. This amendment requires debt issuance costs be presented on the balance sheet as a direct reduction from the carrying amount of the debt liability, consistent with debt discounts or premiums. Adoption of this standard is required for interim and annual periods beginning after December 15, 2015 and is to be applied retrospectively. The adoption of this amendment&nbsp;on November 1, 2016 did not have an impact on our consolidated financial statements&nbsp;and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In November 2015, the FASB issued Accounting Standards Update 2015-17 (&#147;ASU 2015-17&#148;) to simplify the presentation of deferred taxes. This amendment requires that all deferred tax assets and liabilities, along with any related valuation allowances, be classified as noncurrent on the balance sheet. &nbsp;Adoption of this standard is required for annual periods beginning after December 15, 2016. &nbsp;We are currently evaluating the impact ASU 2015-17 will have on our consolidated financial statements&nbsp;and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In February 2016, the FASB issued Accounting Standards Update 2016-02 (&#147;ASU 2016-02&#148;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. &nbsp;The requirements of this standard include a significant increase in required disclosures. &nbsp;We are currently evaluating the impact ASU 2016-02 will have on our consolidated financial statements&nbsp;and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In March 2016, the FASB issued Accounting Standards Update 2016-09 (&#147;ASU 2016-09&#148;) that changes the accounting for certain aspects of share-based payments to employees. &nbsp;The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee&#146;s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. Early adoption is permitted. We are currently evaluating the impact ASU 2016-09 will have on our consolidated financial statements&nbsp;and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>35</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt'>&nbsp;</p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><a href=#TC><font color=#0066cc>Table of Contents</font></a><br clear=all></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=13>MANAGEMENT</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><font style=COLOR:black>The following table sets forth certain information with respect to all of our directors and executive officers as of the date of this prospectus:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:37.95pt> <td width=125 style="BORDER-TOP:black 1pt solid; HEIGHT:37.95pt; BORDER-RIGHT:0px; WIDTH:93.55pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Name</font></p></td> <td width=238 style="BORDER-TOP:black 1pt solid; HEIGHT:37.95pt; BORDER-RIGHT:0px; WIDTH:178.45pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Position with the Company and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Principal Occupation</font></p></td> <td width=58 style="BORDER-TOP:black 1pt solid; HEIGHT:37.95pt; BORDER-RIGHT:0px; WIDTH:43.3pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Age</font></p></td> <td width=110 style="BORDER-TOP:black 1pt solid; HEIGHT:37.95pt; BORDER-RIGHT:black 1pt solid; WIDTH:82.4pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Director and/or Executive</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Officer Since</font></p></td></tr> <tr style=HEIGHT:16.55pt> <td width=125 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:93.55pt; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Dr. Amit Kumar</font></p></td> <td width=238 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:178.45pt; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 2.2pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Executive Chairman of the Board</font></p></td> <td width=58 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:43.3pt; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>52</font></p></td> <td width=110 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:black 1pt solid; WIDTH:82.4pt; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2012</font></p></td></tr> <tr style=HEIGHT:16.55pt> <td width=125 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:93.55pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Robert A. Berman</font></p></td> <td width=238 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:178.45pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Director, President and Chief Executive Officer</font></p></td> <td width=58 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:43.3pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>53</font></p></td> <td width=110 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:black 1pt solid; WIDTH:82.4pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2012</font></p></td></tr> <tr style=HEIGHT:16.55pt> <td width=125 style="BORDER-TOP:black 1pt solid; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:93.55pt; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Dale Fox</font></p></td> <td width=238 style="BORDER-TOP:black 1pt solid; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:178.45pt; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Director</font></p></td> <td width=58 style="BORDER-TOP:black 1pt solid; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:43.3pt; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>49</font></p></td> <td width=110 style="BORDER-TOP:black 1pt solid; HEIGHT:16.55pt; BORDER-RIGHT:black 1pt solid; WIDTH:82.4pt; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2014</font></p></td></tr> <tr style=HEIGHT:16.55pt> <td width=125 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:93.55pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Dr. Arnold Baskies</font></p></td> <td width=238 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:178.45pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Director</font></p></td> <td width=58 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:43.3pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>67</font></p></td> <td width=110 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:black 1pt solid; WIDTH:82.4pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2016</font></p></td></tr> <tr style=HEIGHT:16.55pt> <td width=125 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:93.55pt; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Dr. John Monahan</font></p></td> <td width=238 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:178.45pt; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Director</font></p></td> <td width=58 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:43.3pt; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>70</font></p></td> <td width=110 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:black 1pt solid; WIDTH:82.4pt; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2016</font></p></td></tr> <tr style=HEIGHT:16.55pt> <td width=125 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:93.55pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Michael J. Catelani</font></p></td> <td width=238 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:178.45pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Chief Financial Officer</font></p></td> <td width=58 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:0px; WIDTH:43.3pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>50</font></p></td> <td width=110 style="BORDER-TOP:0px; HEIGHT:16.55pt; BORDER-RIGHT:black 1pt solid; WIDTH:82.4pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.2pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2016</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="BACKGROUND:white; COLOR:black">We believe that our Board represents a desirable mix of backgrounds, skills, and experiences. The principal occupation and business experience during the last five years for our executive officers and directors and some of the specific experiences, qualifications, attributes or skills that led to the conclusion that each person should serve as one of our directors in light of our business and structure is as follows:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style="BACKGROUND:white; COLOR:black">Dr. Amit Kumar, 52,&nbsp;Executive&nbsp;Chairman of the Board and Executive Chairman of Anixa Diagnostics</font></i></b><font style="BACKGROUND:white; COLOR:black">.&nbsp;</font><font style=COLOR:black>Dr. Kumar has served as a director since November 30, 2012 and as Chairman of the Board since August 23, 2016.&nbsp; From June 15, 2015 until August 23, 2016, Dr. Kumar served as Vice Chairman of the Company.&nbsp; Dr. Kumar served as a strategic advisor to the Company since September 19, 2012.&nbsp; Dr. Kumar has been Executive Chairman of Anixa Diagnostics Corporation, a wholly-owned subsidiary of the Company since June 15, 2015. Upon his appointment as Executive Chairman of Anixa, Dr. Kumar resigned from his position as the CEO of Geo Fossil Fuels LLC, an energy company, which he had held since December 2010.&nbsp; From September 2001 to June 2010, Dr. Kumar was President and CEO of CombiMatrix Corporation, a NASDAQ listed biotechnology company and also served as director from September 2000 to June 2012.&nbsp; Dr. Kumar was Vice President of Life Sciences of Acacia Research Corporation, a publicly traded investment company, from July 2000 to August 2007 and also served as a director from January 2003 to August 2007.&nbsp;&nbsp; Dr. Kumar has served as Chairman of the board of directors of Ascent Solar Technologies, Inc., a publicly-held solar energy company, since June 2007, and as a director of Aeolus Pharmaceuticals, Inc. since June 2004.&nbsp; Dr. Kumar holds an A.B. in Chemistry from Occidental College and Ph.D. from Caltech and completed his post-doctoral training at Harvard University. Dr. Kumar has experience in technology driven startups, both at the board and operating levels, in a&nbsp; broad variety of areas including finance, acquisitions, R&amp;D, and marketing, and has served as a director and officer of another publicly traded company.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style="BACKGROUND:white; COLOR:black">Robert A. Berman, 53, Director, President and Chief Executive Officer</font></i></b><font style="BACKGROUND:white; COLOR:black">. Mr. Berman has served as our President and Chief Executive Officer since September 19, 2012 and was elected to our Board on November 30, 2012. Mr. Berman has experience in a broad variety of areas including finance, acquisitions, marketing, and the development, licensing, and monetization of intellectual property.&nbsp; He was recently the CEO of IP Dispute Resolution Corporation (&#147;IPDR&#148;), a consulting company focused on technology licensing and product development, from March 2007 to September 2012. Prior to IPDR, Mr. Berman was the Chief Operating Officer and General Counsel of Acacia Research Corporation from 2000 to March 2007.&nbsp;&nbsp; Mr. Berman holds a J.D. from the Northwestern University School of Law and a B.S. in Entrepreneurial Management from the Wharton School of the University of Pennsylvania.&nbsp;&nbsp;</font><font style=COLOR:black>Mr. Berman has experience in both investing in and starting new ventures and new technologies, in areas including finance, acquisitions, operations, and marketing, and has served as an officer of another publicly traded company.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>36</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style="BACKGROUND:white; COLOR:black">Dale Fox, 49, Director</font></i></b><font style="BACKGROUND:white; COLOR:black">. Mr.</font><font style=COLOR:black>Fox is an entrepreneur and innovator who has launched many companies. He is currently the CEO of Tribogenics, a start-up company he co-founded in 2010 that develops portable, powerful X-ray devices based, in part, upon a technology conceived and licensed from the University of California, Los Angeles.&nbsp; Mr. Fox has raised numerous rounds of capital for many types of companies, including venture capital, strategic investments, and other financings.&nbsp; Mr. Fox has built executive and advisory teams. He received a Bachelor of Business Administration degree from Southern Methodist University&#146;s Cox School of Business. Since 2009, Mr. Fox has taught at the Founders Institute where he teaches classes on start-ups and continues to mentor young entrepreneurs.&nbsp; Mr. Fox is an experienced startup entrepreneur and inventor who has successfully launched a number of companies.&nbsp; As a result, Mr. Fox has gained experience is a broad variety of other areas including finance, research and development and marketing.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Dr. Arnold Baskies, 67, Director.</font></i></b><font style=COLOR:black>&nbsp;&nbsp;Dr. Baskies, Vice Chairman of the National Board of Directors of the American Cancer Society, is a board certified general surgeon and fellowship trained surgical oncologist with special interests in breast cancer, thyroid cancer, and melanoma. Dr. Baskies&nbsp;has been a member of Virtua Surgical Specialists, a multi-specialty practice since 2011. In addition to his pioneering efforts to promote the latest surgical and nonsurgical techniques, including minimally invasive surgery (and advanced radioguided techniques) for diseases of the breast, thyroid, and parathyroid glands, he has cared for thousands of surgical patients in his 30-year career. Dr. Baskies received his Bachelor of Arts degree summa cum laude and was a member of Phi Beta Kappa at Boston University, graduated from the Boston University School of Medicine, completed his surgical residency at Boston Medical Center, and&nbsp;had fellowship training in surgical oncology at the National Cancer Institute.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Dr. John Monahan, 70, Director.&nbsp;&nbsp;</font></i></b><font style=COLOR:black>Dr. Monahan is an experienced executive and has served on a number of biotechnology company boards over the years. He is currently a Scientific Advisory Consultant for Synthetic Biologics, Inc. (NYSE MKT: SYN) and from 2010 through 2015 he was the Sr. Executive Vice President of Research &amp; Development at Synthetic Biologics, Inc. He is also a director of Heat Biologics, Inc. (Nasdaq: HTBX), a position that he has held since 2011, and was a director of Tacere Therapeutics, Inc., a wholly-owned subsidiary of Benitec Biopharma Limited (Nasdaq: BNTC) from 2006 to 2015. In addition to his work with public companies, Dr. Monahan is also currently a member of the Scientific Advisory Board of Agilis Biotherapeutics, Inc., a position that he has held since 2014, and is a board member of several other biotechnology companies. In addition, in 1992 he founded Avigen, Inc., a biotech company that pioneered the development of gene medicines based on adeno-associated virus vectors, now an industry standard. Over a 12-year period as its CEO, Dr. Monahan took Avigen public through an initial public offering raising over $235M and led the company through several Investigational New Drug (IND) applications. Prior to Avigen, Dr. Monahan served as Vice President - Research and Development at Somatix B.V., and Director of Molecular &amp; Cell Biology at Triton Biosciences, Inc. He was also previously Research Group Chief, Department of Molecular Genetics at Hoffmann-LaRoche Inc., and Adjunct Assistant Professor, Department of Cell Biology at New York University. Dr. Monahan earned a Ph.D. in Biochemistry from McMaster University, Hamilton, Canada, and a B.S. in Science from University College, Dublin, Ireland. Dr. Monahan has over 50 publications in scientific literature and has made hundreds of presentations and public TV appearances, to scientific groups, investors and the general public over the years.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Michael J. Catelani, 50, Chief Financial Officer.</font></i></b><font style=COLOR:black>&nbsp; Mr. Catelani, has served as our Chief Financial Officer since November 1, 2016. Previously, Mr. Catelani co-founded Tacere Therapeutics, Inc., a privately held biotechnology company, and served as its Chairman, President and Chief Financial Officer until its sale. Prior to Tacere, Mr. Catelani served on the Board of Directors and was the Chief Financial Officer of Benitec Biopharma Limited, an Australian Stock Exchange-listed biotechnology company. Prior to Benitec, Mr. Catelani served as Vice President and Chief Financial Officer at Axon Instruments, a U.S. corporation publicly traded on the Australian Stock Exchange that was a leading designer and manufacturer of instrumentation and software systems for biotechnology and diagnostics research. Prior to Axon, Mr. Catelani served as the Vice President of Finance for Media Arts Group, Inc., an NYSE-listed company. Mr. Catelani has also worked with several early stage start-up companies in a variety of industries, including biotechnology, retail, waste water recovery, and distributed power generation, in both advisory and management roles and has served as a contract Chief Financial Officer to a number of established businesses in the biotechnology field. Mr. Catelani began his professional career at Ernst &amp; Young and is a CPA. He received his B.S. degree in business administration, with a concentration in accountancy, from Sacramento State University and earned his MBA from the University of California, Davis.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>37</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><a href=#TC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="BACKGROUND:white; COLOR:black">Except for Drs. Kumar and Monahan, none of our current directors or executive officers has served as a director of another public company within the past five years.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>There are no family relationships between or among the directors, executive officers or persons nominated or chosen by the Company to become directors or executive officers.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="BACKGROUND:white; COLOR:black">To the best of our knowledge, during the past ten years, none of the following occurred with respect to a present or former director or executive officer of the Company: (1) any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time; (2) any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses); (3) being subject to any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his or her involvement in any type of business, securities or banking activities; (4) being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodities Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended or vacated; (5) being subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree or finding relating to an alleged violation of the federal or state securities, commodities, banking or insurance laws or regulations or any settlement thereof or involvement in mail or wire fraud in connection with any business entity not subsequently reversed, suspended or vacated and (6) being subject of, or a party to, any disciplinary sanctions or orders imposed by a stock, commodities or derivatives exchange or other self-regulatory organization</font><font style=COLOR:black>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>38</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 8pt; LINE-HEIGHT:107%; TEXT-AUTOSPACE:ideograph-numeric'><a href=#TC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=14>COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Executive Compensation</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">The following table sets forth certain information for the fiscal years ended October 31, 2016 and 2015, with respect to compensation awarded to, earned by or paid to our Executive Chairman, our Chief Executive Officer and our Chief Financial Officer (the &#147;Named Executive Officers&#148;).&nbsp; No other executive officer received total compensation in excess of $100,000 during fiscal year 2016.&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><br>&nbsp;</font></p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=100% colspan=7 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>SUMMARY COMPENSATION TABLE</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=38% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:38.4%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.7%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.58%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.68%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.34%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>All Other</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Compensation</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>($) (3)</font></p></td> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:14.12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Total</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Compensation</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>($)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=38% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:38.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Name and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Principal Position</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.7%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Salary</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>($)</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.68%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Bonus</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>($)</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.34%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Option Awards</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>($) (2)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.7%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Year</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=38% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:38.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Dr. Amit Kumar (1)</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.7%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>2016</font></p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.58%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$300,000</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.68%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$200,000</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.34%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$566,896</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.18%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$12,000</font></p></td> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:14.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$1,078,896</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=38% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:38.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Executive Chairman of the Board</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>2015</font></p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.58%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$112,500</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.68%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp; $-</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.34%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$-</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.18%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$-</font></p></td> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:14.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$112,500</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=38% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:38.4%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Robert A. Berman</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.7%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>2016</font></p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.58%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$300,000</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.68%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$200,000</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.34%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$566,896</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.18%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$-</font></p></td> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:14.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$1.066,896</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=38% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:38.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Chief Executive Officer and Director</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.7%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>2015</font></p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$300,000</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.68%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$150,000</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.34%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$169,081</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$4,160</font></p></td> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:14.12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$623,241</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=38% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:38.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Henry P. Herms (4)</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.7%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>2016</font></p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.58%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$87,500</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.68%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$-</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.34%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$85,034</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.18%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$-</font></p></td> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:14.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$172,534</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=38% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:38.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Chief Financial Officer, Vice President- Finance</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>2015</font></p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.58%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$168,000</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.68%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$-</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.34%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$16,252</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:11.18%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$-</font></p></td> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:14.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$184,252</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style=COLOR:black>1)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>On&nbsp;June 15, 2015 Dr. Kumar was appointed Vice Chairman of the Company and Executive Chairman of Anixa Diagnostics Corporation, a wholly-owned subsidiary of the Company. The above table represents Dr. Kumar&#146;s compensation subsequent to June 15, 2015.&nbsp; Prior to that date Dr. Kumar received compensation for his services as a consultant.<font style=BACKGROUND:white>For more information about Dr. Kumar&#146;s consultancy arrangements, see the section entitled &#147;Transactions with Related Persons&#148; below.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style=COLOR:black>2)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style=COLOR:black>Amounts in the Option Awards column represent the aggregate grant date fair value of stock option awards made during the fiscal years ended October 31, 2016 for each Named Executive Officer in accordance with Accounting Standards Codification (&#147;ASC&#148;) 718 and also reflects the repricing of outstanding options on February 5, 2015. &nbsp;A discussion of assumptions used in valuation of option awards may be found in Note 3 to our Consolidated Financial Statements for fiscal year ended October 31, 2016, included elsewhere in this Annual Report on Form 10-K.&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style=COLOR:black>3)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style=COLOR:black>Amounts in the All Other Compensation column reflect, for each Named Executive Officer, the sum of the incremental cost to us of all perquisites and personal benefits, which for Dr. Kumar consisted solely of compensation for use of a home office, and for Mr. Berman consisted solely of life insurance premiums.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style=COLOR:black>4)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style=COLOR:black>Mr. Herms resigned his position as Chief Financial Officer, Vice President-Finance on November 1, 2016. Mr. Herms retired from the Company on December 31, 2016.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><b><font style="FONT-SIZE:10pt; COLOR:black">Employment Agreements</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in'><b><i><font style="FONT-SIZE:10pt; COLOR:black">Employment Agreement with Robert Berman</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">On September 19, 2012, the Company entered into an Employment Agreement with Mr. Berman (the &#147;Berman Agreement&#148;) to serve as President and Chief Executive Officer of the Company.&nbsp; Pursuant to the Berman Agreement, Mr. Berman initially received an annual base salary of $290,000, which was increased to $300,000 by the Board effective November 1, 2013. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">If Mr. Berman&#146;s employment is terminated by the Company or he terminates his employment for any reason or no reason, the Company shall be obligated to pay to Mr. Berman only any earned compensation and/or bonus due under the Berman Agreement, any unpaid reasonable and necessary expenses, and any accrued and unpaid benefits due to him in accordance with the terms and conditions of the Company&#146;s benefit plans and policies including any accrued but unpaid vacation up to the cap of 20 days through the date of termination.&nbsp; All such payments shall be made in a lump sum immediately following termination as required by law.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>39</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#TC><font color=#0066cc>Table of Contents</font></a><br></font><br></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Consulting Agreement with Amit Kumar</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>On September 19, 2012, the Company entered into a Consulting Agreement with Dr. Amit Kumar (the&nbsp;&#147;Kumar Agreement&#148;) pursuant to which Dr. Kumar agreed to provide business consulting services for an initial annual consulting fee of $120,000. On June 15, 2015, Dr. Kumar was appointed Vice Chairman of the Company and Executive Chairman of Anixa Diagnostics Corporation, a wholly-owned subsidiary of the Company. As a result of this appointment, Dr. Kumar&#146;s cash compensation was increased to $300,000 by the Board. The terms of the Kumar Agreement still remain in effect.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>If Dr. Kumar&#146;s services are terminated by the Company or he terminates his services for any reason or no reason, the Company shall be obligated to pay to Dr. Kumar only any earned compensation and/or bonus due under the Kumar Agreement and any unpaid reasonable and necessary expenses, due to him through the date of termination.&nbsp; All such payments shall be made in a lump sum immediately following termination.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><b><font style="FONT-SIZE:10pt; COLOR:black">Stock Options</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">The following table sets forth certain information with respect to unexercised stock options held by the Named Executive Officers outstanding on October 31, 2016:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.4pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:30pt> <td width=100% colspan=5 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:30pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END TABLE</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=100% colspan=5 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Option Awards</font></p></td></tr> <tr style=HEIGHT:45pt> <td width=28% nowrap style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Number of Securities Underlying Unexercised Options (#)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Exercisable</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Number of Securities Underlying Unexercised Options (#)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Un-Exercisable</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Option Exercise Price</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">($)</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Option Expiration<font size=+0>&nbsp;</font><br>Date</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Name</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Dr. Amit Kumar</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">320,000(1)</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.575</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">9/19/2022</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">106,667(2)</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.575</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">9/19/2022</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">213,333(3)</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.575</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">9/19/2022</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">38,889(4)</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">1,111(4)</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.575</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">11/8/2023</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">44,444(5)</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;155,556(5)</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.920</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">2/18/2026</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Robert A. Berman</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">320,000(1)</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.575</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">9/19/2022</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">106,667(2)</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.575</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">9/19/2022</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">213,333(3)</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.575</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">9/19/2022</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">38,889(4)</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">1,111(4)</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.575</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">11/8/2023</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">44,444(5)</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">155,556(5)</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.920</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">2/18/2026</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Henry P. Herms (6)</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">3,000</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.575</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">11/11/2017</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">4,000</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.575</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">10/7/2019</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">4,000</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.575</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">6/1/2021</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">12,000</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.575</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">9/19/2022</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">21,389(4)</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">611(4)</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.575</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">11/8/2023</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:28.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">6,667(5)</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.84%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">23,333(5)</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:12.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.920</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.16%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">2/18/2026</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>40</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p 0in 12pt? roman?,?serif?; text-align:left; new margin: style="FONT-SIZE:12pt; FONT-FAMILY:" times align=left><font style="FONT-SIZE:10pt; COLOR:black"><a href=#TC><font color=#0066cc>Table of Contents</font></a><br><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">1)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">Options vested and became exercisable in 36 consecutive monthly installments, beginning October 31, 2012 and continuing through September 30, 2015.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">2)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">Options vested upon achievement of a cash milestone.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">3)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">Options were to vest in two equal installments upon achievement of certain stock price targets.&nbsp; On November 8, 2013, the vesting conditions were modified by the Board to provide that the unvested portion of the stock options vest in 23<font style=LETTER-SPACING:-0.15pt>&nbsp;consecutive monthly installments, commencing on November 30, 2013 through September 30, 2015.&nbsp;</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">4)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">Options vest and became exercisable in 36 consecutive monthly installments, beginning December 31, 2013 and continuing through November 30, 2016.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">5)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">Options vest and became exercisable in 36 consecutive monthly installments, beginning March 31, 2016 and continuing through February 28, 2019.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">6)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">On December 19, 2016, the Board amended all of Mr. Herms&#146; option awards in connection with Mr. Herms&#146; retirement such that all unvested options vested on December 31, 2016.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">The following table summarizes stock option grants during fiscal year 2016.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=100% colspan=5 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">GRANTS OF PLAN BASED AWARDS TABLE</font></p></td></tr> <tr style=HEIGHT:47.25pt> <td width=24% style="BORDER-TOP:0px; HEIGHT:47.25pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:24.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=16% style="BORDER-TOP:0px; HEIGHT:47.25pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:16.7%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:47.25pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">All Other Option Awards: Number of Securities Underlying Options</font></p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:47.25pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:15.4%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Exercise Price of Option Awards</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:47.25pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Grant Date<font size=+0>&nbsp;</font><br>Fair Value</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=24% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:24.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Name</font></p></td> <td width=16% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:16.7%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Grant Date</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">(#)</font></p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:15.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">($)</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">($)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=24% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:24.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Dr. Amit Kumar</font></p></td> <td width=16% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:16.7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">2/18/16</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">200,000</font></p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:15.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.920</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$566,896</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=24% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:24.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Robert A. Berman</font></p></td> <td width=16% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:16.7%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">2/18/16</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">200,000</font></p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:15.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.920</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$566,896</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=24% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:24.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Henry P. Herms</font></p></td> <td width=16% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:16.7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">2/18/16</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">30,000</font></p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:15.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.920</font></p></td> <td width=21% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:21.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$85,034</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">The following table summarizes the exercise of stock options during fiscal 2016 by Named Executive Officers:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;</font></p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=30% colspan=3 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">OPTION EXERCISES AND STOCK VESTED TABLE</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=40% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:40%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <td width=30% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Option Awards</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=40% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:40%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Number of Shares</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Acquired on Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">(#)</font></p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Value Realized</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">on Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">($) (1)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=40% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:40%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=40% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:40%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Name</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=40% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:40%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Henry P. Herms</font></p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">4,000</font></p></td> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$9,060</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:13.8pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:13.8pt; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">1)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">The value realized on exercise is calculated based on the difference between the exercise price of the options and the market price of the stock at the time of exercise.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>41</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div><font style=FONT-SIZE:10pt color=#0066cc> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><br><a href=#TC><font style=FONT-SIZE:10pt>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; LINE-HEIGHT:13.8pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style="FONT-SIZE:10pt; COLOR:black">Potential Payments upon Termination or Change in Control</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'></font>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;&nbsp;&nbsp;&nbsp; </font><b><i>Dr. Amit Kumar</i></b></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Options granted Dr. Kumar on November 8, 2013 and February 18, 2016 provide for the vesting of the unvested portion of his options to be accelerated and such accelerated options to become immediately exercisable if Dr. Kumar is terminated without cause or upon a change in control as defined below. The intrinsic value of options granted on&nbsp;November 8, 2013 would be $4,194,&nbsp;which was calculated by multiplying (a) 1,111 options (being the number of options granted to him on November 8, 2013 that would be accelerated) by (b) an amount equal to the excess of (x) our closing share price on October 31, 2016 of $6.35 and (y) the options&#146; exercise price of $2.575 per share. The intrinsic value of options granted on February 18, 2016 would be $533,557,&nbsp;which was calculated by multiplying (a) 155,556 options (being the number of options granted to him on February 18, 2016 that would be accelerated) by (b) an amount equal to the excess of (x) our closing share price on October 31, 2016 of $6.35 and (y) the options&#146; exercise price of $2.92 per share.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><b><i><font style="FONT-SIZE:10pt; COLOR:black">Robert A. Berman</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Options granted Mr. Berman on November 8, 2013 and February 18, 2016 provide for the vesting of the unvested portion of his options to be accelerated and such accelerated options to become immediately exercisable if Mr. Berman is terminated without cause or upon a change in control as defined below. The intrinsic value of options granted on November 8, 2013 would be $4,194,&nbsp;which was calculated by multiplying (a) 1,111 options (being the number of options granted to him on November 8, 2013 that would be accelerated) by (b) an amount equal to the excess of (x) our closing share price on October 31, 2016 of $6.35 and (y) the options&#146; exercise price of $2.575 per share. The intrinsic value of options granted on February 18, 2016 would be $533,557,&nbsp;which was calculated by multiplying (a) 155,556 options (being the number of options granted to him on February 18, 2016 that would be accelerated) by (b) an amount equal to the excess of (x) our closing share price on October 31, 2016 of $6.35 and (y) the options&#146; exercise price of $2.92 per share.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In addition to the acceleration of the options,&nbsp;if Mr. Berman&#146;s employment is terminated by the Company or he terminates his employment for any reason or no reason, the Company shall be obligated to pay to Mr. Berman only any earned compensation and/or bonus due under the Berman Agreement, any unpaid reasonable and necessary expenses, and any accrued and unpaid benefits due to him in accordance with the terms and conditions of the Company&#146;s benefit plans and policies including any accrued but unpaid vacation up to the cap of 20 days through the date of termination (which accrued and unpaid benefits would have a maximum value of $23,077).</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">It is the intent that this definition be construed consistent with the definition of &#147;Change of Control&#148; as defined under Code Section 409A and the applicable treasury regulations, as amended from time to time.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <h5 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'><font style=COLOR:black>Director&#146;s Compensation</font></h5> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:40.5pt'><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">There is no present arrangement for cash compensation of directors for services in that capacity.&nbsp;Consistent with the non-employee director compensation approved on March 28, 2013 for calendar year 2013, on November 8, 2013, the Board approved an amendment to the 2010 Share Incentive Plan to provide that on January 1st of each year commencing on January 1, 2014, each non-employee director (a &#147;Director Participant&#148;) of the Company at that time shall automatically be granted a 10 year nonqualified stock option to purchase 12,000 shares of common stock (or 16,000 in the case of the Chairman of the Board to the extent he qualifies as a Director Participant), with an exercise price equal to the closing price on the date of grant, that will vest in four equal quarterly installments in the year of grant.&nbsp; In addition, each person who is a Director Participant and joins the Board after January 1 of any year, shall be granted on the date such person joins the Board, a nonqualified stock option to purchase 12,000 shares of common stock (or 16,000 in the case of the Chairman of the Board) pro-rated based upon the number of calendar quarters remaining in the calendar year in which such person joins the Board (rounded up for partial quarters).&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">Our employee directors, Dr. Amit Kumar and Robert A. Berman, did not receive any additional compensation for services provided as a director during fiscal year 2016.&nbsp; The following table sets forth compensation of Dale Fox and Drs. Arnold Baskies and John Monahan, our non-employee directors, and Lewis H. Titterton and Bruce F. Johnson, our former non-employee directors, for fiscal year 2016:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>42</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#TC>Table of Contents</a></font></p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:26.25pt> <td width=100% colspan=4 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:26.25pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">DIRECTORS COMPENSATION</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=32% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">All Other</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=32% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Option Awards</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Bonus</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Compensation</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=32% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Name</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">($) (1)</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">($)</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">($)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=32% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Dale Fox</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$33,939</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$ -</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$ -</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=32% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Dr. Arnold Baskies</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$18,240</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$ -</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$ -</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=32% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Dr. John Monahan</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$18,240</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$ -</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$ -</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=32% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Lewis H. Titterton</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$45,251</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$ -</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$ -</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=32% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Bruce F. Johnson</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$38,939</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$ -</font></p></td> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.46%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$ -</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">1)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">Amounts in the Option Awards column represent the aggregate grant date fair value of stock option awards made during the fiscal year ended October 31, 2016, in accordance with ASC 718</font><font style="FONT-SIZE:10pt; COLOR:black">. &nbsp;A discussion of assumptions used in valuation of option awards may be found in Notes 3 to our Consolidated Financial Statements for fiscal year ended October 31, 2016, included elsewhere in this Annual Report on Form 10-K.&nbsp;<font style=BACKGROUND:white>At October 31, 2016, Dale Fox and Drs. Arnold Baskies and John Monahan, and Lewis Titterton and Bruce Johnson held unexercised stock options to purchase 30,000, 6,000, 6,000, 256,400 and 52,800 shares respectively, of our common stock.</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>43</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TC><font color=#0066cc>Table of Contents</font></a><br></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style='FONT-FAMILY:"Times New Roman Bold","serif"; TEXT-TRANSFORM:uppercase; COLOR:black'><a name=15>Transactions with Related Persons</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Aside from compensation arrangements with executive officers described above, there are no other transactions entered into by the Company with related persons.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><font style=COLOR:black>Related Person Transaction Approval Policy</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>While we have no written policy regarding approval of transactions between us and a related person, our Board, as matter of appropriate corporate governance, reviews and approves all such transactions, to the extent required by applicable rules and regulations. Generally, management would present to the Board for approval at the next regularly scheduled Board meeting any related person transactions proposed to be entered into by us.&nbsp; The Board may approve the transaction if it is deemed to be in the best interests of our stockholders and the Company.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><b><font style=COLOR:black>&nbsp;&nbsp; Director Independence</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our Board oversees the activities of our management in the handling of the business and affairs of our company.&nbsp; Our common stock trades on the NASDAQ Capital Markets and we are subject to listing requirements which include the requirement that our Board be comprised of a majority of &#147;independent&#148; directors.&nbsp; Dale Fox and Drs. Arnold Baskies and John Monahan currently meet the definition of &#147;independent&#148; as defined by the SEC. The Board of Directors has separately designated audit, nominating and compensation committees. Our directors, Robert A. Berman and Dr. Amit Kumar, are employees of the Company and as such do not qualify as &#147;independent&#148; directors.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>44</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p left; 0in text-align: roman?,?serif?; new margin: 0pt? style="FONT-SIZE:10pt; FONT-FAMILY:" times align=left><a href=#TC><font color=#0066cc>Table of Contents</font></a></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>&nbsp;</font></b><b><font style='FONT-FAMILY:"Times New Roman Bold","serif"; TEXT-TRANSFORM:uppercase; COLOR:black'><a name=16>Beneficial Ownership of Principal Stockholders, Officers and Directors</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">The following table sets forth certain information with respect to our common stock beneficially owned as of November 30, 2016 (or exercisable within 60 days of such date) by (a) each person who is known by our management to be the beneficial owner of more than 5% of our outstanding common stock, (b) each of our directors and executive officers, and (c) all directors and executive officers as a group:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=281 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:211pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:2pt 0in'><u><font style=FONT-SIZE:10pt>NAME AND ADDRESS OF BENEFICIAL OWNER</font></u></p></td> <td width=174 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:130.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:2pt 0in' align=center><font style=FONT-SIZE:10pt>AMOUNT AND NATURE OF BENEFICIAL <u>OWNERSHIP<font size=+0>&nbsp;</font>(1)(2)(3)(4)</u></font></p></td> <td width=115 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:2pt 0in' align=center><u><font style=FONT-SIZE:10pt>PERCENT OF CLASS<br>(5)</font></u></p></td></tr> <tr> <td width=571 colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:427.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:2pt 0in' align=center><i><font style=FONT-SIZE:10pt>DIRECTORS AND OFFICERS OF THE COMPANY</font></i></p></td></tr> <tr> <td width=281 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:211pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 2.7pt'><font style=FONT-SIZE:10pt>DR. AMIT KUMAR</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>12100 WILSHIRE BOULEVARD, SUITE 1275</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 2.7pt'><font style=FONT-SIZE:10pt>LOS ANGELES, CA 90025</font></p></td> <td width=174 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:130.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt' align=center><font style=FONT-SIZE:10pt>847,533</font></p></td> <td width=115 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>8.93%</font></p></td></tr> <tr> <td width=281 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:211pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>ROBERT A. BERMAN<br>12100 WILSHIRE BOULEVARD, SUITE 1275</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 2.7pt'><font style=FONT-SIZE:10pt>LOS ANGELES, CA 90025</font></p></td> <td width=174 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:130.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt' align=center><font style=FONT-SIZE:10pt>786,683</font></p></td> <td width=115 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>8.29%</font></p></td></tr> <tr> <td width=281 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:211pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>DALE FOX</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>12100 WILSHIRE BOULEVARD, SUITE 1275</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>LOS ANGELES, CA 90025</font></p></td> <td width=174 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:130.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>30,000</font></p></td> <td width=115 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>*</font></p></td></tr> <tr> <td width=281 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:211pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>DR. ARNOLD BASKIES<br>12100 WILSHIRE BOULEVARD, SUITE 1275</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>LOS ANGELES, CA 90025</font></p></td> <td width=174 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:130.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt' align=center><font style=FONT-SIZE:10pt>7,000</font></p></td> <td width=115 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>*</font></p></td></tr> <tr> <td width=281 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:211pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>DR. JOHN MONAHAN<br>12100 WILSHIRE BOULEVARD, SUITE 1275</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>LOS ANGELES, CA 90025</font></p></td> <td width=174 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:130.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt' align=center><font style=FONT-SIZE:10pt>6,000</font></p></td> <td width=115 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>*</font></p></td></tr> <tr> <td width=281 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:211pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>MICHAEL J. CATELANI<br>12100 WILSHIRE BOULEVARD, SUITE 1275</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 2.7pt'><font style=FONT-SIZE:10pt>LOS ANGELES, CA 90025</font></p></td> <td width=174 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:130.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt' align=center><font style=FONT-SIZE:10pt>-</font></p></td> <td width=115 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>-</font></p></td></tr> <tr> <td width=281 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:211pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>ALL DIRECTORS AND EXECUTIVE OFFICERS AS A GROUP (6 PERSONS)</font></p></td> <td width=174 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:130.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt' align=center><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp; 1,677,216</font></p></td> <td width=115 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>16.32%</font></p></td></tr> <tr> <td width=571 colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:427.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><i><font style=FONT-SIZE:10pt>5% STOCKHOLDERS OF THE COMPANY</font></i></p></td></tr> <tr> <td width=281 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:211pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>LEWIS H. TITTERTON</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>1900 PURDY AVENUE, UNIT 2904</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>MIAMI BEACH, FL 33139</font></p></td> <td width=174 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:130.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt' align=center><font style=FONT-SIZE:10pt>802,812</font></p></td> <td width=115 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>8.91%</font></p></td></tr> <tr> <td width=281 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:211pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>BRUCE F. JOHNSON</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>6519 SHABBONA ROAD<br>INDIAN HEAD PARK, IL 60525</font></p></td> <td width=174 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:130.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt' align=center><font style=FONT-SIZE:10pt>471,919</font></p></td> <td width=115 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>5.36%</font></p></td></tr> <tr> <td width=281 style="WIDTH:211pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><br>* LESS THAN 1%.</font></p></td> <td width=174 style="WIDTH:130.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=115 style="WIDTH:1.2in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">1)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">A beneficial owner of a security includes any person who directly or indirectly has or shares voting power and/or investment power with respect to such security or has the right to obtain such voting power and/or investment power within sixty (60) days.&nbsp; Except as otherwise noted, each designated beneficial owner in this Annual Report on Form 10-K has sole voting power and investment power with respect to the shares of common stock beneficially owned by such person.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">2)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style="FONT-SIZE:10pt; COLOR:black">Includes 101,125 shares, 101,125 shares, 30,000 shares, 6,000 shares, 6,000 shares, and 244,250 shares which Dr. Amit Kumar, Robert A. Berman, Dale Fox, Dr. Arnold Baskies, Dr. John Monahan and all directors and executive officers as a group, respectively, and 170,400 shares and 40,800 shares which Lewis H.<font size=+0>&nbsp;</font>Titterrton<font size=+0>&nbsp;</font>and Bruce Johnson, respectively, have the right to acquire within 60 days upon exercise of options granted pursuant to the 2003<font size=+0>&nbsp;</font>Share Incentive Plan<font size=+0>&nbsp;</font>and/or the 2010<font size=+0>&nbsp;</font>Share Incentive Plan.&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>45</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#TC>Table of Contents</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">3)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style="FONT-SIZE:10pt; COLOR:black">Includes 2,000 shares that Dr. Amit Kumar and all directors and executive officers as a group, respectively, and 2,000 shares that Lewis H. Titterton have the right to acquire within 60 days upon exercise of warrants purchased by them in the private placement on July 15, 2014.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">4)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style="FONT-SIZE:10pt; COLOR:black">Includes 640,000 shares, 640,000 shares and 1,280,000 shares which Dr. Amit Kumar, Robert A. Berman and all directors and executive officers as a group, respectively, and 86,000 shares and 12,000 shares that Lewis H. Titterton and Bruce Johnson, respectively, have the right to acquire within 60 days pursuant to option agreements with the Company.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">5)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">Based on 8,752,387 shares of common stock outstanding as of November 30, 2016.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-INDENT:-0.25in'><b><font style="FONT-SIZE:10pt; COLOR:black">Change in Control</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">We are not aware of any arrangement that might result in a change in control of the Company in the future.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-INDENT:-0.25in'>&nbsp;</p> <h5 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'><font style=COLOR:black>Equity Compensation Plan Information</font></h5> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">The following is information as of October 31, 2016 about shares of our common stock that may be issued upon the exercise of options, warrants and rights under all equity compensation plans in effect as of that date, including our 2003 Share Incentive Plan and our 2010 Share Incentive Plan.&nbsp; See Note 5 to Consolidated Financial Statements for more information on these plans.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:141pt> <td width=35% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:141pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:35.8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style="FONT-SIZE:10pt; COLOR:black">Plan category</font></b></p></td> <td width=2% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:141pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:2.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=18% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:141pt; BORDER-RIGHT:0px; WIDTH:18.54%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">Number of securities to be issued upon exercise of outstanding options, warrants and rights&nbsp;<font size=+0>&nbsp;</font><br>(a)</font></b></p></td> <td width=2% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:141pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:2.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:141pt; BORDER-RIGHT:0px; WIDTH:18.54%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">Weighted average exercise price of outstanding options, warrants and rights</font></b></p></td> <td width=2% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:141pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:2.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:141pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.54%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column<br>&nbsp;(a)</font></b></p></td></tr> <tr style=HEIGHT:15pt> <td width=35% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:35.8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:2.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:18.54%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:2.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:18.54%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:2.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.54%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=35% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:35.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Equity compensation plans not approved by security holders (1)(2)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:2.86%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:18.54%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">3,086,472</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:2.86%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:18.54%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">$4.02</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:2.86%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <td width=18% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:18.54%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">431,956</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">1)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10pt; COLOR:black">On<font size=+0>&nbsp;</font>April 23, 2003 the Board adopted the 2003 Share Incentive Plan.&nbsp; Officers, key employees and non-employee directors of, and consultants to, the Company or any of its subsidiaries and affiliates were eligible to participate in the 2003 Share Incentive Plan.&nbsp; The 2003 Share Incentive Plan provided for the grant of stock options, stock appreciation rights, stock awards, performance awards and stock units (the &#147;2003 Benefits&#148;).&nbsp; The maximum number of shares of common stock available for issuance under the 2003 Share Incentive Plan was 2,800,000.&nbsp;<font size=+0>&nbsp;</font>The 2003 Share Incentive Plan was administered by the Stock Option Committee through June 2004, from June 2004 through July 2010, by the Board of Directors, from July 2010 through August 2012, by the Stock Option Committee, from August 2012 through November 2012, by the Executive Committee of the Board of Directors, from November 2012 to July 2015, by the Board of Directors and since July 2015 by the Compensation Committee, which determined the option price, term and provisions of the 2003 Benefits.&nbsp;<font size=+0>&nbsp;</font>&nbsp;&nbsp;The 2003 Share Incentive Plan contains provisions for equitable adjustment of the 2003 Benefits in the event of a merger, consolidation, reorganization, recapitalization, stock dividend, stock split, reverse stock split, spinoff, combination of shares, exchange of shares, dividends in kind or other like change in capital structure or distribution (other than normal cash dividends) to stockholders of the Company.&nbsp; The 2003 Share Incentive Plan terminated with respect to additional grants on April 21, 2013.&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">46</font></p> <hr> <p style="page-break-after:always;"></p> <p left; 0in text-align: 12pt? roman?,?serif?; new margin: style="FONT-SIZE:12pt; FONT-FAMILY:" times align=left><font style="FONT-SIZE:10pt; COLOR:black"><a href=#TC><font color=#0066cc>Table of Contents</font></a><br></font>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; COLOR:black">2)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style="FONT-SIZE:10pt; COLOR:black">On July 14, 2010 the Board adopted the 2010 Share Incentive Plan.&nbsp; Officers, key employees and non-employee directors of, and consultants to, the Company or any of its subsidiaries and affiliates are eligible to participate in the 2010 Share Incentive Plan.&nbsp; The 2010 Share Incentive Plan provides for the grant of stock options, stock appreciation rights, stock awards, and performance awards and stock units (the &#147;2010 Benefits&#148;).&nbsp; The maximum number of shares of common stock available for issuance under the 2010 Share Incentive Plan was initially 600,000 shares.&nbsp;&nbsp; On July 6, 2011 and August 29, 2012, the 2010 Share Incentive Plan was amended by our Board to increase the maximum number of shares of common stock that may be granted to 1,080,000 and 1,200,000 shares, respectively.&nbsp;<font size=+0>&nbsp;</font>On November 8<font style=LETTER-SPACING:-0.15pt>, 2013</font>, the Board approved an amendment to provide that effective and following November<font size=+0>&nbsp;</font><font style=LETTER-SPACING:-0.15pt>8, 2013</font>, the maximum aggregate number of shares available for issuance will be 800,000 shares.&nbsp; Additionally, commencing on the first business day in 2014 and on the first business day of each calendar year thereafter, the maximum aggregate number of shares available for issuance shall be replenished such that, as of such first business day, the maximum aggregate number of shares available for issuance shall be 800,000 shares.<font size=+0>&nbsp;</font>Current and future non-employees directors are automatically granted<font size=+0>&nbsp;</font>a 10 year nonqualified stock option to purchase 12,000 shares of Common Stock (or 16,000 in the case of the Chairman of the Board)<font size=+0>&nbsp;</font>on<font size=+0>&nbsp;</font>January 1st of each year that will vest in four equal quarterly installments.&nbsp;<font size=+0>&nbsp;</font>The 2010 Share Incentive Plan was administered by the Stock Option Committee through August 2012, from August 2012 through November 2012, by the Executive Committee of the Board of Directors, from November 2012 through July 2015, by the Board of Directors and since July 2015, by the Compensation Committee, which determines the option price, term and provisions of the 2010 Benefits.&nbsp; The 2010 Share Incentive Plan terminates with respect to additional grants on July 14, 2020.&nbsp; The Board may amend, suspend or terminate the 2010 Share Incentive Plan at any time.</font></p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all></font></b> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=17>EXPERTS</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.35pt' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The consolidated financial statements of ITUS Corporation and subsidiaries as of October 31, 2016 and 2015, and for each of the years in the two-year period ended October 31, 2016, have been included in the registration statement in reliance upon the report of Haskell &amp; White LLP, independent registered public accounting firm, and upon the authority of said firm as experts in accounting and auditing. The report of Haskell &amp; White LLP includes an explanatory paragraph expressing substantial doubt regarding the Company&#146;s ability to continue as a going concern as described in Note 1 to the Company&#146;s consolidated financial statements.&nbsp;&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.35pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=18>LEGAL MATTERS</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.35pt' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The validity of the common stock being issued pursuant to this registration statement have been passed upon for us by Ellenoff Grossman &amp; Schole LLP located at 1345 Avenue of the Americas, New York, NY 10105.&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=19>DISCLOSURE OF COMMISSION POSITION OF</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=19>&nbsp;INDEMNIFICATION FOR SECURITIES ACT LIABILITIES</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.35pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our directors and officers are indemnified to the fullest extent permitted under Delaware law. We may also purchase and maintain insurance which protects our officers and directors against any liabilities incurred in connection with their service in such a capacity, and such a policy may be obtained by us in the future.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.35pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the foregoing, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by us of expenses incurred or paid by a director, officer or controlling person of ours in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.35pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=20>WHERE YOU CAN FIND ADDITIONAL INFORMATION</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.35pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We have filed with the SEC a registration statement on Form S-1 under the Securities Act, which registers certain of our shares of common stock for public resale.&nbsp; This prospectus, which is part of such registration statement, omits certain information, exhibits, schedules and undertakings set forth in the registration statement. For further information pertaining to us and our common stock, reference is made to the registration statement and the exhibits and schedules to the registration statement. Statements contained in this prospectus as to the contents or provisions of any documents referred to in this prospectus are not necessarily complete, and in each instance where a copy of the document has been filed as an exhibit to the registration statement, reference is made to the exhibit for a more complete description of the matters involved.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.35pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We file reports, proxy statements and other information with the SEC. Information filed with the SEC by us can be inspected and copied at the Public Reference Room maintained by the SEC at 100 F Street, N.E., Washington, D.C. 20549. You may also obtain copies of this information by mail from the Public Reference Section of the SEC at prescribed rates. Further information on the operation of the SEC&#146;s Public Reference Room in Washington, D.C. can be obtained by calling the SEC at 1-800-SEC-0330. The SEC also maintains a web site that contains reports, proxy and information statements and other information about issuers, such as us, who file electronically with the SEC. The address of that website is<i> www.sec.gov</i>.&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.35pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>47</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 27.5pt 0pt 0in; TEXT-AUTOSPACE:'><a href=#TC><font color=#0066cc>Table of Contents</font></a></p><font style='FONT-SIZE:2pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>You should rely only on the information contained in this document. We have not authorized anyone to provide you with information that is different. This document may only be used where it is legal to issue these securities. The information in this document may only be accurate on the date of this document.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Additional risks and uncertainties not presently known or that are currently deemed immaterial may also impair our business operations. The risks and uncertainties described in this document and other risks and uncertainties which we may face in the future will have a greater impact on those who purchase our common stock. These purchasers will purchase our common stock at the market price or at a privately negotiated price and will run the risk of losing their entire investment.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>ITUS CORPORATION</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>947,606 Shares of</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Common Stock</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:1.1pt 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 173.8pt 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 173.8pt 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>PROSPECTUS</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 173.8pt 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 173.8pt 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:1.1pt 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 173.8pt 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 173.8pt 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2017</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>48</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p left; 0in text-align: roman?,?serif?; new margin: 173.8pt 0pt? style="FONT-SIZE:10pt; FONT-FAMILY:" times align=left><a href=#TC><font color=#0066cc>Table of Contents</font></a></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><a name=INDEX>INDEX TO FINANCIAL STATEMENTS</a></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550.1pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0 align=center> <tr style=HEIGHT:15pt> <td width=83% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:83.32%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>&nbsp;</p> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt>INDEX&nbsp;TO&nbsp;CONSOLIDATED FINANCIAL&nbsp;STATEMENTS</font></font></b></p></font></font></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=83% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:83.32%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt>October 31, 2016</font></font></b></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=83% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:83.32%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt>Page</font></font></p></td></tr> <tr style=HEIGHT:15pt> <td width=85% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=85% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt><a href=#21>Report of Independent Registered Public Accounting Firm </a></font></font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt>F-1</font></font></p></td></tr> <tr style=HEIGHT:15pt> <td width=85% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=85% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt><a href=#22>Consolidated Balance Sheets as of October 31, 2016 and 2015 </a></font></font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt>F-2</font></font></p></td></tr> <tr style=HEIGHT:15pt> <td width=85% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=85% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt><a href=#23>Consolidated Statements of Operations for the years ended October 31, 2016 and 2015 </a></font></font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt>F-3</font></font></p></td></tr> <tr style=HEIGHT:15pt> <td width=85% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=85% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt><a href=#STOCK>Consolidated Statements of Shareholders&#146; Equity for the years ended October 31, 2016 and 2015 </a></font></font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt>F-4</font></font></p></td></tr> <tr style=HEIGHT:15pt> <td width=85% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=85% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt><a href=#CF>Consolidated Statements of Cash Flows for the years ended October 31, 2016 and 2015 </a></font></font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt>F-5</font></font></p></td></tr> <tr style=HEIGHT:15pt> <td width=85% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=85% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:85%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt><a href=#NOTES>Notes to Consolidated Financial Statements </a></font></font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><font style=FONT-SIZE:10pt>F-6&nbsp; &#150;&nbsp; F-24</font></font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 173.8pt 11pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>Additional information required by schedules called for under Regulation S-X is either not applicable or is included in the consolidated financial statements or notes thereto.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><font style=FONT-SIZE:10pt>49</font></p><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><font style=FONT-SIZE:9pt> <hr> <p style="page-break-after:always;"></p></font></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:11pt><br><font style=FONT-SIZE:10pt color=#0066cc><a href=#TC>Table of Contents</a></font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><b><font style="FONT-SIZE:10pt; COLOR:black"><a name=21>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; page:WordSection2'><font style=FONT-SIZE:10pt>To The Board of Directors and Shareholders</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0.25in; TEXT-AUTOSPACE:ideograph-numeric; page:WordSection2'><font style=FONT-SIZE:10pt>ITUS Corporation</font></p> <p text-autospace: 0in text-align: wordsection2? page: 0pt; roman?,?serif?; ; new margin: style="FONT-SIZE:12pt; FONT-FAMILY:; page:WordSection2" justify; times align=justify><font new roman?,?serif?? style="FONT-SIZE:10pt; FONT-FAMILY:" times>We have audited the accompanying consolidated balance sheets of ITUS Corporation (the&nbsp;&#147;Company&#148;) as of October 31, 2016 and 2015, and the related consolidated statements of operations, shareholders&#146; equity, and cash flows for each of the years ended October 31, 2016 and 2015.&nbsp;These consolidated financial statements are the responsibility of the Company&#146;s management.&nbsp; Our responsibility is to express an opinion on these consolidated financial statements based on our audits.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).&nbsp; Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement.&nbsp; The Company has determined that it is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.&nbsp; Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company&#146;s internal control over financial reporting.&nbsp; Accordingly, we express no such opinion.&nbsp; An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements.&nbsp; An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall consolidated financial statement presentation.&nbsp;We believe that our audits provide a reasonable basis for our opinion.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of the Company as of October 31, 2016 and 2015, and the consolidated results of its operations and its cash flows for each of the years ended October 31, 2016 and 2015, in conformity with accounting principles generally accepted in the United States.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has limited working capital and limited revenue-generating operations and a history of net losses and net operating cash flow deficits. These conditions raise substantial doubt about the Company&#146;s ability to continue as a going concern. Management&#146;s plans regarding these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>/s/ Haskell &amp; White LLP</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>HASKELL &amp; WHITE LLP</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 8pt; TEXT-AUTOSPACE:ideograph-numeric; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric; page:WordSection2'><font style=FONT-SIZE:10pt>Irvine, California<br>December 7, 2016</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric; page:WordSection2' align=center><font style=FONT-SIZE:10pt>F-1</font><font style=FONT-SIZE:12pt> <hr> <p style="page-break-after:always;"></p> <div 0in style="FONT-SIZE:11pt; FONT-FAMILY:; page:WordSection2" align=left></font><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div> <div text-autospace: left; 0in ideograph-numeric; text-align: wordsection2? 30pt; page: roman?,?serif?; new margin: style="FONT-SIZE:11pt; FONT-FAMILY:; page:WordSection2" times align=center>&nbsp;</div> <div text-autospace: left; 0in ideograph-numeric; text-align: wordsection2? 30pt; page: roman?,?serif?; new margin: style="FONT-SIZE:11pt; FONT-FAMILY:; page:WordSection2" times align=center><b><font style=FONT-SIZE:10pt>ITUS CORPORATION AND SUBSIDIARIES<br></font></b><b><font style=FONT-SIZE:11pt><font style=FONT-SIZE:10pt><a name=22>CONSOLIDATED BALANCE&nbsp;SHEETS</a><br></font></div></font></b> <div style=page:WordSection3 align=center> <table width=1006 bordercolor=transparent style="WIDTH:754.55pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">October 31,</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">2016</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">October 31,</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">2015</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><u><font style="FONT-SIZE:10pt; COLOR:black">ASSETS</font></u></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Current assets:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Cash and cash equivalents </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,488,323 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">4,369,219 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Short&#150;term investments in certificates of deposit</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">750,000 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,400,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Prepaid expenses and other current assets</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">162,069 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">126,528 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Total current assets </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,400,392 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">6,895,747 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Patents, net of accumulated amortization of $965,040 and $639,744, respectively</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,071,071 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,396,367 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Property and equipment, net of accumulated depreciation of $46,950 and $13,617, respectively</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">156,644 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">43,456 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Total assets </font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">5,628,107 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">9,335,570 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><u><font style="FONT-SIZE:10pt; COLOR:black">LIABILITIES&nbsp;AND&nbsp;SHAREHOLDERS&#146;&nbsp;EQUITY</font></u></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Current liabilities:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Accounts payable and accrued expenses</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">468,756 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">380,765 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Royalties and contingent legal fees payable</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">213,017 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Total current liabilities</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">468,756 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">593,782 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Patent acquisition obligation (Note 6)</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">4,171,876 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,688,187 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Total liabilities</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">4,640,632 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">4,281,969 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Commitments and contingencies (Notes 6 and 7)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Shareholders&#146; equity:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% colspan=2 nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% colspan=2 nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Series A convertible preferred stock, par value $100 per share; 140 shares authorized, issued and outstanding</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">14,000 </font></p></td> <td width=2% colspan=2 nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">14,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Common stock, par value $.01 per share; 24,000,000 shares authorized;</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">8,752,387 and 8,724,878 shares issued and outstanding, respectively</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">87,524 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">87,249 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Additional paid-in capital</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">152,051,144 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">151,101,117 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Accumulated deficit </font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(151,165,193)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(146,148,765)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Total shareholders&#146; equity&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">987,475 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black"><font style=FONT-SIZE:10pt>5,053,601</font> </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">Total liabilities and shareholders&#146; equity </font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">5,628,107 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">9,335,570 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3' align=center><br><font style=FONT-SIZE:10pt>The accompanying notes are an integral part of these statements.<br>See Report of Independent Registered Public Accounting Firm.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric; page:WordSection3' align=center><font style=FONT-SIZE:10pt>F-2</font><font style=FONT-SIZE:12pt> <hr> <p style="page-break-after:always;"></p> <p> <p style=page:WordSection3></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font>&nbsp; <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection4' align=center><strong><font style=FONT-SIZE:10pt>ITUS CORPORATION AND SUBSIDIARIES<br><a name=23>CONSOLIDATED STATEMENTS&nbsp;OF&nbsp;OPERATIONS</a></font></strong></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection4' align=center>&nbsp;</p> <div style=page:WordSection4 align=center> <table width=1013 bordercolor=transparent style="WIDTH:10.55in; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">For the years ended October 31,</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;2016</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;2015</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Revenue:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Revenue from licensing activities</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">300,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">255,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Settlement with AU Optronics Corporation</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">9,000,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:25pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Total revenue</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">300,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">9,255,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Operating costs and expenses:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Inventor royalties and contingent legal fees</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">111,192 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">147,670 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Litigation and licensing expenses</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">106,224 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,500,852 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Amortization of patents</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">325,296 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">325,291 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Research and development expenses (including non-cash stock option</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">compensation expenses of $259,930 and $306,584, respectively)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,556,459 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">711,391 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Marketing, general and administrative expenses (including non-cash stock </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">option compensation expense of $613,631 and $2,369,806, respectively)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,709,841 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">5,514,555 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:25pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Total operating costs and expenses</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">4,809,012 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">10,199,759 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Loss from operations</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(4,509,012)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(944,759)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Interest expense (Note 6)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(519,946)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(451,906)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Interest income</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">12,530 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">17,622 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Loss before income taxes</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(5,016,428)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,379,043)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Provision for income taxes (Note 7)</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>-</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Net loss</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(5,016,428)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,379,043)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Net loss per share:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Basic and diluted </font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(0.57)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(0.16)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Weighted average common shares outstanding:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Basic and diluted </font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">8,739,453</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">8,760,126</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; page:WordSection4' align=center><font style=FONT-SIZE:11pt><font style=FONT-SIZE:10pt>The accompanying notes are an integral part of these statements.<br><font size=3><font style=FONT-SIZE:10pt>See Report of Independent Registered Public Accounting Firm</font>.</font></font></font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric; page:WordSection4' align=center><font style=FONT-SIZE:12pt><font style=FONT-SIZE:10pt>F-3</font> <br></font></p><font style=FONT-SIZE:12pt> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric; page:WordSection4' align=center> <hr> <p style="page-break-after:always;"></p></font></p></div> <div text-autospace: left; 0in wordsection4? ideograph-numeric; text-align: 0in; page: roman?,?serif?; new margin: style="FONT-SIZE:11pt; FONT-FAMILY:; page:WordSection2" times align=left><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'><a href=#TC><font color=#0066cc>Table of Contents</font></a><br></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div text-autospace: left; 0in wordsection4? ideograph-numeric; text-align: 0in; page: roman?,?serif?; new margin: style="FONT-SIZE:11pt; FONT-FAMILY:; page:WordSection2" times align=center><font style=FONT-SIZE:10pt><strong>ITUS CORPORATION AND SUBSIDIARIES</strong><br></font><font style=FONT-SIZE:10pt><strong><a name=STOCK>CONSOLIDATED STATEMENTS&nbsp;OF&nbsp;SHAREHOLDERS&#146; EQUITY<br></a></strong><strong>FOR&nbsp;THE&nbsp;YEARS&nbsp;ENDED&nbsp;OCTOBER 31, 2016 and 2015</strong></font></div> <div text-autospace: left; 0in wordsection4? ideograph-numeric; text-align: 0in; page: roman?,?serif?; new margin: style="FONT-SIZE:11pt; FONT-FAMILY:; page:WordSection2" times align=center>&nbsp;</div> <div style=page:WordSection5 align=center> <table width=800 bordercolor=transparent style="WIDTH:800pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% colspan=4 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Series A<br>Convertable<br>Preferred Stock</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% colspan=4 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Common Stock</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Paid-in</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;Capital</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Accumulated</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:9pt; COLOR:black">Deficit</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom><font style="FONT-SIZE:9pt; COLOR:black"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; -ms-text-autospace:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Total<br>Shareholders'<br>Equity</font></p></font></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Shares</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Par Value</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Shares</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;Par Value</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">BALANCE, October 31, 2014</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">140</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">14,000 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">8,788,176 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">87,882 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">148,677,413 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(144,769,722)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">4,009,573 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Stock option compensation to employees and consultants</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">2,676,309 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">2,676,309 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued upon exercise of stock options</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">17,334 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">173 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">44,462 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">44,635 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued to consultants</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">11,600 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">116 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">45,984 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">46,100 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Repurchase 92,232 shares of common stock and cancellation</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">of warrants to purchase 16,000 shares of common stock</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(343,973)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(343,973)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Retire common stock repurchased</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(92,232)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(922)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">922 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Net Loss</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(1,379,043)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(1,379,043)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">BALANCE, October 31, 2015</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">140</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">14,000 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">8,724,878 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">87,249 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">151,101,117 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(146,148,765)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">5,053,601 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Stock option compensation to employees and consultants</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">873,561 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">873,561 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued upon exercise of stock options</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">12,676 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">127 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">33,454 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">33,581 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued to consultants</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">10,833 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">108 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">31,252 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">31,360 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued to acquire patents</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">4,000 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">40 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">11,760 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">11,800 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Net Loss</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(5,016,428)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(5,016,428)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=28% nowrap style="HEIGHT:15.75pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">BALANCE, October 31, 2016</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">140</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">14,000 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">8,752,387 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">87,524 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">152,051,144 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(151,165,193)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">987,475 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5' align=center><font style=FONT-SIZE:10pt>The accompanying notes are an integral part of this statement.<br>See Report of Independent Registered Public Accounting Firm.</font></p> <div style=page:WordSection6> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:12pt><br><font style=FONT-SIZE:10pt>F-4 <br></font></font><font style=FONT-SIZE:12pt> <hr> <p style="page-break-after:always;"></p></font> <p> <p leftr; 0in text-align: roman?,?serif?; new margin: 0pt? style="FONT-SIZE:12pt; FONT-FAMILY:" times align=left><font style=FONT-SIZE:11pt><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></font><font style=FONT-SIZE:11pt><br><strong><br></strong></font></p> <p leftr; 0in text-align: roman?,?serif?; new margin: 0pt? style="FONT-SIZE:12pt; FONT-FAMILY:" times align=center><strong><font style=FONT-SIZE:10pt>ITUS CORPORATION AND SUBSIDIARIES<br><a name=CF>CONSOLIDATED STATEMENTS&nbsp;OF&nbsp;CASH&nbsp;FLOWS</a></font></strong></p> <div align=center> <table width=1019 bordercolor=transparent style="WIDTH:764.4pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=295 colspan=5 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:221.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp; For the years ended October 31,</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=136 colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:101.85pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;2016</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=134 colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:100.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;2015</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Cash flows from&nbsp;operating activities:</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Net loss</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(5,016,428)</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,379,043)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Stock option compensation to employees and consultants</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">873,561 </font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,676,309 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Common stock issued to consultants </font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">31,360 </font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">46,100 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Amortization of patents</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">325,296 </font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">325,291 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Accretion of interest on patent acquisition obligations to interest expense</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">519,946 </font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">451,906 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Loss on acquisition of common stock and warrants to purchase common stock</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">101,280 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Common stock issued to acquire patent license</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">11,800 </font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Depreciation and amortization of property and equipment</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">33,333 </font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">12,515 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Loss on disposal of property and equipment</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">10,680 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Change in operating assets and liabilities:</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Accounts receivable</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">400,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Prepaid expenses and other current assets</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(35,541)</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(65,951)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Accounts payable and accrued expenses</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">87,991 </font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(868,661)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Royalties and contingent legal fees payable</font></p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:80.1pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(213,017)</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.95pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(347,059)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Net cash (used in) provided by operating activities</font></p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:80.1pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(3,381,699)</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,363,367 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Cash flows from investing activities:</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Disbursements to acquire short-term investments in certificates of deposit&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,900,000)</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(2,900,000)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Proceeds from maturities of short-term investments in certificates of deposit&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,550,000 </font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,000,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Purchase of property and equipment</font></p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:80.1pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(146,521)</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.95pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(54,776)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Net cash provided by investing activities</font></p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:80.1pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,503,479 </font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">45,224 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Cash flows from financing activities:</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Proceeds from exercise of employee stock options</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">33,581 </font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">44,635 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Royalty payment applied to patent acquisition obligation</font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(36,257)</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=FONT-SIZE:10pt><font style=COLOR:black>Payments to acquire 92,232 shares of common stock and cancellation of warrants </font>to purchase 16,000 shares of common stock</font></p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:80.1pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;-</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.95pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;(445,253)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Net cash used in financing activities</font></p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=107 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:80.1pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(2,676)</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=105 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(400,618)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:80.1pt; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.95pt; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Net (decrease) increase in cash and cash equivalents </font></p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="HEIGHT:15pt; WIDTH:80.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,880,896)</font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="HEIGHT:15pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="HEIGHT:15pt; WIDTH:78.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,007,973 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=724 style="HEIGHT:15pt; WIDTH:543pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Cash and cash equivalents at beginning of year</font></p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=107 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:80.1pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">4,369,219 </font></p></td> <td width=25 style="HEIGHT:15pt; WIDTH:18.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=105 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:78.95pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,361,246 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=724 style="HEIGHT:15.75pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Cash and cash equivalents at end of year</font></p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=107 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:80.1pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,488,323 </font></p></td> <td width=25 style="HEIGHT:15.75pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=29 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:21.75pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=105 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:78.95pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black"><font style=FONT-SIZE:10pt>4,369,219</font> </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=724 style="HEIGHT:15.75pt; WIDTH:543pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="HEIGHT:15.75pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=107 style="HEIGHT:15.75pt; WIDTH:80.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=25 style="HEIGHT:15.75pt; WIDTH:18.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29 style="HEIGHT:15.75pt; WIDTH:21.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=105 style="HEIGHT:15.75pt; WIDTH:78.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=1019 colspan=6 nowrap style="HEIGHT:15pt; WIDTH:764.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">The accompanying notes are an integral part of these statements.</font></p></td></tr></tr> <tr style=HEIGHT:15pt> <td width=1019 colspan=6 nowrap style="HEIGHT:15pt; WIDTH:764.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">See Report of Independent Registered Public Accounting Firm.</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:12pt>F-5 <br></p></font><font style=FONT-SIZE:12pt> <hr> <p style="page-break-after:always;"></p></font> <p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></p></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b><a name=NOTES>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>BUSINESS&nbsp;AND&nbsp;FUNDING</u></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Description of Business</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>As used herein, &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; the &#147;Company&#148; or &#147;ITUS&#148; means ITUS Corporation and its wholly-owned subsidiaries.&nbsp; <font style=COLOR:black>From inception through October 2012, our primary operations involved the development of patented technologies in the areas of thin-film displays and encryption. &nbsp;Beginning in October of 2012 under the leadership of a new management team, we recapitalized the Company, unencumbered the Company&#146;s assets, changed the Company&#146;s name and ticker symbol, relocated the Company&#146;s headquarters, and modernized its systems.&nbsp; In July of 2015, the Company&#146;s stock was accepted for listing and began trading on the NASDAQ Capital Market.</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt><font style=COLOR:black>In June of 2015, the Company announced the formation of a new subsidiary, Anixa Diagnostics Corporation (&#147;Anixa&#148;), to develop a platform for non-invasive blood tests for the early detection of cancer.&nbsp; That platform is called Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>.&nbsp; In July of 2015, ITUS announced a collaborative research agreement with The Wistar Institute (&#147;Wistar&#148;), the nation&#146;s first independent biomedical research institute and a leading National Cancer Institute designated cancer research center, for the purpose of validating our cancer detection methodologies and establishing protocols for identifying certain biomarkers in the blood which we identified and which are known to be associated with malignancies.&nbsp; In August of 2016 ITUS announced the renewal and expansion of our relationship with Wistar.&nbsp; In October of 2015, ITUS and Wistar announced favorable results from initial testing of a small group of Breast Cancer patients and healthy controls.&nbsp; One hundred percent (100%) of the blood samples tested from patients with varying stages of Breast Cancer showed the presence of the biomarkers we identified, and none of the healthy patient blood samples contained the biomarkers.&nbsp; Breast Cancer is the second most common cancer in the United States and throughout the world.</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt><font style=COLOR:black>In April of 2016, ITUS announced that we had demonstrated the efficacy of our Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>early cancer detection platform with Lung Cancer.&nbsp; Lung cancer is the leading cause of death among cancers in the U.S. and throughout the world, accounting for approximately 27 percent of all cancer related deaths in the U.S. and 19 percent worldwide. In September of 2016, ITUS announced that we had demonstrated the efficacy of our Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>early cancer detection platform with Colon Cancer. Colon Cancer is the third most common cancer in men and the second most common cancer in woman worldwide, with approximately 1.4 million new cases diagnosed each year, and approximately 700,000 deaths. At the end of September 2016 through the end of October 2016, the Company made similar announcements with respect to the efficacy of our Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>early cancer detection platform for Melanoma, Ovarian Cancer, Liver Cancer, Thyroid Cancer, and Pancreatic Cancer. On November 15, 2016, ITUS announced that we had demonstrated the efficacy of our Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>early cancer detection platform with six additional cancer types including </font><font lang=EN>Appendiceal Cancer (cancer of the appendix), Uterine Cancer, Osteosarcoma (cancer of the bone), Leiomyosarcoma (cancer of the soft tissue), Liposarcoma (cancer of the connective tissue), and Vulvar Cancer (cancer of the vulva), bringing the number of cancer types for which the efficacy of </font><font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>has been validated thus far to fourteen.</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Over the next several quarters, we expect Cchek&#153; to be the primary focus of the Company.&nbsp; As part of our legacy operations, the Company remains engaged in limited patent licensing activities in the area of encrypted audio/video conference calling.&nbsp; We do not expect these activities to be a significant part of the Company&#146;s ongoing operations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-6 <br></font></p><font style=FONT-SIZE:12pt> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center> <hr> <p style="page-break-after:always;"></p> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></p></div></div></font><font style=FONT-SIZE:10pt>&nbsp; </font> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">During years ended October 31, 2016 and 2015, our revenue has been derived from technology licensing and the sale of patented technologies, including in connection with the settlement of litigation.&nbsp; In addition to Anixa, the Company may make investments in and form new companies to develop additional emerging technologies.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'><u><font style=FONT-SIZE:10pt>AUO Lawsuit and Settlement</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On December 29, 2014, </font><font style=COLOR:black>the Company and AUO Optronics Corporation (&#147;AUO&#148;) entered into a Settlement Agreement (the &#147;Settlement Agreement&#148;) and a Patent Assignment Agreement (the &#147;Patent Assignment Agreement&#148; and together with the Settlement Agreement, the &#147;Agreements&#148;) pursuant to which the Company received an aggregate of $9,000,000 from AUO.&nbsp; The Agreements were entered into to resolve a lawsuit filed by the Company against AUO, relating to the Company&#146;s patented ePaper&#174; Electrophoretic Display, and Nano Field Emission Display (&#147;nFED&#148;) technologies. </font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i><font style="FONT-SIZE:10pt; COLOR:black">Background</font></i></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In May 2011, the Company entered into an Exclusive License Agreement (the &#147;EPD License Agreement&#148;) and a License Agreement (the &#147;Nano Display License Agreement&#148;) with AUO (together the &#147;AUO License Agreements&#148;).&nbsp; Under the EPD License Agreement, the Company provided AUO with an exclusive, non-transferable, worldwide license to its ePaper&#174; Electrophoretic Display (&#147;EPD&#148;) patents and technology, in connection with AUO jointly developing EPD products with the Company.&nbsp; Under the Nano Display License Agreement, the Company provided AUO with a non-exclusive, non-transferable, worldwide license to its Nano Field Emission Display patents and technology, in connection with AUO jointly developing nFED products with the Company. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">On January 28, 2013, the Company terminated the AUO License Agreements due to numerous alleged material and continual breaches of the agreements by AUO.&nbsp; On January 28, 2013, the Company also filed a lawsuit in the United States District Court for the Northern District of California against AUO and E Ink Corporation in connection with the AUO License Agreements, alleging breach of contract, breach of the implied covenant of good faith and fair dealing, fraudulent inducement, unjust enrichment, unfair business practices, and other charges (the &#147;AUO/E Ink Lawsuit&#148;).&nbsp; In June 2013, the Company and AUO agreed to arbitrate the charges (the case against E Ink Corporation had been dismissed without prejudice) (the &#147;AUO/E Ink Arbitration&#148;).</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i><font style="FONT-SIZE:10pt; COLOR:black">The Agreements</font></i></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Pursuant to the Settlement Agreement, AUO paid the Company $2,000,000 in U.S. currency, net of any Taiwanese withholding taxes. The Settlement Agreement further provides that: </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style=FONT-SIZE:10pt><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>the Company will dismiss the AUO/E Ink Lawsuit and AUO/E Ink Arbitration, with prejudice;</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style=FONT-SIZE:10pt><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>the AUO License Agreements are terminated; </font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style=FONT-SIZE:10pt><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>AUO gives up all rights to the nFED Technology;</font></font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:12pt><br><font style=FONT-SIZE:10pt>F-7</font> <br></font></p><font style=FONT-SIZE:12pt> <hr> <p style="page-break-after:always;"></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric' align=center> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></font></p></div></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style=FONT-SIZE:10pt><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style=COLOR:black>for a period of two years, the Company agrees not to initiate (whether on its own or through a third party) any patent infringement lawsuits against AUO or its affiliates alleging infringement by AUO&#146;s or AUO&#146;s affiliates products or services, for patents owned or controlled by the Company as of the date of the Settlement Agreement. &nbsp;Any potential damages for patent infringement will toll uninterrupted during this two-year period. The prohibition does not apply to patents acquired by the Company after the date of the Settlement Agreement; and&nbsp; </font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style=FONT-SIZE:10pt><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style=COLOR:black>each of AUO and the Company mutually released each other from all claims that either may have against the other in connection with the AUO License Agreements, including any claims relating to the ePaper&#174; Electrophoretic Display and nFED patents and technologies.</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;Pursuant to the Patent Assignment Agreement, AUO paid the Company $7,000,000 in U.S. currency, net of any Taiwanese withholding taxes in exchange for the Company&#146;s ePaper&#174; Electrophoretic Display patent portfolio for which AUO was previously the exclusive licensee, consisting of: </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style=FONT-SIZE:10pt><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>10 active U.S. patents and 1 U.S. pending patent application; and</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style=FONT-SIZE:10pt><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>103 expired and/or abandoned U.S. and foreign patents and/or patent applications. </font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">In connection with the lawsuit and settlement, the Company incurred a total of approximately $3,604,000 of legal fees and litigation costs.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Funding </font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt><font style=COLOR:black>In October 2015, the </font><font style=COLOR:black>&#147;</font><font style=COLOR:black>Company entered into an At Market Issuance Sales Agreement (the </font><font style=COLOR:black>&#147;</font><font style=COLOR:black>Agreement</font><font style=COLOR:black>&#148;</font><font style=COLOR:black>) with National Securities Corporation (</font><font style=COLOR:black>&#147;</font><font style=COLOR:black>National</font><font style=COLOR:black>&#148;</font><font style=COLOR:black>) to create an at-the-market equity program under which it may sell up to $10,000,000 worth of its common stock (the </font><font style=COLOR:black>&#147;</font><font style=COLOR:black>Shares</font><font style=COLOR:black>&#148;</font><font style=COLOR:black>) from time to time through National, as sales agent. The Company has no obligation to sell any of the Shares, and may at any time suspend offers under the Agreement or terminate the Agreement. The Shares will be issued pursuant to the Company</font><font style=COLOR:black>&#146;</font><font style=COLOR:black>s previously filed registration statement that was declared effective by the Securities and Exchange Commission (the &#147;SEC&#148;) on September 18, 2015. As of October 31, 2016, no Shares have been sold under the Agreement.</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">During the year ended October 31, 2016, cash used in operating activities was approximately $3,382,000.&nbsp; Cash provided by investing activities was approximately $1,503,000, which resulted from the proceeds on maturity&nbsp;of certificates of deposit totaling $3,550,000 which was offset by the purchase of certificates of deposit totaling $1,900,000 and the purchase of property and equipment of approximately $147,000.&nbsp; Our cash used in financing activities was approximately $3,000, which resulted from a royalty payment of approximately $36,000 applied to the patent acquisition obligation liability, offset by the proceeds from exercise of stock options of approximately $34,000.&nbsp; As a result, our cash, cash equivalents, and short-term investments at October 31, 2016 decreased approximately $3,531,000 to approximately $3,238,000 from approximately $6,769,000 at the end of fiscal year 2015.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-8 <br></font></p><font style=FONT-SIZE:12pt> <hr> <p style="page-break-after:always;"></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric' align=center> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></font></p></div></div> <p style="BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal; TEXT-INDENT:0.5in"><font style=FONT-SIZE:12pt><font style=FONT-SIZE:10pt><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Based on currently available information as of December 7, 2016, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows from operations&nbsp;will not be sufficient to fund our activities and debt obligations (Note 2) for the next 12 months.&nbsp;</font><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>To date, we have relied primarily upon cash from the public and private sale of equity and debt securities, as well as net proceeds from the December 2014 AUO settlement, to generate the working capital needed to finance our operations.&nbsp;</font><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, we will be required to obtain more working capital.&nbsp;We may seek to obtain working capital through sales of our equity securities or through bank credit facilities or public or private debt from various financial institutions where possible and as permitted pursuant to our existing indebtedness.&nbsp;W</font><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>e cannot be certain that additional funding will be available on acceptable terms, or at all.&nbsp;If we do identify sources for additional funding, </font><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>the sale of additional equity securities or convertible debt could result in dilution to our stockholders.&nbsp;Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities.&nbsp; We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all.&nbsp;</font><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.&nbsp;Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations.</font></font></font></p> <p style="BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal; TEXT-INDENT:0.5in">&nbsp;</p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal; TEXT-INDENT:0.5in"><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>The accompanying financial statements have been prepared assuming that we will continue as a going concern.&nbsp;In order for us to have sufficient capital to execute our business plan, fund our operations and meet our debt obligations over the next 12 months, we&nbsp;will need to raise additional capital.&nbsp;Although we have been successful in the past in raising capital, we cannot provide any assurance that we will be successful in doing so in the future to the extent necessary to be able to fund our operating activities and debt obligations over the next 12 months, which raises substantial doubt about our ability to continue as a going concern.&nbsp;Our financial statements do not include any adjustments that might result from the outcome of this uncertainty.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal">&nbsp;</p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-FAMILY:"Times New Roman","serif"'><font style=FONT-SIZE:12pt><font style=FONT-SIZE:10pt>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>SUBSEQUENT EVENT</u></font></font></font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal">&nbsp;</p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal; TEXT-INDENT:0.5in"><font style=FONT-SIZE:12pt><font style=FONT-SIZE:10pt><font style='FONT-FAMILY:"Times New Roman","serif"'>On November 11, 2016, the holder of all our outstanding Series A Preferred Stock (the &#147;Series A Preferred&#148;) with an aggregate stated value of $3,500,000 exercised its right of redemption to receive such amount from proceeds from the sale of the Company&#146;s equity securities.&nbsp; </font><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>On December 6, 2016, we entered into an agreement with the holder of the Series A Preferred setting forth the terms under which such redemption would take place (the &#147;Series A Redemption Terms&#148;).&nbsp; Pursuant to the Series A Redemption Terms, at closing the holder of the Series A Preferred will receive (i) $500,000 in cash,&nbsp; (ii) a 12% secured debenture evidencing the remaining $3,000,000 amount to be redeemed, $1,000,000 of which is due on or before June 1, 2017 and the remainder of which is due November 11, 2017 (the &#147;Redemption Debenture&#148;), and (iii) a 5 year warrant to purchase 500,000 shares of the Company&#146;s common stock at an exercise price equal to 10% below the thirty (30) day volume weighted average closing price of our common stock&nbsp; at closing. The Redemption Debenture is secured by a lien on the Company&#146;s assets and prohibits the Company from incurring any senior indebtedness </font><font style='FONT-FAMILY:"Times New Roman","serif"'>other than equipment financing in connection with the Company&#146;s business</font><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>.</font></font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>SUMMARY&nbsp;OF&nbsp;SIGNIFICANT&nbsp;ACCOUNTING&nbsp;POLICIES</u></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Basis of Presentation</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The consolidated financial statements include the accounts of ITUS Corporation and its wholly owned subsidiaries.&nbsp; All intercompany transactions have been eliminated.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt><font style=COLOR:black>&nbsp;</font><u>Revenue Recognition</u></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-9 <br></font></p> <p><font style=FONT-SIZE:12pt> <hr> <p style="page-break-after:always;"></p> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left></font>&nbsp;</div> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><u><font style="FONT-SIZE:10pt; COLOR:black">Patent Licensing</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>In certain instances, our past revenue arrangements have provided for the payment of contractually determined fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&nbsp;&nbsp;These arrangements typically include some combination of the following:&nbsp;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&nbsp;&nbsp;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&nbsp;&nbsp;Pursuant to the terms of these agreements, we had no further obligations. &nbsp;&nbsp;As such, the earnings process was complete and revenue has been recognized upon the execution of the agreement, when collectability was reasonably assured, and when all other revenue recognition criteria were met.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Inventor Royalties and Contingent Legal Fees</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Inventor royalties and contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Research and Development Expenses</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Research and development expenses, consisting primarily of salaries and other direct costs associated with developing a platform for non-invasive blood tests for early detection of cancer, are expensed in the consolidated financial statements in the year incurred.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Fair Value Measurements</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt><font style=COLOR:black>Accounting Standards Codification ("ASC") 820 &#147;Fair Value Measurements and Disclosures&#148; (&#147;ASC 820&#148;)</font> defines fair value, establishes a framework for measuring fair value under GAAP, and expands disclosures about fair value measurements.&nbsp; In accordance with ASC 820, we have categorized our financial assets and liabilities, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below.&nbsp; If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Level 1 - Financial instruments whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market which we have the ability to access at the measurement date.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Level 2 - Financial instruments whose values are based on quoted market prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-10 <br></font></p><font style=FONT-SIZE:12pt> <hr> <p style="page-break-after:always;"></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric' align=center> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></font></p></div></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Level 3 &#150; Financial instruments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management&#146;s own assumptions about the assumptions a market participant would use in pricing the instrument.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2016:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">&nbsp;&nbsp;</font></p></td> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Level 1</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Level 2</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Level 3</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Total</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Money market funds &#150; Cash&nbsp; and cash equivalents</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,899,136 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,899,136 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Certificates of deposit - Short term investments</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">750,000 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">750,000 </font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=46% nowrap style="HEIGHT:16.5pt; WIDTH:46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Total financial assets</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,899,136 </font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">750,000 </font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black"><font style=FONT-SIZE:10pt>2,649,136</font> </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2015:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Level 1</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Level 2</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Level 3</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Total</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Money market funds &#150; Cash and cash equivalents</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">467,967 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">467,967 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Certificates of deposit - Short term investments</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,400,000 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,400,000 </font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=46% nowrap style="HEIGHT:16.5pt; WIDTH:46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Total financial assets</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">467,967 </font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,400,000 </font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black"><font style=FONT-SIZE:10pt>2,867,967</font> </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2016:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Level 1</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Level 2</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Level 3</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Total</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Patent acquisition obligation</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">4,171,876 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black"><font style=FONT-SIZE:10pt>4,171,876</font> </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2015:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Level 1</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Level 2</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Level 3</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Total</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Patent acquisition obligation</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,688,187 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black"><font style=FONT-SIZE:10pt>3,688,187</font> </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The following table sets forth a summary of the changes in the fair value of the Company&#146;s Level 3 financial liabilities that are measured at fair value on a recurring basis:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-11</font><font style=FONT-SIZE:12pt><font style=FONT-SIZE:10pt> </font> <p> <hr> <p style="page-break-after:always;"></p> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></p></div></font> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=86% nowrap style="HEIGHT:15pt; WIDTH:86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><u><font style="FONT-SIZE:10pt; COLOR:black">Patent acquisition obligation:</font></u></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=86% nowrap style="HEIGHT:15.75pt; WIDTH:86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Balance October 31, 2014</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,236,281 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=86% nowrap style="HEIGHT:15pt; WIDTH:86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Accretion of interest on patent obligation</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">451,906 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=86% nowrap style="HEIGHT:15pt; WIDTH:86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Balance October 31, 2015</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,688,187 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=86% nowrap style="HEIGHT:15pt; WIDTH:86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Accretion of interest on patent obligation</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">519,946 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=86% nowrap style="HEIGHT:15pt; WIDTH:86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Royalty payment applied to patent acquisition obligation</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(36,257)</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=86% nowrap style="HEIGHT:16.5pt; WIDTH:86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Balance October 31, 2016</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black"><font style=FONT-SIZE:10pt>4,171,876</font> </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Our non-financial assets that are measured on a non-recurring basis include our patents and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists. The estimated fair value of prepaid expenses, accounts payable and accrued expenses approximates their individual carrying amounts due to the short term nature of these measurements.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Cash and Cash Equivalents</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:40.5pt'><font style=FONT-SIZE:10pt>Cash equivalents consists of highly liquid, short term investments with original maturities of three months or less when purchased.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Short-term Investments</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; At October 31, 2016 and 2015, we had certificates of deposit with maturities greater than 90 days and less than 12 months when acquired of $750,000 and $2,400,000, respectively, that were classified as short-term investments and reported at fair value.&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Patents</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Our only identifiable intangible assets are patents and patent rights.&nbsp; We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life.&nbsp; No patent acquisition costs were capitalized during the years ended October 31, 2016 and 2015.&nbsp; We recorded patent amortization expense of approximately $325,000 and $325,000 during the years ended October 31, 2016 and 2015, respectively.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Impairment</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Long-lived assets, including intangible assets that are amortized, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates potential impairment by comparing the carrying amount of the assets with the estimated undiscounted future cash flows associated with them. Should the analysis indicate that an asset is not recoverable, the carrying value of the asset would be reduced to fair value and a corresponding charge would be recognized.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-12</font><font style=FONT-SIZE:12pt><font style=FONT-SIZE:10pt>&nbsp; </font> <p> <hr> <p style="page-break-after:always;"></p> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></p></div></font> <p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Intangible assets that are not amortized are reviewed for impairment at least annually. The Company evaluates potential impairment by comparing the carrying amount of the asset with its estimated fair value. Should the carrying amount exceed the estimated fair value, a corresponding charge would be recognized for the difference.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Income Taxes</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>We recognize deferred tax assets and liabilities for the estimated future tax effects of events that have been recognized in our financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.&nbsp; A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Stock-Based Compensation</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>We maintain stock equity incentive plans under which we may grant non-qualified stock options, incentive stock options, stock appreciation rights, stock awards, performance and performance-based awards, or stock units to employees, non-employee directors and consultants.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><u><font style=FONT-SIZE:10pt>Stock Option Compensation Expense </font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>We account for stock options granted to employees and directors using the accounting guidance in ASC 718 &#147;Stock Compensation&#148; (&#147;ASC 718&#148;).&nbsp; <font style=COLOR:black>In accordance with ASC 718, we estimate the fair value of service based options and performance based options on the date of grant, using the Black-Scholes pricing model.&nbsp; For options vesting if the trading price of the Company&#146;s common stock achieves a defined target, we use a Monte Carlo simulation in estimating the fair value at grant date. </font>We recognize compensation expense for stock option awards over the requisite or implied service period of the grant.&nbsp; With respect to performance based awards, compensation expense is recognized when the performance target is deemed probable.&nbsp; We recorded stock-based compensation expense, related to stock options granted to employees and directors, of approximately $874,000 and $2,192,000, during the years ended October 31, 2016 and 2015, respectively. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Included in stock-based compensation cost for employees and directors during the years ended October 31, 2016 and 2015 was approximately $393,000 and $2,093,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but not yet vested.&nbsp; As of October 31, 2016, there was unrecognized compensation cost related to non-vested stock options granted to employees and directors, related to service based options of approximately $1,139,000 which will be recognized over a weighted-average period of 2.3 years. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>We account for stock options granted to consultants using the accounting guidance included in ASC 505-50 &#147;Equity-Based Payments to Non-Employees&#148; (&#147;ASC 505-50&#148;).&nbsp; In accordance with ASC 505-50, <font style=COLOR:black>we estimate the fair value of service based stock options and performance based options at each reporting period, using the Black-Scholes pricing model.&nbsp; F</font>or options vesting if the trading price of the Company&#146;s common stock achieves a defined target we estimate the fair value at each reporting period using a Monte Carlo simulation.&nbsp; We recognize compensation expense for <font style=COLOR:black>service based stock options and options subject to market conditions</font> over the requisite or implied service period of the grant.&nbsp; For performance based awards, compensation expense is recognized when the performance target is achieved.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-13 <br></font></p><font style=FONT-SIZE:12pt> <hr> <p style="page-break-after:always;"></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric' align=center> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center></font><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></div></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>We recorded consulting expense, related to stock options granted to consultants, during the years ended October 31, 2016 and 2015 of approximately $-0- and $484,000, respectively. &nbsp;Stock-based consulting expense for the years ended October 31, 2016 and 2015 includes approximately $-0- and $484,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but vested in the current period. As of October 31, 2016, there was no unrecognized consulting expense related to non-vested stock options granted to consultants.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt><u>Fair Value Determination</u><u>&nbsp; </u></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>We use the Black-Scholes pricing model in estimating the fair value of stock options which vest over a specific period of time or upon achieving performance targets.&nbsp; <font style=COLOR:black>To determine the weighted average fair value of stock options on the date of grant, employees and directors are included in a single group.&nbsp; The fair value of stock options granted to consultants is determined on an individual basis.&nbsp; The stock options we granted during the year ended October 31, 2015 consisted of awards with 10-year terms that vest over one year, options with 10-year terms that vest over 36 months. The stock options we granted during the year ended October 31, 2014 consisted of awards with 10-year terms that vest over one year and options with 10-year terms that vest over 36 months, options with 5-year terms which vest immediately and options with 10-year terms which vest upon achievement of performance milestones.&nbsp; </font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The following weighted average assumptions were used in estimating the fair value of stock options granted during the years ended October 31, 2016 and 2015:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">For the Year </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Ended October 31,</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">2016</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">2015</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Weighted average fair value at grant date</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2.84 </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">3.09 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Valuation assumptions:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Expected life (years) </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">5.70</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">5.75</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Expected volatility</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">181.1%</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">117.8%</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Risk-free interest rate</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1.26%</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2.01%</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Expected dividend yield</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">0%</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">0%</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding.&nbsp; We use the simplified method to determine expected term.&nbsp; The simplified method was adopted since we do not believe that historical experience is representative of future performance because of the impact of the changes in our operations and the change in terms from historical options which vested immediately to terms including vesting periods of up to three years.&nbsp; Under the Black-Scholes pricing model, we estimated the expected volatility of our shares of common stock based upon the historical volatility of our share price over a period of time equal to the expected term of the options.&nbsp; We estimated the risk-free interest rate based on the implied yield available on the applicable grant date of a U.S. Treasury note with a term equal to the expected term of the underlying grants.&nbsp; We made the dividend yield assumption based on our history of not paying dividends and our expectation not to pay dividends in the future.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Under ASC 718, the amount of stock-based compensation expense recognized is based on the portion of the awards that are ultimately expected to vest.&nbsp; Accordingly, if deemed necessary, we reduce the fair value of the stock option awards for expected forfeitures, which are forfeitures of the unvested portion of surrendered options.&nbsp; Based on our historical experience and future expectations, we have not reduced the amount of stock-based compensation expenses for anticipated forfeitures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-14</font><font style=FONT-SIZE:12pt>&nbsp; <hr> <p style="page-break-after:always;"></p> <p> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></div></font> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>We will reconsider use of the Black-Scholes pricing model if additional information becomes available in the future that indicates another model would be more appropriate.&nbsp; If factors change and we employ different assumptions in the application of ASC 718 in future periods, the compensation expense that we record under ASC 718 may differ significantly from what we have recorded in the current period.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Net&nbsp;Loss&nbsp;Per&nbsp;Share of Common Stock </font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>In accordance with ASC 260, &#147;Earnings Per Share&#148;, basic net loss per common share (&#147;Basic EPS&#148;) is computed by dividing net loss by the weighted average number of common shares outstanding.&nbsp; Diluted net loss per common share (&#147;Diluted EPS&#148;) is computed by dividing net loss by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding.&nbsp; Diluted EPS for all years presented is the same as Basic EPS, as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive.&nbsp; For this reason, excluded from the calculation of Diluted EPS for the years ended October 31, 2016 and 2015, were options to purchase 3,086,472 and 2,672,471 shares, respectively, warrants to purchase 707,379 shares and 1,028,931 shares, respectively, preferred stock convertible into 739,958 shares.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Use of Estimates </font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&nbsp; Estimates and assumptions are used for, but not limited to, determining stock-based compensation, asset impairment evaluations, tax assets and liabilities, license fee revenue, the allowance for doubtful accounts, depreciation lives and other contingencies.&nbsp; Actual results could differ from those estimates.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=left><u><font style=FONT-SIZE:10pt>Effect of Recently Issued Pronouncements</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2014-09 (&#147;ASU 2014-09&#148;), Revenue from Contracts with Customers.&nbsp; This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &nbsp;This standard update is effective for&nbsp;interim and annual&nbsp;reporting periods beginning after December 15,&nbsp;2016, and are to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. &nbsp;In July 2015, a one-year deferral of the effective date of the new guidance was approved. &nbsp;We are currently evaluating the impact ASU 2014-09 will have on our consolidated financial statements&nbsp;and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-15 <br></font></p><font style=FONT-SIZE:12pt> <hr> <p style="page-break-after:always;"></p> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></font></p></div></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>In June 2014, the FASB issued Accounting Standards Update 2014-12 (&#147;ASU 2014-12&#148;), Compensation &#150; Stock Compensation.&nbsp; This amendment requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. We do not expect this update to have a significant impact on our consolidated financial statements and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>In August 2014, the FASB issued Accounting Standards Update 2014-15 (&#147;ASU 2014-15&#148;). This amendment requires management to assess an entity&#146;s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods&nbsp;ending after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption. We do not expect this update to have a significant impact on our consolidated financial statements and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>In April 2015, the FASB issued Accounting Standards Update 2015-03 (&#147;ASU 2015-03&#148;) to simplify the presentation of debt issuance costs. This amendment requires debt issuance costs be presented on the balance sheet as a direct reduction from the carrying amount of the debt liability, consistent with debt discounts or premiums. Adoption of this standard is required for interim and annual periods beginning after December 15, 2015 and is to be applied retrospectively. The adoption of this amendment on November 1, 2016 did not have an impact on our consolidated financial statements&nbsp;and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>In November 2015, the FASB issued Accounting Standards Update 2015-17 (&#147;ASU 2015-17&#148;) to simplify the presentation of deferred taxes. This amendment requires that all deferred tax assets and liabilities, along with any related valuation allowances, be classified as noncurrent on the balance sheet. Adoption of this standard is required for annual periods beginning after December 15, 2016. We are currently evaluating the impact ASU 2015-17 will have on our consolidated financial statements&nbsp;and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>In February 2016, the FASB issued Accounting Standards Update 2016-02 (&#147;ASU 2016-02&#148;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. We are currently evaluating the impact ASU 2016-02 will have on our consolidated financial statements&nbsp;and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>In March 2016, the FASB issued Accounting Standards Update 2016-09 (&#147;ASU 2016-09&#148;) that changes the accounting for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee&#146;s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. &nbsp;The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. Early adoption is permitted. We are currently evaluating the impact ASU 2016-09 will have on our consolidated financial statements&nbsp;and related disclosures.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:12pt><font style=FONT-SIZE:10pt>F-16</font> <br></font></p><font style=FONT-SIZE:12pt> <hr> <p style="page-break-after:always;"></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric' align=center> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></font></p></div></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Concentration of Credit Risks</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Financial instruments that potentially subject us to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable. Cash equivalents are primarily highly rated money market funds. Short-term investments are certificates of deposit within federally insured limits. Where applicable, management reviews our accounts receivable and other receivables for potential doubtful accounts and maintains an allowance for estimated uncollectible amounts. Our policy is to write-off uncollectable amounts at the time it is determined that collection will not occur. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Two licensees accounted for 67% and 33%, respectively, of revenues from patent licensing activities during fiscal year 2016. Three licensees accounted for 53%, 37% and 10%, respectively, of revenues from patent licensing activities during fiscal year 2015. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>ACCOUNTS PAYABLE AND ACCRUED EXPENSES</u></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Accounts payable and accrued liabilities consist of the following as of:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">October 31,</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">2016</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">2015</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Accounts payable</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">373,224 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">374,703 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Payroll and related expenses</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">49,901 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Accrued other</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">45,631 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">6,062 </font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">468,756 </font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black"><font style=FONT-SIZE:10pt>380,765</font> </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>SHAREHOLDERS&#146; EQUITY</u></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style="FONT-SIZE:10pt; COLOR:black">Reverse Stock Split</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:40.5pt'><font style=FONT-SIZE:10pt>On June 26, 2015, we effected a 1-for-25 reverse stock split (the &#147;Stock Split&#148;) of our issued common stock and preferred stock.&nbsp; Each shareholders&#146; percentage ownership and proportional voting power remained unchanged as a result of the Stock Split.&nbsp; All applicable share data, per share amounts and related information in the consolidated financial statements and notes thereto have been adjusted retroactively to give effect to the Stock Split.&nbsp; As a result of the Stock Split, the number of shares of our common stock and preferred stock authorized was also decreased by the same proportion as the outstanding shares.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Common Stock Issuances</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>During the years ended October 31, 2016 and 2015, we issued 10,833 shares and 11,600 shares, respectively, of common stock to consultants for services rendered, pursuant to the 2010 Share Plan.&nbsp; We recorded consulting expense for the years ended October 31, 2016 and 2015 of approximately $31,000 and $46,000, respectively, for shares of common stock issued to consultants.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 4.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:-4.5pt'><u><font style=FONT-SIZE:10pt>Stock&nbsp;Option&nbsp;Plans</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>As of October 31, 2016, we have two stock option plans: the ITUS Corporation 2003 Share Incentive Plan (the &#147;2003 Share Plan&#148;) and the ITUS Corporation 2010 Share Incentive Plan (the &#147;2010 Share Plan&#148;) which were adopted by our Board of Directors on April 21, 2003 and July 14, 2010, respectively.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-17 <br></font></p><font style=FONT-SIZE:12pt> <hr> <p style="page-break-after:always;"></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric' align=center> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font><br></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></p></div></div></font> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><br><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The 2003 Share Plan provided for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to key employees and consultants.&nbsp; The maximum number of shares of common stock in the 2003 Share Plan was 2,800,000 shares. The 2003 Share Plan was administered by the Stock Option Committee through June 2004, from June 2004 through July 2010, by the Board of Directors, from July 2010 through August 2012, by the Stock Option Committee, from August 2012 through November 2012, by the Executive Committee of the Board of Directors, from November 2012 to July 2015, by the Board of Directors and since July 2015 by the Compensation Committee, which determined the option price, term and provisions of each option.&nbsp; The exercise price with respect to all of the options granted under the 2003 Share Plan since its inception was equal to the fair market value of the underlying common stock at the grant date. &nbsp;In accordance with the provisions of the 2003 Share Plan, the plan terminated with respect to the grant of future options on April 21, 2013. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Information regarding the 2003 Share Plan for the two years ended October 31, 2016 is as follows:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Average Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Price Per Share</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Aggregate</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Intrinsic Value</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Shares</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Options Outstanding at October 31, 2014</font></p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">493,991 </font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$18.00</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Exercised</font></p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(4,000)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.58</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Forfeited</font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(123,791)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$14.71</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Options Outstanding at October 31, 2015</font></p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">366,200 </font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$17.86</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Exercised</font></p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(11,080)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.58</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Forfeited</font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(129,520)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$17.72</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:16.5pt> <td width=49% nowrap style="HEIGHT:16.5pt; WIDTH:49%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Options Outstanding and Exercisable at <br>October 31, 2016</font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">225,600 </font></p></td> <td width=1% nowrap style="HEIGHT:16.5pt; WIDTH:1.62%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:16.5pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$18.69</font></p></td> <td width=1% nowrap style="HEIGHT:16.5pt; WIDTH:1.62%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=15% nowrap style="HEIGHT:16.5pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black"><font style=FONT-SIZE:10pt>142,470</font> </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The following table summarizes information about stock options outstanding and exercisable under the 2003 Share Plan as of October 31, 2016:</font></p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=25% nowrap style="HEIGHT:15.75pt; WIDTH:25%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" rowspan=4 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Weighted Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">(in years)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=25% nowrap style="HEIGHT:15.75pt; WIDTH:25%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Exercise Price</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=25% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:25%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Exercise Prices</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Outstanding</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> <tr style=HEIGHT:15.75pt> <td width=25% nowrap style="HEIGHT:15.75pt; WIDTH:25%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=25% nowrap style="HEIGHT:15.75pt; WIDTH:25%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$&nbsp; 1.79 - $&nbsp; 7.75</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">41,200</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">1.77</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.91 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=25% nowrap style="HEIGHT:15.75pt; WIDTH:25%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$14.75 - $17.50</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">50,400</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">.43</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$16.98 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=25% nowrap style="HEIGHT:15.75pt; WIDTH:25%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$20.50 - $23.00</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">94,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">.83</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$22.04 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=25% nowrap style="HEIGHT:15.75pt; WIDTH:25%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$29.25 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">40,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">.81</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$29.25 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:12pt><br><font style=FONT-SIZE:10pt>F-18</font> <br></font></p><font style=FONT-SIZE:12pt> <hr> <p style="page-break-after:always;"></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric' align=center> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></font></p></div></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The 2010 Share Plan provides for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to key employees and consultants.&nbsp; The maximum number of shares of common stock in the 2010 Share Plan was initially 600,000 shares. On July 6, 2011, the 2010 Share Plan was amended by our Board of Directors to increase the maximum number of shares of common stock in the plan to 1,080,000 shares and on August 29, 2012, the maximum number of shares in the plan was further increased to 1,200,000 shares.&nbsp; On November 8, 2013, the Board of Directors approved an amendment to provide that effective November 8, 2013, the maximum aggregate number of shares available for future issuance will be 800,000 shares and that on the first business day in 2014 and on the first business day of each calendar year thereafter the maximum aggregate number of shares available for future issuance shall be replenished such that 800,000 shares will be available. Accordingly, on November 8, 2013, January 2, 2014 and January 2, 2015, the number of shares in the 2010 Share Plan was increased to 1,957,000 shares, 2,225,400 shares and 2,569,400 shares, respectively.&nbsp; In addition, on November 8, 2013, the 2010 Share Plan was amended to provide that on the first business day of each year commencing on January 2, 2014, each non-employee director of the Company at that time shall automatically be granted a 10-year stock option to purchase 12,000 shares of common stock (16,000 for the Chairman) that will vest in four equal quarterly installments. The 2010 Share Plan was administered by the Stock Option Committee through August 2012, from August 2012 through November 2012, by the Executive Committee of the Board of Directors, from November 2012 through July 2015, by the Board of Directors and since July 2015, by the Compensation Committee, which determines the option price, term and provisions of each option. The exercise price with respect to all of the options granted under the 2010 Share Plan was equal to the fair market value of the underlying common stock at the grant date.&nbsp; As of October 31, 2016, the 2010 Share Plan had 431,956 shares available for future grants.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Information regarding the 2010 Share Plan as of October 31, 2016 is as follows: </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Average Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Price Per Share</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Aggregate&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Intrinsic</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Value</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Shares</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Options Outstanding at October 31, 2014</font></p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">728,561 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$5.75 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Granted</font></p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">60,400 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.91 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Exercised</font></p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(13,334)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.58 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Forfeited</font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(249,355)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$6.24 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Options Outstanding at October 31, 2015</font></p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">526,272 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$3.33 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Granted</font></p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">557,000 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.92 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=49% nowrap style="HEIGHT:15.75pt; WIDTH:49%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Exercised</font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(2,400)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$4.25 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:16.5pt> <td width=49% nowrap style="HEIGHT:16.5pt; WIDTH:49%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Options Outstanding at October 31, 2016</font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,080,872 </font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:16.5pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$3.12 </font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=15% nowrap style="HEIGHT:16.5pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,569,079 </font></p></td></tr> <tr style=HEIGHT:11.7pt> <td width=49% nowrap style="HEIGHT:11.7pt; WIDTH:49%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Options Exercisable at October 31, 2016</font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:11.7pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">659,439 </font></p></td> <td width=2% nowrap style="HEIGHT:11.7pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=15% nowrap style="HEIGHT:11.7pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$3.16 </font></p></td> <td width=2% nowrap style="HEIGHT:11.7pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:11.7pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=15% nowrap style="HEIGHT:11.7pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,126,338 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-AUTOSPACE:'><br><font style=FONT-SIZE:10pt>The following table summarizes information about stock options outstanding under the 2010 Share Plan as of October 31, 2016:</font></p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% colspan=3 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Options Outstanding</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% colspan=3 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Options Exercisable</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">(in years)</font></p></td> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Contractual Life </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">(in years)</font></p></td> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15.75pt> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Exercise Price</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Exercise Price</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Exercise Prices</font></p></td> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Outstanding</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Exercisable</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15.75pt> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.58 - $9.25</font></p></td> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">1,080,872</font></p></td> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">7.71</font></p></td> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$3.12 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">659,439</font></p></td> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">6.71</font></p></td> <td width=14% nowrap style="HEIGHT:15.75pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$3.16 </font></p></td></tr></table></div> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:12pt><br><font style=FONT-SIZE:10pt>F-19</font></font><font style=FONT-SIZE:12pt>&nbsp; <hr> <p style="page-break-after:always;"></p></font> <p><font style=FONT-SIZE:12pt> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font><br></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></p></div> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric' align=left></font>&nbsp;</div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>In addition to options granted under the 2003 Share Plan and the 2010 Share Plan, during the years ended October 31, 2012 and 2013, the Board of Directors approved the grant of stock options to purchase 1,660,000 shares and 120,000 shares, respectively. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan for the two years ended October 31, 2016 is as follows:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=60% style="HEIGHT:15pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Average Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Price Per Share</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Aggregate</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Intrinsic</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Value</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=60% style="HEIGHT:15pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=60% style="HEIGHT:15pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Shares</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=60% style="HEIGHT:15pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=60% nowrap style="HEIGHT:15.75pt; WIDTH:60%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Options Outstanding at October 31, 2014, 2015 and 2016</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,780,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.70 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:16.5pt> <td width=60% style="HEIGHT:16.5pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Options Outstanding and exercisable at October 31, 2016</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,780,000</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.70 </font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:16.5pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=11% style="HEIGHT:16.5pt; WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black"><font style=FONT-SIZE:10pt>6,494,275</font> </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The following table summarizes information about stock options outstanding and exercisable that were not granted under the 2003 Share Plan or the 2010 Share Plan as of October 31, 2016</font>:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=24% style="HEIGHT:15pt; WIDTH:24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=24% nowrap style="HEIGHT:15pt; WIDTH:24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=4 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Weighted Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">(in years)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% nowrap style="HEIGHT:15pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=24% nowrap style="HEIGHT:15pt; WIDTH:24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=24% nowrap style="HEIGHT:15pt; WIDTH:24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Exercise Price</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=24% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Exercise Prices</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=24% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:10pt; COLOR:black">Outstanding</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=24% style="HEIGHT:15pt; WIDTH:24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=24% style="HEIGHT:15pt; WIDTH:24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% style="HEIGHT:15pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% style="HEIGHT:15pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=24% style="HEIGHT:15pt; WIDTH:24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$ 2.58 - $ 5.56</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=24% style="HEIGHT:15pt; WIDTH:24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,780,000</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=23% style="HEIGHT:15pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">5.76</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=23% style="HEIGHT:15pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">$2.70 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><u><font style="FONT-SIZE:10pt; COLOR:black">Re-Priced Stock Options</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">On January 28, 2015, the Board of Directors authorized management of the Company to re-price issued and outstanding stock options for all of the officers, directors and employees of the Company, at any time prior to February 16, 2015.&nbsp; On February 5, 2015, management acted to re-price 2,184,125 issued and outstanding stock options (the &#147;Re-Priced Options&#148;) pursuant to the authority granted by the Board of Directors. The new exercise price of the Re-Priced Options is $2.575, the closing sales price of the Company&#146;s common stock on February 5, 2015.&nbsp; All other terms of the previously granted Re-Priced Options remain the same.&nbsp; The Company recorded additional stock-based compensation of approximately $297,000, as of February 5, 2015, related to this re-pricing.&nbsp; This amount was determined to be the incremental value of the fair value of the Re-Priced Options compared to the fair value of the original option immediately before the re-pricing.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Preferred Stock</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>In May 1986, our shareholders authorized 200,000 shares of preferred stock with a par value of $100 per share.&nbsp; The shares of preferred stock may be issued in series at the direction of the Board of Directors, and the relative rights, preferences and limitations of such shares will all be determined by the Board of Directors.&nbsp; As of October 31, 2016, 140 shares of preferred stock had been designated and issued as Series A Preferred Stock.&nbsp; </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-20</font><font style=FONT-SIZE:12pt><font style=FONT-SIZE:10pt>&nbsp; </font> <hr> <p style="page-break-after:always;"></p></font> <p><font style=FONT-SIZE:12pt> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br></font></font></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><u><font style=FONT-SIZE:10pt>Series A Convertible Preferred&nbsp;Stock</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>On September 9, 2014, the Company designated 140 shares of the preferred stock as Series A Convertible Preferred Stock, par value $100 per share, in accordance with the Certificate of Designation of Series A Convertible Preferred Stock filed with the Secretary of State of the State of Delaware on September 9, 2014 (the &#147;Series A Convertible Preferred Stock&#148;).&nbsp; On September 9, 2014, 140 shares of Series A Convertible Preferred Stock with a stated value of $25,000 per share were issued in connection with the conversion of a Convertible Debenture due November 2016.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i><font style=FONT-SIZE:10pt>Ranking&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></i></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The Series A Convertible Preferred Stock ranked senior to the Company&#146;s common stock, to all series of any other classes of equity which may be issued and to any indebtedness, unless the Company obtained the prior written consent of the Series A Convertible Preferred Stock holder.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt><font style=COLOR:black>&nbsp;</font><i>Redemption</i></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>At any time on or after November 11, 2016 (the &#147;Redemption Date&#148;), and upon at least 60 days prior written notice to the Company (a &#147;Redemption Notice&#148;), any holder of the Series A Convertible Preferred Stock had a one-time right to require the Company to redeem all or some of its shares of Series A Convertible Preferred Stock (a &#147;Redemption&#148;) for cash generated from a subsequent sale of the Company&#146;s equity securities.&nbsp;&nbsp;The redemption price being equal to the stated value ($25,000 per share) of the shares of Series A Convertible Preferred Stock being converted, (the &#147;Redemption Purchase Price&#148;). &nbsp;Upon receipt of a Redemption Notice, the Company shall complete a sale or sales of its equity securities for the purpose of accumulating net proceeds sufficient to pay the Redemption Purchase Price. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style=FONT-SIZE:10pt>On September 9, 2016, the holder of 140 shares of the Series A Convertible Preferred Stock delivered a Redemption Notice to the Company requesting a redemption date of November 11, 2016 (it being understood by the holder of the Series A Convertible Preferred Stock that the Company may only redeem shares of Series A Convertible Preferred Stock with the proceeds from the sale of the Company&#146;s equity securities).&nbsp;On December 6, 2016, we entered into an agreement with the holder of the Series A Preferred Stock to exchange the Series A Preferred Stock for a secured debenture, cash and warrants. See Note 2, Subsequent Event.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i><font style=FONT-SIZE:10pt>Optional Conversion</font></i></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:13.5pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Holders of the Series A Convertible Preferred Stock had the right at any time convert their shares of Series A Convertible Preferred Stock into such number of shares of the Company&#146;s common stock in such an amount equal to (a) the stated value of $25,000 per share of the shares of Series A Convertible Preferred Stock being converted, divided by the conversion price of $4.73, multiplied by (b) the number of shares of Series A Preferred Stock being converted.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">The holder did not have the right to convert any portion of the Series A Convertible Preferred Stock if after giving effect to such conversion, the holder, together with any affiliate thereof, would beneficially own in excess of 4.99% of the number of shares of common stock outstanding immediately after giving effect to such conversion.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-21</font><font style=FONT-SIZE:12pt><font style=FONT-SIZE:10pt>&nbsp; </font> <hr> <p style="page-break-after:always;"></p> <p> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></p></div></font> <p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The embedded conversion option had certain anti-dilution protection provisions which would be triggered if the Company issues its common stock, or certain common stock equivalents, (as defined) at a price below $3.55 per share. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i><font style=FONT-SIZE:10pt>Board and Observer Rights</font></i></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Each holder of Series A Convertible Preferred Stock shall have the right, upon 10 days' prior written notice, to designate one representative, reasonably acceptable to the Company, who shall be entitled to attend and observe meetings of the Company&#146;s Board of Directors in a non-voting observer capacity (the &#147;Observer&#148;).</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i><font style=FONT-SIZE:10pt>Accounting for the Series A Convertible Preferred Stock</font></i></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The Company determined that the economic characteristics and risks of the conversion feature and the preferred stock instrument were clearly and closely related as equity instruments and accordingly, the conversion feature would not require separate accounting.&nbsp;&nbsp; In addition, the redemption feature was contingent upon Series A Convertible Preferred Stock not being converted into common stock and upon the holder delivering a redemption notice to the Company.&nbsp;&nbsp; Further, the redemption purchase price may only be paid from the proceeds of a subsequent sale of equity securities. Accordingly, the Series A Convertible Preferred Stock was accounted for as an equity instrument. Further, because the conversion rate of the Series A Convertible Preferred Stock of $4.73 per share was less than the Company&#146;s closing stock price on the date of this transaction, the Company determined that the Series A Convertible Preferred Stock contained a beneficial conversion feature. The beneficial conversion feature was recorded in additional paid-in-capital as a result of the Company&#146;s accumulated deficit<font style='FONT-FAMILY:"Times New Roman","sans-serif"'>. </font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Common Stock Purchase Warrants</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:40.5pt'><font style=FONT-SIZE:10pt>As of October 31, 2016, we had warrants to purchase 10,000 shares and 10,000 shares of common stock at $9.25 and $13.875 per share, respectively, expiring on August 19, 2019, warrants to purchase 369,979 shares of common stock at $7.75 per share expiring on November 11, 2016, warrants to purchase 8,000 shares of common stock at $6.925 per share expiring on June 2, 2017 and warrants to purchase 309,400 shares of common stock at $10.00 per share expiring on July 15, 2019.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><br><font style=FONT-SIZE:10pt>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>COMMITMENTS AND CONTINGENCIES </u></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Patent Acquisition Obligations</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; TEXT-DECORATION:none; COLOR:black">As of October 31, 2016, we have incurred obligations due no later than November 2017 related to the acquisition of patents, which have a discounted present value of approximately $4,172,000, and which amount will be reduced by royalties paid during the period, if any.&nbsp; The payment due in November 2017 is payable at the option of the Company in cash or common stock.&nbsp; We recorded interest expense of approximately $520,000 and $452,000, respectively, for the years ended October 31, 2016 and 2015, for the accretion of interest on patent acquisition obligations.&nbsp; The payment due date of November 2017 may be extended for up to two years if any patent infringement lawsuit initiated by the Company is stayed because of any re-exam or similar proceeding in the United States Patent and Trademark Office.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-22</font><font style=FONT-SIZE:12pt><font style=FONT-SIZE:10pt>&nbsp; </font> <hr> <p style="page-break-after:always;"></p></font> <p><font style=FONT-SIZE:12pt> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></font></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=COLOR:black><br><font style=FONT-SIZE:10pt>Leases</font></font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt><font style=COLOR:black>We lease approximately 3,000 square feet of office space in Los Angeles, California pursuant to a lease that expires May 31, 2019.&nbsp; The lease contains base rentals of approximately $11,000 per month with annual increases of approximately 3% and an escalation clause for increases in certain operating expenses.&nbsp; </font>As of October 31, 2016, our non-cancelable operating lease commitments for the years ending October 31, 2017, 2018 and 2019 were approximately $129,000, 134,000 and $80,000, respectively.&nbsp; Rent expense for the years ended October 31, 2016 and 2015, was approximately $104,000 and $100,000, respectively.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=FONT-SIZE:10pt>Litigation Matters</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">On December 29, 2014, we settled our lawsuit against AUO which had been filed on January 28, 2013. For a more detailed description of the settlement with AUO see Note 1, &#147;Business and Funding - Description of Business - AUO Lawsuit and Settlement&#148;.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'><font style="FONT-SIZE:10pt; COLOR:black">Other than suits we bring to enforce our patent rights we are not a party to any material pending legal proceedings other than that which arise in the ordinary course of business. &nbsp;We believe that any liability that may ultimately result from the resolution of these matters will not, individually or in the aggregate, have a material adverse effect on our financial position or results of operations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>INCOME TAXES</u>&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Income tax provision (benefit) consists of the following:</font></p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style="HEIGHT:15pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Year Ended October 31,</font></p></td></tr> <tr style="HEIGHT:15pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">2016</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">2015</font></p></td></tr> <tr style="HEIGHT:15pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Federal:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style="HEIGHT:15pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Current</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td></tr> <tr style="HEIGHT:15pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Deferred</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,631,000)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(487,000)</font></p></td></tr> <tr style="HEIGHT:15pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">State:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style="HEIGHT:15pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Current</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0pt" valign=bottom><font style="FONT-SIZE:11pt; COLOR:black"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0.04in 0pt 0in; PADDING-RIGHT:0px; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></font></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td></tr> <tr style="HEIGHT:15pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Deferred</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom><font style="FONT-SIZE:11pt; COLOR:black"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; PADDING-RIGHT:0px; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(134,000)</font></p></font></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(120,000)</font></p></td></tr> <tr style="HEIGHT:15.1pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% style="HEIGHT:15.1pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Adjustment to valuation allowance related to net deferred tax assets</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0.04in 0pt 0in; PADDING-RIGHT:0px; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,765,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.1pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">607,000 </font></p></td></tr> <tr style="HEIGHT:15.75pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>The tax effects of temporary differences that give rise to significant portions of the deferred tax asset, net, at October 31, 2016 and 2015, are as follows:</font></p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">2016</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">2015</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Long-term deferred tax assets:</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Federal and state NOL and tax credit carryforwards</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">33,079,000 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">31,261,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Deferred compensation</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">6,232,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">6,522,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Intangibles</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">713,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">483,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Other</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">289,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">282,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Subtotal</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">40,313,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">38,548,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Less: valuation allowance</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(40,313,000)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(38,548,000)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Deferred tax asset, net</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:10pt>F-23</font><font style=FONT-SIZE:12pt><font style=FONT-SIZE:10pt>&nbsp; </font> <hr> <p style="page-break-after:always;"></p></font> <p><font style=FONT-SIZE:12pt> <div 0in margin:text-align: left style="FONT-SIZE:11pt; FONT-FAMILY:" align=left><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center></font>&nbsp;</p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>As of October 31, 2016, we had tax net operating loss and tax credit carryforwards of approximately $79,428,000 and $1,110,000, respectively, available within statutory limits (expiring at various dates between 2020 and 2035), to offset any future regular Federal corporate taxable income and taxes payable.&nbsp; If the tax benefits relating to deductions of option holders&#146; income are ultimately realized, those benefits will be credited directly to additional paid-in capital. Certain changes in stock ownership can result in a limitation on the amount of net operating loss and tax credit carryovers that can be utilized each year. As of October 31, 2016, management has not determined the extent of any such limitations, if any.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>We had New York, California and Pennsylvania tax net operating loss carryforwards of approximately $76,847,000, $4,849,000 and $841,000, respectively,&nbsp;as of October 31, 2016, available within statutory limits (expiring at various dates between 2020 and 2035), to offset future corporate taxable income and taxes payable, if any, under certain computations of such taxes.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>We have provided a valuation allowance against our deferred tax asset due to our current and historical pre-tax losses and the uncertainty regarding their realizability.&nbsp; The primary differences from the Federal statutory rate of 34% and the effective rate of 0% is attributable to certain permanent differences and a change in the valuation allowance. The following is a reconciliation of income taxes at the Federal statutory tax rate to income tax expense (benefit):</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=46% style="HEIGHT:15pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% colspan=11 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">Year Ended October 31,</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=46% style="HEIGHT:15pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">2016</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:10pt; COLOR:black">2015</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=46% style="HEIGHT:15pt; WIDTH:46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Income tax benefit at U.S. </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=10% style="HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=10% style="HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=46% style="HEIGHT:15pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 10pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Federal statutory income&nbsp; Tax rate</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,706,000)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(34.0)</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">%</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(469,000)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(34.0)</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">%</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=46% style="HEIGHT:15pt; WIDTH:46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">State income taxes</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(411,000)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=10% style="HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(8.2)</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">%</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(117,000)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=10% style="HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(8.5)</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">%</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=46% style="HEIGHT:15pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Permanent differences</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">0.1 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">%</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">0.1 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">%</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=1% colspan=2 nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Expiring net operating&nbsp; losses, credits and other</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">350,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=10% style="HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">7.0&nbsp;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">%</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(22,000)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=10% style="HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1.6)</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">%</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=46% style="HEIGHT:15pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Change in valuation allowance</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0.04in 0pt 0in; PADDING-RIGHT:0px; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,765,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% style="HEIGHT:15pt; WIDTH:10%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">35.1</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">%</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">607,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% style="HEIGHT:15pt; WIDTH:10%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">44.0 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">%</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Income tax provision</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=10% style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">0.0 </font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">%</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">-</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=10% style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:10pt; COLOR:black">0.0 </font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">%</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>During the two fiscal years ended October 31, 2016, we incurred no Federal and no State income taxes. We have no unrecognized tax benefits as of October 31, 2016 and 2015 and we account for interest and penalties related to income tax matters in marketing, general and administrative expenses.&nbsp; Tax years to which our net operating losses relate remain open to examination by Federal authorities and other jurisdictions to the extent which the net operating losses have yet to be utilized.</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'><font style=FONT-SIZE:10pt> </font> <div style=page:WordSection8> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt>F-24</font></p></div></font></font></div></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <hr> <p style="page-break-after:always;"></p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all style=></font></b> <p left; 0in text-align: roman?,?serif?; new margin: 0pt? style="FONT-SIZE:10pt; FONT-FAMILY:" times align=left><font style=COLOR:black><a href=#TC><font color=#0066cc>Table of Contents</font></a><br></p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>PART II</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>INFORMATION NOT REQUIRED IN PROSPECTUS</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>ITEM 13. &nbsp;OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The Company is paying all expenses of this issuance. No portion of these expenses will be borne by Meetrix. Meetrix, however, will pay any expenses incurred in selling its common stock following the issuance, including any brokerage commissions or costs of sale.&nbsp; Following is an itemized statement of all expenses in connection with the issuance and distribution of the securities to be registered.&nbsp; All of the amounts shown are estimates, except for the SEC Registration Fees.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=86% style="HEIGHT:15pt; WIDTH:86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>SEC Registration Fee</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>553.53</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=86% style="HEIGHT:15pt; WIDTH:86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Accounting Fees and Expenses</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>7,500.00</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=86% style="HEIGHT:15pt; WIDTH:86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Legal Fees and Expenses</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>25,000.00</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=86% style="HEIGHT:15pt; WIDTH:86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Miscellaneous Fees and Expenses</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,500.00</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=86% style="HEIGHT:15.75pt; WIDTH:86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><b><font style=COLOR:black>Total</font></b></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:black 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:black 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>34,553.53</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>ITEM 14.&nbsp; INDEMNIFICATION OF OFFICERS AND DIRECTORS</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Under Section 145 of the DGCL, a corporation may indemnify its directors, officers, employees and agents and its former directors, officers, employees and agents and those who serve, at the corporation's request, in such capacities with another enterprise, against expenses (including attorney's fees), as well as judgments, fines and settlements, actually and reasonably incurred in connection with the defense of any action, suit or proceeding (other than an action by or in the right of the corporation) in which they or any of them were or are made parties or are threatened to be made parties by reason of their serving or having served in such capacity. The DGCL provides, however, that such person must have acted in good faith and in a manner he or she reasonably believed to be in (or not opposed to) the best interests of the corporation and, in the case of a criminal action, such person must have had no reasonable cause to believe his or her conduct was unlawful. In addition, the DGCL does not permit indemnification in an action or suit by or in the right of the corporation, where such person has been adjudged liable to the corporation for negligence or misconduct in the performance of his/her duty to the corporation, unless, and only to the extent that, a court determines that such person fairly and reasonably is entitled to indemnity for costs the court deems proper in light of liability adjudication. Indemnity is mandatory to the extent a claim, issue or matter has been successfully defended.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Section 102(b)(7) of the DGCL permits a corporation to include in its certificate of incorporation a provision eliminating or limiting the personal liability of a director to the corporation or its shareholders for monetary damages for breach of fiduciary duty as a director, provided that such provision shall not eliminate or limit the liability of a director (i) for any breach of the director's duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) under Section 174 of the DGCL (relating to unlawful payment of dividends and unlawful stock purchase or redemption) or (iv) for any transaction from which the director derived an improper personal benefit.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Article XIII of the bylaws of the Company contains provisions which are designed to provide mandatory indemnification of directors and officers of the Company to the full extent permitted by law, as now in effect or later amended. The bylaws further provide that, if and to the extent required by the DGCL, an advance payment of expenses to a director or officer of the Company that is entitled to indemnification will only be made upon delivery to the Company of an undertaking, by or on behalf of the director or officer, to repay all amounts so advanced if it is ultimately determined that such director is not entitled to indemnification.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>ITEM 15. &nbsp;RECENT SALES OF UNREGISTERED SECURITIES</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>On September 9, 2014, we issued 140 shares of Series A Preferred Stock having an aggregate value of $3,500,000&nbsp; (the "Series A Preferred") and a warrant to purchase 370,000 shares of the Company&#146;s common stock (the &#147;September 2014 Warrant&#148;). The September 2014 Warrant expired on November 11, 2016.&nbsp; Holders of our Series A Preferred had a one-time right to require the Company to redeem the Series A Preferred shares, which right was set to expire on November 11, 2016 (the "Redemption Date"). Under its terms, the Series A Preferred could only be redeemed from the proceeds of the sale of the Company&#146;s equity securities.&nbsp; On November 11, 2016 the holder of all of our outstanding Series A Preferred exercised its right of redemption. On December 6, 2016, we entered into an agreement with the holder of the Series A Preferred setting forth the terms under which such redemption would take place (the &#147;Redemption Agreement&#148;) in lieu of paying the redemption from proceeds of the sale of equity securities. Pursuant to the Redemption Agreement, at closing the holder of the Series A Preferred will receive (i) $500,000 in cash,&nbsp; (ii) a 12% secured debenture evidencing the remaining $3,000,000 amount to be redeemed, $1,000,000 of which is due on or before June 1, 2017 and the remainder of which is due November 11, 2017 (the &#147;Redemption Debenture&#148;), and (iii) a 5 year warrant to purchase 500,000 shares of the Company&#146;s common stock with substantially the same terms as the expired September 2014 Warrant at an<font size=+0>&nbsp;</font>exercise price equal to 10% below the thirty (30) day volume weighted average closing price of our common stock at closing. The Redemption Debenture is secured by a lien on the Company&#146;s assets and prohibits the Company from incurring any senior indebtedness<font size=+0>&nbsp;</font>other than equipment financing in connection with the Company&#146;s business. The securities were issued in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act as they were issued to an accredited investor, without a view to distribution, and were not issued through any general solicitation or advertisement.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>50</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><br><a href=#TC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>During the fiscal year ended October 31, 2014, the Company issued an aggregate of 12,400 shares of our common stock to various companies in payment of public relations and investor relations services and 48,000 shares of our common stock to inventors in connection with the acquisition of patents. The common stock was issued in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act as they were issued to accredited investors, without a view to distribution, and were not issued through any general solicitation or advertisement.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>During the fiscal year ended October 31, 2015, the Company issued an aggregate of 11,600 shares of our common stock to various companies in payment of public relations and investor relations services. The common stock was issued in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act as they were issued to accredited investors, without a view to distribution, and were not issued through any general solicitation or advertisement.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>During the fiscal year ended October 31, 2016, the Company issued an aggregate of 10,833 shares of our common stock to various companies in payment of public relations and investor relations services and 4,000 shares of our common stock to inventors in connection with the acquisition of patents. The common stock was issued in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act as they were issued to accredited investors, without a view to distribution, and were not issued through any general solicitation or advertisement.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 27.5pt 0pt 0in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0px 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>ITEM 16. &nbsp;EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0pt 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0pt'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The following exhibits are filed with this registration statement.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Certificate of Incorporation, as amended.&nbsp; (Incorporated by reference to Form 10-Q for the fiscal quarter ended July 31, 1992 and Form S-3, dated February 11, 2014.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amendment to the Certificate of Incorporation. (Incorporated by reference to Form 10-K for the fiscal year ended October 31, 2013.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Certificate of Amendment to the Certificate of Incorporation. (Incorporated by reference to Exhibit 3.1 on Form 8-K, dated September 4, 2014.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock. (Incorporated by reference to Exhibit 3.1 of our Form 8-K, dated September 10, 2014.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Amended and Restated By-laws. (Incorporated by reference to Exhibit 3.1 to our Form 8-K dated, November 8, 2012.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>51</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font><br></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Certificate of Amendment to the Certificate of Incorporation (Incorporated by reference to Exhibit 3.1 on Form 8-K, dated June 25, 2015.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Form of Warrant issued to investors in connection with the Company&#146;s registered direct offering. (Incorporated by reference to Exhibit 4.1 to Form 8-K, dated July 15, 2014).</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Form of Warrant to be issued to Adaptive Capital LLC (Incorporated by reference to Exhibit 4.2 to our Form 10-K for the fiscal year ended October 31, 2016).</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Opinion of Ellenoff Grossman &amp; Schole LLP (Filed herewith)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>2003 Share Incentive Plan.&nbsp; (Incorporated by reference to Exhibit 4 to our Form S-8 dated May 5, 2003.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Amendment No. 1 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 4(e) to our Form S-8 dated November 9, 2004.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Amendment No. 2 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2006.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Amendment No. 3 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 10.2 to our Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2006.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Amendment No. 4 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 4(g) to our Form S-8 dated September 21, 2007.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Amendment No. 5 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 4(g) to our Form S-8 dated January 21, 2009.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Amendment No. 6 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 10.5 to our Form 8-K, dated July 20, 2010.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>2010 Share Incentive Plan. (Incorporated by reference to Exhibit 10.1 to our Form 8-K, dated July 20, 2010.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Amendment No. 1 to the 2010 Share Incentive Plan. (Incorporated by reference to Exhibit 10.1 to our Form 8-K, dated July 7, 2011.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Amendment No. 2 to the 2010 Share Incentive Plan. (Incorporated by reference to Exhibit 10.1 to our Form 8-K, dated September 5, 2012.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Amendment No. 3 to the 2010 Share Incentive Plan (Incorporated by reference to Exhibit 10.1 to our Form 10-Q for the fiscal quarter ended January 31, 2014.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Employment Agreement, dated as of September 19, 2012, between the Company and Robert Berman. (Incorporated by reference to Exhibit 10.35 to our Form 10-K for the fiscal year ended October 31, 2012.)&nbsp; (Portions of Section 4 of this exhibit have been redacted and filed separately with the Commission in accordance with a request for, and related Order by the Commission, dated May 3, 2013, File No. 0-11254-CF#29240, granting confidential treatment for portions of Section 4 of this exhibit to pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Consulting Agreement, dated as of September 19, 2012, between the Company and Amit Kumar.&nbsp; (Incorporated by reference to Exhibit 10.37 to our Form 10-K for the fiscal year ended October 31, 2012.)&nbsp; (Portions of Section 4 of this exhibit have been redacted and filed separately with the Commission in accordance with a request for, and related Order by the Commission, dated May 3, 2013, File No. 0-11254-CF#29240, granting confidential treatment for portions of Section 4 of this exhibit to pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>52</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Securities Purchase Agreement, dated July 15, 2014, between the Company and the Purchasers named therein in connection with the Company&#146;s registered direct offering. (Incorporated by reference to Exhibit 10.1 to Form 8-K, dated July 15, 2014.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Termination Agreements, each dated August 29, 2014, relating to the Company&#146;s transaction with Videocon Industries Limited. (Incorporated by reference to Exhibit 10.20 to our Form S-1 dated December 8, 2014.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Debt Conversion Agreement, dated September 9, 2014, between the Company and Adaptive Capital, LLC. (Incorporated by reference to Exhibit 10.21 to our Form S-1 dated December 8, 2014.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Warrant issued to Adaptive Capital, LLC. (Incorporated by reference to Exhibit 10.22 to our Form S-1 dated December 8, 2014.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>At Market Issuance Sales Agreement, dated October 2, 2015, between the Company and National Securities Corporation (Incorporated by reference to Exhibit 10.1 to Form 8-K, dated October 2, 2015.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Letter Agreement, dated December 6, 2016, between the Company and Adaptive Capital LLC (Incorporated by reference to Exhibit 10.19 to our Form 10-K for the fiscal year ended October 31, 2016).</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Form of 12% Secured Debenture, dated December 9, 2016, to be issued to Adaptive Capital LLC (Incorporated by reference to Exhibit 10.20 to our Form 10-K for the fiscal year ended October 31, 2016).</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">10.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Letter Agreement, dated October 17, 2016, between the Company and Mike Catelani (Incorporated by reference to Exhibit 10.21 to our Form 10-K for the fiscal year ended October 31, 2016).</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Subsidiaries of ITUS Corporation. (Incorporated by reference to Exhibit 21 to our Form 10-K for the fiscal year ended October 31, 2016)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">23.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Consent of Haskell &amp; White LLP.&nbsp; (Filed herewith)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">23.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;<font style=FONT-SIZE:10pt>Consent of Ellenoff Grossman &amp; Schole LLP (contained in Exhibit 5.1)</font></font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Collaborative Research Agreement, dated July 14, 2015, between Anixa Diagnostic Corporation and The Wistar Institute of Anatomy and Biology (Incorporated by reference to Exhibit 99.1 to our Form 10-K for the fiscal year ended October 31, 2016)<font size=+0>&nbsp;</font>(Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">99.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>First Amendment to The Collaborative Research Agreement, dated August 4, 2016, between Anixa Diagnostic Corporation and The Wistar Institute of Anatomy and Biology (Incorporated by reference to Exhibit 99.2 to our Form 10-K for the fiscal year ended October 31, 2016)<font size=+0>&nbsp;</font>(Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>53</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">99.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Collaborative Research Agreement, dated August 4, 2016, between Anixa Diagnostic Corporation and The Wistar Institute of Anatomy and Biology. (Previously submitted with our Form 10-K for the fiscal year ended October 31, 2016)<font size=+0>&nbsp;</font>(Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">99.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;<font style=FONT-SIZE:10pt>Patent Acquisition Agreement, dated November 11, 2013, between the Company and Meetrix Communications, Inc. (Filed herewith.)</font></font>&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">101.ins &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>Instance Document. (Filed herewith.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">101.def &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>XBRL Taxonomy Extension Definition Linkbase Document. (Filed herewith.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">101.sch &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>XBRL Taxonomy Extension Schema Document. (Filed herewith.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">101.cal &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>XBRL Taxonomy Extension Calculation Linkbase Document. (Filed herewith.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">101.lab &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>XBRL Taxonomy Extension Label Linkbase Document. (Filed herewith.)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">101.pre &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size=+0>&nbsp;</font>XBRL Taxonomy Extension Presentation Linkbase Document. (Filed herewith.)</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>54</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 27.5pt 0pt 0in; TEXT-AUTOSPACE:'>&nbsp;</p> <p><font style='FONT-SIZE:2pt; FONT-FAMILY:"Times New Roman","serif"'><font size=2 color=#0066cc><a href=#TC>Table of Contents</a></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 11pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>ITEM 17. &nbsp;UNDERTAKINGS</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:6pt 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">The undersigned registrant hereby undertakes:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the provisions above, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities, other than the payment by us of expenses incurred or paid by one of our directors, officers, or controlling persons in the successful defense of any action, suit or proceeding, is asserted by one of our directors, officers, or controlling persons in connection with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification is against public policy as expressed in the Securities Act, and we will be governed by the final adjudication of such issue.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 27.5pt 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>&nbsp;55</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black> <hr> <p style="page-break-after:always;"></p></font></b></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TC><font color=#0066cc>Table of Contents</font></a></p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all></font></b> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>SIGNATURES</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'><font style=COLOR:black>Pursuant to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Los Angeles, State of California on this 27<sup>th</sup> day of January, 2017.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:27.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <table width=600 bordercolor=transparent style="WIDTH:6.25in; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=404 style="HEIGHT:15pt; WIDTH:303pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=312 colspan=2 style="HEIGHT:15pt; WIDTH:3.25in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>ITUS CORPORATION</font></b></p></td></tr> <tr style=HEIGHT:15pt> <td width=404 style="HEIGHT:15pt; WIDTH:303pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=27 style="HEIGHT:15pt; WIDTH:20pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=285 style="HEIGHT:15pt; WIDTH:214pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15pt> <td width=404 style="HEIGHT:15pt; WIDTH:303pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=27 nowrap style="HEIGHT:15pt; WIDTH:20pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>By:</font></p></td> <td width=285 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:214pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>/s/ Robert A. Berman</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=404 style="HEIGHT:15pt; WIDTH:303pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=27 style="HEIGHT:15pt; WIDTH:20pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=285 style="HEIGHT:15pt; WIDTH:214pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Name: Robert A. Berman</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=404 style="HEIGHT:15pt; WIDTH:303pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=27 style="HEIGHT:15pt; WIDTH:20pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=285 nowrap style="HEIGHT:15pt; WIDTH:214pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Title:&nbsp;&nbsp;&nbsp;President and Chief Executive Officer&nbsp;&nbsp;</font></p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>POWER OF ATTORNEY</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Robert Berman his true and lawful attorney-in-fact, with full power of substitution and&nbsp;resubstitution&nbsp;for him and in his name, place and stead, in any and all capacities to sign any and all amendments including post-effective amendments to this registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the SEC, hereby ratifying and confirming all that said attorney-in-fact or his substitute, each acting alone, may lawfully do or cause to be done by virtue thereof.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated below.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>By:</font></p></td> <td width=50% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>/s/ Robert A. Berman&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=20% nowrap style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>January 27, 2017</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Robert A. Berman</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>President, Chief Executive Officer</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>and Director (Principal Executive Officer)</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>By:</font></p></td> <td width=50% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>/s/ Michael J. Catelani&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=20% nowrap style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>January 27, 2017</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Michael J. Catelani</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Chief Financial Officer</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>(Principal Financial and Accounting Officer)</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>By:</font></p></td> <td width=50% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>/s/&nbsp;Dr.&nbsp;Amit&nbsp;Kumar&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=20% nowrap style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>January 27, 2017</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Dr. Amit Kumar</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Executive Chairman of the Board</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>By:</font></p></td> <td width=50% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>/s/&nbsp;Dale Fox&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=20% nowrap style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>January 27, 2017</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Dale Fox</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Director</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>By:&nbsp;</font></p></td> <td width=50% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>/s/ Dr. Arnold Baskies&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=20% nowrap style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>January 27, 2017</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Dr. Arnold Baskies</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Director</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>By:</font></p></td> <td width=50% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>/s/&nbsp;Dr. John Monahan&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>January 27, 2017</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Dr. John Monahan</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=50% style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Director</font></p></td> <td width=20% style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27% style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=20% nowrap style="HEIGHT:15pt; WIDTH:20.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>56</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></body>
<!-- EDGAR Validation Code: 6B010A93 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>exhibit5_1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<head><title>exhibit 5.1</title> </head> <body style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman'; COLOR:#000000; MARGIN-TOP:0px"> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; PADDING-RIGHT:0px" align=right><b>Exhibit 5.1</b></p> <p style=MARGIN:0px align=left><br> <table width=100% bordercolor=transparent style=WIDTH:100% cellspacing=0> <tr> <td><img width=1000 height=598 style="HEIGHT:177px; WIDTH:361px" src=logo.jpg></td> <td> <p align=right><font style=FONT-SIZE:12pt><br>1345 AVENUE OF THE AMERICAS, 11<sup>th</sup> FLOOR <br>NEW YORK, NEW YORK 10017<br>TELEPHONE:&nbsp;&nbsp; (212) 370-1300<br>FACSIMILE: &nbsp;&nbsp;&nbsp;(212) 370-7889 <br>www.egsllp.com<br></font></p></td></tr></table></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Garamond,Times New Roman; MARGIN:0px; PADDING-RIGHT:0px" align=left>&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Garamond,Times New Roman; MARGIN:0px; PADDING-RIGHT:0px" align=right><br>&nbsp;</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px">January 27, 2017</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px">ITUS Corporation<br>12100 Wilshire Boulevard, Suite 1275</p> <p style="FONT-SIZE:12pt; MARGIN:0px">Los Angeles, CA 90025</p> <p style=MARGIN:0px><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:12pt; WIDTH:96px; FLOAT:left; MARGIN-TOP:0px; TEXT-INDENT:48px">Re:</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px"><u>Registration Statement on Form S-1</u></p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px">Gentlemen: </p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px" align=justify>We have acted as counsel to ITUS Corporation, a Delaware corporation (the <font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#147;</font><b>Company</b><font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#148;</font>), in connection with a Registration Statement on Form S-1 (the <font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#147;</font><b>Registration Statement</b><font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#148;</font>), filed by the Company with the Securities and Exchange Commission (the <font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#147;</font><b>Commission</b><font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#148;</font>) pursuant to the Securities Act of 1933, as amended. The Registration Statement relates to the registration of the issuance of 947,606 shares (the <font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#147;</font><b>Shares</b><font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#148;</font>) of the Company<font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#146;</font>s common stock, par value $0.01 per share, to Meetrix Communications, Inc. (<font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#147;</font><b>Meetrix</b><font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#148;</font>) pursuant to a certain Patent Acquisition Agreement, dated November 11, 2013, by and between the Company and Meetrix (the <font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#147;</font><b>Patent Acquisition Agreement</b><font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#148;</font>). &nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px" align=justify>In connection with the opinion expressed herein, we have examined the Patent Acquisition Agreement and such additional documents, records and matters of law as we have deemed relevant or necessary for purposes of such opinion. &nbsp;In our examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity with the originals of all documents submitted to us as copies, the authenticity of the originals of such documents and the legal competence of all signatories to such documents.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px" align=justify>Based on the foregoing, and subject to the assumptions, qualifications and limitations set forth herein, we are of the opinion that the Shares, when issued in accordance with the terms of the Patent Acquisition Agreement and as described in the Registration Statement, will be duly authorized, validly issued, fully paid and non-assessable.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px" align=justify>The opinions expressed herein are limited solely to the General Corporation Law of the State of Delaware, including the applicable provisions of the Delaware Constitution and the reported judicial decisions interpreting such law, as currently in effect, and we express no opinion as to the effect of any other law of the State of Delaware or the laws of any other jurisdiction. </p> <p style=MARGIN:0px align=justify><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px" align=justify>We hereby consent to the filing of this opinion as Exhibit 5.1 to the Registration Statement and to the reference to our firm under the caption <font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#147;</font>Legal Matters<font style="FONT-FAMILY:Times New Roman Unicode MS,Times New Roman">&#148;</font> in the prospectus constituting a part of the Registration Statement. In giving such consent, we do not thereby admit that we are included in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder. We assume no obligation to update or supplement any of the opinion set forth herein to reflect any changes of law or fact that may occur following the date hereof.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px" align=justify>&nbsp;</p> <p style=MARGIN:0px align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; PADDING-LEFT:300px; MARGIN:0px"> <table width=512 bordercolor=transparent style="WIDTH:384pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0 align=right> <tr height=21 style=HEIGHT:15.75pt> <td /> <td /> <td /> <td /> <td /> <td /> <td /> <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </td> <td /> <td /> <td width=512 height=21 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:384pt; BORDER-BOTTOM:0px; BORDER-LEFT:0px">Very truly yours,</td></tr> <tr height=21 style=HEIGHT:15.75pt> <td /> <td /> <td /> <td /> <td /> <td /> <td /> <td /> <td /> <td /> <td height=21 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px">/s/ Ellenoff Grossman &amp; Schole LLP</td></tr></table></p> <p style=MARGIN:0px><br>&nbsp;</p></body>
<!-- EDGAR Validation Code: 1B6DE6D3 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>exhibit23_1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<head><title>Exhibit 23.1</title> </head> <body style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman'; COLOR:#000000; MARGIN-TOP:0px"> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><b>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </b></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px align=justify><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>We consent to the inclusion in this Registration Statement on Form S-1 of <b><i>ITUS Corporation</i></b> (the &#147;Company&#148;) of our report dated December 7, 2016, relating to our audits of the Company&#146;s consolidated financial statements as of October 31, 2016 and 2015, and for each of the years then ended, included in the Company&#146;s Annual Report on Form 10-K for the year ended October 31, 2016, which report includes an explanatory paragraph expressing substantial doubt regarding the Company&#146;s ability to continue as a going concern. We also consent to the reference to us under the heading &#147;Experts&#148; in this Registration Statement.</p> <p style=MARGIN:0px align=justify><br></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; PADDING-LEFT:288px; MARGIN:0px; TEXT-INDENT:48px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HASKELL &amp; WHITE LLP</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px">Irvine, California</p> <p style="FONT-SIZE:12pt; MARGIN:0px">January 27, 2017</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br><br></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p></body>
<!-- EDGAR Validation Code: 27B099C3 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_X0"R17AI9@  34T *@    @ !P$^  4
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M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )7 ^@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M10 4444 %5KFW#*7488?K5FBDU<#'HI\J[)67T/%,K(D**** "BBB@ HHHH
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MF5G)68F%6;+_ %Y]UJM4]H<7"^^:2W$:-%%%:E!1110 4444 %%%% !1110
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M]*(;@B6BBBM!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!0O?]>/]W^IJM5F]_UX_P!W^IJM64MR0HHHI %%
M%% !1110!I6O_'LGX_SJ:H;7_CV3\?YU-6JV*"BBBF 4444 %%%% !1110 4
M444 %(0&!!Y!ZTM% %5K)">&8>U/CM8XVW<DCIFIZ*5D 4444P"BBB@ HHHH
M **** "FNP12QZ"G52O9.D8^II-V0%:1S(Y8]Z;1161(4444 %%%% !2@$D
M=3258M$W3;CT6A:L"[&@CC51VI]%%;%!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !5&]3#AQWX-7J1E5UPP!%)JZ R*L69Q/CU%6#9Q9_
MB_.I4B2,?*N/>I47<5A]%%%6,**** "BBB@ HHHH *S[W_7CV6M"J%Y_K_\
M@-3+83*U%%%9B"BBB@ HHHH EMY/+E!/W3P:TZQZNVL^X"-NHZ>]7%]!HMT4
M458PHHHH **** "BBB@ HHHH *@>UB<YP5/M4]%%K@5ULXE.3EOK5BBBDE8
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M %:%HFV$'^\<U0QDX%:RJ%4*.PQ506HT+1116@PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J
MC?#YU/J,5>JM>+F$-_=-*6P,H4445D2%%%% !1110 4H)!R*2B@#0M[@2#:W
M#_SJQ6/5N&[_ (9?P:K4NX[EVBD!!&0<BEJQA1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 445DZGXCTS1I FH320Y4,&\B1E/XJ",TG))78FTMS6HKFT\>>&Y,[-09L=
M=MM*?_9:5O'7AQ%R]^ZCU-M*/_9:CVM/^9?>+GCW.CHK,TG7M-UQ96TVY\Y8
MB YV,N"?]X"K=Y<_8[.6X,,LWEKN\N%=SM]!WJU)-70[JUR"]_UX_P!W^IJM
M7.Z-XP;Q)K4\,=J(+>*'<-YR['<.O8=>GZUT58J:GJB5)2U045R<WC-CX@M]
M*@L9(V:=8Y'N!@@$\X4?H<_A764HS4M@4D]@HHHJAA1110!I6O\ Q[)^/\ZF
MJ&U_X]D_'^=35JMB@HHHI@%%%% !1110 54O6PBKZG-4=4UPVMY'IMC;F\U*
M5"XB#;51?[SMV'\ZY'6?%7B'1;U#JNFVC6S':&MV;\LD]?J!6-2K&*U(E-(Z
M^I(?]>GU%5C<1I:_:)#Y<83>Q?C:,9YK#76-=OXA=:'IL#0]8FNG(:4>H48P
M/J:ER2!R2.YHKD_"7BNYUZXNK*^L?LUU;#+E0=O7!!!Y!_'U]*ZRMH34U=%1
MDI*Z"BBBJ&%%9>H>(-*TMQ'=WL:2GI$N7<_\!7)_2J3^+(%7<FE:S(F,[TL7
MQC\<5#J16[)YDCH:*YJ+QWX?DE,4EX]O*."D\3(1^F*Z-'61%="&5AD$=Q3C
M.,MF-23V'44450PHHHH S[QLS8_NBJ].=MTC-ZFFUB]R0HHHH **** "BBB@
M"2W7=.@]\UJ50LAF8GT%7ZTCL-!1115#"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBHY9HX(S)-(L:#JSL !0!)14-O=6]TF^WGCF3INC<,/TJ:@ HHHH *
M*** "BBJ.I:O8:1");^Y2%6.%!Y9CZ #D_A2;2U8-V+U%<W-XSLK=#+-I^K1
MP 9,SV;!/S-:FE:S8:W;-<:?<":-6VL=I!!ZX((J54BW9,E23=DS0HHHJR@H
MHHH **XF^\>-'XCM]&M].D21[E(9)+D;<!F R%'7@Y!S7;5$9QE>W0E23V"F
MNH=&4]Q3J*LHR"""0>H/-)5F\BVOO'1NOUJM6+5B0HHHH **Y.\\9M'KT&E0
M6,B.]PD3O<#& 6 R .O7@YKK*F,U+82DGL%%%%4,**** )(IGB/RGCT-78KI
M).#\K>AK.J*ZN4M+=YY Y5,9$:%CU[ <TU*P7L;M%<<OCO1+=]DE\RD=4>"0
M$?\ CM;>E^(;#6&*VC2MA=P9X616'L2!FG&K"3LF"G%[,UJ***T*"BL"[\8:
M-83/%>SSV[*Q7,EM( Q'H=N#1:^,]$OI5BL[B:X<L%(CM93MSTS\O%1[2%[7
M)YX[7-^BBBK*"BL_5-:T_1HDEU"<PHY(4B-FZ?[H-8Z?$#P[))Y<=U-(Q/ 6
MW<D_I4.I"+LV2Y13LV=117/)XUT!I1%)>F"0]%GA>/\ 4C%;L4T<\2RPR))&
MPRKHV01[&G&<9;,:DGL244450PHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ K-UZ-9?#^I(ZAE-M)P?]TUI50UK_D!:C_U[2?^@FIE\+$]
MCA_A-_Q[:I_OQ_R:O1B RD$ @\$'O7EGPTU;3]-M]16^O(+<N\97S7"[L!LX
MKK-:\9Z3:Z/=26>IV\EUY;"%8V#G>1@''U]:YZ$XQHJ[,J4DH*Y8T;01HVO:
MI/;(D=E>+&RHO\+C=N '8<Y_'VKH*JZ>\DFFVLDS!I7A5G8#&20,FK5=$$DM
M#6*26AY5X0 'C76P!@ R8 _ZZ5WM<%X1_P"1VUO_ 'I?_1E=[7+0^ RI?"<!
MKX ^).F8'7RL_P#?1KOZX#7_ /DI.E_]LO\ T(UW]%+XI>H4]V%%5-0U*TTN
MU-Q=RB./.!W+'T [FLQ]?OUB-POA^\-L!DL70/C_ ',YK1R2W+<DC>HJCI6K
MV>LVGVFSD+*#AE8893Z$4[4]3MM(LFN[LN(P<?*I8D]O\FGS*U^@75KF[:?\
M>Z_C_.IZX;2?'=I<V\\AC92)=L5N@,DL@P.=H_\ U>],F^)*VERJ7NBWMO&W
M1I!M8C_=/^-"KT[7N+VD;;G>45FV^JQW5O'<0!7BD4,C ]0:E^W'^X/SK7F1
M=T7:*Y>;QE"UZ]EIUG+J%S'_ *P0D!$^KGBJ[^.5LKE(-7TNXT\R?=D9@\9_
MX$*CVT.Y//$["D)"@DD #J:HKJ'F(KH$96&58'((]:RM?UQK#3)6,<SLZ,JB
M"(L<XZD]A[U3FDKE-I*Y@^!KXZAJ>O:Q+\TL\JK'G^%?FX^F-OY5U+ /]X!N
M<\^M>:^"M<32K2ZC>QOKC?(&S;1;P.._(KOM,U%=4M3.MM<VX#E=EQ'L8\#G
M&3QS7-1FG!+J8TI)QL<[\0KUX=(@LHCAKJ7! [JO;\RM=AI\*V_V>!!A8U"*
M/8#%>9^.M32[U.R2.*<+;ELF2,J&.1G;GKTKL+#Q9%-?P1#2-74R.$#-;  9
MXR3GIZFE"I'VCN^P1DN=G8A54DA0"3R0.M.HHKM-PK@_%?B:]GU:/PUH3[;N
M5@DTX/*9[ ]L#DGM]:[:YG6VM9KAONQ(7/T S7E7PW!U#Q?=WUP=THA>7)_O
MLPR?U/YUSUY.Z@NIE4;NHKJ>@Z#X;L=!MP(8Q)=,/WMRXR[D]>>P]JVJ**WC
M%15D:))*R.=\6^&[?7M)F_<K]MC0M!(!\V1_#]#6GHQD;1+ S(T<OV>/>CK@
MJVT9!'UJ_14J"4N9"Y5>X45F:WKEGH%C]KO?,\LMM41H6)/IZ#\<5SL/Q%TX
MZ.]_<0NDAE9([:,[G*C'S'H .?\ ]=*56$79L'.*=FSM:9*=L3GT%8OAGQ)#
MXEL9+B*WD@,3[&5CD9QG@U<UG4;72]-DN;R98H@0,GJ3Z =S3YXN/,MA\R:N
M045@#Q!?3P"YM- O);8C(=G1&8>H7.35C1_$=AK3/'"7CN(_OP3#:X]>*Q4X
MMV(4DS7HHK(O=>C@U$:;:V\EY?%=S11D (/5F/ _SZU3:6XVTMS7HK#@\02#
M5H=-O]-FM)IP3$Q=71L#/4?YZ>M;E)23V!-/8**PU\1&\N)H=)L)+X0';)*)
M%CCSZ GJ?PJ72==&I75S9RVDUI=VX!>*0@\'N".O_P"JDIQ;L+F1T=B.7/TJ
MY68;R#3M.N+RY8K#$,N54L0/H.:P=-^(6F7]Q=AE:""(+Y.[F28DG(5!D^G]
M:U]I&-DV5S):,[&BN)O/B&MA.OVK0=2@MV.!),FPGZ \?K6R_BW219PSP3/=
M/.NZ*WMD+RM_P$=/QQ0JT'U$JD7U-VBN'?XCP6MZL&HZ/?V2-T:5<-CU*G''
MTS7:12I/"DL3AXW4,K \$'H:<:D9_"QQDI;$E%-=U1&=V"JHR23@ 5SEUXM
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M_P"1HI7]FKA3OR:G(?#7_D'7W_75?Y5V]<1\-?\ D'WW_75?Y5V]%#^&@I?
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MX8,WTR .*N445HE8H****8!1110 4444 %%%% !1110 4444 %%%% !1110
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M&WPJ?;FI*K61S$1Z&K-:K8H****8!1110 4444 %%%% !1110 4444 %%%%
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M]8M6)"BBB@ HHHH **** +EB>7'TJY5*Q^^_TJ[6D=AH****H84444 %%%%
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MQ$Q]35FM8[%(****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZOH*AJ'+L*X4445(@HHHH *DBB:5\#\32PP-*?1>YK0CC6-=JCBJ4;C!$6-
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M** "BI$@D?HI^IJPED!R[9]A32; J!2QPH)-6XK/O)^56E14&%4"G5:B.P@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>5
<FILENAME>itus-20161031.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Jan 25 23:38:52 EST 2017 -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:itus="http://www.copytele.com/20161031" xmlns:compsci="http://compsciresources.com" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="itus-20161031.xsd"/>
  <context id="c0_AsOf31Oct2016">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c1_AsOf31Oct2015">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c2_AsOf31Oct2016_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c3_AsOf31Oct2015_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c4_AsOf31Oct2016_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c5_AsOf31Oct2015_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c6_From1Nov2015To31Oct2016">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c7_From1Nov2014To31Oct2015">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c8_From1Nov2015To31Oct2016_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c9_From1Nov2014To31Oct2015_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c10_From1Nov2015To31Oct2016_SellingAndMarketingExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c11_From1Nov2014To31Oct2015_SellingAndMarketingExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c12_AsOf31Oct2014_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-10-31</instant>
    </period>
  </context>
  <context id="c13_AsOf31Oct2014_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-10-31</instant>
    </period>
  </context>
  <context id="c14_AsOf31Oct2014_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-10-31</instant>
    </period>
  </context>
  <context id="c15_AsOf31Oct2014_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-10-31</instant>
    </period>
  </context>
  <context id="c16_AsOf31Oct2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2014-10-31</instant>
    </period>
  </context>
  <context id="c17_From1Nov2014To31Oct2015_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c18_From1Nov2014To31Oct2015_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c19_From1Nov2014To31Oct2015_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c20_AsOf31Oct2015_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c21_AsOf31Oct2015_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c22_AsOf31Oct2015_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c23_AsOf31Oct2015_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c24_From1Nov2015To31Oct2016_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c25_From1Nov2015To31Oct2016_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c26_From1Nov2015To31Oct2016_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c27_AsOf31Oct2016_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c28_AsOf31Oct2016_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c29_AsOf31Oct2016_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c30_AsOf31Oct2016_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c31_AsOf30Nov2016">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2016-11-30</instant>
    </period>
  </context>
  <context id="c32_AsOf30Apr2016">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2016-04-30</instant>
    </period>
  </context>
  <context id="c33_From29Dec2014To29Dec2014_AUOSettlementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">itus:AUOSettlementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-12-29</startDate>
      <endDate>2014-12-29</endDate>
    </period>
  </context>
  <context id="c34_From1Nov2015To31Oct2016_AUOSettlementMember_AUOMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">itus:AUOSettlementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:AUOMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c35_From1Nov2015To31Oct2016_PatentAssignmentAgreementMember_AUOMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">itus:PatentAssignmentAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:AUOMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c36_From1Nov2015To31Oct2016_AUOSettlementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">itus:AUOSettlementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c37_From1Nov2014To31Oct2015_AgreementMember_NationalSecuritiesCorporationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">itus:AgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:NationalSecuritiesCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c38_From1Nov2015To31Oct2016_AgreementMember_NationalSecuritiesCorporationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">itus:AgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:NationalSecuritiesCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c39_From11Nov2016To11Nov2016_SeriesAPreferredStockMember_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-11</startDate>
      <endDate>2016-11-11</endDate>
    </period>
  </context>
  <context id="c40_From6Dec2016To6Dec2016_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-12-06</startDate>
      <endDate>2016-12-06</endDate>
    </period>
  </context>
  <context id="c41_AsOf6Dec2016_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-06</instant>
    </period>
  </context>
  <context id="c42_AsOf6Dec2016_SecuredDebentureDueJune12017Member_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">itus:SecuredDebentureDueJune12017Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-06</instant>
    </period>
  </context>
  <context id="c43_From6Dec2016To6Dec2016_WarrantMember_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-12-06</startDate>
      <endDate>2016-12-06</endDate>
    </period>
  </context>
  <context id="c44_From1Nov2015To31Oct2016_MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c45_From1Nov2015To31Oct2016_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c46_From1Nov2015To31Oct2016_PatentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c47_From1Nov2014To31Oct2015_PatentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c48_From1Nov2015To31Oct2016_StockOptionsGrantedToEmployeesAndDirectorsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">itus:StockOptionsGrantedToEmployeesAndDirectorsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c49_From1Nov2014To31Oct2015_StockOptionsGrantedToEmployeesAndDirectorsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">itus:StockOptionsGrantedToEmployeesAndDirectorsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c50_AsOf31Oct2016_StockOptionsGrantedToEmployeesAndDirectorsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">itus:StockOptionsGrantedToEmployeesAndDirectorsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c51_From1Nov2015To31Oct2016_StockAwardGrantedConsultantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">itus:StockAwardGrantedConsultantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c52_From1Nov2014To31Oct2015_StockAwardGrantedConsultantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">itus:StockAwardGrantedConsultantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c53_From1Nov2014To31Oct2015_AwardsOfOptionsWith10YearTermsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">itus:AwardsOfOptionsWith10YearTermsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c54_From1Nov2013To31Oct2014_AwardsOfOptionsWith10YearTermsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">itus:AwardsOfOptionsWith10YearTermsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-11-01</startDate>
      <endDate>2014-10-31</endDate>
    </period>
  </context>
  <context id="c55_From1Nov2015To31Oct2016_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c56_From1Nov2014To31Oct2015_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c57_From1Nov2015To31Oct2016_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c58_From1Nov2014To31Oct2015_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c59_From1Nov2015To31Oct2016_ConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c60_From1Nov2015To31Oct2016_SalesRevenueNetMember_CustomerConcentrationRiskMember_Licensees1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:Licensees1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c61_From1Nov2015To31Oct2016_SalesRevenueNetMember_CustomerConcentrationRiskMember_Licensees2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:Licensees2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c62_From1Nov2014To31Oct2015_SalesRevenueNetMember_CustomerConcentrationRiskMember_Licensees1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:Licensees1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c63_From1Nov2014To31Oct2015_SalesRevenueNetMember_CustomerConcentrationRiskMember_Licensees2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:Licensees2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c64_From1Nov2014To31Oct2015_SalesRevenueNetMember_CustomerConcentrationRiskMember_Licensees3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:Licensees3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c65_AsOf31Oct2016_MoneyMarketFundsMember_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c66_AsOf31Oct2016_MoneyMarketFundsMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c67_AsOf31Oct2016_MoneyMarketFundsMember_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c68_AsOf31Oct2016_MoneyMarketFundsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c69_AsOf31Oct2016_CertificatesOfDepositMember_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c70_AsOf31Oct2016_CertificatesOfDepositMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c71_AsOf31Oct2016_CertificatesOfDepositMember_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c72_AsOf31Oct2016_CertificatesOfDepositMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c73_AsOf31Oct2016_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c74_AsOf31Oct2016_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c75_AsOf31Oct2016_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c76_AsOf31Oct2015_MoneyMarketFundsMember_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c77_AsOf31Oct2015_MoneyMarketFundsMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c78_AsOf31Oct2015_MoneyMarketFundsMember_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c79_AsOf31Oct2015_MoneyMarketFundsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c80_AsOf31Oct2015_FairValueInputsLevel1Member_GlobalDepositoryReceiptsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:GainLossOnInvestmentsByCategoryAxis">itus:GlobalDepositoryReceiptsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c81_AsOf31Oct2015_FairValueInputsLevel2Member_GlobalDepositoryReceiptsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:GainLossOnInvestmentsByCategoryAxis">itus:GlobalDepositoryReceiptsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c82_AsOf31Oct2015_FairValueInputsLevel3Member_GlobalDepositoryReceiptsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:GainLossOnInvestmentsByCategoryAxis">itus:GlobalDepositoryReceiptsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c83_AsOf31Oct2015_GlobalDepositoryReceiptsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:GainLossOnInvestmentsByCategoryAxis">itus:GlobalDepositoryReceiptsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c84_AsOf31Oct2015_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c85_AsOf31Oct2015_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c86_AsOf31Oct2015_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c87_From1Nov2015To31Oct2016_EmployeeStockOptionMember_A2010SharePlanMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c88_From1Nov2014To31Oct2015_EmployeeStockOptionMember_A2010SharePlanMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c89_From1Nov2015To31Oct2016_EmployeeStockOptionMember_A2003SharePlanMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c90_AsOf31Oct2010_EmployeeStockOptionMember_A2010SharePlanMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-10-31</instant>
    </period>
  </context>
  <context id="c91_AsOf6Jul2011_EmployeeStockOptionMember_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-06</instant>
    </period>
  </context>
  <context id="c92_AsOf29Aug2012_EmployeeStockOptionMember_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-08-29</instant>
    </period>
  </context>
  <context id="c93_AsOf8Nov2013_EmployeeStockOptionMember_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-11-08</instant>
    </period>
  </context>
  <context id="c94_AsOf2Jan2014_EmployeeStockOptionMember_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-01-02</instant>
    </period>
  </context>
  <context id="c95_AsOf2Jan2015_EmployeeStockOptionMember_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-01-02</instant>
    </period>
  </context>
  <context id="c96_From2Jan2014To2Jan2014_EmployeeStockOptionMember_A2010SharePlanMember_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-02</startDate>
      <endDate>2014-01-02</endDate>
    </period>
  </context>
  <context id="c97_From2Jan2014To2Jan2014_EmployeeStockOptionMember_A2010SharePlanMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-02</startDate>
      <endDate>2014-01-02</endDate>
    </period>
  </context>
  <context id="c98_From2Jan2014To2Jan2014_EmployeeStockOptionMember_A2010SharePlanMember_BoardOfDirectorsChairmanMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-02</startDate>
      <endDate>2014-01-02</endDate>
    </period>
  </context>
  <context id="c99_AsOf31Oct2016_EmployeeStockOptionMember_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c100_From1Nov2011To31Oct2012_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-11-01</startDate>
      <endDate>2012-10-31</endDate>
    </period>
  </context>
  <context id="c101_From1Nov2012To31Oct2013_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-11-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="c102_AsOf5Feb2015_RePricedOptionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">itus:RePricedOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-02-05</instant>
    </period>
  </context>
  <context id="c103_From5Feb2015To5Feb2015_RePricedOptionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">itus:RePricedOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-02-05</startDate>
      <endDate>2015-02-05</endDate>
    </period>
  </context>
  <context id="c104_AsOf31May1986_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>1986-05-31</instant>
    </period>
  </context>
  <context id="c105_AsOf31Oct2016_SeriesAPreferredStockMember_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c106_AsOf9Sep2014_SeriesAPreferredStockMember_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-09</instant>
    </period>
  </context>
  <context id="c107_AsOf9Sep2014_SeriesAPreferredStockMember_ConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-09</instant>
    </period>
  </context>
  <context id="c108_From1Nov2015To31Oct2016_SeriesAPreferredStockMember_ConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c109_AsOf31Oct2016_SeriesAPreferredStockMember_ConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c110_AsOf31Oct2016_CommonStockMember_SeriesAPreferredStockMember_ConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c111_AsOf31Oct2016_WarrantsWithExercisePrice925Member_CommonStockMember_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">itus:WarrantsWithExercisePrice925Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c112_AsOf31Oct2016_WarrantsWithExercisePrice13875Member_CommonStockMember_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">itus:WarrantsWithExercisePrice13875Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c113_AsOf31Oct2016_WarrantsWithExercisePrice775Member_CommonStockMember_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">itus:WarrantsWithExercisePrice775Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c114_AsOf31Oct2016_WarrantsWithExercisePrice6925Member_CommonStockMember_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">itus:WarrantsWithExercisePrice6925Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c115_AsOf31Oct2016_WarrantsWithExercisePrice1000Member_CommonStockMember_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">itus:WarrantsWithExercisePrice1000Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c116_AsOf31Oct2014_A2003SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-10-31</instant>
    </period>
  </context>
  <context id="c117_From1Nov2014To31Oct2015_A2003SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c118_AsOf31Oct2015_A2003SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c119_From1Nov2015To31Oct2016_A2003SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c120_AsOf31Oct2016_A2003SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c121_AsOf31Oct2014_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-10-31</instant>
    </period>
  </context>
  <context id="c122_From1Nov2014To31Oct2015_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c123_AsOf31Oct2015_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c124_From1Nov2015To31Oct2016_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c125_AsOf31Oct2016_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c126_AsOf31Oct2016_RangeOfExercisePrices179To775Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices179To775Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c127_From1Nov2015To31Oct2016_RangeOfExercisePrices179To775Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices179To775Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c128_AsOf31Oct2016_RangeOfExercisePrices1475To1725Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices1475To1725Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c129_From1Nov2015To31Oct2016_RangeOfExercisePrices1475To1725Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices1475To1725Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c130_AsOf31Oct2016_RangeOfExercisePrices2050To2300Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices2050To2300Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c131_From1Nov2015To31Oct2016_RangeOfExercisePrices2050To2300Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices2050To2300Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c132_AsOf31Oct2016_RangeOfExercisePrices2925Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices2925Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c133_From1Nov2015To31Oct2016_RangeOfExercisePrices2925Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices2925Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c134_AsOf31Oct2016_A2010SharePlanMember_RangeOfExercisePrices258To925Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">itus:RangeOfExercisePrices258To925Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c135_From1Nov2015To31Oct2016_A2010SharePlanMember_RangeOfExercisePrices258To925Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">itus:RangeOfExercisePrices258To925Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c136_From1Nov2015To31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c137_AsOf31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c138_AsOf31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices258To556Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices258To556Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c139_From1Nov2015To31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices258To556Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices258To556Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c140_AsOf31Oct2016_OfficeSpaceInLosAngelesCaliforniaMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">itus:OfficeSpaceInLosAngelesCaliforniaMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c141_From1Nov2015To31Oct2016_OfficeSpaceInLosAngelesCaliforniaMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">itus:OfficeSpaceInLosAngelesCaliforniaMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c142_From1Nov2014To31Oct2015_OfficeSpaceInLosAngelesCaliforniaMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">itus:OfficeSpaceInLosAngelesCaliforniaMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-11-01</startDate>
      <endDate>2015-10-31</endDate>
    </period>
  </context>
  <context id="c143_AsOf31Oct2016_FederalCorporateTaxableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">itus:FederalCorporateTaxableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c144_AsOf31Oct2016_NewYorkStateMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">itus:NewYorkStateMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c145_AsOf31Oct2016_CaliforniaStateMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">itus:CaliforniaStateMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c146_AsOf31Oct2016_PennsylvaniaStateMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">itus:PennsylvaniaStateMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <unit id="usd">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="shares">
    <measure>xbrli:shares</measure>
  </unit>
  <unit id="usdPershares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="pure">
    <measure>xbrli:pure</measure>
  </unit>
  <unit id="sqft">
    <measure>utr:sqft</measure>
  </unit>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">2488323</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">4369219</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:ShortTermInvestments unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">750000</us-gaap:ShortTermInvestments>
  <us-gaap:ShortTermInvestments unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">2400000</us-gaap:ShortTermInvestments>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">162069</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">126528</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">3400392</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">6895747</us-gaap:AssetsCurrent>
  <itus:FiniteLivedPatentsNet unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">2071071</itus:FiniteLivedPatentsNet>
  <itus:FiniteLivedPatentsNet unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">2396367</itus:FiniteLivedPatentsNet>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">156644</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">43456</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:Assets unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">5628107</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">9335570</us-gaap:Assets>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">468756</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">380765</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <itus:RoyaltiesAndContingentLegalFeesPayable unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">213017</itus:RoyaltiesAndContingentLegalFeesPayable>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">468756</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">593782</us-gaap:LiabilitiesCurrent>
  <itus:PatentAcquisitionObligation unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">4171876</itus:PatentAcquisitionObligation>
  <itus:PatentAcquisitionObligation unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">3688187</itus:PatentAcquisitionObligation>
  <us-gaap:Liabilities unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">4640632</us-gaap:Liabilities>
  <us-gaap:Liabilities unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">4281969</us-gaap:Liabilities>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c0_AsOf31Oct2016" xs:nil="true"/>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c1_AsOf31Oct2015" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">14000</us-gaap:PreferredStockValue>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">14000</us-gaap:PreferredStockValue>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c2_AsOf31Oct2016_PreferredStockMember" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c3_AsOf31Oct2015_PreferredStockMember" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c4_AsOf31Oct2016_SeriesAPreferredStockMember" decimals="0">14000</us-gaap:PreferredStockValue>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c5_AsOf31Oct2015_SeriesAPreferredStockMember" decimals="0">14000</us-gaap:PreferredStockValue>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">87524</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">87249</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapital unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">152051144</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">151101117</us-gaap:AdditionalPaidInCapital>
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">-151165193</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">-146148765</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">987475</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">5053601</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">5628107</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">9335570</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">965040</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">639744</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">46950</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">13617</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c0_AsOf31Oct2016" decimals="INF">19860</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c1_AsOf31Oct2015" decimals="INF">19860</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c2_AsOf31Oct2016_PreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c3_AsOf31Oct2015_PreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c2_AsOf31Oct2016_PreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c3_AsOf31Oct2015_PreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c2_AsOf31Oct2016_PreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c3_AsOf31Oct2015_PreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c4_AsOf31Oct2016_SeriesAPreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c5_AsOf31Oct2015_SeriesAPreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c4_AsOf31Oct2016_SeriesAPreferredStockMember" decimals="INF">140</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c5_AsOf31Oct2015_SeriesAPreferredStockMember" decimals="INF">140</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c4_AsOf31Oct2016_SeriesAPreferredStockMember" decimals="INF">140</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c5_AsOf31Oct2015_SeriesAPreferredStockMember" decimals="INF">140</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c0_AsOf31Oct2016" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c1_AsOf31Oct2015" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c0_AsOf31Oct2016" decimals="INF">24000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c1_AsOf31Oct2015" decimals="INF">24000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c0_AsOf31Oct2016" decimals="INF">8752387</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c1_AsOf31Oct2015" decimals="INF">8724878</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c0_AsOf31Oct2016" decimals="INF">8752387</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c1_AsOf31Oct2015" decimals="INF">8724878</us-gaap:CommonStockSharesOutstanding>
  <itus:RevenueFromPatentAssertionActivities unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">300000</itus:RevenueFromPatentAssertionActivities>
  <itus:RevenueFromPatentAssertionActivities unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">255000</itus:RevenueFromPatentAssertionActivities>
  <us-gaap:RevenueFromRelatedParties unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">9000000</us-gaap:RevenueFromRelatedParties>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">300000</us-gaap:SalesRevenueNet>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">9255000</us-gaap:SalesRevenueNet>
  <us-gaap:RoyaltyExpense unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">111192</us-gaap:RoyaltyExpense>
  <us-gaap:RoyaltyExpense unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">147670</us-gaap:RoyaltyExpense>
  <itus:LitigationAndLicensingExpenses unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">106224</itus:LitigationAndLicensingExpenses>
  <itus:LitigationAndLicensingExpenses unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">3500852</itus:LitigationAndLicensingExpenses>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">325296</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">325291</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">1556459</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">711391</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">2709841</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">5514555</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:CostsAndExpenses unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">4809012</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">10199759</us-gaap:CostsAndExpenses>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">-4509012</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-944759</us-gaap:OperatingIncomeLoss>
  <us-gaap:InterestExpense unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">519946</us-gaap:InterestExpense>
  <us-gaap:InterestExpense unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">451906</us-gaap:InterestExpense>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">12530</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">17622</us-gaap:InvestmentIncomeInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">-5016428</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-1379043</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" xs:nil="true"/>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">-5016428</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-1379043</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c6_From1Nov2015To31Oct2016" decimals="2">-0.57</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-16</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c6_From1Nov2015To31Oct2016" decimals="INF">8739453</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c7_From1Nov2014To31Oct2015" decimals="INF">8760126</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c8_From1Nov2015To31Oct2016_ResearchAndDevelopmentExpenseMember" decimals="0">259930</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c9_From1Nov2014To31Oct2015_ResearchAndDevelopmentExpenseMember" decimals="0">306584</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c10_From1Nov2015To31Oct2016_SellingAndMarketingExpenseMember" decimals="0">613631</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c11_From1Nov2014To31Oct2015_SellingAndMarketingExpenseMember" decimals="0">2369806</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c12_AsOf31Oct2014_SeriesAPreferredStockMember" decimals="INF">140</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c12_AsOf31Oct2014_SeriesAPreferredStockMember" decimals="0">14000</us-gaap:StockholdersEquity>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c13_AsOf31Oct2014_CommonStockMember" decimals="INF">8788176</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c13_AsOf31Oct2014_CommonStockMember" decimals="0">87882</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c14_AsOf31Oct2014_AdditionalPaidInCapitalMember" decimals="0">148677413</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c15_AsOf31Oct2014_RetainedEarningsMember" decimals="0">-144769722</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c16_AsOf31Oct2014" decimals="0">4009573</us-gaap:StockholdersEquity>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c17_From1Nov2014To31Oct2015_AdditionalPaidInCapitalMember" decimals="0">2676309</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">2676309</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c18_From1Nov2014To31Oct2015_CommonStockMember" decimals="INF">17334</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c18_From1Nov2014To31Oct2015_CommonStockMember" decimals="0">173</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c17_From1Nov2014To31Oct2015_AdditionalPaidInCapitalMember" decimals="0">44462</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">44635</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c18_From1Nov2014To31Oct2015_CommonStockMember" decimals="INF">11600</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c18_From1Nov2014To31Oct2015_CommonStockMember" decimals="0">116</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c17_From1Nov2014To31Oct2015_AdditionalPaidInCapitalMember" decimals="0">45984</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">46100</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <itus:AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants unitRef="usd" contextRef="c17_From1Nov2014To31Oct2015_AdditionalPaidInCapitalMember" decimals="0">-343973</itus:AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants>
  <itus:AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-343973</itus:AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants>
  <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares unitRef="shares" contextRef="c18_From1Nov2014To31Oct2015_CommonStockMember" decimals="INF">-92232</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
  <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue unitRef="usd" contextRef="c18_From1Nov2014To31Oct2015_CommonStockMember" decimals="0">-922</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
  <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue unitRef="usd" contextRef="c17_From1Nov2014To31Oct2015_AdditionalPaidInCapitalMember" decimals="0">922</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c19_From1Nov2014To31Oct2015_RetainedEarningsMember" decimals="0">-1379043</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c20_AsOf31Oct2015_SeriesAPreferredStockMember" decimals="INF">140</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c20_AsOf31Oct2015_SeriesAPreferredStockMember" decimals="0">14000</us-gaap:StockholdersEquity>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c21_AsOf31Oct2015_CommonStockMember" decimals="INF">8724878</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c21_AsOf31Oct2015_CommonStockMember" decimals="0">87249</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c22_AsOf31Oct2015_AdditionalPaidInCapitalMember" decimals="0">151101117</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c23_AsOf31Oct2015_RetainedEarningsMember" decimals="0">-146148765</us-gaap:StockholdersEquity>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c24_From1Nov2015To31Oct2016_AdditionalPaidInCapitalMember" decimals="0">873561</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">873561</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c25_From1Nov2015To31Oct2016_CommonStockMember" decimals="INF">12676</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c25_From1Nov2015To31Oct2016_CommonStockMember" decimals="0">127</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c24_From1Nov2015To31Oct2016_AdditionalPaidInCapitalMember" decimals="0">33454</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">33581</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c25_From1Nov2015To31Oct2016_CommonStockMember" decimals="INF">10833</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c25_From1Nov2015To31Oct2016_CommonStockMember" decimals="0">108</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c24_From1Nov2015To31Oct2016_AdditionalPaidInCapitalMember" decimals="0">31252</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">31360</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <itus:StockIssuedDuringPeriodSharesPatentLicense unitRef="shares" contextRef="c25_From1Nov2015To31Oct2016_CommonStockMember" decimals="INF">4000</itus:StockIssuedDuringPeriodSharesPatentLicense>
  <itus:StockIssuedDuringPeriodValuePatentLicense unitRef="usd" contextRef="c25_From1Nov2015To31Oct2016_CommonStockMember" decimals="0">40</itus:StockIssuedDuringPeriodValuePatentLicense>
  <itus:StockIssuedDuringPeriodValuePatentLicense unitRef="usd" contextRef="c24_From1Nov2015To31Oct2016_AdditionalPaidInCapitalMember" decimals="0">11760</itus:StockIssuedDuringPeriodValuePatentLicense>
  <itus:StockIssuedDuringPeriodValuePatentLicense unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">11800</itus:StockIssuedDuringPeriodValuePatentLicense>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c26_From1Nov2015To31Oct2016_RetainedEarningsMember" decimals="0">-5016428</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c27_AsOf31Oct2016_SeriesAPreferredStockMember" decimals="INF">140</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c27_AsOf31Oct2016_SeriesAPreferredStockMember" decimals="0">14000</us-gaap:StockholdersEquity>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c28_AsOf31Oct2016_CommonStockMember" decimals="INF">8752387</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c28_AsOf31Oct2016_CommonStockMember" decimals="0">87524</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c29_AsOf31Oct2016_AdditionalPaidInCapitalMember" decimals="0">152051144</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c30_AsOf31Oct2016_RetainedEarningsMember" decimals="0">-151165193</us-gaap:StockholdersEquity>
  <us-gaap:TreasuryStockSharesAcquired unitRef="shares" contextRef="c7_From1Nov2014To31Oct2015" decimals="INF">92232</us-gaap:TreasuryStockSharesAcquired>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c1_AsOf31Oct2015" decimals="INF">16000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:StockOptionPlanExpense unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">873561</us-gaap:StockOptionPlanExpense>
  <us-gaap:StockOptionPlanExpense unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">2676309</us-gaap:StockOptionPlanExpense>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">31360</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">46100</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <itus:AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">-519946</itus:AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense>
  <itus:AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-451906</itus:AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense>
  <itus:GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-101280</itus:GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">-11800</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">33333</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">12515</us-gaap:DepreciationAndAmortization>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-10680</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:IncreaseDecreaseInAccountsReceivable unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-400000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">35541</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">65951</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">87991</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-868661</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <itus:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">-213017</itus:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable>
  <itus:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-347059</itus:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">-3381699</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">1363367</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsToAcquireShortTermInvestments unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">1900000</us-gaap:PaymentsToAcquireShortTermInvestments>
  <us-gaap:PaymentsToAcquireShortTermInvestments unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">2900000</us-gaap:PaymentsToAcquireShortTermInvestments>
  <us-gaap:ProceedsFromSaleOfShortTermInvestments unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">3550000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
  <us-gaap:ProceedsFromSaleOfShortTermInvestments unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">3000000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">146521</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">54776</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">1503479</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">45224</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">33581</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">44635</us-gaap:ProceedsFromStockOptionsExercised>
  <itus:PaymentToAcquireRoyaltyInterestInPatentRights unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">36257</itus:PaymentToAcquireRoyaltyInterestInPatentRights>
  <itus:PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">445253</itus:PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">-2676</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-400618</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">-1880896</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">1007973</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c16_AsOf31Oct2014" decimals="0">3361246</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <dei:EntityRegistrantName contextRef="c6_From1Nov2015To31Oct2016">ITUS CORPORATION</dei:EntityRegistrantName>
  <dei:DocumentType contextRef="c6_From1Nov2015To31Oct2016">S-1</dei:DocumentType>
  <dei:CurrentFiscalYearEndDate contextRef="c6_From1Nov2015To31Oct2016">--10-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityCommonStockSharesOutstanding unitRef="shares" contextRef="c31_AsOf30Nov2016" decimals="INF">8752387</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityPublicFloat unitRef="usd" contextRef="c32_AsOf30Apr2016" decimals="0">21608013</dei:EntityPublicFloat>
  <dei:AmendmentFlag contextRef="c6_From1Nov2015To31Oct2016">false</dei:AmendmentFlag>
  <dei:EntityCentralIndexKey contextRef="c6_From1Nov2015To31Oct2016">0000715446</dei:EntityCentralIndexKey>
  <dei:EntityCurrentReportingStatus contextRef="c6_From1Nov2015To31Oct2016">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityVoluntaryFilers contextRef="c6_From1Nov2015To31Oct2016">No</dei:EntityVoluntaryFilers>
  <dei:EntityFilerCategory contextRef="c6_From1Nov2015To31Oct2016">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityWellKnownSeasonedIssuer contextRef="c6_From1Nov2015To31Oct2016">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:DocumentFiscalYearFocus contextRef="c6_From1Nov2015To31Oct2016">2016</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="c6_From1Nov2015To31Oct2016">FY</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentPeriodEndDate contextRef="c6_From1Nov2015To31Oct2016">2016-10-31</dei:DocumentPeriodEndDate>
  <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 11pt;&quot;&gt;&lt;font style=&quot;text-decoration: underline;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1.&amp;#160; BUSINESS&amp;#160;AND&amp;#160;FUNDING&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Description of Business&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;As used herein, &amp;#x201c;we,&amp;#x201d; &amp;#x201c;us,&amp;#x201d; &amp;#x201c;our,&amp;#x201d; the &amp;#x201c;Company&amp;#x201d; or &amp;#x201c;ITUS&amp;#x201d; means ITUS Corporation and its wholly-owned subsidiaries. &amp;#160;From inception through October 2012, our primary operations involved the development of patented technologies in the areas of thin-film displays and encryption. &amp;#160;Beginning in October of 2012 under the leadership of a new management team, we recapitalized the Company, unencumbered the Company&amp;#x2019;s assets, changed the Company&amp;#x2019;s name and ticker symbol, relocated the Company&amp;#x2019;s headquarters, and modernized its systems. &amp;#160;In July of 2015, the Company&amp;#x2019;s stock was accepted for listing and began trading on the NASDAQ Capital Market.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;In June of 2015, the Company announced the formation of a new subsidiary, Anixa Diagnostics Corporation (&amp;#x201c;Anixa&amp;#x201d;), to develop a platform for non-invasive blood tests for the early detection of cancer. &amp;#160;That platform is called Cchek&lt;font style=&quot;font-size: 11pt;&quot;&gt;&lt;sup&gt;TM&lt;/sup&gt;&lt;/font&gt;&lt;/font&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;. &amp;#160;In July of 2015, ITUS announced a collaborative research agreement with The Wistar Institute (&amp;#x201c;Wistar&amp;#x201d;), the nation&amp;#x2019;s first independent biomedical research institute and a leading National Cancer Institute designated cancer research center, for the purpose of validating our cancer detection methodologies and establishing protocols for identifying certain biomarkers in the blood which we identified and which are known to be associated with malignancies. &amp;#160;In August of 2016 ITUS announced the renewal and expansion of our relationship with Wistar. &amp;#160;In October of 2015, ITUS and Wistar announced favorable results from initial testing of a small group of Breast Cancer patients and healthy controls. &amp;#160;One hundred percent (100%) of the blood samples tested from patients with varying stages of Breast Cancer showed the presence of the biomarkers we identified, and none of the healthy patient blood samples contained the biomarkers. Breast Cancer is the second most common cancer in the United States and throughout the world.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;In April of 2016, ITUS announced that we had demonstrated the efficacy of our Cchek&lt;sup&gt;TM &lt;/sup&gt;&lt;/font&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;early cancer detection platform with Lung Cancer. &amp;#160;Lung cancer is the leading cause of death among cancers in the U.S. and throughout the world, accounting for approximately 27 percent of all cancer related deaths in the U.S. and 19 percent worldwide. In September of 2016, ITUS announced that we had demonstrated the efficacy of our Cchek&lt;sup&gt;TM &lt;/sup&gt;&lt;/font&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;early cancer detection platform with Colon Cancer. Colon Cancer is the third most common cancer in men and the second most common cancer in woman worldwide, with approximately 1.4 million new cases diagnosed each year, and approximately 700,000 deaths. At the end of September 2016 through the end of October 2016, the Company made similar announcements with respect to the efficacy of our Cchek&lt;sup&gt;TM&lt;/sup&gt; &lt;/font&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;early cancer detection platform for Melanoma, Ovarian Cancer, Liver Cancer, Thyroid Cancer, and Pancreatic Cancer. On November 15, 2016, ITUS announced that we had demonstrated the efficacy of our Cchek&lt;sup&gt;TM&lt;/sup&gt; &lt;/font&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;early cancer detection platform with six additional cancer types including Appendiceal Cancer (cancer of the appendix), Uterine Cancer, Osteosarcoma (cancer of the bone), Leiomyosarcoma (cancer of the soft tissue), Liposarcoma (cancer of the connective tissue), and Vulvar Cancer (cancer of the vulva), bringing the number of cancer types for which the efficacy of Cchek&lt;sup&gt;TM&lt;/sup&gt; &lt;/font&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;has been validated thus far to fourteen.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Over the next several quarters, we expect Cchek&amp;#x2122; to be the primary focus of the Company. &amp;#160;As part of our legacy operations, the Company remains engaged in limited patent licensing activities in the area of encrypted audio/video conference calling. &amp;#160;We do not expect these activities to be a significant part of the Company&amp;#x2019;s ongoing operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;During years ended October 31, 2016 and 2015, our revenue has been derived from technology licensing and the sale of patented technologies, including in connection with the settlement of litigation. &amp;#160;In addition to Anixa, the Company may make investments in and form new companies to develop additional emerging technologies.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;AUO Lawsuit and Settlement&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; BACKGROUND:white; COLOR:black&quot;&gt;On December 29, 2014, the Company and AUO Optronics Corporation (&amp;#x201c;AUO&amp;#x201d;) entered into a Settlement Agreement (the &amp;#x201c;Settlement Agreement&amp;#x201d;) and a Patent Assignment Agreement (the &amp;#x201c;Patent Assignment Agreement&amp;#x201d; and together with the Settlement Agreement, the &amp;#x201c;Agreements&amp;#x201d;) pursuant to which the Company received an aggregate of $9,000,000 from AUO. &amp;#160;The Agreements were entered into to resolve a lawsuit filed by the Company against AUO, relating to the Company&amp;#x2019;s patented ePaper&amp;#xae; Electrophoretic Display, and Nano Field Emission Display (&amp;#x201c;nFED&amp;#x201d;) technologies. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;i&gt;&lt;font style=&quot;FONT-SIZE:11pt; BACKGROUND:white; COLOR:black&quot;&gt;Background&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; BACKGROUND:white; COLOR:black&quot;&gt;In May 2011, the Company entered into an Exclusive License Agreement (the &amp;#x201c;EPD License Agreement&amp;#x201d;) and a License Agreement (the &amp;#x201c;Nano Display License Agreement&amp;#x201d;) with AUO (together the &amp;#x201c;AUO License Agreements&amp;#x201d;). &amp;#160;Under the EPD License Agreement, the Company provided AUO with an exclusive, non-transferable, worldwide license to its ePaper&amp;#xae; Electrophoretic Display (&amp;#x201c;EPD&amp;#x201d;) patents and technology, in connection with AUO jointly developing EPD products with the Company. &amp;#160;Under the Nano Display License Agreement, the Company provided AUO with a non-exclusive, non-transferable, worldwide license to its Nano Field Emission Display patents and technology, in connection with AUO jointly developing nFED products with the Company. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; BACKGROUND:white; COLOR:black&quot;&gt;On January 28, 2013, the Company terminated the AUO License Agreements due to numerous alleged material and continual breaches of the agreements by AUO. &amp;#160;On January 28, 2013, the Company also filed a lawsuit in the United States District Court for the Northern District of California against AUO and E Ink Corporation in connection with the AUO License Agreements, alleging breach of contract, breach of the implied covenant of good faith and fair dealing, fraudulent inducement, unjust enrichment, unfair business practices, and other charges (the &amp;#x201c;AUO/E Ink Lawsuit&amp;#x201d;). &amp;#160;In June 2013, the Company and AUO agreed to arbitrate the charges (the case against E Ink Corporation had been dismissed without prejudice) (the &amp;#x201c;AUO/E Ink Arbitration&amp;#x201d;).&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;i&gt;&lt;font style=&quot;FONT-SIZE:11pt; BACKGROUND:white; COLOR:black&quot;&gt;The Agreements&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; BACKGROUND:white; COLOR:black&quot;&gt;Pursuant to the Settlement Agreement, AUO paid the Company $2,000,000 in U.S. currency, net of any Taiwanese withholding taxes. The Settlement Agreement further provides that: &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: Symbol; background: white; color: black;&quot;&gt;&amp;#x2022; &lt;/font&gt;&lt;font style=&quot;font-size: 11pt; background: white; color: black;&quot;&gt;the Company will dismiss the AUO/E Ink Lawsuit and AUO/E Ink Arbitration, with prejudice;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: Symbol; background: white; color: black;&quot;&gt;&amp;#x2022; &lt;/font&gt;&lt;font style=&quot;font-size: 11pt; background: white; color: black;&quot;&gt;the AUO License Agreements are terminated; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: Symbol; background: white; color: black;&quot;&gt;&amp;#x2022; &lt;/font&gt;&lt;font style=&quot;font-size: 11pt; background: white; color: black;&quot;&gt;AUO gives up all rights to the nFED Technology;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: Symbol; background: white; color: black;&quot;&gt;&amp;#x2022; &lt;/font&gt;&lt;font style=&quot;font-size: 11pt; background: white; color: black;&quot;&gt;for a period of two years, the Company agrees not to initiate (whether on its own or through a third party) any patent infringement lawsuits against AUO or its affiliates alleging infringement by AUO&amp;#x2019;s or AUO&amp;#x2019;s affiliates products or services, for patents owned or controlled by the Company as of the date of the Settlement Agreement. &amp;#160;Any potential damages for patent infringement will toll uninterrupted during this two-year period. The prohibition does not apply to patents acquired by the Company after the date of the Settlement Agreement; and &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: Symbol; background: white; color: black;&quot;&gt;&amp;#x2022; &lt;/font&gt;&lt;font style=&quot;font-size: 11pt; background: white; color: black;&quot;&gt;each of AUO and the Company mutually released each other from all claims that either may have against the other in connection with the AUO License Agreements, including any claims relating to the ePaper&amp;#xae; Electrophoretic Display and nFED patents and technologies.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; BACKGROUND:white; COLOR:black&quot;&gt;&amp;#160;Pursuant to the Patent Assignment Agreement, AUO paid the Company $7,000,000 in U.S. currency, net of any Taiwanese withholding taxes in exchange for the Company&amp;#x2019;s ePaper&amp;#xae; Electrophoretic Display patent portfolio for which AUO was previously the exclusive licensee, consisting of: &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: Symbol; background: white; color: black;&quot;&gt;&amp;#x2022; &lt;/font&gt;&lt;font style=&quot;font-size: 11pt; background: white; color: black;&quot;&gt;10 active U.S. patents and 1 U.S. pending patent application; and&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: Symbol; background: white; color: black;&quot;&gt;&amp;#x2022; &lt;/font&gt;&lt;font style=&quot;font-size: 11pt; background: white; color: black;&quot;&gt;103 expired and/or abandoned U.S. and foreign patents and/or patent applications. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; BACKGROUND:white; COLOR:black&quot;&gt;In connection with the lawsuit and settlement, the Company incurred a total of approximately $3,604,000 of legal fees and litigation costs.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Funding &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In October 2015, the &amp;#x201c;Company entered into an At Market Issuance Sales Agreement (the &amp;#x201c;Agreement&amp;#x201d;) with National Securities Corporation (&amp;#x201c;National&amp;#x201d;) to create an at-the-market equity program under which it may sell up to $10,000,000 worth of its common stock (the &amp;#x201c;Shares&amp;#x201d;) from time to time through National, as sales agent. The Company has no obligation to sell any of the Shares, and may at any time suspend offers under the Agreement or terminate the Agreement. The Shares will be issued pursuant to the Company&amp;#x2019;s previously filed registration statement that was declared effective by the Securities and Exchange Commission (the &amp;#x201c;SEC&amp;#x201d;) on September 18, 2015. As of October 31, 2016, no Shares have been sold under the Agreement.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; BACKGROUND:white; COLOR:black&quot;&gt;During the year ended October 31, 2016, cash used in operating activities was approximately $3,382,000.&amp;#160; Cash provided by investing activities was approximately $1,503,000, which resulted from the proceeds on maturity&amp;#160;of certificates of deposit totaling $3,550,000 which was offset by the purchase of certificates of deposit totaling $1,900,000 and the purchase of property and equipment of approximately $147,000.&amp;#160; Our cash used in financing activities was approximately $3,000, which resulted from a royalty payment of approximately $36,000 applied to the patent acquisition obligation liability, offset by the proceeds from exercise of stock options of approximately $34,000. &amp;#160;As a result, our cash, cash equivalents, and short-term investments at October 31, 2016 decreased approximately $3,531,000 to approximately $3,238,000 from approximately $6,769,000 at the end of fiscal year 2015.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; background: white; color: black;&quot;&gt;Based on currently available information as of December 7, 2016, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows from operations will not be sufficient to fund our activities and debt obligations (Note 2) for the next 12 months. To date, we have relied primarily upon cash from the public and private sale of equity and debt securities, as well as net proceeds from the December 2014 AUO settlement, to generate the working capital needed to finance our operations. If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, we will be required to obtain more working capital. We may seek to obtain working capital through sales of our equity securities or through bank credit facilities or public or private debt from various financial institutions where possible and as permitted pursuant to our existing indebtedness. We cannot be certain that additional funding will be available on acceptable terms, or at all. If we do identify sources for additional funding, the sale of additional equity securities or convertible debt could result in dilution to our stockholders. Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities. We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all. If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition. Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; background: white; color: black;&quot;&gt;The accompanying financial statements have been prepared assuming that we will continue as a going concern. In order for us to have sufficient capital to execute our business plan, fund our operations and meet our debt obligations over the next 12 months, we will need to raise additional capital. Although we have been successful in the past in raising capital, we cannot provide any assurance that we will be successful in doing so in the future to the extent necessary to be able to fund our operating activities and debt obligations over the next 12 months, which raises substantial doubt about our ability to continue as a going concern. Our financial statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
  <us-gaap:ProceedsFromLegalSettlements unitRef="usd" contextRef="c33_From29Dec2014To29Dec2014_AUOSettlementMember" decimals="0">9000000</us-gaap:ProceedsFromLegalSettlements>
  <us-gaap:ProceedsFromLegalSettlements unitRef="usd" contextRef="c34_From1Nov2015To31Oct2016_AUOSettlementMember_AUOMember" decimals="0">2000000</us-gaap:ProceedsFromLegalSettlements>
  <us-gaap:ProceedsFromLegalSettlements unitRef="usd" contextRef="c35_From1Nov2015To31Oct2016_PatentAssignmentAgreementMember_AUOMember" decimals="0">7000000</us-gaap:ProceedsFromLegalSettlements>
  <us-gaap:LegalFees unitRef="usd" contextRef="c36_From1Nov2015To31Oct2016_AUOSettlementMember" decimals="0">3604000</us-gaap:LegalFees>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c37_From1Nov2014To31Oct2015_AgreementMember_NationalSecuritiesCorporationMember" decimals="0">10000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c38_From1Nov2015To31Oct2016_AgreementMember_NationalSecuritiesCorporationMember" decimals="0">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:CashPeriodIncreaseDecrease unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">3531000</us-gaap:CashPeriodIncreaseDecrease>
  <us-gaap:CashCashEquivalentsAndShortTermInvestments unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">3238000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
  <us-gaap:CashCashEquivalentsAndShortTermInvestments unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">6769000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
  <us-gaap:SubsequentEventsTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 11pt;&quot;&gt;&lt;font style=&quot;text-decoration: underline;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2.&amp;#160; SUBSEQUENT EVENT&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;On November 11, 2016, the holder of all our outstanding Series A Preferred Stock (the &amp;#x201c;Series A Preferred&amp;#x201d;) with an aggregate stated value of $3,500,000 exercised its right of redemption to receive such amount from proceeds from the sale of the Company&amp;#x2019;s equity securities. On December 6, 2016, we entered into an agreement with the holder of the Series A Preferred setting forth the terms under which such redemption would take place (the &amp;#x201c;Series A Redemption Terms&amp;#x201d;). Pursuant to the Series A Redemption Terms, at closing the holder of the Series A Preferred will receive (i) $500,000 in cash, (ii) a 12% secured debenture evidencing the remaining $3,000,000 amount to be redeemed, $1,000,000 of which is due on or before June 1, 2017 and the remainder of which is due November 11, 2017 (the &amp;#x201c;Redemption Debenture&amp;#x201d;), and (iii) a 5 year warrant to purchase 500,000 shares of the Company&amp;#x2019;s common stock at an exercise price equal to 10% below the thirty (30) day volume weighted average closing price of our common stock at closing. The Redemption Debenture is secured by a lien on the Company&amp;#x2019;s assets and prohibits the Company from incurring any senior indebtedness other than equipment financing in connection with the Company&amp;#x2019;s business.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:ConversionOfStockAmountConverted1 unitRef="usd" contextRef="c39_From11Nov2016To11Nov2016_SeriesAPreferredStockMember_SubsequentEventMember" decimals="0">3500000</us-gaap:ConversionOfStockAmountConverted1>
  <itus:ConversionOfStockCashPaid unitRef="usd" contextRef="c40_From6Dec2016To6Dec2016_SubsequentEventMember" decimals="0">500000</itus:ConversionOfStockCashPaid>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c41_AsOf6Dec2016_SubsequentEventMember" decimals="2">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:ConversionOfStockAmountIssued1 unitRef="usd" contextRef="c40_From6Dec2016To6Dec2016_SubsequentEventMember" decimals="0">3000000</us-gaap:ConversionOfStockAmountIssued1>
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c42_AsOf6Dec2016_SecuredDebentureDueJune12017Member_SubsequentEventMember" decimals="0">1000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c41_AsOf6Dec2016_SubsequentEventMember" decimals="INF">500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ConversionOfStockDescription contextRef="c43_From6Dec2016To6Dec2016_WarrantMember_SubsequentEventMember">exercise price equal to 10% below the thirty (30) day volume weighted average closing price of our common stock at closing</us-gaap:ConversionOfStockDescription>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 11pt;&quot;&gt;&lt;font style=&quot;text-decoration: underline;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3.&amp;#160; SUMMARY&amp;#160;OF&amp;#160;SIGNIFICANT&amp;#160;ACCOUNTING&amp;#160;POLICIES&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Basis of Presentation&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The consolidated financial statements include the accounts of ITUS Corporation and its wholly owned subsidiaries. &amp;#160;All intercompany transactions have been eliminated.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;&amp;#160;&lt;font style=&quot;text-decoration:underline&quot;&gt;Revenue Recognition&lt;/font&gt; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Patent Licensing&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In certain instances, our past revenue arrangements have provided for the payment of contractually determined fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&amp;#160;&amp;#160;These arrangements typically include some combination of the following:&amp;#160;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&amp;#160;&amp;#160;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&amp;#160;&amp;#160;Pursuant to the terms of these agreements, we had no further obligations. &amp;#160;&amp;#160;As such, the earnings process was complete and revenue has been recognized upon the execution of the agreement, when collectability was reasonably assured, and when all other revenue recognition criteria were met.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Inventor Royalties and Contingent Legal Fees&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Inventor royalties and contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Research and Development Expenses&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 11pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Research and development expenses, consisting primarily of salaries and other direct costs associated with developing a platform for non-invasive blood tests for early detection of cancer, are expensed in the consolidated financial statements in the year incurred.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Fair Value Measurements&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Accounting Standards Codification (&amp;#x201c;ASC&amp;#x201d;) 820 &amp;#x201c;Fair Value Measurements and Disclosures&amp;#x201d; (&amp;#x201c;ASC 820&amp;#x201d;) defines fair value, establishes a framework for measuring fair value under GAAP, and expands disclosures about fair value measurements. &amp;#160;In accordance with ASC 820, we have categorized our financial assets and liabilities, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. &amp;#160;If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Level 1 - Financial instruments whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market which we have the ability to access at the measurement date.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Level 2 - Financial instruments whose values are based on quoted market prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Level 3 &amp;#x2013; Financial instruments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. &amp;#160;These inputs reflect management&amp;#x2019;s own assumptions about the assumptions a market participant would use in pricing the instrument. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2016:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Money market funds &amp;#x2013; Cash&amp;#160; and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Certificates of deposit - Short term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 46%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,649,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2015:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Money market funds &amp;#x2013; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;467,967 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;467,967 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Certificates of deposit - Short term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,400,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,400,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 46%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;467,967 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,400,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,867,967 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2016:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2015:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,688,187 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,688,187 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following table sets forth a summary of the changes in the fair value of the Company&amp;#x2019;s Level 3 financial liabilities that are measured at fair value on a recurring basis:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Patent acquisition obligation:&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Balance October 31, 2014&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,236,281 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Accretion of interest on patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;451,906 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Balance October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,688,187 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Accretion of interest on patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;519,946 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Royalty payment applied to patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(36,257)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Balance October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Our non-financial assets that are measured on a non-recurring basis include our patents and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists. &amp;#160;The estimated fair value of prepaid expenses, accounts payable and accrued expenses approximates their individual carrying amounts due to the short term nature of these measurements.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:40.5pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Cash equivalents consists of highly liquid, short term investments with original maturities of three months or less when purchased.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Short-term Investments&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;At October 31, 2016 and 2015, we had certificates of deposit with maturities greater than 90 days and less than 12 months when acquired of $750,000 and $2,400,000, respectively, that were classified as short-term investments and reported at fair value. &amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Patents&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Our only identifiable intangible assets are patents and patent rights. &amp;#160;We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life. &amp;#160;No patent acquisition costs were capitalized during the years ended October 31, 2016 and 2015. &amp;#160;We recorded patent amortization expense of approximately $325,000 and $325,000 during the years ended October 31, 2016 and 2015, respectively.&lt;a name=&quot;_DV_M82&quot;&gt;&lt;/a&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Impairment&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Long-lived assets, including intangible assets that are amortized, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates potential impairment by comparing the carrying amount of the assets with the estimated undiscounted future cash flows associated with them. Should the analysis indicate that an asset is not recoverable, the carrying value of the asset would be reduced to fair value and a corresponding charge would be recognized.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Intangible assets that are not amortized are reviewed for impairment at least annually. The Company evaluates potential impairment by comparing the carrying amount of the asset with its estimated fair value. Should the carrying amount exceed the estimated fair value, a corresponding charge would be recognized for the difference.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Income Taxes&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We recognize deferred tax assets and liabilities for the estimated future tax effects of events that have been recognized in our financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. &amp;#160;A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Stock-Based Compensation&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We maintain stock equity incentive plans under which we may grant non-qualified stock options, incentive stock options, stock appreciation rights, stock awards, performance and performance-based awards, or stock units to employees, non-employee directors and consultants.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Stock Option Compensation Expense &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We account for stock options granted to employees and directors using the accounting guidance in ASC 718 &amp;#x201c;Stock Compensation&amp;#x201d; (&amp;#x201c;ASC 718&amp;#x201d;). &amp;#160;In accordance with ASC 718, we estimate the fair value of service based options and performance based options on the date of grant, using the Black-Scholes pricing model. &amp;#160;For options vesting if the trading price of the Company&amp;#x2019;s common stock achieves a defined target, we use a Monte Carlo simulation in estimating the fair value at grant date. We recognize compensation expense for stock option awards over the requisite or implied service period of the grant. &amp;#160;With respect to performance based awards, compensation expense is recognized when the performance target is deemed probable. &amp;#160;We recorded stock-based compensation expense, related to stock options granted to employees and directors, of approximately $874,000 and $2,192,000, during the years ended October 31, 2016 and 2015, respectively. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Included in stock-based compensation cost for employees and directors during the years ended October 31, 2016 and 2015 was approximately $393,000 and $2,093,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but not yet vested. &amp;#160;As of October 31, 2016, there was unrecognized compensation cost related to non-vested stock options granted to employees and directors, related to service based options of approximately $1,139,000 which will be recognized over a weighted-average period of 2.3 years. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We account for stock options granted to consultants using the accounting guidance included in ASC 505-50 &amp;#x201c;Equity-Based Payments to Non-Employees&amp;#x201d; (&amp;#x201c;ASC 505-50&amp;#x201d;). &amp;#160;In accordance with ASC 505-50, we estimate the fair value of service based stock options and performance based options at each reporting period, using the Black-Scholes pricing model. &amp;#160;For options vesting if the trading price of the Company&amp;#x2019;s common stock achieves a defined target we estimate the fair value at each reporting period using a Monte Carlo simulation. &amp;#160;We recognize compensation expense for service based stock options and options subject to market conditions over the requisite or implied service period of the grant. &amp;#160;For performance based awards, compensation expense is recognized when the performance target is achieved.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We recorded consulting expense, related to stock options granted to consultants, during the years ended October 31, 2016 and 2015 of approximately $-0- and $484,000, respectively. &amp;#160;Stock-based consulting expense for the years ended October 31, 2016 and 2015 includes approximately $-0- and $484,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but vested in the current period. As of October 31, 2016, there was no unrecognized consulting expense related to non-vested stock options granted to consultants. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Fair Value Determination &amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We use the Black-Scholes pricing model in estimating the fair value of stock options which vest over a specific period of time or upon achieving performance targets. &amp;#160;To determine the weighted average fair value of stock options on the date of grant, employees and directors are included in a single group. &amp;#160;The fair value of stock options granted to consultants is determined on an individual basis. &amp;#160;The stock options we granted during the year ended October 31, 2015 consisted of awards with 10-year terms that vest over one year, options with 10-year terms that vest over 36 months. The stock options we granted during the year ended October 31, 2014 consisted of awards with 10-year terms that vest over one year and options with 10-year terms that vest over 36 months, options with 5-year terms which vest immediately and options with 10-year terms which vest upon achievement of performance milestones. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following weighted average assumptions were used in estimating the fair value of stock options granted during the years ended October 31, 2016 and 2015:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;5&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;For the Year &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted average fair value at grant date&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2.84 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3.09 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Valuation assumptions:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Expected life (years) &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;5.70&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;5.75&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Expected volatility&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;181.1%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;117.8%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1.26%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2.01%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Expected dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding. &amp;#160;We use the simplified method to determine expected term. &amp;#160;The simplified method was adopted since we do not believe that historical experience is representative of future performance because of the impact of the changes in our operations and the change in terms from historical options which vested immediately to terms including vesting periods of up to three years. &amp;#160;Under the Black-Scholes pricing model, we estimated the expected volatility of our shares of common stock based upon the historical volatility of our share price over a period of time equal to the expected term of the options. &amp;#160;We estimated the risk-free interest rate based on the implied yield available on the applicable grant date of a U.S. Treasury note with a term equal to the expected term of the underlying grants. &amp;#160;We made the dividend yield assumption based on our history of not paying dividends and our expectation not to pay dividends in the future. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Under ASC 718, the amount of stock-based compensation expense recognized is based on the portion of the awards that are ultimately expected to vest. &amp;#160;Accordingly, if deemed necessary, we reduce the fair value of the stock option awards for expected forfeitures, which are forfeitures of the unvested portion of surrendered options. &amp;#160;Based on our historical experience and future expectations, we have not reduced the amount of stock-based compensation expenses for anticipated forfeitures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We will reconsider use of the Black-Scholes pricing model if additional information becomes available in the future that indicates another model would be more appropriate. &amp;#160;If factors change and we employ different assumptions in the application of ASC 718 in future periods, the compensation expense that we record under ASC 718 may differ significantly from what we have recorded in the current period.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Net&amp;#160;Loss&amp;#160;Per&amp;#160;Share of Common Stock &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In accordance with ASC 260, &amp;#x201c;Earnings Per Share&amp;#x201d;, basic net loss per common share (&amp;#x201c;Basic EPS&amp;#x201d;) is computed by dividing net loss by the weighted average number of common shares outstanding. &amp;#160;Diluted net loss per common share (&amp;#x201c;Diluted EPS&amp;#x201d;) is computed by dividing net loss by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding. &amp;#160;Diluted EPS for all years presented is the same as Basic EPS, as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive. &amp;#160;For this reason, excluded from the calculation of Diluted EPS for the years ended October 31, 2016 and 2015, were options to purchase 3,086,472 and 2,672,471 shares, respectively, warrants to purchase 707,379 shares and 1,028,931 shares, respectively, preferred stock convertible into 739,958 shares.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Use of Estimates &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. &amp;#160;Estimates and assumptions are used for, but not limited to, determining stock-based compensation, asset impairment evaluations, tax assets and liabilities, license fee revenue, the allowance for doubtful accounts, depreciation lives and other contingencies. &amp;#160;Actual results could differ from those estimates.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Effect of Recently Issued Pronouncements&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In May 2014, the Financial Accounting Standards Board (&quot;FASB&quot;) issued Accounting Standards Update 2014-09 (&amp;#x201c;ASU 2014-09&amp;#x201d;), Revenue from Contracts with Customers. &amp;#160;This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &amp;#160;This standard update is effective for&amp;#160;interim and annual&amp;#160;reporting periods beginning after December 15,&amp;#160;2016, and are to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. &amp;#160;In July 2015, a one-year deferral of the effective date of the new guidance was approved. &amp;#160;We are currently evaluating the impact ASU 2014-09 will have on our consolidated financial statements&amp;#160;and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In June 2014, the FASB issued Accounting Standards Update 2014-12 (&amp;#x201c;ASU 2014-12&amp;#x201d;), Compensation &amp;#x2013; Stock Compensation. &amp;#160;This amendment requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. &amp;#160;&amp;#160;We do not expect this update to have a significant impact on our consolidated financial statements and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;In August 2014, the FASB issued Accounting Standards Update 2014-15 (&amp;#x201c;ASU 2014-15&amp;#x201d;). &amp;#160;This amendment requires management to assess an entity&amp;#x2019;s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods ending after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption. We do not expect this update to have a significant impact on our consolidated financial statements and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;In April 2015, the FASB issued Accounting Standards Update 2015-03 (&amp;#x201c;ASU 2015-03&amp;#x201d;) to simplify the presentation of debt issuance costs. This amendment requires debt issuance costs be presented on the balance sheet as a direct reduction from the carrying amount of the debt liability, consistent with debt discounts or premiums. Adoption of this standard is required for interim and annual periods beginning after December 15, 2015 and is to be applied retrospectively. &amp;#160;The adoption of this amendment on November 1, 2016 did not have an impact on our consolidated financial statements&amp;#160;and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In November 2015, the FASB issued Accounting Standards Update 2015-17 (&amp;#x201c;ASU 2015-17&amp;#x201d;) to simplify the presentation of deferred taxes. This amendment requires that all deferred tax assets and liabilities, along with any related valuation allowances, be classified as noncurrent on the balance sheet. &amp;#160;Adoption of this standard is required for annual periods beginning after December 15, 2016. &amp;#160;We are currently evaluating the impact ASU 2015-17 will have on our consolidated financial statements&amp;#160;and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In February 2016, the FASB issued Accounting Standards Update 2016-02 (&amp;#x201c;ASU 2016-02&amp;#x201d;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. &amp;#160;The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. &amp;#160;The requirements of this standard include a significant increase in required disclosures. &amp;#160;We are currently evaluating the impact ASU 2016-02 will have on our consolidated financial statements&amp;#160;and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In March 2016, the FASB issued Accounting Standards Update 2016-09 (&amp;#x201c;ASU 2016-09&amp;#x201d;) that changes the accounting for certain aspects of share-based payments to employees. &amp;#160;The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee&amp;#x2019;s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. &amp;#160;The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. Early adoption is permitted. &amp;#160;We are currently evaluating the impact ASU 2016-09 will have on our consolidated financial statements&amp;#160;and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Concentration of Credit Risks&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Financial instruments that potentially subject us to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable. &amp;#160;Cash equivalents are primarily highly rated money market funds. Short-term investments are certificates of deposit within federally insured limits. &amp;#160;Where applicable, management reviews our accounts receivable and other receivables for potential doubtful accounts and maintains an allowance for estimated uncollectible amounts. &amp;#160;Our policy is to write-off uncollectable amounts at the time it is determined that collection will not occur. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Two licensees accounted for 67% and 33%, respectively, of revenues from patent licensing activities during fiscal year 2016. &amp;#160;Three licensees accounted for 53%, 37% and 10%, respectively, of revenues from patent licensing activities during fiscal year 2015. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Basis of Presentation&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The consolidated financial statements include the accounts of ITUS Corporation and its wholly owned subsidiaries. &amp;#160;All intercompany transactions have been eliminated.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
  <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Revenue Recognition&lt;/font&gt; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Patent Licensing&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In certain instances, our past revenue arrangements have provided for the payment of contractually determined fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&amp;#160;&amp;#160;These arrangements typically include some combination of the following:&amp;#160;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&amp;#160;&amp;#160;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&amp;#160;&amp;#160;Pursuant to the terms of these agreements, we had no further obligations. &amp;#160;&amp;#160;As such, the earnings process was complete and revenue has been recognized upon the execution of the agreement, when collectability was reasonably assured, and when all other revenue recognition criteria were met.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Inventor Royalties and Contingent Legal Fees&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Inventor royalties and contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Research and Development Expenses&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 11pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Research and development expenses, consisting primarily of salaries and other direct costs associated with developing a platform for non-invasive blood tests for early detection of cancer, are expensed in the consolidated financial statements in the year incurred.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Fair Value Measurements&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Accounting Standards Codification (&amp;#x201c;ASC&amp;#x201d;) 820 &amp;#x201c;Fair Value Measurements and Disclosures&amp;#x201d; (&amp;#x201c;ASC 820&amp;#x201d;) defines fair value, establishes a framework for measuring fair value under GAAP, and expands disclosures about fair value measurements. &amp;#160;In accordance with ASC 820, we have categorized our financial assets and liabilities, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. &amp;#160;If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Level 1 - Financial instruments whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market which we have the ability to access at the measurement date.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Level 2 - Financial instruments whose values are based on quoted market prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Level 3 &amp;#x2013; Financial instruments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. &amp;#160;These inputs reflect management&amp;#x2019;s own assumptions about the assumptions a market participant would use in pricing the instrument. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2016:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Money market funds &amp;#x2013; Cash&amp;#160; and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Certificates of deposit - Short term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 46%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,649,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2015:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Money market funds &amp;#x2013; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;467,967 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;467,967 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Certificates of deposit - Short term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,400,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,400,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 46%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;467,967 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,400,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,867,967 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2016:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2015:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,688,187 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,688,187 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following table sets forth a summary of the changes in the fair value of the Company&amp;#x2019;s Level 3 financial liabilities that are measured at fair value on a recurring basis:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Patent acquisition obligation:&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Balance October 31, 2014&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,236,281 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Accretion of interest on patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;451,906 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Balance October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,688,187 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Accretion of interest on patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;519,946 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Royalty payment applied to patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(36,257)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Balance October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Our non-financial assets that are measured on a non-recurring basis include our patents and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists. &amp;#160;The estimated fair value of prepaid expenses, accounts payable and accrued expenses approximates their individual carrying amounts due to the short term nature of these measurements.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:40.5pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Cash equivalents consists of highly liquid, short term investments with original maturities of three months or less when purchased&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:InvestmentPolicyTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Short-term Investments&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;At October 31, 2016 and 2015, we had certificates of deposit with maturities greater than 90 days and less than 12 months when acquired of $750,000 and $2,400,000, respectively, that were classified as short-term investments and reported at fair value.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
  <us-gaap:MaturityOfTimeDeposits contextRef="c44_From1Nov2015To31Oct2016_MinimumMember">P90D</us-gaap:MaturityOfTimeDeposits>
  <us-gaap:MaturityOfTimeDeposits contextRef="c45_From1Nov2015To31Oct2016_MaximumMember">P12Y</us-gaap:MaturityOfTimeDeposits>
  <us-gaap:CertificatesOfDepositAtCarryingValue unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">750000</us-gaap:CertificatesOfDepositAtCarryingValue>
  <us-gaap:CertificatesOfDepositAtCarryingValue unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">2400000</us-gaap:CertificatesOfDepositAtCarryingValue>
  <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="c46_From1Nov2015To31Oct2016_PatentsMember">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Patents&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Our only identifiable intangible assets are patents and patent rights. &amp;#160;We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life. &amp;#160;No patent acquisition costs were capitalized during the years ended October 31, 2016 and 2015. &amp;#160;We recorded patent amortization expense of approximately $325,000 and $325,000 during the years ended October 31, 2016 and 2015, respectively.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
  <us-gaap:AmortizationOfAcquisitionCosts unitRef="usd" contextRef="c46_From1Nov2015To31Oct2016_PatentsMember" decimals="0">325000</us-gaap:AmortizationOfAcquisitionCosts>
  <us-gaap:AmortizationOfAcquisitionCosts unitRef="usd" contextRef="c47_From1Nov2014To31Oct2015_PatentsMember" decimals="0">325000</us-gaap:AmortizationOfAcquisitionCosts>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Impairment&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Long-lived assets, including intangible assets that are amortized, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates potential impairment by comparing the carrying amount of the assets with the estimated undiscounted future cash flows associated with them. Should the analysis indicate that an asset is not recoverable, the carrying value of the asset would be reduced to fair value and a corresponding charge would be recognized.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Intangible assets that are not amortized are reviewed for impairment at least annually. The Company evaluates potential impairment by comparing the carrying amount of the asset with its estimated fair value. Should the carrying amount exceed the estimated fair value, a corresponding charge would be recognized for the difference.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Income Taxes&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We recognize deferred tax assets and liabilities for the estimated future tax effects of events that have been recognized in our financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. &amp;#160;A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Stock-Based Compensation&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We maintain stock equity incentive plans under which we may grant non-qualified stock options, incentive stock options, stock appreciation rights, stock awards, performance and performance-based awards, or stock units to employees, non-employee directors and consultants.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Stock Option Compensation Expense &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We account for stock options granted to employees and directors using the accounting guidance in ASC 718 &amp;#x201c;Stock Compensation&amp;#x201d; (&amp;#x201c;ASC 718&amp;#x201d;). &amp;#160;In accordance with ASC 718, we estimate the fair value of service based options and performance based options on the date of grant, using the Black-Scholes pricing model. &amp;#160;For options vesting if the trading price of the Company&amp;#x2019;s common stock achieves a defined target, we use a Monte Carlo simulation in estimating the fair value at grant date. We recognize compensation expense for stock option awards over the requisite or implied service period of the grant. &amp;#160;With respect to performance based awards, compensation expense is recognized when the performance target is deemed probable. &amp;#160;We recorded stock-based compensation expense, related to stock options granted to employees and directors, of approximately $874,000 and $2,192,000, during the years ended October 31, 2016 and 2015, respectively. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Included in stock-based compensation cost for employees and directors during the years ended October 31, 2016 and 2015 was approximately $393,000 and $2,093,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but not yet vested. &amp;#160;As of October 31, 2016, there was unrecognized compensation cost related to non-vested stock options granted to employees and directors, related to service based options of approximately $1,139,000 which will be recognized over a weighted-average period of 2.3 years. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We account for stock options granted to consultants using the accounting guidance included in ASC 505-50 &amp;#x201c;Equity-Based Payments to Non-Employees&amp;#x201d; (&amp;#x201c;ASC 505-50&amp;#x201d;). &amp;#160;In accordance with ASC 505-50, we estimate the fair value of service based stock options and performance based options at each reporting period, using the Black-Scholes pricing model. &amp;#160;For options vesting if the trading price of the Company&amp;#x2019;s common stock achieves a defined target we estimate the fair value at each reporting period using a Monte Carlo simulation. &amp;#160;We recognize compensation expense for service based stock options and options subject to market conditions over the requisite or implied service period of the grant. &amp;#160;For performance based awards, compensation expense is recognized when the performance target is achieved.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We recorded consulting expense, related to stock options granted to consultants, during the years ended October 31, 2016 and 2015 of approximately $-0- and $484,000, respectively. &amp;#160;Stock-based consulting expense for the years ended October 31, 2016 and 2015 includes approximately $-0- and $484,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but vested in the current period. As of October 31, 2016, there was no unrecognized consulting expense related to non-vested stock options granted to consultants.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c48_From1Nov2015To31Oct2016_StockOptionsGrantedToEmployeesAndDirectorsMember" decimals="0">874000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c49_From1Nov2014To31Oct2015_StockOptionsGrantedToEmployeesAndDirectorsMember" decimals="0">2192000</us-gaap:ShareBasedCompensation>
  <itus:AmortizationRelatedToCompensationCost unitRef="usd" contextRef="c48_From1Nov2015To31Oct2016_StockOptionsGrantedToEmployeesAndDirectorsMember" decimals="0">393000</itus:AmortizationRelatedToCompensationCost>
  <itus:AmortizationRelatedToCompensationCost unitRef="usd" contextRef="c49_From1Nov2014To31Oct2015_StockOptionsGrantedToEmployeesAndDirectorsMember" decimals="0">2093000</itus:AmortizationRelatedToCompensationCost>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized unitRef="usd" contextRef="c50_AsOf31Oct2016_StockOptionsGrantedToEmployeesAndDirectorsMember" decimals="0">1139000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c48_From1Nov2015To31Oct2016_StockOptionsGrantedToEmployeesAndDirectorsMember">P2Y109D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c51_From1Nov2015To31Oct2016_StockAwardGrantedConsultantsMember" decimals="0">0</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c52_From1Nov2014To31Oct2015_StockAwardGrantedConsultantsMember" decimals="0">484000</us-gaap:ShareBasedCompensation>
  <itus:AmortizationRelatedToCompensationCost unitRef="usd" contextRef="c51_From1Nov2015To31Oct2016_StockAwardGrantedConsultantsMember" decimals="0">0</itus:AmortizationRelatedToCompensationCost>
  <itus:AmortizationRelatedToCompensationCost unitRef="usd" contextRef="c52_From1Nov2014To31Oct2015_StockAwardGrantedConsultantsMember" decimals="0">484000</itus:AmortizationRelatedToCompensationCost>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Fair Value Determination &amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We use the Black-Scholes pricing model in estimating the fair value of stock options which vest over a specific period of time or upon achieving performance targets. &amp;#160;To determine the weighted average fair value of stock options on the date of grant, employees and directors are included in a single group. &amp;#160;The fair value of stock options granted to consultants is determined on an individual basis. &amp;#160;The stock options we granted during the year ended October 31, 2015 consisted of awards with 10-year terms that vest over one year, options with 10-year terms that vest over 36 months. The stock options we granted during the year ended October 31, 2014 consisted of awards with 10-year terms that vest over one year and options with 10-year terms that vest over 36 months, options with 5-year terms which vest immediately and options with 10-year terms which vest upon achievement of performance milestones. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following weighted average assumptions were used in estimating the fair value of stock options granted during the years ended October 31, 2016 and 2015:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;5&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;For the Year &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted average fair value at grant date&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2.84 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3.09 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Valuation assumptions:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Expected life (years) &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;5.70&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;5.75&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Expected volatility&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;181.1%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;117.8%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1.26%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2.01%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Expected dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding. &amp;#160;We use the simplified method to determine expected term. &amp;#160;The simplified method was adopted since we do not believe that historical experience is representative of future performance because of the impact of the changes in our operations and the change in terms from historical options which vested immediately to terms including vesting periods of up to three years. &amp;#160;Under the Black-Scholes pricing model, we estimated the expected volatility of our shares of common stock based upon the historical volatility of our share price over a period of time equal to the expected term of the options. &amp;#160;We estimated the risk-free interest rate based on the implied yield available on the applicable grant date of a U.S. Treasury note with a term equal to the expected term of the underlying grants. &amp;#160;We made the dividend yield assumption based on our history of not paying dividends and our expectation not to pay dividends in the future. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Under ASC 718, the amount of stock-based compensation expense recognized is based on the portion of the awards that are ultimately expected to vest. &amp;#160;Accordingly, if deemed necessary, we reduce the fair value of the stock option awards for expected forfeitures, which are forfeitures of the unvested portion of surrendered options. &amp;#160;Based on our historical experience and future expectations, we have not reduced the amount of stock-based compensation expenses for anticipated forfeitures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We will reconsider use of the Black-Scholes pricing model if additional information becomes available in the future that indicates another model would be more appropriate. &amp;#160;If factors change and we employ different assumptions in the application of ASC 718 in future periods, the compensation expense that we record under ASC 718 may differ significantly from what we have recorded in the current period&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription contextRef="c53_From1Nov2014To31Oct2015_AwardsOfOptionsWith10YearTermsMember">The stock options we granted during the year ended October 31, 2015 consisted of awards with 10-year terms that vest over one year, options with 10-year terms that vest over 36 months.</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription contextRef="c54_From1Nov2013To31Oct2014_AwardsOfOptionsWith10YearTermsMember">The stock options we granted during the year ended October 31, 2014 consisted of awards with 10-year terms that vest over one year and options with 10-year terms that vest over 36 months, options with 5-year terms which vest immediately and options with 10-year terms which vest upon achievement of performance milestones.</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Net&amp;#160;Loss&amp;#160;Per&amp;#160;Share of Common Stock &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In accordance with ASC 260, &amp;#x201c;Earnings Per Share&amp;#x201d;, basic net loss per common share (&amp;#x201c;Basic EPS&amp;#x201d;) is computed by dividing net loss by the weighted average number of common shares outstanding. &amp;#160;Diluted net loss per common share (&amp;#x201c;Diluted EPS&amp;#x201d;) is computed by dividing net loss by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding. &amp;#160;Diluted EPS for all years presented is the same as Basic EPS, as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive. &amp;#160;For this reason, excluded from the calculation of Diluted EPS for the years ended October 31, 2016 and 2015, were options to purchase 3,086,472 and 2,672,471 shares, respectively, warrants to purchase 707,379 shares and 1,028,931 shares, respectively, preferred stock convertible into 739,958 shares.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c55_From1Nov2015To31Oct2016_EmployeeStockOptionMember" decimals="INF">3086472</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c56_From1Nov2014To31Oct2015_EmployeeStockOptionMember" decimals="INF">2672471</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c57_From1Nov2015To31Oct2016_WarrantMember" decimals="INF">707379</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c58_From1Nov2014To31Oct2015_WarrantMember" decimals="INF">1028931</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c59_From1Nov2015To31Oct2016_ConvertiblePreferredStockMember" decimals="INF">739958</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:UseOfEstimates contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Use of Estimates &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. &amp;#160;Estimates and assumptions are used for, but not limited to, determining stock-based compensation, asset impairment evaluations, tax assets and liabilities, license fee revenue, the allowance for doubtful accounts, depreciation lives and other contingencies. &amp;#160;Actual results could differ from those estimates&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Effect of Recently Issued Pronouncements&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In May 2014, the Financial Accounting Standards Board (&quot;FASB&quot;) issued Accounting Standards Update 2014-09 (&amp;#x201c;ASU 2014-09&amp;#x201d;), Revenue from Contracts with Customers. &amp;#160;This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &amp;#160;This standard update is effective for&amp;#160;interim and annual&amp;#160;reporting periods beginning after December 15,&amp;#160;2016, and are to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. &amp;#160;In July 2015, a one-year deferral of the effective date of the new guidance was approved. &amp;#160;We are currently evaluating the impact ASU 2014-09 will have on our consolidated financial statements&amp;#160;and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In June 2014, the FASB issued Accounting Standards Update 2014-12 (&amp;#x201c;ASU 2014-12&amp;#x201d;), Compensation &amp;#x2013; Stock Compensation. &amp;#160;This amendment requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. &amp;#160;&amp;#160;We do not expect this update to have a significant impact on our consolidated financial statements and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;In August 2014, the FASB issued Accounting Standards Update 2014-15 (&amp;#x201c;ASU 2014-15&amp;#x201d;). &amp;#160;This amendment requires management to assess an entity&amp;#x2019;s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods ending after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption. We do not expect this update to have a significant impact on our consolidated financial statements and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;In April 2015, the FASB issued Accounting Standards Update 2015-03 (&amp;#x201c;ASU 2015-03&amp;#x201d;) to simplify the presentation of debt issuance costs. This amendment requires debt issuance costs be presented on the balance sheet as a direct reduction from the carrying amount of the debt liability, consistent with debt discounts or premiums. Adoption of this standard is required for interim and annual periods beginning after December 15, 2015 and is to be applied retrospectively. &amp;#160;The adoption of this amendment on November 1, 2016 did not have an impact on our consolidated financial statements&amp;#160;and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In November 2015, the FASB issued Accounting Standards Update 2015-17 (&amp;#x201c;ASU 2015-17&amp;#x201d;) to simplify the presentation of deferred taxes. This amendment requires that all deferred tax assets and liabilities, along with any related valuation allowances, be classified as noncurrent on the balance sheet. &amp;#160;Adoption of this standard is required for annual periods beginning after December 15, 2016. &amp;#160;We are currently evaluating the impact ASU 2015-17 will have on our consolidated financial statements&amp;#160;and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In February 2016, the FASB issued Accounting Standards Update 2016-02 (&amp;#x201c;ASU 2016-02&amp;#x201d;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. &amp;#160;The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. &amp;#160;The requirements of this standard include a significant increase in required disclosures. &amp;#160;We are currently evaluating the impact ASU 2016-02 will have on our consolidated financial statements&amp;#160;and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In March 2016, the FASB issued Accounting Standards Update 2016-09 (&amp;#x201c;ASU 2016-09&amp;#x201d;) that changes the accounting for certain aspects of share-based payments to employees. &amp;#160;The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee&amp;#x2019;s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. &amp;#160;The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. Early adoption is permitted. &amp;#160;We are currently evaluating the impact ASU 2016-09 will have on our consolidated financial statements&amp;#160;and related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Concentration of Credit Risks&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Financial instruments that potentially subject us to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable. &amp;#160;Cash equivalents are primarily highly rated money market funds. Short-term investments are certificates of deposit within federally insured limits. &amp;#160;Where applicable, management reviews our accounts receivable and other receivables for potential doubtful accounts and maintains an allowance for estimated uncollectible amounts. &amp;#160;Our policy is to write-off uncollectable amounts at the time it is determined that collection will not occur. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Two licensees accounted for 67% and 33%, respectively, of revenues from patent licensing activities during fiscal year 2016. &amp;#160;Three licensees accounted for 53%, 37% and 10%, respectively, of revenues from patent licensing activities during fiscal year 2015.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c60_From1Nov2015To31Oct2016_SalesRevenueNetMember_CustomerConcentrationRiskMember_Licensees1Member" decimals="2">0.67</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c61_From1Nov2015To31Oct2016_SalesRevenueNetMember_CustomerConcentrationRiskMember_Licensees2Member" decimals="2">0.33</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c62_From1Nov2014To31Oct2015_SalesRevenueNetMember_CustomerConcentrationRiskMember_Licensees1Member" decimals="2">0.53</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c63_From1Nov2014To31Oct2015_SalesRevenueNetMember_CustomerConcentrationRiskMember_Licensees2Member" decimals="2">0.37</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c64_From1Nov2014To31Oct2015_SalesRevenueNetMember_CustomerConcentrationRiskMember_Licensees3Member" decimals="2">0.10</us-gaap:ConcentrationRiskPercentage1>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFVDB3Xzjr8GYI25Uk9Vy6/qcRrEsuAZfUt5UQC5nlxkGiq5YLv5a+F+/7ledHhFpceslIpB8H2YAcKJFlbjmJJqGSqwhlfgWnh4//mUBfEtsgz1qQUnYwkk41CHpPbGVQeGj8u65aqnL] CSR-->
  <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Money market funds &amp;#x2013; Cash&amp;#160; and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Certificates of deposit - Short term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 46%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,649,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Money market funds &amp;#x2013; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;467,967 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;467,967 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Certificates of deposit - Short term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,400,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,400,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 46%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;467,967 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,400,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,867,967 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,688,187 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,688,187 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c65_AsOf31Oct2016_MoneyMarketFundsMember_FairValueInputsLevel1Member" decimals="0">1899136</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c66_AsOf31Oct2016_MoneyMarketFundsMember_FairValueInputsLevel2Member" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c67_AsOf31Oct2016_MoneyMarketFundsMember_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c68_AsOf31Oct2016_MoneyMarketFundsMember" decimals="0">1899136</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c69_AsOf31Oct2016_CertificatesOfDepositMember_FairValueInputsLevel1Member" xs:nil="true"/>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c70_AsOf31Oct2016_CertificatesOfDepositMember_FairValueInputsLevel2Member" decimals="0">750000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c71_AsOf31Oct2016_CertificatesOfDepositMember_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c72_AsOf31Oct2016_CertificatesOfDepositMember" decimals="0">750000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c73_AsOf31Oct2016_FairValueInputsLevel1Member" decimals="0">1899136</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c74_AsOf31Oct2016_FairValueInputsLevel2Member" decimals="0">750000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c75_AsOf31Oct2016_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">2649136</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c76_AsOf31Oct2015_MoneyMarketFundsMember_FairValueInputsLevel1Member" decimals="0">467967</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c77_AsOf31Oct2015_MoneyMarketFundsMember_FairValueInputsLevel2Member" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c78_AsOf31Oct2015_MoneyMarketFundsMember_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c79_AsOf31Oct2015_MoneyMarketFundsMember" decimals="0">467967</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c80_AsOf31Oct2015_FairValueInputsLevel1Member_GlobalDepositoryReceiptsMember" xs:nil="true"/>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c81_AsOf31Oct2015_FairValueInputsLevel2Member_GlobalDepositoryReceiptsMember" decimals="0">2400000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c82_AsOf31Oct2015_FairValueInputsLevel3Member_GlobalDepositoryReceiptsMember" xs:nil="true"/>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c83_AsOf31Oct2015_GlobalDepositoryReceiptsMember" decimals="0">2400000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c84_AsOf31Oct2015_FairValueInputsLevel1Member" decimals="0">467967</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c85_AsOf31Oct2015_FairValueInputsLevel2Member" decimals="0">2400000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c86_AsOf31Oct2015_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">2867967</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations unitRef="usd" contextRef="c73_AsOf31Oct2016_FairValueInputsLevel1Member" xs:nil="true"/>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations unitRef="usd" contextRef="c74_AsOf31Oct2016_FairValueInputsLevel2Member" xs:nil="true"/>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations unitRef="usd" contextRef="c75_AsOf31Oct2016_FairValueInputsLevel3Member" decimals="0">4171876</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">4171876</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations unitRef="usd" contextRef="c84_AsOf31Oct2015_FairValueInputsLevel1Member" xs:nil="true"/>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations unitRef="usd" contextRef="c85_AsOf31Oct2015_FairValueInputsLevel2Member" xs:nil="true"/>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations unitRef="usd" contextRef="c86_AsOf31Oct2015_FairValueInputsLevel3Member" decimals="0">3688187</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">3688187</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Patent acquisition obligation:&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Balance October 31, 2014&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,236,281 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Accretion of interest on patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;451,906 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Balance October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,688,187 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Accretion of interest on patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;519,946 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Royalty payment applied to patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(36,257)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Balance October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c16_AsOf31Oct2014" decimals="0">3236281</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">3688187</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">4171876</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;5&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;For the Year &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted average fair value at grant date&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2.84 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3.09 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Valuation assumptions:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Expected life (years) &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;5.70&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;5.75&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Expected volatility&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;181.1%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;117.8%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1.26%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2.01%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Expected dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue unitRef="usdPershares" contextRef="c6_From1Nov2015To31Oct2016" decimals="2">2.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue unitRef="usdPershares" contextRef="c7_From1Nov2014To31Oct2015" decimals="2">3.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c6_From1Nov2015To31Oct2016">P5Y255D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c7_From1Nov2014To31Oct2015">P5Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c6_From1Nov2015To31Oct2016" decimals="3">1.811</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c7_From1Nov2014To31Oct2015" decimals="3">1.178</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c6_From1Nov2015To31Oct2016" decimals="4">0.0126</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c7_From1Nov2014To31Oct2015" decimals="4">0.0201</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c6_From1Nov2015To31Oct2016" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c7_From1Nov2014To31Oct2015" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 11pt;&quot;&gt;&lt;font style=&quot;text-decoration: underline;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;4.&amp;#160; ACCOUNTS PAYABLE AND ACCRUED EXPENSES&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Accounts payable and accrued liabilities consist of the following as of:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Accounts payable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;373,224 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;374,703 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Payroll and related expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;49,901 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Accrued other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;45,631 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;6,062 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;font style=&quot;font-family: times new roman,times,serif; font-size: 12pt; display: none;&quot;&gt;Total&lt;/font&gt;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;468,756 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;380,765 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Accounts payable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;373,224 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;374,703 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Payroll and related expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;49,901 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Accrued other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;45,631 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;6,062 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;font style=&quot;font-family: times new roman,times,serif; font-size: 12pt; display: none;&quot;&gt;Total&lt;/font&gt;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;468,756 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;380,765 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">373224</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">374703</us-gaap:AccountsPayableCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">49901</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">45631</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">6062</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:NotesPayableCurrent unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">468756</us-gaap:NotesPayableCurrent>
  <us-gaap:NotesPayableCurrent unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">380765</us-gaap:NotesPayableCurrent>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 11pt;&quot;&gt;&lt;font style=&quot;text-decoration: underline;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;5.&amp;#160; SHAREHOLDERS&amp;#x2019; EQUITY&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; BACKGROUND:white; COLOR:black&quot;&gt;Reverse Stock Split&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:40.5pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; BACKGROUND:white; COLOR:black&quot;&gt;On June 26, 2015, we effected a 1-for-25 reverse stock split (the &amp;#x201c;Stock Split&amp;#x201d;) of our issued common stock and preferred stock. &amp;#160;Each shareholders&amp;#x2019; percentage ownership and proportional voting power remained unchanged as a result of the Stock Split. &amp;#160;All applicable share data, per share amounts and related information in the consolidated financial statements and notes thereto have been adjusted retroactively to give effect to the Stock Split. &amp;#160;As a result of the Stock Split, the number of shares of our common stock and preferred stock authorized was also decreased by the same proportion as the outstanding shares.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Common Stock Issuances&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;During the years ended October 31, 2016 and 2015, we issued 10,833 shares and 11,600 shares, respectively, of common stock to consultants for services rendered, pursuant to the 2010 Share Plan. &amp;#160;We recorded consulting expense for the years ended October 31, 2016 and 2015 of approximately $31,000 and $46,000, respectively, for shares of common stock issued to consultants. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt 4.5pt; TEXT-INDENT:-4.5pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Stock&amp;#160;Option&amp;#160;Plans&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;As of October 31, 2016, we have two stock option plans: the ITUS Corporation 2003 Share Incentive Plan (the &amp;#x201c;2003 Share Plan&amp;#x201d;) and the ITUS Corporation 2010 Share Incentive Plan (the &amp;#x201c;2010 Share Plan&amp;#x201d;) which were adopted by our Board of Directors on April 21, 2003 and July 14, 2010, respectively.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The 2003 Share Plan provided for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to key employees and consultants. &amp;#160;The maximum number of shares of common stock in the 2003 Share Plan was 2,800,000 shares. The 2003 Share Plan was administered by the Stock Option Committee through June 2004, from June 2004 through July 2010, by the Board of Directors, from July 2010 through August 2012, by the Stock Option Committee, from August 2012 through November 2012, by the Executive Committee of the Board of Directors, from November 2012 to July 2015, by the Board of Directors and since July 2015 by the Compensation Committee, which determined the option price, term and provisions of each option. &amp;#160;The exercise price with respect to all of the options granted under the 2003 Share Plan since its inception was equal to the fair market value of the underlying common stock at the grant date. &amp;#160;In accordance with the provisions of the 2003 Share Plan, the plan terminated with respect to the grant of future options on April 21, 2013. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Information regarding the 2003 Share Plan for the two years ended October 31, 2016 is as follows:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; colspan=&quot;2&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Intrinsic Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding at October 31, 2014&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;493,991 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$18.00&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(4,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.58&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(123,791)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$14.71&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding at October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;366,200 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$17.86&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(11,080)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.58&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(129,520)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$17.72&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding and Exercisable at &lt;br /&gt;October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;225,600 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$18.69&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;142,470 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following table summarizes information about stock options outstanding and exercisable under the 2003 Share Plan as of October 31, 2016:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 25%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&amp;#160; 1.79 - $&amp;#160; 7.75&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;41,200&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1.77&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.91 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$14.75 - $17.50&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;50,400&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;.43&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$16.98 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$20.50 - $23.00&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;94,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;.83&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$22.04 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$29.25 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;40,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;.81&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$29.25 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The 2010 Share Plan provides for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to key employees and consultants. &amp;#160;The maximum number of shares of common stock in the 2010 Share Plan was initially 600,000 shares. On July 6, 2011, the 2010 Share Plan was amended by our Board of Directors to increase the maximum number of shares of common stock in the plan to 1,080,000 shares and on August 29, 2012, the maximum number of shares in the plan was further increased to 1,200,000 shares. &amp;#160;On November 8, 2013, the Board of Directors approved an amendment to provide that effective November 8, 2013, the maximum aggregate number of shares available for future issuance will be 800,000 shares and that on the first business day in 2014 and on the first business day of each calendar year thereafter the maximum aggregate number of shares available for future issuance shall be replenished such that 800,000 shares will be available. Accordingly, on November 8, 2013, January 2, 2014 and January 2, 2015, the number of shares in the 2010 Share Plan was increased to 1,957,000 shares, 2,225,400 shares and 2,569,400 shares, respectively. &amp;#160;In addition, on November 8, 2013, the 2010 Share Plan was amended to provide that on the first business day of each year commencing on January 2, 2014, each non-employee director of the Company at that time shall automatically be granted a 10-year stock option to purchase 12,000 shares of common stock (16,000 for the Chairman) that will vest in four equal quarterly installments. The 2010 Share Plan was administered by the Stock Option Committee through August 2012, from August 2012 through November 2012, by the Executive Committee of the Board of Directors, from November 2012 through July 2015, by the Board of Directors and since July 2015, by the Compensation Committee, which determines the option price, term and provisions of each option. The exercise price with respect to all of the options granted under the 2010 Share Plan was equal to the fair market value of the underlying common stock at the grant date. &amp;#160;As of October 31, 2016, the 2010 Share Plan had 431,956 shares available for future grants. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Information regarding the 2010 Share Plan as of October 31, 2016 is as follows: &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Aggregate&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding at October 31, 2014&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;728,561 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$5.75 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;60,400 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.91 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(13,334)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.58 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(249,355)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$6.24 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding at October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;526,272 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$3.33 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;557,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.92 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(2,400)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$4.25 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding at October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 15%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,080,872 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$3.12 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,569,079 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.7pt;&quot;&gt;
&lt;td style=&quot;height: 11.7pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Exercisable at October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 11.7pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;659,439 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 11.7pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 11.7pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$3.16 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 11.7pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 11.7pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 11.7pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,126,338 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following table summarizes information about stock options outstanding under the 2010 Share Plan as of October 31, 2016:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 42%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 42%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 42%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 42%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Exercisable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Contractual Life &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.58 - $9.25&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,080,872&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;7.71&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$3.12 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;659,439&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;6.71&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$3.16 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black; display: none;&quot;&gt;0&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In addition to options granted under the 2003 Share Plan and the 2010 Share Plan, during the years ended October 31, 2012 and 2013, the Board of Directors approved the grant of stock options to purchase 1,660,000 shares and 120,000 shares, respectively. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan for the two years ended October 31, 2016 is as follows:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 60%; padding: 0in; width: 60%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 11%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 11%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 60%; padding: 0in; width: 60%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 60%; padding: 0in; width: 60%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 60%; padding: 0in; width: 60%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; width: 1%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 11%; padding: 0in; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 60%; background: #cceeff; padding: 0in; white-space: nowrap; width: 60%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding at October 31, 2014, 2015 and 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.70 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1%; background: #cceeff; padding: 0in; width: 1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 11%; background: #cceeff; padding: 0in; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 60%; padding: 0in; width: 60%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding and exercisable at October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 12%; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.70 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 1%; padding: 0in; width: 1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 11%; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;6,494,275 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The following table summarizes information about stock options outstanding and exercisable that were not granted under the 2003 Share Plan or the 2010 Share Plan as of October 31, 2016:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 24%; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 24%; padding: 0in; white-space: nowrap; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 23%;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; padding: 0in; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 24%; padding: 0in; white-space: nowrap; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 24%; padding: 0in; white-space: nowrap; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 23%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 24%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 24%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 24%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 24%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 24%; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 24%; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; padding: 0in; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; padding: 0in; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$ 2.58 - $ 5.56&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;5.76&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.70 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black; display: none;&quot;&gt;0&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Re-Priced Stock Options&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;On January 28, 2015, the Board of Directors authorized management of the Company to re-price issued and outstanding stock options for all of the officers, directors and employees of the Company, at any time prior to February 16, 2015. &amp;#160;On February 5, 2015, management acted to re-price 2,184,125 issued and outstanding stock options (the &amp;#x201c;Re-Priced Options&amp;#x201d;) pursuant to the authority granted by the Board of Directors. The new exercise price of the Re-Priced Options is $2.575, the closing sales price of the Company&amp;#x2019;s common stock on February 5, 2015. &amp;#160;All other terms of the previously granted Re-Priced Options remain the same. &amp;#160;The Company recorded additional stock-based compensation of approximately $297,000, as of February 5, 2015, related to this re-pricing. &amp;#160;This amount was determined to be the incremental value of the fair value of the Re-Priced Options compared to the fair value of the original option immediately before the re-pricing.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Preferred Stock&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In May 1986, our shareholders authorized 200,000 shares of preferred stock with a par value of $100 per share. &amp;#160;The shares of preferred stock may be issued in series at the direction of the Board of Directors, and the relative rights, preferences and limitations of such shares will all be determined by the Board of Directors. &amp;#160;As of October 31, 2016, 140 shares of preferred stock had been designated and issued as Series A Preferred Stock. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Series A Convertible Preferred&amp;#160;Stock&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;On September 9, 2014, the Company designated 140 shares of the preferred stock as Series A Convertible Preferred Stock, par value $100 per share, in accordance with the Certificate of Designation of Series A Convertible Preferred Stock filed with the Secretary of State of the State of Delaware on September 9, 2014 (the &amp;#x201c;Series A Convertible Preferred Stock&amp;#x201d;). &amp;#160;On September 9, 2014, 140 shares of Series A Convertible Preferred Stock with a stated value of $25,000 per share were issued in connection with the conversion of a Convertible Debenture due November 2016.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;i&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Ranking&amp;#160;&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The Series A Convertible Preferred Stock ranked senior to the Company&amp;#x2019;s common stock, to all series of any other classes of equity which may be issued and to any indebtedness, unless the Company obtained the prior written consent of the Series A Convertible Preferred Stock holder.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;&amp;#160;&lt;i&gt;Redemption&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;At any time on or after November 11, 2016 (the &amp;#x201c;Redemption Date&amp;#x201d;), and upon at least 60 days prior written notice to the Company (a &amp;#x201c;Redemption Notice&amp;#x201d;), any holder of the Series A Convertible Preferred Stock had a one-time right to require the Company to redeem all or some of its shares of Series A Convertible Preferred Stock (a &amp;#x201c;Redemption&amp;#x201d;) for cash generated from a subsequent sale of the Company&amp;#x2019;s equity securities. The redemption price being equal to the stated value ($25,000 per share) of the shares of Series A Convertible Preferred Stock being converted, (the &amp;#x201c;Redemption Purchase Price&amp;#x201d;). Upon receipt of a Redemption Notice, the Company shall complete a sale or sales of its equity securities for the purpose of accumulating net proceeds sufficient to pay the Redemption Purchase Price. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;On September 9, 2016, the holder of 140 shares of the Series A Convertible Preferred Stock delivered a Redemption Notice to the Company requesting a redemption date of November 11, 2016 (it being understood by the holder of the Series A Convertible Preferred Stock that the Company may only redeem shares of Series A Convertible Preferred Stock with the proceeds from the sale of the Company&amp;#x2019;s equity securities). On December 6, 2016, we entered into an agreement with the holder of the Series A Preferred Stock to exchange the Series A Preferred Stock for a secured debenture, cash and warrants. See Note 2, Subsequent Event.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;i&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Optional Conversion&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Holders of the Series A Convertible Preferred Stock had the right at any time convert their shares of Series A Convertible Preferred Stock into such number of shares of the Company&amp;#x2019;s common stock in such an amount equal to (a) the stated value of $25,000 per share of the shares of Series A Convertible Preferred Stock being converted, divided by the conversion price of $4.73, multiplied by (b) the number of shares of Series A Preferred Stock being converted. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The holder did not have the right to convert any portion of the Series A Convertible Preferred Stock if after giving effect to such conversion, the holder, together with any affiliate thereof, would beneficially own in excess of 4.99% of the number of shares of common stock outstanding immediately after giving effect to such conversion.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The embedded conversion option had certain anti-dilution protection provisions which would be triggered if the Company issues its common stock, or certain common stock equivalents, (as defined) at a price below $3.55 per share. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;i&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Board and Observer Rights&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Each holder of Series A Convertible Preferred Stock shall have the right, upon 10 days&apos; prior written notice, to designate one representative, reasonably acceptable to the Company, who shall be entitled to attend and observe meetings of the Company&amp;#x2019;s Board of Directors in a non-voting observer capacity (the &amp;#x201c;Observer&amp;#x201d;).&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;i&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Accounting for the Series A Convertible Preferred Stock&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The Company determined that the economic characteristics and risks of the conversion feature and the preferred stock instrument were clearly and closely related as equity instruments and accordingly, the conversion feature would not require separate accounting. &amp;#160;&amp;#160;In addition, the redemption feature was contingent upon Series A Convertible Preferred Stock not being converted into common stock and upon the holder delivering a redemption notice to the Company. &amp;#160;&amp;#160;Further, the redemption purchase price may only be paid from the proceeds of a subsequent sale of equity securities. Accordingly, the Series A Convertible Preferred Stock was accounted for as an equity instrument. Further, because the conversion rate of the Series A Convertible Preferred Stock of $4.73 per share was less than the Company&amp;#x2019;s closing stock price on the date of this transaction, the Company determined that the Series A Convertible Preferred Stock contained a beneficial conversion feature. The beneficial conversion feature was recorded in additional paid-in-capital as a result of the Company&amp;#x2019;s accumulated deficit&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;; COLOR:black&quot;&gt;. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Common Stock Purchase Warrants&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-indent: 40.5pt;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;As of October 31, 2016, we had warrants to purchase 10,000 shares and 10,000 shares of common stock at $9.25 and $13.875 per share, respectively, expiring on August 19, 2019, warrants to purchase 369,979 shares of common stock at $7.75 per share expiring on November 11, 2016, warrants to purchase 8,000 shares of common stock at $6.925 per share expiring on June 2, 2017 and warrants to purchase 309,400 shares of common stock at $10.00 per share expiring on July 15, 2019.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c87_From1Nov2015To31Oct2016_EmployeeStockOptionMember_A2010SharePlanMember_ConsultantMember" decimals="INF">10833</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c88_From1Nov2014To31Oct2015_EmployeeStockOptionMember_A2010SharePlanMember_ConsultantMember" decimals="INF">11600</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <itus:ConsultationFeesRelatedToOptions unitRef="usd" contextRef="c87_From1Nov2015To31Oct2016_EmployeeStockOptionMember_A2010SharePlanMember_ConsultantMember" decimals="0">31000</itus:ConsultationFeesRelatedToOptions>
  <itus:ConsultationFeesRelatedToOptions unitRef="usd" contextRef="c88_From1Nov2014To31Oct2015_EmployeeStockOptionMember_A2010SharePlanMember_ConsultantMember" decimals="0">46000</itus:ConsultationFeesRelatedToOptions>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c89_From1Nov2015To31Oct2016_EmployeeStockOptionMember_A2003SharePlanMember_CommonStockMember" decimals="INF">2800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized unitRef="shares" contextRef="c90_AsOf31Oct2010_EmployeeStockOptionMember_A2010SharePlanMember_CommonStockMember" decimals="INF">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized unitRef="shares" contextRef="c91_AsOf6Jul2011_EmployeeStockOptionMember_A2010SharePlanMember" decimals="INF">1080000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized unitRef="shares" contextRef="c92_AsOf29Aug2012_EmployeeStockOptionMember_A2010SharePlanMember" decimals="INF">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant unitRef="shares" contextRef="c93_AsOf8Nov2013_EmployeeStockOptionMember_A2010SharePlanMember" decimals="INF">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant unitRef="shares" contextRef="c94_AsOf2Jan2014_EmployeeStockOptionMember_A2010SharePlanMember" decimals="INF">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized unitRef="shares" contextRef="c93_AsOf8Nov2013_EmployeeStockOptionMember_A2010SharePlanMember" decimals="INF">1957000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized unitRef="shares" contextRef="c94_AsOf2Jan2014_EmployeeStockOptionMember_A2010SharePlanMember" decimals="INF">2225400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized unitRef="shares" contextRef="c95_AsOf2Jan2015_EmployeeStockOptionMember_A2010SharePlanMember" decimals="INF">2569400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1 contextRef="c96_From2Jan2014To2Jan2014_EmployeeStockOptionMember_A2010SharePlanMember_MaximumMember">P10Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c97_From2Jan2014To2Jan2014_EmployeeStockOptionMember_A2010SharePlanMember_CommonStockMember" decimals="INF">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c98_From2Jan2014To2Jan2014_EmployeeStockOptionMember_A2010SharePlanMember_BoardOfDirectorsChairmanMember_CommonStockMember" decimals="INF">16000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant unitRef="shares" contextRef="c99_AsOf31Oct2016_EmployeeStockOptionMember_A2010SharePlanMember" decimals="INF">431956</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c100_From1Nov2011To31Oct2012_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="INF">1660000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c101_From1Nov2012To31Oct2013_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="INF">120000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c102_AsOf5Feb2015_RePricedOptionsMember" decimals="INF">2184125</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c102_AsOf5Feb2015_RePricedOptionsMember" decimals="3">2.575</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c103_From5Feb2015To5Feb2015_RePricedOptionsMember" decimals="0">297000</us-gaap:ShareBasedCompensation>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c104_AsOf31May1986_PreferredStockMember" decimals="INF">200000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c104_AsOf31May1986_PreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c105_AsOf31Oct2016_SeriesAPreferredStockMember_PreferredStockMember" decimals="INF">140</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c106_AsOf9Sep2014_SeriesAPreferredStockMember_PreferredStockMember" decimals="INF">140</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c106_AsOf9Sep2014_SeriesAPreferredStockMember_PreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion unitRef="shares" contextRef="c107_AsOf9Sep2014_SeriesAPreferredStockMember_ConvertiblePreferredStockMember" decimals="INF">140</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c107_AsOf9Sep2014_SeriesAPreferredStockMember_ConvertiblePreferredStockMember" decimals="0">25000</us-gaap:PreferredStockParOrStatedValuePerShare>
  <itus:ConvertiblePreferredStockRedemptionNoticePeriod contextRef="c108_From1Nov2015To31Oct2016_SeriesAPreferredStockMember_ConvertiblePreferredStockMember">P60D</itus:ConvertiblePreferredStockRedemptionNoticePeriod>
  <us-gaap:PreferredStockRedemptionPricePerShare unitRef="usdPershares" contextRef="c109_AsOf31Oct2016_SeriesAPreferredStockMember_ConvertiblePreferredStockMember" decimals="0">25000</us-gaap:PreferredStockRedemptionPricePerShare>
  <us-gaap:PreferredStockRedemptionDate contextRef="c108_From1Nov2015To31Oct2016_SeriesAPreferredStockMember_ConvertiblePreferredStockMember">2016-11-11</us-gaap:PreferredStockRedemptionDate>
  <itus:ConvertiblePreferredStockSharesConvertedStatedValue unitRef="usdPershares" contextRef="c109_AsOf31Oct2016_SeriesAPreferredStockMember_ConvertiblePreferredStockMember" decimals="0">25000</itus:ConvertiblePreferredStockSharesConvertedStatedValue>
  <itus:ConvertiblePreferredStockConversionPrice unitRef="usdPershares" contextRef="c109_AsOf31Oct2016_SeriesAPreferredStockMember_ConvertiblePreferredStockMember" decimals="2">4.73</itus:ConvertiblePreferredStockConversionPrice>
  <itus:ConvertiblePreferredStockOwnershipThresholdPercentage unitRef="pure" contextRef="c108_From1Nov2015To31Oct2016_SeriesAPreferredStockMember_ConvertiblePreferredStockMember" decimals="4">0.0499</itus:ConvertiblePreferredStockOwnershipThresholdPercentage>
  <itus:CommonStockAntidilutionThresholdPrice unitRef="usdPershares" contextRef="c109_AsOf31Oct2016_SeriesAPreferredStockMember_ConvertiblePreferredStockMember" decimals="2">3.55</itus:CommonStockAntidilutionThresholdPrice>
  <itus:ConertiblePreferredStockObserverDesignationNoticePeriod contextRef="c108_From1Nov2015To31Oct2016_SeriesAPreferredStockMember_ConvertiblePreferredStockMember">P10D</itus:ConertiblePreferredStockObserverDesignationNoticePeriod>
  <itus:ConvertiblePreferredStockConversionPrice unitRef="usdPershares" contextRef="c110_AsOf31Oct2016_CommonStockMember_SeriesAPreferredStockMember_ConvertiblePreferredStockMember" decimals="2">4.73</itus:ConvertiblePreferredStockConversionPrice>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c111_AsOf31Oct2016_WarrantsWithExercisePrice925Member_CommonStockMember_WarrantMember" decimals="INF">10000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c112_AsOf31Oct2016_WarrantsWithExercisePrice13875Member_CommonStockMember_WarrantMember" decimals="INF">10000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c111_AsOf31Oct2016_WarrantsWithExercisePrice925Member_CommonStockMember_WarrantMember" decimals="2">9.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c112_AsOf31Oct2016_WarrantsWithExercisePrice13875Member_CommonStockMember_WarrantMember" decimals="3">13.875</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c113_AsOf31Oct2016_WarrantsWithExercisePrice775Member_CommonStockMember_WarrantMember" decimals="INF">369979</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c113_AsOf31Oct2016_WarrantsWithExercisePrice775Member_CommonStockMember_WarrantMember" decimals="2">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c114_AsOf31Oct2016_WarrantsWithExercisePrice6925Member_CommonStockMember_WarrantMember" decimals="INF">8000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c114_AsOf31Oct2016_WarrantsWithExercisePrice6925Member_CommonStockMember_WarrantMember" decimals="3">6.925</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c115_AsOf31Oct2016_WarrantsWithExercisePrice1000Member_CommonStockMember_WarrantMember" decimals="INF">309400</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c115_AsOf31Oct2016_WarrantsWithExercisePrice1000Member_CommonStockMember_WarrantMember" decimals="2">10.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; colspan=&quot;2&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Intrinsic Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding at October 31, 2014&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;493,991 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$18.00&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(4,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.58&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(123,791)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$14.71&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding at October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;366,200 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$17.86&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(11,080)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.58&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(129,520)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$17.72&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding and Exercisable at &lt;br /&gt;October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;225,600 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$18.69&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;142,470 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Aggregate&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding at October 31, 2014&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;728,561 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$5.75 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;60,400 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.91 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(13,334)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.58 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(249,355)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$6.24 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding at October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;526,272 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$3.33 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;557,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.92 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(2,400)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$4.25 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding at October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 15%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,080,872 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$3.12 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;3,569,079 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.7pt;&quot;&gt;
&lt;td style=&quot;height: 11.7pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Exercisable at October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 11.7pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;659,439 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 11.7pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 11.7pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$3.16 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 11.7pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 11.7pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 11.7pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,126,338 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c116_AsOf31Oct2014_A2003SharePlanMember" decimals="INF">493991</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c116_AsOf31Oct2014_A2003SharePlanMember" decimals="2">18.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c117_From1Nov2014To31Oct2015_A2003SharePlanMember" decimals="INF">4000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c117_From1Nov2014To31Oct2015_A2003SharePlanMember" decimals="2">2.58</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod unitRef="shares" contextRef="c117_From1Nov2014To31Oct2015_A2003SharePlanMember" decimals="INF">123791</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c117_From1Nov2014To31Oct2015_A2003SharePlanMember" decimals="2">14.71</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c118_AsOf31Oct2015_A2003SharePlanMember" decimals="INF">366200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c118_AsOf31Oct2015_A2003SharePlanMember" decimals="2">17.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c119_From1Nov2015To31Oct2016_A2003SharePlanMember" decimals="INF">11080</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c119_From1Nov2015To31Oct2016_A2003SharePlanMember" decimals="2">2.58</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod unitRef="shares" contextRef="c119_From1Nov2015To31Oct2016_A2003SharePlanMember" decimals="INF">129520</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c119_From1Nov2015To31Oct2016_A2003SharePlanMember" decimals="2">17.72</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber unitRef="shares" contextRef="c120_AsOf31Oct2016_A2003SharePlanMember" decimals="INF">225600</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c120_AsOf31Oct2016_A2003SharePlanMember" decimals="2">18.69</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue unitRef="usd" contextRef="c120_AsOf31Oct2016_A2003SharePlanMember" decimals="0">142470</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c121_AsOf31Oct2014_A2010SharePlanMember" decimals="INF">728561</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c121_AsOf31Oct2014_A2010SharePlanMember" decimals="2">5.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c122_From1Nov2014To31Oct2015_A2010SharePlanMember" decimals="INF">60400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c122_From1Nov2014To31Oct2015_A2010SharePlanMember" decimals="2">2.91</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c122_From1Nov2014To31Oct2015_A2010SharePlanMember" decimals="INF">13334</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c122_From1Nov2014To31Oct2015_A2010SharePlanMember" decimals="2">2.58</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod unitRef="shares" contextRef="c122_From1Nov2014To31Oct2015_A2010SharePlanMember" decimals="INF">249355</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c122_From1Nov2014To31Oct2015_A2010SharePlanMember" decimals="2">6.24</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c123_AsOf31Oct2015_A2010SharePlanMember" decimals="INF">526272</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c123_AsOf31Oct2015_A2010SharePlanMember" decimals="2">3.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c124_From1Nov2015To31Oct2016_A2010SharePlanMember" decimals="INF">557000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c124_From1Nov2015To31Oct2016_A2010SharePlanMember" decimals="2">2.92</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c124_From1Nov2015To31Oct2016_A2010SharePlanMember" decimals="INF">2400</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c124_From1Nov2015To31Oct2016_A2010SharePlanMember" decimals="2">4.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c125_AsOf31Oct2016_A2010SharePlanMember" decimals="INF">1080872</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c125_AsOf31Oct2016_A2010SharePlanMember" decimals="2">3.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue unitRef="usd" contextRef="c125_AsOf31Oct2016_A2010SharePlanMember" decimals="0">3569079</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber unitRef="shares" contextRef="c125_AsOf31Oct2016_A2010SharePlanMember" decimals="INF">659439</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c125_AsOf31Oct2016_A2010SharePlanMember" decimals="2">3.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 unitRef="usd" contextRef="c125_AsOf31Oct2016_A2010SharePlanMember" decimals="0">2126338</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c119_From1Nov2015To31Oct2016_A2003SharePlanMember">&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 25%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&amp;#160; 1.79 - $&amp;#160; 7.75&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;41,200&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1.77&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.91 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$14.75 - $17.50&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;50,400&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;.43&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$16.98 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$20.50 - $23.00&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;94,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;.83&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$22.04 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$29.25 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;40,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;.81&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$29.25 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c126_AsOf31Oct2016_RangeOfExercisePrices179To775Member" decimals="INF">41200</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c127_From1Nov2015To31Oct2016_RangeOfExercisePrices179To775Member">P1Y281D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c126_AsOf31Oct2016_RangeOfExercisePrices179To775Member" decimals="2">2.91</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c128_AsOf31Oct2016_RangeOfExercisePrices1475To1725Member" decimals="INF">50400</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c129_From1Nov2015To31Oct2016_RangeOfExercisePrices1475To1725Member">P156D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c128_AsOf31Oct2016_RangeOfExercisePrices1475To1725Member" decimals="2">16.98</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c130_AsOf31Oct2016_RangeOfExercisePrices2050To2300Member" decimals="INF">94000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c131_From1Nov2015To31Oct2016_RangeOfExercisePrices2050To2300Member">P302D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c130_AsOf31Oct2016_RangeOfExercisePrices2050To2300Member" decimals="2">22.04</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c132_AsOf31Oct2016_RangeOfExercisePrices2925Member" decimals="INF">40000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c133_From1Nov2015To31Oct2016_RangeOfExercisePrices2925Member">P295D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c132_AsOf31Oct2016_RangeOfExercisePrices2925Member" decimals="2">29.25</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c124_From1Nov2015To31Oct2016_A2010SharePlanMember">&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 42%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 42%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 42%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 42%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Exercisable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Contractual Life &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.58 - $9.25&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,080,872&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;7.71&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$3.12 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;659,439&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;6.71&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$3.16 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black; display: none;&quot;&gt;0&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c134_AsOf31Oct2016_A2010SharePlanMember_RangeOfExercisePrices258To925Member" decimals="INF">1080872</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c135_From1Nov2015To31Oct2016_A2010SharePlanMember_RangeOfExercisePrices258To925Member">P7Y259D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c134_AsOf31Oct2016_A2010SharePlanMember_RangeOfExercisePrices258To925Member" decimals="2">3.12</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c134_AsOf31Oct2016_A2010SharePlanMember_RangeOfExercisePrices258To925Member" decimals="INF">659439</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c135_From1Nov2015To31Oct2016_A2010SharePlanMember_RangeOfExercisePrices258To925Member">P6Y259D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c134_AsOf31Oct2016_A2010SharePlanMember_RangeOfExercisePrices258To925Member" decimals="2">3.16</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c136_From1Nov2015To31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 60%; padding: 0in; width: 60%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 11%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 11%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 60%; padding: 0in; width: 60%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 60%; padding: 0in; width: 60%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 60%; padding: 0in; width: 60%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; width: 1%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 11%; padding: 0in; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 60%; background: #cceeff; padding: 0in; white-space: nowrap; width: 60%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding at October 31, 2014, 2015 and 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.70 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1%; background: #cceeff; padding: 0in; width: 1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 11%; background: #cceeff; padding: 0in; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 60%; padding: 0in; width: 60%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Options Outstanding and exercisable at October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 12%; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.70 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 1%; padding: 0in; width: 1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 11%; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;6,494,275 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c137_AsOf31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="INF">1780000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c137_AsOf31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="2">2.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber unitRef="shares" contextRef="c137_AsOf31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="INF">1780000</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c137_AsOf31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="2">2.70</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue unitRef="usd" contextRef="c137_AsOf31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="0">6494275</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue>
  <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c136_From1Nov2015To31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 24%; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 24%; padding: 0in; white-space: nowrap; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 23%;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; padding: 0in; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 24%; padding: 0in; white-space: nowrap; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 24%; padding: 0in; white-space: nowrap; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 23%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 24%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 24%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 24%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 24%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 24%; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 24%; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; padding: 0in; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; padding: 0in; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$ 2.58 - $ 5.56&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;5.76&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$2.70 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black; display: none;&quot;&gt;0&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
  <itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable unitRef="shares" contextRef="c138_AsOf31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices258To556Member" decimals="INF">1780000</itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable>
  <itus:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c139_From1Nov2015To31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices258To556Member">P5Y277D</itus:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c138_AsOf31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices258To556Member" decimals="2">2.70</itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 11pt;&quot;&gt;&lt;font style=&quot;text-decoration: underline;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;6.&amp;#160; COMMITMENTS AND CONTINGENCIES&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 12pt;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Patent Acquisition Obligations&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 12pt; ; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;text-decoration: none; color: black;&quot;&gt;As of October 31, 2016, we have incurred obligations due no later than November 2017 related to the acquisition of patents, which have a discounted present value of approximately $4,172,000, and which amount will be reduced by royalties paid during the period, if any.&amp;#160; The payment due in November 2017 is payable at the option of the Company in cash or common stock.&amp;#160; We recorded interest expense of approximately $520,000 and $452,000, respectively, for the years ended October 31, 2016 and 2015, for the accretion of interest on patent acquisition obligations. The payment due date of November 2017 may be extended for up to two years if any patent infringement lawsuit initiated by the Company is stayed because of any re-exam or similar proceeding in the United States Patent and Trademark Office.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p&gt;&lt;font style=&quot;font-family: times new roman,times,serif; font-size: 12pt;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Leases&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 12pt; ; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;We lease approximately 3,000 square feet of office space in Los Angeles, California pursuant to a lease that expires May 31, 2019.&amp;#160; The lease contains base rentals of approximately $11,000 per month with annual increases of approximately 3% and an escalation clause for increases in certain operating expenses.&amp;#160; &lt;/font&gt;As of October 31, 2016, our non-cancelable operating lease commitments for the years ending October 31, 2017, 2018 and 2019 were approximately $129,000, 134,000 and $80,000, respectively.&amp;#160; Rent expense for the years ended October 31, 2016 and 2015, was approximately $104,000 and $100,000, respectively.&amp;#160;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 12pt;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Litigation Matters&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin-left: 0in; ; margin-right: 0in; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;On December 29, 2014, we settled our lawsuit against AUO which had been filed on January 28, 2013. For a more detailed description of the settlement with AUO see Note 1, &amp;#x201c;Business and Funding - Description of Business - AUO Lawsuit and Settlement&amp;#x201d;.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin-left: 0in; ; margin-right: 0in; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Other than suits we bring to enforce our patent rights we are not a party to any material pending legal proceedings other than that which arise in the ordinary course of business. &amp;#160;We believe that any liability that may ultimately result from the resolution of these matters will not, individually or in the aggregate, have a material adverse effect on our financial position or results of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <itus:PatentAcquisitionObligationsDiscountedPresentValue unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">4172000</itus:PatentAcquisitionObligationsDiscountedPresentValue>
  <itus:InterestExpensePatentAcquisitionObligations unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">520000</itus:InterestExpensePatentAcquisitionObligations>
  <itus:InterestExpensePatentAcquisitionObligations unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">452000</itus:InterestExpensePatentAcquisitionObligations>
  <itus:PatentAcquisitionObligationPaymentDueDateExtensionPeriod contextRef="c6_From1Nov2015To31Oct2016">P2Y</itus:PatentAcquisitionObligationPaymentDueDateExtensionPeriod>
  <us-gaap:AreaOfLand unitRef="sqft" contextRef="c140_AsOf31Oct2016_OfficeSpaceInLosAngelesCaliforniaMember" decimals="0">3000</us-gaap:AreaOfLand>
  <us-gaap:OperatingLeasesRentExpenseMinimumRentals unitRef="usd" contextRef="c141_From1Nov2015To31Oct2016_OfficeSpaceInLosAngelesCaliforniaMember" decimals="0">11000</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
  <itus:LeaseBaseRentAnnualIncrease unitRef="pure" contextRef="c141_From1Nov2015To31Oct2016_OfficeSpaceInLosAngelesCaliforniaMember" decimals="2">0.03</itus:LeaseBaseRentAnnualIncrease>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">129000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">134000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">80000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:LeaseAndRentalExpense unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">104000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:LeaseAndRentalExpense unitRef="usd" contextRef="c142_From1Nov2014To31Oct2015_OfficeSpaceInLosAngelesCaliforniaMember" decimals="0">100000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 11pt;&quot;&gt;&lt;font style=&quot;text-decoration: underline;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;7.&amp;#160; INCOME TAXES&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;Income tax provision (benefit) consists of the following:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 30%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Year Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Federal:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Current&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Deferred&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(1,631,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(487,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;State:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Current&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;- &lt;br /&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Deferred&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(134,000) &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(120,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.1pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15.1pt; width: 70%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Adjustment to valuation&lt;/font&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt; allowance related to net deferred tax assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.1pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.1pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,765,000&amp;#160; &lt;br /&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.1pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.1pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.1pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;607,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;font style=&quot;font-family: times new roman,times,serif; font-size: 12pt; display: none;&quot;&gt;&lt;font style=&quot;font-size: 12pt; color: black;&quot;&gt;Income Tax Provision (Benefit)&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The tax effects of temporary differences that give rise to significant portions of the deferred tax asset, net, at October 31, 2016 and 2015, are as follows:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Long-term deferred tax assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Federal and state NOL and tax credit carryforwards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: times new roman,times,serif; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;33,079,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: times new roman,times,serif; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;31,261,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Deferred compensation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;6,232,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;6,522,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Intangibles&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;713,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;483,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;289,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;282,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 20pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Subtotal&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;40,313,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;38,548,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Less: valuation allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(40,313,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(38,548,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Deferred tax asset, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: times new roman,times,serif; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: times new roman,times,serif; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;As of October 31, 2016, we had tax net operating loss and tax credit carryforwards of approximately $79,428,000 and $1,110,000, respectively, available within statutory limits (expiring at various dates between 2020 and 2035), to offset any future regular Federal corporate taxable income and taxes payable. &amp;#160;If the tax benefits relating to deductions of option holders&amp;#x2019; income are ultimately realized, those benefits will be credited directly to additional paid-in capital. &amp;#160;Certain changes in stock ownership can result in a limitation on the amount of net operating loss and tax credit carryovers that can be utilized each year. As of October 31, 2016, management has not determined the extent of any such limitations, if any.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 11pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;We had New York, California and Pennsylvania tax net operating loss carryforwards of approximately $76,847,000, $4,849,000 and $841,000, respectively, as of October 31, 2016, available within statutory limits (expiring at various dates between 2020 and 2035), to offset future corporate taxable income and taxes payable, if any, under certain computations of such taxes. &amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;We have provided a valuation allowance against our deferred tax asset due to our current and historical pre-tax losses and the uncertainty regarding their realizability. &amp;#160;The primary differences from the Federal statutory rate of 34% and the effective rate of 0% is attributable to certain permanent differences and a change in the valuation allowance. &amp;#160;The following is a reconciliation of income taxes at the Federal statutory tax rate to income tax expense (benefit):&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 1%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;11&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Year Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 1%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 1%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Income tax benefit at U.S. &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Federal statutory income&amp;#160; Tax rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(1,706,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(34.0)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(469,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(34.0)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;State income taxes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(411,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(8.2)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(117,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(8.5)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Permanent differences&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0.1 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0.1 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Expiring net operating&amp;#160; losses, credits and other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;350,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;7.0 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(22,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(1.6)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Change in valuation allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,765,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;35.1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;607,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;44.0 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Income tax provision&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 1%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0.0 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 1%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0.0 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;During the two fiscal years ended October 31, 2016, we incurred no Federal and no State income taxes. &amp;#160;We have no unrecognized tax benefits as of October 31, 2016 and 2015 and we account for interest and penalties related to income tax matters in marketing, general and administrative expenses. &amp;#160;Tax years to which our net operating losses relate remain open to examination by Federal authorities and other jurisdictions to the extent which the net operating losses have yet to be utilized.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:OperatingLossCarryforwards unitRef="usd" contextRef="c143_AsOf31Oct2016_FederalCorporateTaxableMember" decimals="0">79428000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:TaxCreditCarryforwardAmount unitRef="usd" contextRef="c143_AsOf31Oct2016_FederalCorporateTaxableMember" decimals="0">1110000</us-gaap:TaxCreditCarryforwardAmount>
  <itus:OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange contextRef="c6_From1Nov2015To31Oct2016">expiring at various dates between 2020 and 2035</itus:OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange>
  <us-gaap:OperatingLossCarryforwards unitRef="usd" contextRef="c144_AsOf31Oct2016_NewYorkStateMember" decimals="0">76847000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OperatingLossCarryforwards unitRef="usd" contextRef="c145_AsOf31Oct2016_CaliforniaStateMember" decimals="0">4849000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OperatingLossCarryforwards unitRef="usd" contextRef="c146_AsOf31Oct2016_PennsylvaniaStateMember" decimals="0">841000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 30%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Year Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Federal:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Current&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Deferred&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(1,631,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(487,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;State:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Current&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;- &lt;br /&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Deferred&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(134,000) &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(120,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.1pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15.1pt; width: 70%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Adjustment to valuation&lt;/font&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt; allowance related to net deferred tax assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.1pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.1pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,765,000&amp;#160; &lt;br /&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.1pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.1pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.1pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;607,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;font style=&quot;font-family: times new roman,times,serif; font-size: 12pt; display: none;&quot;&gt;&lt;font style=&quot;font-size: 12pt; color: black;&quot;&gt;Income Tax Provision (Benefit)&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
  <us-gaap:CurrentFederalTaxExpenseBenefit unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:CurrentFederalTaxExpenseBenefit unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" xs:nil="true"/>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">-1631000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-487000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" xs:nil="true"/>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">-134000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-120000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">1765000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
  <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">607000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Long-term deferred tax assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Federal and state NOL and tax credit carryforwards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: times new roman,times,serif; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;33,079,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: times new roman,times,serif; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;31,261,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Deferred compensation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;6,232,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;6,522,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Intangibles&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;713,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;483,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;289,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;282,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in 0in 0in 20pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Subtotal&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;40,313,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;38,548,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 70%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Less: valuation allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(40,313,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(38,548,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Deferred tax asset, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: times new roman,times,serif; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; font-family: times new roman,times,serif; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <itus:FederalAndStateNOLAndTaxCreditCarryforwards unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">33079000</itus:FederalAndStateNOLAndTaxCreditCarryforwards>
  <itus:FederalAndStateNOLAndTaxCreditCarryforwards unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">31261000</itus:FederalAndStateNOLAndTaxCreditCarryforwards>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">6232000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">6522000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
  <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">713000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
  <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">483000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
  <us-gaap:DeferredTaxAssetsOther unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">289000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:DeferredTaxAssetsOther unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">282000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:DeferredTaxAssetsGross unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">40313000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsGross unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">38548000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c0_AsOf31Oct2016" decimals="0">40313000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c1_AsOf31Oct2015" decimals="0">38548000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsNet unitRef="usd" contextRef="c0_AsOf31Oct2016" xs:nil="true"/>
  <us-gaap:DeferredTaxAssetsNet unitRef="usd" contextRef="c1_AsOf31Oct2015" xs:nil="true"/>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c6_From1Nov2015To31Oct2016">&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 1%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;11&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Year Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 1%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15pt; border-right: 0px; width: 1%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Income tax benefit at U.S. &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Federal statutory income&amp;#160; Tax rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(1,706,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(34.0)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(469,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(34.0)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;State income taxes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(411,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(8.2)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(117,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(8.5)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Permanent differences&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;2,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0.1 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0.1 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Expiring net operating&amp;#160; losses, credits and other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;350,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;7.0 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(22,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;(1.6)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;height: 15pt; width: 46%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Change in valuation allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;1,765,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;35.1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;607,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 2%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 10%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;44.0 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15pt; width: 1%; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;Income tax provision&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 1%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0.0 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 1%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 10%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;0.0 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 1%; background: #cceeff; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;font-size: 11pt; color: black;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">-1706000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate unitRef="pure" contextRef="c6_From1Nov2015To31Oct2016" decimals="3">0.340</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-469000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate unitRef="pure" contextRef="c7_From1Nov2014To31Oct2015" decimals="3">0.340</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">-411000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes unitRef="pure" contextRef="c6_From1Nov2015To31Oct2016" decimals="3">-0.082</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-117000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes unitRef="pure" contextRef="c7_From1Nov2014To31Oct2015" decimals="3">-0.085</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">2000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
  <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential unitRef="pure" contextRef="c6_From1Nov2015To31Oct2016" decimals="3">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
  <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">1000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
  <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential unitRef="pure" contextRef="c7_From1Nov2014To31Oct2015" decimals="3">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
  <itus:IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">350000</itus:IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits unitRef="pure" contextRef="c6_From1Nov2015To31Oct2016" decimals="3">0.070</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
  <itus:IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">-22000</itus:IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits unitRef="pure" contextRef="c7_From1Nov2014To31Oct2015" decimals="3">-0.016</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c6_From1Nov2015To31Oct2016" decimals="0">1765000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance unitRef="pure" contextRef="c6_From1Nov2015To31Oct2016" decimals="3">0.351</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c7_From1Nov2014To31Oct2015" decimals="0">607000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance unitRef="pure" contextRef="c7_From1Nov2014To31Oct2015" decimals="3">0.440</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations unitRef="pure" contextRef="c6_From1Nov2015To31Oct2016" decimals="3">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations unitRef="pure" contextRef="c7_From1Nov2014To31Oct2015" decimals="3">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>itus-20161031.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Jan 25 23:38:52 EST 2017 -->
<xs:schema elementFormDefault="qualified" xmlns:num="http://www.xbrl.org/dtr/type/numeric" targetNamespace="http://www.copytele.com/20161031" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:itus="http://www.copytele.com/20161031" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="itus-20161031_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="itus-20161031_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="itus-20161031_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="itus-20161031_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.copytele.com/role/ConsolidatedBalanceSheet" id="itus_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/ConsolidatedBalanceSheet_Parentheticals" id="itus_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/ConsolidatedIncomeStatement" id="itus_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/ConsolidatedIncomeStatement_Parentheticals" id="itus_r_ConsolidatedIncomeStatement_Parentheticals">
        <link:definition>004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/ShareholdersEquityType2or3" id="itus_r_ShareholdersEquityType2or3">
        <link:definition>005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/ShareholdersEquityType2or3_Parentheticals" id="itus_r_ShareholdersEquityType2or3_Parentheticals">
        <link:definition>006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/ConsolidatedCashFlow" id="itus_r_ConsolidatedCashFlow">
        <link:definition>007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/ConsolidatedCashFlow_Parentheticals" id="itus_r_ConsolidatedCashFlow_Parentheticals">
        <link:definition>008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/BUSINESSANDFUNDING" id="itus_r_BUSINESSANDFUNDING">
        <link:definition>009 - Disclosure - BUSINESS AND FUNDING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/SUBSEQUENTEVENT" id="itus_r_SUBSEQUENTEVENT">
        <link:definition>010 - Disclosure - SUBSEQUENT EVENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" id="itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" id="itus_r_ACCOUNTSPAYABLEANDACCRUEDEXPENSES">
        <link:definition>012 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/SHAREHOLDERSEQUITY" id="itus_r_SHAREHOLDERSEQUITY">
        <link:definition>013 - Disclosure - SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/COMMITMENTSANDCONTINGENCIES" id="itus_r_COMMITMENTSANDCONTINGENCIES">
        <link:definition>014 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/INCOMETAXES" id="itus_r_INCOMETAXES">
        <link:definition>015 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/AccountingPoliciesByPolicy" id="itus_r_AccountingPoliciesByPolicy">
        <link:definition>016 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" id="itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" id="itus_r_ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables">
        <link:definition>018 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/SHAREHOLDERSEQUITYTables" id="itus_r_SHAREHOLDERSEQUITYTables">
        <link:definition>019 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/INCOMETAXESTables" id="itus_r_INCOMETAXESTables">
        <link:definition>020 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/BUSINESSANDFUNDINGDetails" id="itus_r_BUSINESSANDFUNDINGDetails">
        <link:definition>021 - Disclosure - BUSINESS AND FUNDING (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/SUBSEQUENTEVENTDetails" id="itus_r_SUBSEQUENTEVENTDetails">
        <link:definition>022 - Disclosure - SUBSEQUENT EVENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" id="itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" id="itus_r_HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable">
        <link:definition>024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/SummaryofthechangesinthefairvalueoftheCompanysLevel3financialliabilitiesonrecurringbasisTable" id="itus_r_SummaryofthechangesinthefairvalueoftheCompanysLevel3financialliabilitiesonrecurringbasisTable">
        <link:definition>025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Summary of the changes in the fair value of the Company's Level 3 financial liabilities on recurring basis</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable" id="itus_r_WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable">
        <link:definition>026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Weighted average assumptions used in estimating the fair value of stock options</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/AccountspayableandaccruedliabilitiesTable" id="itus_r_AccountspayableandaccruedliabilitiesTable">
        <link:definition>027 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - Accounts payable and accrued liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/SHAREHOLDERSEQUITYDetails" id="itus_r_SHAREHOLDERSEQUITYDetails">
        <link:definition>028 - Disclosure - SHAREHOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFVDB3Xzjr8GYI25Uk9Vy6/qcRrEsuAZfUt5UQC5nlxkGiq5YLv5a+F+/7ledHhFpceslIpB8H2YAcKJFlbjmJJqGSqwhlfgWnh4//mUBfEtsf0EzUE0kTvsWh1ZusAUDKnQa56eMSxUU] CSR-->
      <link:roleType roleURI="http://www.copytele.com/role/Informationregardingthe2003and2010SharePlanTable" id="itus_r_Informationregardingthe2003and2010SharePlanTable">
        <link:definition>029 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Information regarding the 2003 and 2010 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/Stockoptionsoutstandingandexercisableunder2003shareplanTable" id="itus_r_Stockoptionsoutstandingandexercisableunder2003shareplanTable">
        <link:definition>030 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Stock options outstanding and exercisable under 2003 share plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/Stockoptionsoutstandingunder2010SharePlanTable" id="itus_r_Stockoptionsoutstandingunder2010SharePlanTable">
        <link:definition>031 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Stock options outstanding under 2010 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/Informationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable" id="itus_r_Informationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable">
        <link:definition>032 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/Stockoptionsgrantednotunder2003SharePlanand2010SharePlanTable" id="itus_r_Stockoptionsgrantednotunder2003SharePlanand2010SharePlanTable">
        <link:definition>033 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Stock options granted not under 2003 Share Plan and 2010 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/COMMITMENTSANDCONTINGENCIESDetails" id="itus_r_COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>034 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/INCOMETAXESDetails" id="itus_r_INCOMETAXESDetails">
        <link:definition>035 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/IncometaxprovisionbenefitTable" id="itus_r_IncometaxprovisionbenefitTable">
        <link:definition>036 - Disclosure - INCOME TAXES (Details) - Income tax provision (benefit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable" id="itus_r_ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable">
        <link:definition>037 - Disclosure - INCOME TAXES (Details) - The tax effects of temporary differences of the deferred tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/ReconciliationofincometaxesattheFederalstatutorytaxrateTable" id="itus_r_ReconciliationofincometaxesattheFederalstatutorytaxrateTable">
        <link:definition>038 - Disclosure - INCOME TAXES (Details) - Reconciliation of income taxes at the Federal statutory tax rate</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.copytele.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Disclosure - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:element name="HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract"/>
  <xs:element name="SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract"/>
  <xs:element name="WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract"/>
  <xs:element name="AccountsPayableAndAccruedLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_AccountsPayableAndAccruedLiabilitiesAbstract"/>
  <xs:element name="InformationRegardingThe2003And2010SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_InformationRegardingThe2003And2010SharePlanAbstract"/>
  <xs:element name="StockOptionsOutstandingAndExercisableUnder2003SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_StockOptionsOutstandingAndExercisableUnder2003SharePlanAbstract"/>
  <xs:element name="StockOptionsOutstandingUnder2010SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_StockOptionsOutstandingUnder2010SharePlanAbstract"/>
  <xs:element name="InformationRegardingStockOptionsThatWereNotGrantedUnderThe2003SharePlanOrThe2010SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_InformationRegardingStockOptionsThatWereNotGrantedUnderThe2003SharePlanOrThe2010SharePlanAbstract"/>
  <xs:element name="StockOptionsGrantedNotUnder2003SharePlanAnd2010SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_StockOptionsGrantedNotUnder2003SharePlanAnd2010SharePlanAbstract"/>
  <xs:element name="IncomeTaxProvisionBenefitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_IncomeTaxProvisionBenefitAbstract"/>
  <xs:element name="TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract"/>
  <xs:element name="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract"/>
  <xs:element name="ChangeInOperatingAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_ChangeInOperatingAssetsAndLiabilitiesAbstract"/>
  <xs:element name="TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract"/>
  <xs:element name="ValuationAssumptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_ValuationAssumptionsAbstract"/>
  <xs:element name="LongTermDeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_LongTermDeferredTaxAssetsAbstract"/>
  <xs:element name="IncomeTaxBenefitAtUSAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_IncomeTaxBenefitAtUSAbstract"/>
  <xs:element name="FiniteLivedPatentsNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_FiniteLivedPatentsNet"/>
  <xs:element name="RoyaltiesAndContingentLegalFeesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_RoyaltiesAndContingentLegalFeesPayable"/>
  <xs:element name="PatentAcquisitionObligation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_PatentAcquisitionObligation"/>
  <xs:element name="RevenueFromPatentAssertionActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_RevenueFromPatentAssertionActivities"/>
  <xs:element name="LitigationAndLicensingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_LitigationAndLicensingExpenses"/>
  <xs:element name="AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants"/>
  <xs:element name="StockIssuedDuringPeriodValuePatentLicense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_StockIssuedDuringPeriodValuePatentLicense"/>
  <xs:element name="StockIssuedDuringPeriodSharesPatentLicense" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_StockIssuedDuringPeriodSharesPatentLicense"/>
  <xs:element name="AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense"/>
  <xs:element name="GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants"/>
  <xs:element name="IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable"/>
  <xs:element name="PaymentToAcquireRoyaltyInterestInPatentRights" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
  <xs:element name="PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant"/>
  <xs:element name="AccountingPoliciesbyPolicyPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_AccountingPoliciesbyPolicyPoliciesTable"/>
  <xs:element name="AccountingPoliciesbyPolicyPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_AccountingPoliciesbyPolicyPoliciesLineItems"/>
  <xs:element name="SHAREHOLDERSEQUITYTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SHAREHOLDERSEQUITYTablesTable"/>
  <xs:element name="SHAREHOLDERSEQUITYTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SHAREHOLDERSEQUITYTablesLineItems"/>
  <xs:element name="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable"/>
  <xs:element name="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems"/>
  <xs:element name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
  <xs:element name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
  <xs:element name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
  <xs:element name="FederalAndStateNOLAndTaxCreditCarryforwards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_FederalAndStateNOLAndTaxCreditCarryforwards"/>
  <xs:element name="IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther"/>
  <xs:element name="BUSINESSANDFUNDINGDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_BUSINESSANDFUNDINGDetailsTable"/>
  <xs:element name="BUSINESSANDFUNDINGDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_BUSINESSANDFUNDINGDetailsLineItems"/>
  <xs:element name="SUBSEQUENTEVENTDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SUBSEQUENTEVENTDetailsTable"/>
  <xs:element name="SUBSEQUENTEVENTDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SUBSEQUENTEVENTDetailsLineItems"/>
  <xs:element name="ConversionOfStockCashPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_ConversionOfStockCashPaid"/>
  <xs:element name="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
  <xs:element name="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
  <xs:element name="AmortizationRelatedToCompensationCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_AmortizationRelatedToCompensationCost"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SHAREHOLDERSEQUITYDetailsTable"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SHAREHOLDERSEQUITYDetailsLineItems"/>
  <xs:element name="ConsultationFeesRelatedToOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_ConsultationFeesRelatedToOptions"/>
  <xs:element name="ConvertiblePreferredStockRedemptionNoticePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_ConvertiblePreferredStockRedemptionNoticePeriod"/>
  <xs:element name="ConvertiblePreferredStockSharesConvertedStatedValue" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="itus_ConvertiblePreferredStockSharesConvertedStatedValue"/>
  <xs:element name="ConvertiblePreferredStockConversionPrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="itus_ConvertiblePreferredStockConversionPrice"/>
  <xs:element name="ConvertiblePreferredStockOwnershipThresholdPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_ConvertiblePreferredStockOwnershipThresholdPercentage"/>
  <xs:element name="CommonStockAntidilutionThresholdPrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="itus_CommonStockAntidilutionThresholdPrice"/>
  <xs:element name="ConertiblePreferredStockObserverDesignationNoticePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_ConertiblePreferredStockObserverDesignationNoticePeriod"/>
  <xs:element name="COMMITMENTSANDCONTINGENCIESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_COMMITMENTSANDCONTINGENCIESDetailsTable"/>
  <xs:element name="COMMITMENTSANDCONTINGENCIESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems"/>
  <xs:element name="PatentAcquisitionObligationsDiscountedPresentValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_PatentAcquisitionObligationsDiscountedPresentValue"/>
  <xs:element name="InterestExpensePatentAcquisitionObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_InterestExpensePatentAcquisitionObligations"/>
  <xs:element name="PatentAcquisitionObligationPaymentDueDateExtensionPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod"/>
  <xs:element name="LeaseBaseRentAnnualIncrease" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_LeaseBaseRentAnnualIncrease"/>
  <xs:element name="INCOMETAXESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_INCOMETAXESDetailsTable"/>
  <xs:element name="INCOMETAXESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_INCOMETAXESDetailsLineItems"/>
  <xs:element name="OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange"/>
  <xs:element name="A2003SharePlanMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_A2003SharePlanMember"/>
  <xs:element name="A2010SharePlanMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_A2010SharePlanMember"/>
  <xs:element name="AUOMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_AUOMember"/>
  <xs:element name="AUOSettlementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_AUOSettlementMember"/>
  <xs:element name="AgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_AgreementMember"/>
  <xs:element name="AwardsOfOptionsWith10YearTermsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_AwardsOfOptionsWith10YearTermsMember"/>
  <xs:element name="CaliforniaStateMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_CaliforniaStateMember"/>
  <xs:element name="ConsultantMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_ConsultantMember"/>
  <xs:element name="FederalCorporateTaxableMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_FederalCorporateTaxableMember"/>
  <xs:element name="GlobalDepositoryReceiptsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_GlobalDepositoryReceiptsMember"/>
  <xs:element name="Licensees1Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_Licensees1Member"/>
  <xs:element name="Licensees2Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_Licensees2Member"/>
  <xs:element name="Licensees3Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_Licensees3Member"/>
  <xs:element name="NationalSecuritiesCorporationMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_NationalSecuritiesCorporationMember"/>
  <xs:element name="NewYorkStateMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_NewYorkStateMember"/>
  <xs:element name="OfficeSpaceInLosAngelesCaliforniaMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_OfficeSpaceInLosAngelesCaliforniaMember"/>
  <xs:element name="PatentAssignmentAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_PatentAssignmentAgreementMember"/>
  <xs:element name="PennsylvaniaStateMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_PennsylvaniaStateMember"/>
  <xs:element name="RangeOfExercisePrices1475To1725Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_RangeOfExercisePrices1475To1725Member"/>
  <xs:element name="RangeOfExercisePrices179To775Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_RangeOfExercisePrices179To775Member"/>
  <xs:element name="RangeOfExercisePrices2050To2300Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_RangeOfExercisePrices2050To2300Member"/>
  <xs:element name="RangeOfExercisePrices258To556Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_RangeOfExercisePrices258To556Member"/>
  <xs:element name="RangeOfExercisePrices258To925Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_RangeOfExercisePrices258To925Member"/>
  <xs:element name="RangeOfExercisePrices2925Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_RangeOfExercisePrices2925Member"/>
  <xs:element name="RePricedOptionsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_RePricedOptionsMember"/>
  <xs:element name="SecuredDebentureDueJune12017Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SecuredDebentureDueJune12017Member"/>
  <xs:element name="SecuredDebentureDueNovember112017Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SecuredDebentureDueNovember112017Member"/>
  <xs:element name="StockAwardGrantedConsultantsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_StockAwardGrantedConsultantsMember"/>
  <xs:element name="StockOptionsGrantedToEmployeesAndDirectorsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_StockOptionsGrantedToEmployeesAndDirectorsMember"/>
  <xs:element name="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
  <xs:element name="WarrantsWithExercisePrice1000Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_WarrantsWithExercisePrice1000Member"/>
  <xs:element name="WarrantsWithExercisePrice13875Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_WarrantsWithExercisePrice13875Member"/>
  <xs:element name="WarrantsWithExercisePrice6925Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_WarrantsWithExercisePrice6925Member"/>
  <xs:element name="WarrantsWithExercisePrice775Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_WarrantsWithExercisePrice775Member"/>
  <xs:element name="WarrantsWithExercisePrice925Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_WarrantsWithExercisePrice925Member"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>itus-20161031_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Jan 25 23:38:52 EST 2017 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedBalanceSheet" roleURI="http://www.copytele.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedIncomeStatement" roleURI="http://www.copytele.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedCashFlow" roleURI="http://www.copytele.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_AccountspayableandaccruedliabilitiesTable" roleURI="http://www.copytele.com/role/AccountspayableandaccruedliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_IncometaxprovisionbenefitTable" roleURI="http://www.copytele.com/role/IncometaxprovisionbenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable" roleURI="http://www.copytele.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_FiniteLivedPatentsNet" xlink:href="itus-20161031.xsd#itus_FiniteLivedPatentsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="itus_FiniteLivedPatentsNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_RoyaltiesAndContingentLegalFeesPayable" xlink:href="itus-20161031.xsd#itus_RoyaltiesAndContingentLegalFeesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="itus_RoyaltiesAndContingentLegalFeesPayable" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligation" xlink:href="itus-20161031.xsd#itus_PatentAcquisitionObligation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="itus_PatentAcquisitionObligation" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet"/>
    <loc xlink:type="locator" xlink:label="itus_RevenueFromPatentAssertionActivities" xlink:href="itus-20161031.xsd#itus_RevenueFromPatentAssertionActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SalesRevenueNet" xlink:to="itus_RevenueFromPatentAssertionActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_RevenueFromRelatedParties" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_RoyaltyExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_LitigationAndLicensingExpenses" xlink:href="itus-20161031.xsd#itus_LitigationAndLicensingExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="itus_LitigationAndLicensingExpenses" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_SalesRevenueNet" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostsAndExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_InvestmentIncomeInterest" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_InterestExpense" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFVDB3Xzjr8GYI25Uk9Vy6/qcRrEsuAZfUt5UQC5nlxkGiq5YLv5a+F+/7ledHhFpceslIpB8H2YAcKJFlbjmJJqGSqwhlfgWnh4//mUBfEtsSe+zD92qQDHFN3xvptxHzYRTKLXJcXVU] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_StockOptionPlanExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationAndAmortization" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:href="itus-20161031.xsd#itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:href="itus-20161031.xsd#itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants" xlink:href="itus-20161031.xsd#itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20161031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant" xlink:href="itus-20161031.xsd#itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/AccountspayableandaccruedliabilitiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/IncometaxprovisionbenefitTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" order="5" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:label="itus_FederalAndStateNOLAndTaxCreditCarryforwards" xlink:href="itus-20161031.xsd#itus_FederalAndStateNOLAndTaxCreditCarryforwards"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="itus_FederalAndStateNOLAndTaxCreditCarryforwards" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" weight="-1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>itus-20161031_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Jan 25 23:38:52 EST 2017 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedBalanceSheet" roleURI="http://www.copytele.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.copytele.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedIncomeStatement" roleURI="http://www.copytele.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.copytele.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ShareholdersEquityType2or3" roleURI="http://www.copytele.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://www.copytele.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedCashFlow" roleURI="http://www.copytele.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedCashFlow_Parentheticals" roleURI="http://www.copytele.com/role/ConsolidatedCashFlow_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_BUSINESSANDFUNDING" roleURI="http://www.copytele.com/role/BUSINESSANDFUNDING"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SUBSEQUENTEVENT" roleURI="http://www.copytele.com/role/SUBSEQUENTEVENT"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ACCOUNTSPAYABLEANDACCRUEDEXPENSES" roleURI="http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SHAREHOLDERSEQUITY" roleURI="http://www.copytele.com/role/SHAREHOLDERSEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_COMMITMENTSANDCONTINGENCIES" roleURI="http://www.copytele.com/role/COMMITMENTSANDCONTINGENCIES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_INCOMETAXES" roleURI="http://www.copytele.com/role/INCOMETAXES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_AccountingPoliciesByPolicy" roleURI="http://www.copytele.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" roleURI="http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SHAREHOLDERSEQUITYTables" roleURI="http://www.copytele.com/role/SHAREHOLDERSEQUITYTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_INCOMETAXESTables" roleURI="http://www.copytele.com/role/INCOMETAXESTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" roleURI="http://www.copytele.com/role/HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SummaryofthechangesinthefairvalueoftheCompanysLevel3financialliabilitiesonrecurringbasisTable" roleURI="http://www.copytele.com/role/SummaryofthechangesinthefairvalueoftheCompanysLevel3financialliabilitiesonrecurringbasisTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable" roleURI="http://www.copytele.com/role/WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_AccountspayableandaccruedliabilitiesTable" roleURI="http://www.copytele.com/role/AccountspayableandaccruedliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_Informationregardingthe2003and2010SharePlanTable" roleURI="http://www.copytele.com/role/Informationregardingthe2003and2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_Stockoptionsoutstandingandexercisableunder2003shareplanTable" roleURI="http://www.copytele.com/role/Stockoptionsoutstandingandexercisableunder2003shareplanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_Stockoptionsoutstandingunder2010SharePlanTable" roleURI="http://www.copytele.com/role/Stockoptionsoutstandingunder2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_Informationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable" roleURI="http://www.copytele.com/role/Informationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_Stockoptionsgrantednotunder2003SharePlanand2010SharePlanTable" roleURI="http://www.copytele.com/role/Stockoptionsgrantednotunder2003SharePlanand2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_IncometaxprovisionbenefitTable" roleURI="http://www.copytele.com/role/IncometaxprovisionbenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable" roleURI="http://www.copytele.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ReconciliationofincometaxesattheFederalstatutorytaxrateTable" roleURI="http://www.copytele.com/role/ReconciliationofincometaxesattheFederalstatutorytaxrateTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_BUSINESSANDFUNDINGDetails" roleURI="http://www.copytele.com/role/BUSINESSANDFUNDINGDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SUBSEQUENTEVENTDetails" roleURI="http://www.copytele.com/role/SUBSEQUENTEVENTDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SHAREHOLDERSEQUITYDetails" roleURI="http://www.copytele.com/role/SHAREHOLDERSEQUITYDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.copytele.com/role/COMMITMENTSANDCONTINGENCIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_INCOMETAXESDetails" roleURI="http://www.copytele.com/role/INCOMETAXESDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#DocumentAndEntityInformation" roleURI="http://www.copytele.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_FiniteLivedPatentsNet" xlink:href="itus-20161031.xsd#itus_FiniteLivedPatentsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="itus_FiniteLivedPatentsNet" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RoyaltiesAndContingentLegalFeesPayable" xlink:href="itus-20161031.xsd#itus_RoyaltiesAndContingentLegalFeesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="itus_RoyaltiesAndContingentLegalFeesPayable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligation" xlink:href="itus-20161031.xsd#itus_PatentAcquisitionObligation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="itus_PatentAcquisitionObligation" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Liabilities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingencies" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RevenueFromPatentAssertionActivities" xlink:href="itus-20161031.xsd#itus_RevenueFromPatentAssertionActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="itus_RevenueFromPatentAssertionActivities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromRelatedParties" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenueFromRelatedParties" xlink:to="us-gaap_SalesRevenueNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_RoyaltyExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_LitigationAndLicensingExpenses" xlink:href="itus-20161031.xsd#itus_LitigationAndLicensingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="itus_LitigationAndLicensingExpenses" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_CostsAndExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_InterestExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockIssuedDuringPeriodValuePatentLicense" xlink:href="itus-20161031.xsd#itus_StockIssuedDuringPeriodValuePatentLicense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="itus_StockIssuedDuringPeriodValuePatentLicense" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockIssuedDuringPeriodSharesPatentLicense" xlink:href="itus-20161031.xsd#itus_StockIssuedDuringPeriodSharesPatentLicense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="itus_StockIssuedDuringPeriodSharesPatentLicense" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants" xlink:href="itus-20161031.xsd#itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockSharesAcquired" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:href="itus-20161031.xsd#itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants" xlink:href="itus-20161031.xsd#itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ChangeInOperatingAssetsAndLiabilitiesAbstract" xlink:href="itus-20161031.xsd#itus_ChangeInOperatingAssetsAndLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="itus_ChangeInOperatingAssetsAndLiabilitiesAbstract" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ChangeInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ChangeInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ChangeInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:href="itus-20161031.xsd#itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ChangeInOperatingAssetsAndLiabilitiesAbstract" xlink:to="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20161031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant" xlink:href="itus-20161031.xsd#itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedCashFlow_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockSharesAcquired" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/BUSINESSANDFUNDING">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SUBSEQUENTEVENT">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SHAREHOLDERSEQUITY">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/COMMITMENTSANDCONTINGENCIES">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/INCOMETAXES">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:href="itus-20161031.xsd#itus_AccountingPoliciesbyPolicyPoliciesLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_AccountingPoliciesbyPolicyPoliciesTable" xlink:href="itus-20161031.xsd#itus_AccountingPoliciesbyPolicyPoliciesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="itus_AccountingPoliciesbyPolicyPoliciesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PatentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_PatentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_UseOfEstimates" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="16" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SHAREHOLDERSEQUITYTables">
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYTablesLineItems" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYTablesTable" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SHAREHOLDERSEQUITYTablesLineItems" xlink:to="itus_SHAREHOLDERSEQUITYTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYTablesTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2003SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2003SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2003SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2010SharePlanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/INCOMETAXESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable">
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:href="itus-20161031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:href="itus-20161031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestmentsByCategoryAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnInvestmentsByCategoryAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="us-gaap_GainLossOnInvestmentsByCategoryAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_GainLossOnInvestmentsByCategoryAxis" xlink:to="us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_GainLossOnInvestmentsByCategoryAxis" xlink:to="us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CertificatesOfDepositMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_GlobalDepositoryReceiptsMember" xlink:href="itus-20161031.xsd#itus_GlobalDepositoryReceiptsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain" xlink:to="itus_GlobalDepositoryReceiptsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SummaryofthechangesinthefairvalueoftheCompanysLevel3financialliabilitiesonrecurringbasisTable">
    <loc xlink:type="locator" xlink:label="itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract" xlink:href="itus-20161031.xsd#itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:href="itus-20161031.xsd#itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract" xlink:to="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20161031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable">
    <loc xlink:type="locator" xlink:label="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:href="itus-20161031.xsd#itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ValuationAssumptionsAbstract" xlink:href="itus-20161031.xsd#itus_ValuationAssumptionsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:to="itus_ValuationAssumptionsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ValuationAssumptionsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/AccountspayableandaccruedliabilitiesTable">
    <loc xlink:type="locator" xlink:label="itus_AccountsPayableAndAccruedLiabilitiesAbstract" xlink:href="itus-20161031.xsd#itus_AccountsPayableAndAccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_NotesPayableCurrent" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/Informationregardingthe2003and2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2003SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2003SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2003SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2010SharePlanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="12" xbrldt:closed="true"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFVDB3Xzjr8GYI25Uk9Vy6/qcRrEsuAZfUt5UQC5nlxkGiq5YLv5a+F+/7ledHhFpceslIpB8H2YAcKJFlbjmJJqGSqwhlfgWnh4//mUBfEtsI03U0W8372AoqoQC9wINvfiO7FVGpQu9] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="15" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/Stockoptionsoutstandingandexercisableunder2003shareplanTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices179To775Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices179To775Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="itus_RangeOfExercisePrices179To775Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices1475To1725Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices1475To1725Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="itus_RangeOfExercisePrices1475To1725Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices2050To2300Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices2050To2300Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="itus_RangeOfExercisePrices2050To2300Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices2925Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices2925Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="itus_RangeOfExercisePrices2925Member" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/Stockoptionsoutstandingunder2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2010SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices258To925Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices258To925Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="itus_RangeOfExercisePrices258To925Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/Informationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/Stockoptionsgrantednotunder2003SharePlanand2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices258To556Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices258To556Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="itus_RangeOfExercisePrices258To556Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="itus-20161031.xsd#itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/IncometaxprovisionbenefitTable">
    <loc xlink:type="locator" xlink:label="itus_IncomeTaxProvisionBenefitAbstract" xlink:href="itus-20161031.xsd#itus_IncomeTaxProvisionBenefitAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable">
    <loc xlink:type="locator" xlink:label="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:href="itus-20161031.xsd#itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract"/>
    <loc xlink:type="locator" xlink:label="itus_LongTermDeferredTaxAssetsAbstract" xlink:href="itus-20161031.xsd#itus_LongTermDeferredTaxAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:to="itus_LongTermDeferredTaxAssetsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_FederalAndStateNOLAndTaxCreditCarryforwards" xlink:href="itus-20161031.xsd#itus_FederalAndStateNOLAndTaxCreditCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_LongTermDeferredTaxAssetsAbstract" xlink:to="itus_FederalAndStateNOLAndTaxCreditCarryforwards" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_LongTermDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_LongTermDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_LongTermDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsNet" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ReconciliationofincometaxesattheFederalstatutorytaxrateTable">
    <loc xlink:type="locator" xlink:label="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:href="itus-20161031.xsd#itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" xlink:href="itus-20161031.xsd#itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/BUSINESSANDFUNDINGDetails">
    <loc xlink:type="locator" xlink:label="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:href="itus-20161031.xsd#itus_BUSINESSANDFUNDINGDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_BUSINESSANDFUNDINGDetailsTable" xlink:href="itus-20161031.xsd#itus_BUSINESSANDFUNDINGDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="itus_BUSINESSANDFUNDINGDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_BUSINESSANDFUNDINGDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_BUSINESSANDFUNDINGDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_AUOMember" xlink:href="itus-20161031.xsd#itus_AUOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="itus_AUOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_NationalSecuritiesCorporationMember" xlink:href="itus-20161031.xsd#itus_NationalSecuritiesCorporationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="itus_NationalSecuritiesCorporationMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_AUOSettlementMember" xlink:href="itus-20161031.xsd#itus_AUOSettlementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="itus_AUOSettlementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAssignmentAgreementMember" xlink:href="itus-20161031.xsd#itus_PatentAssignmentAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="itus_PatentAssignmentAgreementMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_AgreementMember" xlink:href="itus-20161031.xsd#itus_AgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="itus_AgreementMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromLegalSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_ProceedsFromLegalSettlements" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LegalFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_LegalFees" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20161031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_CashPeriodIncreaseDecrease" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SUBSEQUENTEVENTDetails">
    <loc xlink:type="locator" xlink:label="itus_SUBSEQUENTEVENTDetailsLineItems" xlink:href="itus-20161031.xsd#itus_SUBSEQUENTEVENTDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SUBSEQUENTEVENTDetailsTable" xlink:href="itus-20161031.xsd#itus_SUBSEQUENTEVENTDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SUBSEQUENTEVENTDetailsLineItems" xlink:to="itus_SUBSEQUENTEVENTDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUBSEQUENTEVENTDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUBSEQUENTEVENTDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUBSEQUENTEVENTDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUBSEQUENTEVENTDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_SecuredDebentureDueJune12017Member" xlink:href="itus-20161031.xsd#itus_SecuredDebentureDueJune12017Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="itus_SecuredDebentureDueJune12017Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUBSEQUENTEVENTDetailsLineItems" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ConversionOfStockCashPaid" xlink:href="itus-20161031.xsd#itus_ConversionOfStockCashPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUBSEQUENTEVENTDetailsLineItems" xlink:to="itus_ConversionOfStockCashPaid" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUBSEQUENTEVENTDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUBSEQUENTEVENTDetailsLineItems" xlink:to="us-gaap_ConversionOfStockAmountIssued1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUBSEQUENTEVENTDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUBSEQUENTEVENTDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConversionOfStockDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUBSEQUENTEVENTDetailsLineItems" xlink:to="us-gaap_ConversionOfStockDescription" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="itus-20161031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="itus-20161031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_Licensees1Member" xlink:href="itus-20161031.xsd#itus_Licensees1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="itus_Licensees1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_Licensees2Member" xlink:href="itus-20161031.xsd#itus_Licensees2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="itus_Licensees2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_Licensees3Member" xlink:href="itus-20161031.xsd#itus_Licensees3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="itus_Licensees3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsGrantedToEmployeesAndDirectorsMember" xlink:href="itus-20161031.xsd#itus_StockOptionsGrantedToEmployeesAndDirectorsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="itus_StockOptionsGrantedToEmployeesAndDirectorsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockAwardGrantedConsultantsMember" xlink:href="itus-20161031.xsd#itus_StockAwardGrantedConsultantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="itus_StockAwardGrantedConsultantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_AwardsOfOptionsWith10YearTermsMember" xlink:href="itus-20161031.xsd#itus_AwardsOfOptionsWith10YearTermsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="itus_AwardsOfOptionsWith10YearTermsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PatentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_PatentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaturityOfTimeDeposits" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaturityOfTimeDeposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_MaturityOfTimeDeposits" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CertificatesOfDepositAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_CertificatesOfDepositAtCarryingValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfAcquisitionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfAcquisitionCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AmortizationOfAcquisitionCosts" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_AmortizationRelatedToCompensationCost" xlink:href="itus-20161031.xsd#itus_AmortizationRelatedToCompensationCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="itus_AmortizationRelatedToCompensationCost" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SHAREHOLDERSEQUITYDetails">
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ConsultantMember" xlink:href="itus-20161031.xsd#itus_ConsultantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="itus_ConsultantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BoardOfDirectorsChairmanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BoardOfDirectorsChairmanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_BoardOfDirectorsChairmanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RePricedOptionsMember" xlink:href="itus-20161031.xsd#itus_RePricedOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="itus_RePricedOptionsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantsWithExercisePrice925Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice925Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="itus_WarrantsWithExercisePrice925Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantsWithExercisePrice13875Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice13875Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="itus_WarrantsWithExercisePrice13875Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantsWithExercisePrice775Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice775Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="itus_WarrantsWithExercisePrice775Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantsWithExercisePrice6925Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice6925Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="itus_WarrantsWithExercisePrice6925Member" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantsWithExercisePrice1000Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice1000Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="itus_WarrantsWithExercisePrice1000Member" order="4" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2010SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2003SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2003SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2003SharePlanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ConsultationFeesRelatedToOptions" xlink:href="itus-20161031.xsd#itus_ConsultationFeesRelatedToOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="itus_ConsultationFeesRelatedToOptions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ConvertiblePreferredStockRedemptionNoticePeriod" xlink:href="itus-20161031.xsd#itus_ConvertiblePreferredStockRedemptionNoticePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="itus_ConvertiblePreferredStockRedemptionNoticePeriod" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockRedemptionPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockRedemptionPricePerShare" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionDate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockRedemptionDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockRedemptionDate" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ConvertiblePreferredStockSharesConvertedStatedValue" xlink:href="itus-20161031.xsd#itus_ConvertiblePreferredStockSharesConvertedStatedValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="itus_ConvertiblePreferredStockSharesConvertedStatedValue" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ConvertiblePreferredStockConversionPrice" xlink:href="itus-20161031.xsd#itus_ConvertiblePreferredStockConversionPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="itus_ConvertiblePreferredStockConversionPrice" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ConvertiblePreferredStockOwnershipThresholdPercentage" xlink:href="itus-20161031.xsd#itus_ConvertiblePreferredStockOwnershipThresholdPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="itus_ConvertiblePreferredStockOwnershipThresholdPercentage" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_CommonStockAntidilutionThresholdPrice" xlink:href="itus-20161031.xsd#itus_CommonStockAntidilutionThresholdPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="itus_CommonStockAntidilutionThresholdPrice" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ConertiblePreferredStockObserverDesignationNoticePeriod" xlink:href="itus-20161031.xsd#itus_ConertiblePreferredStockObserverDesignationNoticePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="itus_ConertiblePreferredStockObserverDesignationNoticePeriod" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="23" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/COMMITMENTSANDCONTINGENCIESDetails">
    <loc xlink:type="locator" xlink:label="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:href="itus-20161031.xsd#itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:href="itus-20161031.xsd#itus_COMMITMENTSANDCONTINGENCIESDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="itus_COMMITMENTSANDCONTINGENCIESDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_OfficeSpaceInLosAngelesCaliforniaMember" xlink:href="itus-20161031.xsd#itus_OfficeSpaceInLosAngelesCaliforniaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="itus_OfficeSpaceInLosAngelesCaliforniaMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligationsDiscountedPresentValue" xlink:href="itus-20161031.xsd#itus_PatentAcquisitionObligationsDiscountedPresentValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="itus_PatentAcquisitionObligationsDiscountedPresentValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_InterestExpensePatentAcquisitionObligations" xlink:href="itus-20161031.xsd#itus_InterestExpensePatentAcquisitionObligations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="itus_InterestExpensePatentAcquisitionObligations" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod" xlink:href="itus-20161031.xsd#itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AreaOfLand" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AreaOfLand"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_AreaOfLand" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_LeaseBaseRentAnnualIncrease" xlink:href="itus-20161031.xsd#itus_LeaseBaseRentAnnualIncrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="itus_LeaseBaseRentAnnualIncrease" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/INCOMETAXESDetails">
    <loc xlink:type="locator" xlink:label="itus_INCOMETAXESDetailsLineItems" xlink:href="itus-20161031.xsd#itus_INCOMETAXESDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_INCOMETAXESDetailsTable" xlink:href="itus-20161031.xsd#itus_INCOMETAXESDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="itus_INCOMETAXESDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_INCOMETAXESDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_FederalCorporateTaxableMember" xlink:href="itus-20161031.xsd#itus_FederalCorporateTaxableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="itus_FederalCorporateTaxableMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_NewYorkStateMember" xlink:href="itus-20161031.xsd#itus_NewYorkStateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="itus_NewYorkStateMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_CaliforniaStateMember" xlink:href="itus-20161031.xsd#itus_CaliforniaStateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="itus_CaliforniaStateMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PennsylvaniaStateMember" xlink:href="itus-20161031.xsd#itus_PennsylvaniaStateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="itus_PennsylvaniaStateMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange" xlink:href="itus-20161031.xsd#itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.copytele.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentDescription" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="15" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>itus-20161031_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Jan 25 23:38:52 EST 2017 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and cash equivalents at beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US">Cash and cash equivalents at end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short&#8211;term investments in certificates of deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_FiniteLivedPatentsNet" xlink:href="itus-20161031.xsd#itus_FiniteLivedPatentsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_FiniteLivedPatentsNet_lbl" xml:lang="en-US">Patents, net of accumulated amortization of $965,040 and $639,744, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_FiniteLivedPatentsNet" xlink:to="itus_FiniteLivedPatentsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Patents, accumulated amortization (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net of accumulated depreciation of $46,950 and $13,617, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment, accumulated depreciation (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RoyaltiesAndContingentLegalFeesPayable" xlink:href="itus-20161031.xsd#itus_RoyaltiesAndContingentLegalFeesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RoyaltiesAndContingentLegalFeesPayable_lbl" xml:lang="en-US">Royalties and contingent legal fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RoyaltiesAndContingentLegalFeesPayable" xlink:to="itus_RoyaltiesAndContingentLegalFeesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligation" xlink:href="itus-20161031.xsd#itus_PatentAcquisitionObligation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_PatentAcquisitionObligation_lbl" xml:lang="en-US">Patent acquisition obligation (Note 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAcquisitionObligation" xlink:to="itus_PatentAcquisitionObligation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Notes 6 and 7)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding Series A convertible preferred stock, par value $100 per share; 140 shares authorized, issued and outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl0" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl0" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, par value $.01 per share; 24,000,000 shares authorized; 8,752,387 and 8,724,878 shares issued and outstanding, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RevenueFromPatentAssertionActivities" xlink:href="itus-20161031.xsd#itus_RevenueFromPatentAssertionActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RevenueFromPatentAssertionActivities_lbl" xml:lang="en-US">Revenue from licensing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RevenueFromPatentAssertionActivities" xlink:to="itus_RevenueFromPatentAssertionActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromRelatedParties_lbl" xml:lang="en-US">Settlement with AU Optronics Corporation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromRelatedParties" xlink:to="us-gaap_RevenueFromRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_SalesRevenueNet_lbl" xml:lang="en-US">Total revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyExpense_lbl" xml:lang="en-US">Inventor royalties and contingent legal fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_LitigationAndLicensingExpenses" xlink:href="itus-20161031.xsd#itus_LitigationAndLicensingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_LitigationAndLicensingExpenses_lbl" xml:lang="en-US">Litigation and licensing expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_LitigationAndLicensingExpenses" xlink:to="itus_LitigationAndLicensingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of patents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses (including non-cash stock option compensation expenses of $259,930 and $306,584, respectively)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Non-cash Stock Option Compensation Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Marketing, general and administrative expenses (including non-cash stock option compensation expense of $613,631 and $2,369,806, respectively)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xml:lang="en-US">Selling and Marketing Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total operating costs and expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense (Note 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Loss before income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes (Note 7)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income Tax Provision (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US">Income tax provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Stock option compensation to employees and consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Common stock issued upon exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Common stock issued upon exercise of stock options (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Options Exercised, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Common stock issued to consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Common stock issued to consultants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants" xlink:href="itus-20161031.xsd#itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants_lbl" xml:lang="en-US">Repurchase 92,232 shares of common stock and cancellation of warrants to purchase 16,000 shares of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants" xlink:to="itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl" xml:lang="en-US">Treasury Stock, Shares, Acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesAcquired" xlink:to="us-gaap_TreasuryStockSharesAcquired_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl0" xml:lang="en-US">Number of Common Stock Acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesAcquired" xlink:to="us-gaap_TreasuryStockSharesAcquired_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0" xml:lang="en-US">Number Of Warrants Cancelled</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl" xml:lang="en-US">Retire common stock repurchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xml:lang="en-US">Retire common stock repurchased (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockIssuedDuringPeriodValuePatentLicense" xlink:href="itus-20161031.xsd#itus_StockIssuedDuringPeriodValuePatentLicense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockIssuedDuringPeriodValuePatentLicense_lbl" xml:lang="en-US">Common stock issued to acquire patents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodValuePatentLicense" xlink:to="itus_StockIssuedDuringPeriodValuePatentLicense_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockIssuedDuringPeriodSharesPatentLicense" xlink:href="itus-20161031.xsd#itus_StockIssuedDuringPeriodSharesPatentLicense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_StockIssuedDuringPeriodSharesPatentLicense_lbl" xml:lang="en-US">Common stock issued to acquire patents (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodSharesPatentLicense" xlink:to="itus_StockIssuedDuringPeriodSharesPatentLicense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Stock option compensation to employees and consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Common stock issued to consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:href="itus-20161031.xsd#itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl" xml:lang="en-US">Accretion of interest on patent acquisition obligations to interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:to="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl0" xml:lang="en-US">Accretion of interest on patent obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:to="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants" xlink:href="itus-20161031.xsd#itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants_lbl" xml:lang="en-US">Loss on acquisition of common stock and warrants to purchase common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants" xlink:to="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Common stock issued to acquire patent license</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US">Loss on disposal of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:href="itus-20161031.xsd#itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl" xml:lang="en-US">Royalties and contingent legal fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:to="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash (used in) provided by operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US">Disbursements to acquire short-term investments in certificates of deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl0" xml:lang="en-US">Payments to Acquire Short-term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" xml:lang="en-US">Proceeds from maturities of short-term investments in certificates of deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl0" xml:lang="en-US">Proceeds from Sale of Short-term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of employee stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20161031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl" xml:lang="en-US">Royalty payment applied to patent acquisition obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl0" xml:lang="en-US">Royalty payment applied to patent acquisition obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl1" xml:lang="en-US">Payment to Acquire Royalty Interest in Patent Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl1"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant" xlink:href="itus-20161031.xsd#itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant_lbl" xml:lang="en-US">Payments to acquire 92,232 shares of common stock and cancellation of warrants to purchase 16,000 shares of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant" xlink:to="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used in financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net (decrease) increase in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:href="itus-20161031.xsd#itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract_lbl" xml:lang="en-US">Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:to="itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xml:lang="en-US">Cash and Cash Equivalents [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US">Money Market Funds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Money market funds &#8211; Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xml:lang="en-US">Certificates of Deposit [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CertificatesOfDepositMember" xlink:to="us-gaap_CertificatesOfDepositMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xml:lang="en-US">Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Total financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestmentsByCategoryAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnInvestmentsByCategoryAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnInvestmentsByCategoryAxis_lbl" xml:lang="en-US">Investments by Category [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestmentsByCategoryAxis" xlink:to="us-gaap_GainLossOnInvestmentsByCategoryAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_GlobalDepositoryReceiptsMember" xlink:href="itus-20161031.xsd#itus_GlobalDepositoryReceiptsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_GlobalDepositoryReceiptsMember_lbl" xml:lang="en-US">Global Depository Receipts [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_GlobalDepositoryReceiptsMember" xlink:to="itus_GlobalDepositoryReceiptsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_lbl" xml:lang="en-US">Patent acquisition obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value, Hierarchy [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract" xlink:href="itus-20161031.xsd#itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract_lbl" xml:lang="en-US">Summary of the changes in the fair value of the Company&apos;s Level 3 financial liabilities on recurring basis [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract" xlink:to="itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Balance October 31, 2014</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:href="itus-20161031.xsd#itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract_lbl" xml:lang="en-US">Weighted average assumptions used in estimating the fair value of stock options [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:to="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average fair value at grant date (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life (years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AccountsPayableAndAccruedLiabilitiesAbstract" xlink:href="itus-20161031.xsd#itus_AccountsPayableAndAccruedLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AccountsPayableAndAccruedLiabilitiesAbstract_lbl" xml:lang="en-US">Accounts payable and accrued liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="itus_AccountsPayableAndAccruedLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Payroll and related expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders&apos; Equity Note [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_InformationRegardingThe2003And2010SharePlanAbstract" xlink:href="itus-20161031.xsd#itus_InformationRegardingThe2003And2010SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_InformationRegardingThe2003And2010SharePlanAbstract_lbl" xml:lang="en-US">Information regarding the 2003 and 2010 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_InformationRegardingThe2003And2010SharePlanAbstract" xlink:to="itus_InformationRegardingThe2003And2010SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_A2003SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2003SharePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_A2003SharePlanMember_lbl" xml:lang="en-US">2003 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_A2003SharePlanMember" xlink:to="itus_A2003SharePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Options Outstanding, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Options Outstanding, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Options Outstanding at October 31, 2014, 2015 and 2016</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Outstanding, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Options Outstanding, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Options Outstanding at October 31, 2014, 2015 and 2016</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Exercised, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Options Forfeited, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Forfeited, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl0" xml:lang="en-US">Options Outstanding and exercisable at October 31, 2016</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Options Outstanding and exercisable at October 31, 2016</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Aggregate Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl0" xml:lang="en-US">Options Outstanding and exercisable at October 31, 2016</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_A2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2010SharePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_A2010SharePlanMember_lbl" xml:lang="en-US">2010 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_A2010SharePlanMember" xlink:to="itus_A2010SharePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Options Granted, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Granted, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Options Outstanding, Aggregate Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Options Exercisable, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Exercisable, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Options Exercisable, Aggregate Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsOutstandingAndExercisableUnder2003SharePlanAbstract" xlink:href="itus-20161031.xsd#itus_StockOptionsOutstandingAndExercisableUnder2003SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockOptionsOutstandingAndExercisableUnder2003SharePlanAbstract_lbl" xml:lang="en-US">Stock options outstanding and exercisable under 2003 share plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockOptionsOutstandingAndExercisableUnder2003SharePlanAbstract" xlink:to="itus_StockOptionsOutstandingAndExercisableUnder2003SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices179To775Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices179To775Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_RangeOfExercisePrices179To775Member_lbl" xml:lang="en-US">Range Of Exercise Prices $1.79 To $7.75 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices179To775Member" xlink:to="itus_RangeOfExercisePrices179To775Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US">Options Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options Outstanding,Weighted Average Remaining Contractual Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xml:lang="en-US">Options Outstanding, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices1475To1725Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices1475To1725Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_RangeOfExercisePrices1475To1725Member_lbl" xml:lang="en-US">Range Of Exercise Prices $14.75 To $17.25 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices1475To1725Member" xlink:to="itus_RangeOfExercisePrices1475To1725Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices2050To2300Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices2050To2300Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_RangeOfExercisePrices2050To2300Member_lbl" xml:lang="en-US">Range Of Exercise Prices $20.50 To $23.00 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices2050To2300Member" xlink:to="itus_RangeOfExercisePrices2050To2300Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices2925Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices2925Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_RangeOfExercisePrices2925Member_lbl" xml:lang="en-US">Range Of Exercise Prices $29.25 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices2925Member" xlink:to="itus_RangeOfExercisePrices2925Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsOutstandingUnder2010SharePlanAbstract" xlink:href="itus-20161031.xsd#itus_StockOptionsOutstandingUnder2010SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockOptionsOutstandingUnder2010SharePlanAbstract_lbl" xml:lang="en-US">Stock options outstanding under 2010 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockOptionsOutstandingUnder2010SharePlanAbstract" xlink:to="itus_StockOptionsOutstandingUnder2010SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices258To925Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices258To925Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_RangeOfExercisePrices258To925Member_lbl" xml:lang="en-US">Range Of Exercise Prices $2.58 To $9.25 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices258To925Member" xlink:to="itus_RangeOfExercisePrices258To925Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Options Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options Exercisable,Weighted Average Remaining Contractual Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Options Exercisable, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_lbl" xml:lang="en-US">Stock Options Not Granted Under 2003 Share Plan Or 2010 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:to="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_InformationRegardingStockOptionsThatWereNotGrantedUnderThe2003SharePlanOrThe2010SharePlanAbstract" xlink:href="itus-20161031.xsd#itus_InformationRegardingStockOptionsThatWereNotGrantedUnderThe2003SharePlanOrThe2010SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_InformationRegardingStockOptionsThatWereNotGrantedUnderThe2003SharePlanOrThe2010SharePlanAbstract_lbl" xml:lang="en-US">Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_InformationRegardingStockOptionsThatWereNotGrantedUnderThe2003SharePlanOrThe2010SharePlanAbstract" xlink:to="itus_InformationRegardingStockOptionsThatWereNotGrantedUnderThe2003SharePlanOrThe2010SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsGrantedNotUnder2003SharePlanAnd2010SharePlanAbstract" xlink:href="itus-20161031.xsd#itus_StockOptionsGrantedNotUnder2003SharePlanAnd2010SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockOptionsGrantedNotUnder2003SharePlanAnd2010SharePlanAbstract_lbl" xml:lang="en-US">Stock options granted not under 2003 Share Plan and 2010 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockOptionsGrantedNotUnder2003SharePlanAnd2010SharePlanAbstract" xlink:to="itus_StockOptionsGrantedNotUnder2003SharePlanAnd2010SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices258To556Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices258To556Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_RangeOfExercisePrices258To556Member_lbl" xml:lang="en-US">Range Of Exercise Prices $2.58 To $5.56 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices258To556Member" xlink:to="itus_RangeOfExercisePrices258To556Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="itus-20161031.xsd#itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Weighted Average Remaining Contractual Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_IncomeTaxProvisionBenefitAbstract" xlink:href="itus-20161031.xsd#itus_IncomeTaxProvisionBenefitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_IncomeTaxProvisionBenefitAbstract_lbl" xml:lang="en-US">Income tax provision (benefit) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_IncomeTaxProvisionBenefitAbstract" xlink:to="itus_IncomeTaxProvisionBenefitAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xml:lang="en-US">Adjustment to valuation allowance related to net deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:href="itus-20161031.xsd#itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract_lbl" xml:lang="en-US">The tax effects of temporary differences of the deferred tax [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:to="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_FederalAndStateNOLAndTaxCreditCarryforwards" xlink:href="itus-20161031.xsd#itus_FederalAndStateNOLAndTaxCreditCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_FederalAndStateNOLAndTaxCreditCarryforwards_lbl" xml:lang="en-US">Federal and state NOL and tax credit carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_FederalAndStateNOLAndTaxCreditCarryforwards" xlink:to="itus_FederalAndStateNOLAndTaxCreditCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xml:lang="en-US">Deferred compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Intangibles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Subtotal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less: valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax asset, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:href="itus-20161031.xsd#itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract_lbl" xml:lang="en-US">Reconciliation of income taxes at the Federal statutory tax rate [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal statutory income Tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal statutory income Tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Permanent differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Permanent differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" xlink:href="itus-20161031.xsd#itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther_lbl" xml:lang="en-US">Expiring net operating losses, credits and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" xlink:to="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xml:lang="en-US">Expiring net operating losses, credits and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Income tax provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders&#8217; equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenue:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract_lbl" xml:lang="en-US">Operating costs and expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Net loss per share:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted average common shares outstanding:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ChangeInOperatingAssetsAndLiabilitiesAbstract" xlink:href="itus-20161031.xsd#itus_ChangeInOperatingAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ChangeInOperatingAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Change in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ChangeInOperatingAssetsAndLiabilitiesAbstract" xlink:to="itus_ChangeInOperatingAssetsAndLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract" xlink:href="itus-20161031.xsd#itus_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract_lbl" xml:lang="en-US">The accompanying notes are an integral part of these statements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract" xlink:to="itus_TheAccompanyingNotesAreAnIntegralPartOfTheseStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ValuationAssumptionsAbstract" xlink:href="itus-20161031.xsd#itus_ValuationAssumptionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ValuationAssumptionsAbstract_lbl" xml:lang="en-US">Valuation assumptions:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ValuationAssumptionsAbstract" xlink:to="itus_ValuationAssumptionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Federal:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">State:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_LongTermDeferredTaxAssetsAbstract" xlink:href="itus-20161031.xsd#itus_LongTermDeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_LongTermDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Long-term deferred tax assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_LongTermDeferredTaxAssetsAbstract" xlink:to="itus_LongTermDeferredTaxAssetsAbstract_lbl"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFVDB3Xzjr8GYI25Uk9Vy6/qcRrEsuAZfUt5UQC5nlxkGiq5YLv5a+F+/7ledHhFpceslIpB8H2YAcKJFlbjmJJqGSqwhlfgWnh4//mUBfEtsSe+zD92qQDGXP7UBIpxbVU0OSB2tzio4] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_IncomeTaxBenefitAtUSAbstract" xlink:href="itus-20161031.xsd#itus_IncomeTaxBenefitAtUSAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_IncomeTaxBenefitAtUSAbstract_lbl" xml:lang="en-US">Income tax benefit at U.S.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_IncomeTaxBenefitAtUSAbstract" xlink:to="itus_IncomeTaxBenefitAtUSAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AUOSettlementMember" xlink:href="itus-20161031.xsd#itus_AUOSettlementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_AUOSettlementMember_lbl" xml:lang="en-US">AUO Settlement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AUOSettlementMember" xlink:to="itus_AUOSettlementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AUOMember" xlink:href="itus-20161031.xsd#itus_AUOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_AUOMember_lbl" xml:lang="en-US">AUO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AUOMember" xlink:to="itus_AUOMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAssignmentAgreementMember" xlink:href="itus-20161031.xsd#itus_PatentAssignmentAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_PatentAssignmentAgreementMember_lbl" xml:lang="en-US">Patent Assignment Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAssignmentAgreementMember" xlink:to="itus_PatentAssignmentAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AgreementMember" xlink:href="itus-20161031.xsd#itus_AgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_AgreementMember_lbl" xml:lang="en-US">Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AgreementMember" xlink:to="itus_AgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_NationalSecuritiesCorporationMember" xlink:href="itus-20161031.xsd#itus_NationalSecuritiesCorporationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_NationalSecuritiesCorporationMember_lbl" xml:lang="en-US">National Securities Corporation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_NationalSecuritiesCorporationMember" xlink:to="itus_NationalSecuritiesCorporationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SecuredDebentureDueJune12017Member" xlink:href="itus-20161031.xsd#itus_SecuredDebentureDueJune12017Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_SecuredDebentureDueJune12017Member_lbl" xml:lang="en-US">Secured Debenture Due June 1,2017 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SecuredDebentureDueJune12017Member" xlink:to="itus_SecuredDebentureDueJune12017Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PatentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsGrantedToEmployeesAndDirectorsMember" xlink:href="itus-20161031.xsd#itus_StockOptionsGrantedToEmployeesAndDirectorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_StockOptionsGrantedToEmployeesAndDirectorsMember_lbl" xml:lang="en-US">Stock Options Granted To Employees And Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockOptionsGrantedToEmployeesAndDirectorsMember" xlink:to="itus_StockOptionsGrantedToEmployeesAndDirectorsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockAwardGrantedConsultantsMember" xlink:href="itus-20161031.xsd#itus_StockAwardGrantedConsultantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_StockAwardGrantedConsultantsMember_lbl" xml:lang="en-US">Stock Award Granted Consultants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockAwardGrantedConsultantsMember" xlink:to="itus_StockAwardGrantedConsultantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AwardsOfOptionsWith10YearTermsMember" xlink:href="itus-20161031.xsd#itus_AwardsOfOptionsWith10YearTermsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_AwardsOfOptionsWith10YearTermsMember_lbl" xml:lang="en-US">Awards Of Options With 10 Year Terms [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AwardsOfOptionsWith10YearTermsMember" xlink:to="itus_AwardsOfOptionsWith10YearTermsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Employee Stock Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Sales Revenue, Net [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_Licensees1Member" xlink:href="itus-20161031.xsd#itus_Licensees1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_Licensees1Member_lbl" xml:lang="en-US">Licensees 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_Licensees1Member" xlink:to="itus_Licensees1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_Licensees2Member" xlink:href="itus-20161031.xsd#itus_Licensees2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_Licensees2Member_lbl" xml:lang="en-US">Licensees 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_Licensees2Member" xlink:to="itus_Licensees2Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_Licensees3Member" xlink:href="itus-20161031.xsd#itus_Licensees3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_Licensees3Member_lbl" xml:lang="en-US">Licensees 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_Licensees3Member" xlink:to="itus_Licensees3Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ConsultantMember" xlink:href="itus-20161031.xsd#itus_ConsultantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_ConsultantMember_lbl" xml:lang="en-US">Consultant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConsultantMember" xlink:to="itus_ConsultantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BoardOfDirectorsChairmanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BoardOfDirectorsChairmanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors Chairman [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BoardOfDirectorsChairmanMember" xlink:to="us-gaap_BoardOfDirectorsChairmanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RePricedOptionsMember" xlink:href="itus-20161031.xsd#itus_RePricedOptionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_RePricedOptionsMember_lbl" xml:lang="en-US">Re-Priced Options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RePricedOptionsMember" xlink:to="itus_RePricedOptionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl" xml:lang="en-US">Equity Interest Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantsWithExercisePrice925Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice925Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_WarrantsWithExercisePrice925Member_lbl" xml:lang="en-US">Warrants With Exercise Price $9.25 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantsWithExercisePrice925Member" xlink:to="itus_WarrantsWithExercisePrice925Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantsWithExercisePrice13875Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice13875Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_WarrantsWithExercisePrice13875Member_lbl" xml:lang="en-US">Warrants With Exercise Price $13.875 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantsWithExercisePrice13875Member" xlink:to="itus_WarrantsWithExercisePrice13875Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantsWithExercisePrice775Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice775Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_WarrantsWithExercisePrice775Member_lbl" xml:lang="en-US">Warrants With Exercise Price $7.75 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantsWithExercisePrice775Member" xlink:to="itus_WarrantsWithExercisePrice775Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantsWithExercisePrice6925Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice6925Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_WarrantsWithExercisePrice6925Member_lbl" xml:lang="en-US">Warrants With Exercise Price $6.925 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantsWithExercisePrice6925Member" xlink:to="itus_WarrantsWithExercisePrice6925Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantsWithExercisePrice1000Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice1000Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_WarrantsWithExercisePrice1000Member_lbl" xml:lang="en-US">Warrants With Exercise Price $10.00 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantsWithExercisePrice1000Member" xlink:to="itus_WarrantsWithExercisePrice1000Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_OfficeSpaceInLosAngelesCaliforniaMember" xlink:href="itus-20161031.xsd#itus_OfficeSpaceInLosAngelesCaliforniaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_OfficeSpaceInLosAngelesCaliforniaMember_lbl" xml:lang="en-US">Office Space in Los Angeles, California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_OfficeSpaceInLosAngelesCaliforniaMember" xlink:to="itus_OfficeSpaceInLosAngelesCaliforniaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_FederalCorporateTaxableMember" xlink:href="itus-20161031.xsd#itus_FederalCorporateTaxableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_FederalCorporateTaxableMember_lbl" xml:lang="en-US">Federal Corporate Taxable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_FederalCorporateTaxableMember" xlink:to="itus_FederalCorporateTaxableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_NewYorkStateMember" xlink:href="itus-20161031.xsd#itus_NewYorkStateMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_NewYorkStateMember_lbl" xml:lang="en-US">New York State [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_NewYorkStateMember" xlink:to="itus_NewYorkStateMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_CaliforniaStateMember" xlink:href="itus-20161031.xsd#itus_CaliforniaStateMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_CaliforniaStateMember_lbl" xml:lang="en-US">California State [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_CaliforniaStateMember" xlink:to="itus_CaliforniaStateMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_PennsylvaniaStateMember" xlink:href="itus-20161031.xsd#itus_PennsylvaniaStateMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_PennsylvaniaStateMember_lbl" xml:lang="en-US">Pennsylvania State [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PennsylvaniaStateMember" xlink:to="itus_PennsylvaniaStateMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromLegalSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLegalSettlements_lbl" xml:lang="en-US">Proceeds from Legal Settlements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLegalSettlements" xlink:to="us-gaap_ProceedsFromLegalSettlements_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LegalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LegalFees_lbl" xml:lang="en-US">Legal Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashPeriodIncreaseDecrease_lbl" xml:lang="en-US">Cash, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashPeriodIncreaseDecrease" xlink:to="us-gaap_CashPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Conversion of Stock, Amount Converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ConversionOfStockCashPaid" xlink:href="itus-20161031.xsd#itus_ConversionOfStockCashPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ConversionOfStockCashPaid_lbl" xml:lang="en-US">Conversion of Stock, Cash Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConversionOfStockCashPaid" xlink:to="itus_ConversionOfStockCashPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl" xml:lang="en-US">Conversion of Stock, Amount Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt Instrument, Face Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConversionOfStockDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockDescription_lbl" xml:lang="en-US">Conversion of Stock, Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockDescription" xlink:to="us-gaap_ConversionOfStockDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaturityOfTimeDeposits" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaturityOfTimeDeposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaturityOfTimeDeposits_lbl" xml:lang="en-US">Maturity of Time Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaturityOfTimeDeposits" xlink:to="us-gaap_MaturityOfTimeDeposits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CertificatesOfDepositAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CertificatesOfDepositAtCarryingValue_lbl" xml:lang="en-US">Certificates of Deposit, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CertificatesOfDepositAtCarryingValue" xlink:to="us-gaap_CertificatesOfDepositAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfAcquisitionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfAcquisitionCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfAcquisitionCosts_lbl" xml:lang="en-US">Amortization of Acquisition Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfAcquisitionCosts" xlink:to="us-gaap_AmortizationOfAcquisitionCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Share-based Compensation (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_AmortizationRelatedToCompensationCost" xlink:href="itus-20161031.xsd#itus_AmortizationRelatedToCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AmortizationRelatedToCompensationCost_lbl" xml:lang="en-US">Amortization Related To Compensation Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AmortizationRelatedToCompensationCost" xlink:to="itus_AmortizationRelatedToCompensationCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription_lbl" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Award Vesting Period, Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration Risk, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ConsultationFeesRelatedToOptions" xlink:href="itus-20161031.xsd#itus_ConsultationFeesRelatedToOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ConsultationFeesRelatedToOptions_lbl" xml:lang="en-US">Consultation Fees Related To Options (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConsultationFeesRelatedToOptions" xlink:to="itus_ConsultationFeesRelatedToOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ConvertiblePreferredStockRedemptionNoticePeriod" xlink:href="itus-20161031.xsd#itus_ConvertiblePreferredStockRedemptionNoticePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ConvertiblePreferredStockRedemptionNoticePeriod_lbl" xml:lang="en-US">Convertible Preferred Stock Redemption, Notice Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConvertiblePreferredStockRedemptionNoticePeriod" xlink:to="itus_ConvertiblePreferredStockRedemptionNoticePeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockRedemptionPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare_lbl" xml:lang="en-US">Preferred Stock, Redemption Price Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionPricePerShare" xlink:to="us-gaap_PreferredStockRedemptionPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionDate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockRedemptionDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockRedemptionDate_lbl" xml:lang="en-US">Preferred Stock, Redemption Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionDate" xlink:to="us-gaap_PreferredStockRedemptionDate_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ConvertiblePreferredStockSharesConvertedStatedValue" xlink:href="itus-20161031.xsd#itus_ConvertiblePreferredStockSharesConvertedStatedValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ConvertiblePreferredStockSharesConvertedStatedValue_lbl" xml:lang="en-US">Convertible Preferred Stock, Shares Converted, Stated Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConvertiblePreferredStockSharesConvertedStatedValue" xlink:to="itus_ConvertiblePreferredStockSharesConvertedStatedValue_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ConvertiblePreferredStockConversionPrice" xlink:href="itus-20161031.xsd#itus_ConvertiblePreferredStockConversionPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ConvertiblePreferredStockConversionPrice_lbl" xml:lang="en-US">Convertible Preferred Stock, Conversion Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConvertiblePreferredStockConversionPrice" xlink:to="itus_ConvertiblePreferredStockConversionPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ConvertiblePreferredStockOwnershipThresholdPercentage" xlink:href="itus-20161031.xsd#itus_ConvertiblePreferredStockOwnershipThresholdPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ConvertiblePreferredStockOwnershipThresholdPercentage_lbl" xml:lang="en-US">Convertible Preferred Stock, Ownership Threshold, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConvertiblePreferredStockOwnershipThresholdPercentage" xlink:to="itus_ConvertiblePreferredStockOwnershipThresholdPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_CommonStockAntidilutionThresholdPrice" xlink:href="itus-20161031.xsd#itus_CommonStockAntidilutionThresholdPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_CommonStockAntidilutionThresholdPrice_lbl" xml:lang="en-US">Common Stock, Anti-dilution Threshold Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_CommonStockAntidilutionThresholdPrice" xlink:to="itus_CommonStockAntidilutionThresholdPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ConertiblePreferredStockObserverDesignationNoticePeriod" xlink:href="itus-20161031.xsd#itus_ConertiblePreferredStockObserverDesignationNoticePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ConertiblePreferredStockObserverDesignationNoticePeriod_lbl" xml:lang="en-US">Conertible Preferred Stock, Observer Designation, Notice Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConertiblePreferredStockObserverDesignationNoticePeriod" xlink:to="itus_ConertiblePreferredStockObserverDesignationNoticePeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligationsDiscountedPresentValue" xlink:href="itus-20161031.xsd#itus_PatentAcquisitionObligationsDiscountedPresentValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_PatentAcquisitionObligationsDiscountedPresentValue_lbl" xml:lang="en-US">Patent Acquisition Obligations Discounted, Present Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAcquisitionObligationsDiscountedPresentValue" xlink:to="itus_PatentAcquisitionObligationsDiscountedPresentValue_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_InterestExpensePatentAcquisitionObligations" xlink:href="itus-20161031.xsd#itus_InterestExpensePatentAcquisitionObligations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_InterestExpensePatentAcquisitionObligations_lbl" xml:lang="en-US">Interest Expense, Patent Acquisition Obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_InterestExpensePatentAcquisitionObligations" xlink:to="itus_InterestExpensePatentAcquisitionObligations_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod" xlink:href="itus-20161031.xsd#itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod_lbl" xml:lang="en-US">Patent Acquisition Obligation, Payment Due Date Extension Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod" xlink:to="itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AreaOfLand" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AreaOfLand"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AreaOfLand_lbl" xml:lang="en-US">Area of Land (in Square Feet)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl" xml:lang="en-US">Operating Leases, Rent Expense, Minimum Rentals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_LeaseBaseRentAnnualIncrease" xlink:href="itus-20161031.xsd#itus_LeaseBaseRentAnnualIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_LeaseBaseRentAnnualIncrease_lbl" xml:lang="en-US">Lease, Base Rent, Annual Increase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_LeaseBaseRentAnnualIncrease" xlink:to="itus_LeaseBaseRentAnnualIncrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Operating Leases, Rent Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xml:lang="en-US">Tax Credit Carryforward, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange" xlink:href="itus-20161031.xsd#itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange_lbl" xml:lang="en-US">Operating Loss Carryforward and Tax Credit Carryforward Expiration, Date Range</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange" xlink:to="itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Income Statement Location [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AccountingPoliciesbyPolicyPoliciesTable" xlink:href="itus-20161031.xsd#itus_AccountingPoliciesbyPolicyPoliciesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AccountingPoliciesbyPolicyPoliciesTable_lbl" xml:lang="en-US">Accounting Policies, by Policy (Policies) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesTable" xlink:to="itus_AccountingPoliciesbyPolicyPoliciesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:href="itus-20161031.xsd#itus_AccountingPoliciesbyPolicyPoliciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AccountingPoliciesbyPolicyPoliciesLineItems_lbl" xml:lang="en-US">Accounting Policies, by Policy (Policies) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="itus_AccountingPoliciesbyPolicyPoliciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US">Plan Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYTablesTable" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYTablesTable_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYTablesTable" xlink:to="itus_SHAREHOLDERSEQUITYTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYTablesLineItems" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYTablesLineItems_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Tables) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYTablesLineItems" xlink:to="itus_SHAREHOLDERSEQUITYTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xml:lang="en-US">Cash and Cash Equivalents [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain_lbl" xml:lang="en-US">Marketable Securities and Investments Held at Cost [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain" xlink:to="us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:href="itus-20161031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:href="itus-20161031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) - Information regarding the 2003 and 2010 Share Plan [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) - Information regarding the 2003 and 2010 Share Plan [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeMember_lbl" xml:lang="en-US">Range [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) - Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) - Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_BUSINESSANDFUNDINGDetailsTable" xlink:href="itus-20161031.xsd#itus_BUSINESSANDFUNDINGDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_BUSINESSANDFUNDINGDetailsTable_lbl" xml:lang="en-US">BUSINESS AND FUNDING (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_BUSINESSANDFUNDINGDetailsTable" xlink:to="itus_BUSINESSANDFUNDINGDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:href="itus-20161031.xsd#itus_BUSINESSANDFUNDINGDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_BUSINESSANDFUNDINGDetailsLineItems_lbl" xml:lang="en-US">BUSINESS AND FUNDING (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="itus_BUSINESSANDFUNDINGDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SUBSEQUENTEVENTDetailsTable" xlink:href="itus-20161031.xsd#itus_SUBSEQUENTEVENTDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SUBSEQUENTEVENTDetailsTable_lbl" xml:lang="en-US">SUBSEQUENT EVENT (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SUBSEQUENTEVENTDetailsTable" xlink:to="itus_SUBSEQUENTEVENTDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SUBSEQUENTEVENTDetailsLineItems" xlink:href="itus-20161031.xsd#itus_SUBSEQUENTEVENTDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SUBSEQUENTEVENTDetailsLineItems_lbl" xml:lang="en-US">SUBSEQUENT EVENT (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SUBSEQUENTEVENTDetailsLineItems" xlink:to="itus_SUBSEQUENTEVENTDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xml:lang="en-US">Concentration Risk Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Equity Award [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="itus-20161031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="itus-20161031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsTable_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="itus_SHAREHOLDERSEQUITYDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsLineItems_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_lbl" xml:lang="en-US">Property Subject to or Available for Operating Lease [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:href="itus-20161031.xsd#itus_COMMITMENTSANDCONTINGENCIESDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_COMMITMENTSANDCONTINGENCIESDetailsTable_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:to="itus_COMMITMENTSANDCONTINGENCIESDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:href="itus-20161031.xsd#itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US">Income Tax Authority [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_INCOMETAXESDetailsTable" xlink:href="itus-20161031.xsd#itus_INCOMETAXESDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_INCOMETAXESDetailsTable_lbl" xml:lang="en-US">INCOME TAXES (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_INCOMETAXESDetailsTable" xlink:to="itus_INCOMETAXESDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_INCOMETAXESDetailsLineItems" xlink:href="itus-20161031.xsd#itus_INCOMETAXESDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_INCOMETAXESDetailsLineItems_lbl" xml:lang="en-US">INCOME TAXES (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="itus_INCOMETAXESDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl1" xml:lang="en-US">Accretion of interest on patent acquisition obligations to interest expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:to="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants_lbl0" xml:lang="en-US">Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants" xlink:to="itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_AmortizationRelatedToCompensationCost_lbl0" xml:lang="en-US">Amount of amortization related to compensation cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AmortizationRelatedToCompensationCost" xlink:to="itus_AmortizationRelatedToCompensationCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_CommonStockAntidilutionThresholdPrice_lbl0" xml:lang="en-US">The price per share, below which certain anti-dilution protection provision will be triggered.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_CommonStockAntidilutionThresholdPrice" xlink:to="itus_CommonStockAntidilutionThresholdPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ConertiblePreferredStockObserverDesignationNoticePeriod_lbl0" xml:lang="en-US">Notice period the holder is required to deliver before it can designate an observer to observe meetings of the company&apos;s board, in &apos;PnYnMnDTnHnMnS&apos; format.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConertiblePreferredStockObserverDesignationNoticePeriod" xlink:to="itus_ConertiblePreferredStockObserverDesignationNoticePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ConsultationFeesRelatedToOptions_lbl0" xml:lang="en-US">Amount of consultation fees related to options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConsultationFeesRelatedToOptions" xlink:to="itus_ConsultationFeesRelatedToOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ConversionOfStockCashPaid_lbl0" xml:lang="en-US">Amount of cash paid in part noncash conversion of stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConversionOfStockCashPaid" xlink:to="itus_ConversionOfStockCashPaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ConvertiblePreferredStockConversionPrice_lbl0" xml:lang="en-US">The conversion price of the convertible preferred stock during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConvertiblePreferredStockConversionPrice" xlink:to="itus_ConvertiblePreferredStockConversionPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ConvertiblePreferredStockOwnershipThresholdPercentage_lbl0" xml:lang="en-US">The threshold percentage of ownership of an affiliate beneficially own thorough convertible preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConvertiblePreferredStockOwnershipThresholdPercentage" xlink:to="itus_ConvertiblePreferredStockOwnershipThresholdPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ConvertiblePreferredStockRedemptionNoticePeriod_lbl0" xml:lang="en-US">Notice period the entity is required to deliver before it can redeem Convertible Preferred Stock, in &apos;PnYnMnDTnHnMnS&apos; format.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConvertiblePreferredStockRedemptionNoticePeriod" xlink:to="itus_ConvertiblePreferredStockRedemptionNoticePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ConvertiblePreferredStockSharesConvertedStatedValue_lbl0" xml:lang="en-US">The stated value per share of convertible preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConvertiblePreferredStockSharesConvertedStatedValue" xlink:to="itus_ConvertiblePreferredStockSharesConvertedStatedValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_FederalAndStateNOLAndTaxCreditCarryforwards_lbl0" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss and tax carryforwards.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_FederalAndStateNOLAndTaxCreditCarryforwards" xlink:to="itus_FederalAndStateNOLAndTaxCreditCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_FiniteLivedPatentsNet_lbl0" xml:lang="en-US">Net carrying amount after accumulated amortization as of the balance sheet date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_FiniteLivedPatentsNet" xlink:to="itus_FiniteLivedPatentsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants_lbl0" xml:lang="en-US">The gains and losses resulting from the acquisition of common stock and cancellatio n of warrants to purchase common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants" xlink:to="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther_lbl0" xml:lang="en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to expiring net operating losses, credits and other.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" xlink:to="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl0" xml:lang="en-US">The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred for royalties and legal fees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:to="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_InterestExpensePatentAcquisitionObligations_lbl0" xml:lang="en-US">Interest expense recorded during the period for the accretion of interest on patent acquisition obligations.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_InterestExpensePatentAcquisitionObligations" xlink:to="itus_InterestExpensePatentAcquisitionObligations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_LeaseBaseRentAnnualIncrease_lbl0" xml:lang="en-US">The percentage annual increase of base rent of lease.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_LeaseBaseRentAnnualIncrease" xlink:to="itus_LeaseBaseRentAnnualIncrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_LitigationAndLicensingExpenses_lbl0" xml:lang="en-US">Litigation and licensing expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_LitigationAndLicensingExpenses" xlink:to="itus_LitigationAndLicensingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange_lbl0" xml:lang="en-US">Expiration date range of operating loss carryforward and tax credit carryforward.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange" xlink:to="itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_PatentAcquisitionObligation_lbl0" xml:lang="en-US">Obligation related to patent acquisition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAcquisitionObligation" xlink:to="itus_PatentAcquisitionObligation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod_lbl0" xml:lang="en-US">The extension period of the payment due date of patent acquisition obligation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod" xlink:to="itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_PatentAcquisitionObligationsDiscountedPresentValue_lbl0" xml:lang="en-US">Discounted present value of patent acquisition obligations.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAcquisitionObligationsDiscountedPresentValue" xlink:to="itus_PatentAcquisitionObligationsDiscountedPresentValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl2" xml:lang="en-US">The cash outflow from the purchase of royalty interests in patent rights is the amount of cash the patent user pays the owner of the patent.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant_lbl0" xml:lang="en-US">The cash outflow to reacquire common stock and cancellation of warrant during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant" xlink:to="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_RevenueFromPatentAssertionActivities_lbl0" xml:lang="en-US">Amount of revenue recognized from patent assertion activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RevenueFromPatentAssertionActivities" xlink:to="itus_RevenueFromPatentAssertionActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_RoyaltiesAndContingentLegalFeesPayable_lbl0" xml:lang="en-US">Royalties and contingent legal fees payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RoyaltiesAndContingentLegalFeesPayable" xlink:to="itus_RoyaltiesAndContingentLegalFeesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription_lbl0" xml:lang="en-US">The description of vesting period related to the share based compensation arrangement by share based payment award.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl1" xml:lang="en-US">Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding and exercisable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl1" xml:lang="en-US">Number of options outstanding and exercisable, including both vested and non-vested options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Weighted average price per share at which the shares are outstanding and exercisable under the stock option plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl0" xml:lang="en-US">The number of shares reserved for issuance or issued but not exercised pertaining to the outstanding and exercisable stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl0" xml:lang="en-US">The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding and exercisable stock options which are in the customized range of exercise prices.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl0" xml:lang="en-US">Weighted average remaining contractual term of outstanding and exercisable stock options, in &apos;PnYnMnDTnHnMnS&apos; format, for example, &apos;P1Y5M13D&apos; represents the reported fact of one year, five months, and thirteen days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_StockIssuedDuringPeriodSharesPatentLicense_lbl0" xml:lang="en-US">Common stock issued to acquire patent license.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodSharesPatentLicense" xlink:to="itus_StockIssuedDuringPeriodSharesPatentLicense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_StockIssuedDuringPeriodValuePatentLicense_lbl0" xml:lang="en-US">Common stock issued to acquire patent license.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodValuePatentLicense" xlink:to="itus_StockIssuedDuringPeriodValuePatentLicense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_A2003SharePlanMember_lbl0" xml:lang="en-US">A2003 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_A2003SharePlanMember" xlink:to="itus_A2003SharePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_A2010SharePlanMember_lbl0" xml:lang="en-US">A2010 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_A2010SharePlanMember" xlink:to="itus_A2010SharePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AUOMember_lbl0" xml:lang="en-US">AUO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AUOMember" xlink:to="itus_AUOMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AUOSettlementMember_lbl0" xml:lang="en-US">AUO Settlement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AUOSettlementMember" xlink:to="itus_AUOSettlementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AgreementMember_lbl0" xml:lang="en-US">Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AgreementMember" xlink:to="itus_AgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AwardsOfOptionsWith10YearTermsMember_lbl0" xml:lang="en-US">Awards Of Options With 10 Year Terms [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AwardsOfOptionsWith10YearTermsMember" xlink:to="itus_AwardsOfOptionsWith10YearTermsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_CaliforniaStateMember_lbl0" xml:lang="en-US">California State [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_CaliforniaStateMember" xlink:to="itus_CaliforniaStateMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ConsultantMember_lbl0" xml:lang="en-US">Consultant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConsultantMember" xlink:to="itus_ConsultantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_FederalCorporateTaxableMember_lbl0" xml:lang="en-US">Federal Corporate Taxable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_FederalCorporateTaxableMember" xlink:to="itus_FederalCorporateTaxableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_GlobalDepositoryReceiptsMember_lbl0" xml:lang="en-US">Global Depository Receipts [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_GlobalDepositoryReceiptsMember" xlink:to="itus_GlobalDepositoryReceiptsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_Licensees1Member_lbl0" xml:lang="en-US">Licensees 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_Licensees1Member" xlink:to="itus_Licensees1Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_Licensees2Member_lbl0" xml:lang="en-US">Licensees 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_Licensees2Member" xlink:to="itus_Licensees2Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_Licensees3Member_lbl0" xml:lang="en-US">Licensees 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_Licensees3Member" xlink:to="itus_Licensees3Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_NationalSecuritiesCorporationMember_lbl0" xml:lang="en-US">National Securities Corporation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_NationalSecuritiesCorporationMember" xlink:to="itus_NationalSecuritiesCorporationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_NewYorkStateMember_lbl0" xml:lang="en-US">New York State [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_NewYorkStateMember" xlink:to="itus_NewYorkStateMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_OfficeSpaceInLosAngelesCaliforniaMember_lbl0" xml:lang="en-US">Office Space In Los Angeles California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_OfficeSpaceInLosAngelesCaliforniaMember" xlink:to="itus_OfficeSpaceInLosAngelesCaliforniaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_PatentAssignmentAgreementMember_lbl0" xml:lang="en-US">Patent Assignment Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAssignmentAgreementMember" xlink:to="itus_PatentAssignmentAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_PennsylvaniaStateMember_lbl0" xml:lang="en-US">Pennsylvania State [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PennsylvaniaStateMember" xlink:to="itus_PennsylvaniaStateMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RangeOfExercisePrices1475To1725Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 1475 To 1725 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices1475To1725Member" xlink:to="itus_RangeOfExercisePrices1475To1725Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RangeOfExercisePrices179To775Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 179 To 775 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices179To775Member" xlink:to="itus_RangeOfExercisePrices179To775Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RangeOfExercisePrices2050To2300Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 2050 To 2300 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices2050To2300Member" xlink:to="itus_RangeOfExercisePrices2050To2300Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RangeOfExercisePrices258To556Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 258 To 556 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices258To556Member" xlink:to="itus_RangeOfExercisePrices258To556Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RangeOfExercisePrices258To925Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 258 To 925 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices258To925Member" xlink:to="itus_RangeOfExercisePrices258To925Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RangeOfExercisePrices2925Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 2925 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices2925Member" xlink:to="itus_RangeOfExercisePrices2925Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RePricedOptionsMember_lbl0" xml:lang="en-US">Re Priced Options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RePricedOptionsMember" xlink:to="itus_RePricedOptionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SecuredDebentureDueJune12017Member_lbl0" xml:lang="en-US">Secured Debenture Due June 12017 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SecuredDebentureDueJune12017Member" xlink:to="itus_SecuredDebentureDueJune12017Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_SecuredDebentureDueNovember112017Member" xlink:href="itus-20161031.xsd#itus_SecuredDebentureDueNovember112017Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SecuredDebentureDueNovember112017Member_lbl" xml:lang="en-US">Secured Debenture Due November 112017 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SecuredDebentureDueNovember112017Member" xlink:to="itus_SecuredDebentureDueNovember112017Member_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockAwardGrantedConsultantsMember_lbl0" xml:lang="en-US">Stock Award Granted Consultants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockAwardGrantedConsultantsMember" xlink:to="itus_StockAwardGrantedConsultantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockOptionsGrantedToEmployeesAndDirectorsMember_lbl0" xml:lang="en-US">Stock Options Granted To Employees And Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockOptionsGrantedToEmployeesAndDirectorsMember" xlink:to="itus_StockOptionsGrantedToEmployeesAndDirectorsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_lbl0" xml:lang="en-US">Stock Options Not Granted Under 2003 Share Plan Or 2010 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:to="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_WarrantsWithExercisePrice1000Member_lbl0" xml:lang="en-US">Warrants With Exercise Price 1000 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantsWithExercisePrice1000Member" xlink:to="itus_WarrantsWithExercisePrice1000Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_WarrantsWithExercisePrice13875Member_lbl0" xml:lang="en-US">Warrants With Exercise Price 13875 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantsWithExercisePrice13875Member" xlink:to="itus_WarrantsWithExercisePrice13875Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_WarrantsWithExercisePrice6925Member_lbl0" xml:lang="en-US">Warrants With Exercise Price 6925 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantsWithExercisePrice6925Member" xlink:to="itus_WarrantsWithExercisePrice6925Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_WarrantsWithExercisePrice775Member_lbl0" xml:lang="en-US">Warrants With Exercise Price 775 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantsWithExercisePrice775Member" xlink:to="itus_WarrantsWithExercisePrice775Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_WarrantsWithExercisePrice925Member_lbl0" xml:lang="en-US">Warrants With Exercise Price 925 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantsWithExercisePrice925Member" xlink:to="itus_WarrantsWithExercisePrice925Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_DocumentAndEntityInformationAbstract" xlink:href="itus-20161031.xsd#itus_DocumentAndEntityInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_DocumentAndEntityInformationAbstract" xlink:to="itus_DocumentAndEntityInformationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants_lbl1" xml:lang="en-US">GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants" xlink:to="itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl1" xml:lang="en-US">IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:to="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl2" xml:lang="en-US">AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:to="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockIssuedDuringPeriodSharesPatentLicense_lbl1" xml:lang="en-US">StockIssuedDuringPeriodSharesPatentLicense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodSharesPatentLicense" xlink:to="itus_StockIssuedDuringPeriodSharesPatentLicense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant_lbl1" xml:lang="en-US">PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant" xlink:to="itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl2" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl2" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl0" xml:lang="en-US">Interest Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl0" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl0" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl0" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl0" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_lbl0" xml:lang="en-US">Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl0" xml:lang="en-US">Stock or Unit Option Plan Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNet_lbl0" xml:lang="en-US">Revenue, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl0" xml:lang="en-US">Notes Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl1" xml:lang="en-US">Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl1"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>itus-20161031_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Jan 25 23:38:52 EST 2017 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedBalanceSheet" roleURI="http://www.copytele.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.copytele.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedIncomeStatement" roleURI="http://www.copytele.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.copytele.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ShareholdersEquityType2or3" roleURI="http://www.copytele.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://www.copytele.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedCashFlow" roleURI="http://www.copytele.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ConsolidatedCashFlow_Parentheticals" roleURI="http://www.copytele.com/role/ConsolidatedCashFlow_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_BUSINESSANDFUNDING" roleURI="http://www.copytele.com/role/BUSINESSANDFUNDING"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SUBSEQUENTEVENT" roleURI="http://www.copytele.com/role/SUBSEQUENTEVENT"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ACCOUNTSPAYABLEANDACCRUEDEXPENSES" roleURI="http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SHAREHOLDERSEQUITY" roleURI="http://www.copytele.com/role/SHAREHOLDERSEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_COMMITMENTSANDCONTINGENCIES" roleURI="http://www.copytele.com/role/COMMITMENTSANDCONTINGENCIES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_INCOMETAXES" roleURI="http://www.copytele.com/role/INCOMETAXES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_AccountingPoliciesByPolicy" roleURI="http://www.copytele.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" roleURI="http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SHAREHOLDERSEQUITYTables" roleURI="http://www.copytele.com/role/SHAREHOLDERSEQUITYTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_INCOMETAXESTables" roleURI="http://www.copytele.com/role/INCOMETAXESTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" roleURI="http://www.copytele.com/role/HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SummaryofthechangesinthefairvalueoftheCompanysLevel3financialliabilitiesonrecurringbasisTable" roleURI="http://www.copytele.com/role/SummaryofthechangesinthefairvalueoftheCompanysLevel3financialliabilitiesonrecurringbasisTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable" roleURI="http://www.copytele.com/role/WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_AccountspayableandaccruedliabilitiesTable" roleURI="http://www.copytele.com/role/AccountspayableandaccruedliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_Informationregardingthe2003and2010SharePlanTable" roleURI="http://www.copytele.com/role/Informationregardingthe2003and2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_Stockoptionsoutstandingandexercisableunder2003shareplanTable" roleURI="http://www.copytele.com/role/Stockoptionsoutstandingandexercisableunder2003shareplanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_Stockoptionsoutstandingunder2010SharePlanTable" roleURI="http://www.copytele.com/role/Stockoptionsoutstandingunder2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_Informationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable" roleURI="http://www.copytele.com/role/Informationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_Stockoptionsgrantednotunder2003SharePlanand2010SharePlanTable" roleURI="http://www.copytele.com/role/Stockoptionsgrantednotunder2003SharePlanand2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_IncometaxprovisionbenefitTable" roleURI="http://www.copytele.com/role/IncometaxprovisionbenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable" roleURI="http://www.copytele.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_ReconciliationofincometaxesattheFederalstatutorytaxrateTable" roleURI="http://www.copytele.com/role/ReconciliationofincometaxesattheFederalstatutorytaxrateTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_BUSINESSANDFUNDINGDetails" roleURI="http://www.copytele.com/role/BUSINESSANDFUNDINGDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SUBSEQUENTEVENTDetails" roleURI="http://www.copytele.com/role/SUBSEQUENTEVENTDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_SHAREHOLDERSEQUITYDetails" roleURI="http://www.copytele.com/role/SHAREHOLDERSEQUITYDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.copytele.com/role/COMMITMENTSANDCONTINGENCIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#itus_r_INCOMETAXESDetails" roleURI="http://www.copytele.com/role/INCOMETAXESDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20161031.xsd#DocumentAndEntityInformation" roleURI="http://www.copytele.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_PreferredStockMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="FiniteLivedPatentsNet" xlink:href="itus-20161031.xsd#itus_FiniteLivedPatentsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="FiniteLivedPatentsNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RoyaltiesAndContingentLegalFeesPayable" xlink:href="itus-20161031.xsd#itus_RoyaltiesAndContingentLegalFeesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="RoyaltiesAndContingentLegalFeesPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="PatentAcquisitionObligation" xlink:href="itus-20161031.xsd#itus_PatentAcquisitionObligation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="PatentAcquisitionObligation" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Liabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingencies" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_PreferredStockMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RevenueFromPatentAssertionActivities" xlink:href="itus-20161031.xsd#itus_RevenueFromPatentAssertionActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="RevenueFromPatentAssertionActivities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromRelatedParties" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromRelatedParties" xlink:to="us-gaap_SalesRevenueNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_RoyaltyExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="LitigationAndLicensingExpenses" xlink:href="itus-20161031.xsd#itus_LitigationAndLicensingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="LitigationAndLicensingExpenses" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_CostsAndExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_InterestExpense" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="4.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValuePatentLicense" xlink:href="itus-20161031.xsd#itus_StockIssuedDuringPeriodValuePatentLicense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodValuePatentLicense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesPatentLicense" xlink:href="itus-20161031.xsd#itus_StockIssuedDuringPeriodSharesPatentLicense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesPatentLicense" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants" xlink:href="itus-20161031.xsd#itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued_0" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="4.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockSharesAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:href="itus-20161031.xsd#itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants" xlink:href="itus-20161031.xsd#itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInOperatingAssetsAndLiabilitiesAbstract" xlink:href="itus-20161031.xsd#itus_ChangeInOperatingAssetsAndLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ChangeInOperatingAssetsAndLiabilitiesAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:href="itus-20161031.xsd#itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeInOperatingAssetsAndLiabilitiesAbstract" xlink:to="IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20161031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentToAcquireRoyaltyInterestInPatentRights" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant" xlink:href="itus-20161031.xsd#itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ConsolidatedCashFlow_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockSharesAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/BUSINESSANDFUNDING">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SUBSEQUENTEVENT">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SHAREHOLDERSEQUITY">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/COMMITMENTSANDCONTINGENCIES">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/INCOMETAXES">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="AccountingPoliciesbyPolicyPoliciesTable" xlink:href="itus-20161031.xsd#itus_AccountingPoliciesbyPolicyPoliciesTable"/>
    <loc xlink:type="locator" xlink:label="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:href="itus-20161031.xsd#itus_AccountingPoliciesbyPolicyPoliciesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="AccountingPoliciesbyPolicyPoliciesTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PatentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_PatentsMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesTable" xlink:to="AccountingPoliciesbyPolicyPoliciesLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_UseOfEstimates" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SHAREHOLDERSEQUITYTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYTablesTable" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYTablesTable"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYTablesLineItems" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="SHAREHOLDERSEQUITYTablesTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYTablesTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A2003SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2003SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2003SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="A2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2010SharePlanMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYTablesTable" xlink:to="SHAREHOLDERSEQUITYTablesLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/INCOMETAXESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable">
    <loc xlink:type="locator" xlink:label="HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:href="itus-20161031.xsd#itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract"/>
    <loc xlink:type="locator" xlink:label="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:href="itus-20161031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable"/>
    <loc xlink:type="locator" xlink:label="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:href="itus-20161031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:to="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_MoneyMarketFundsMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CertificatesOfDepositMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestmentsByCategoryAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnInvestmentsByCategoryAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="us-gaap_GainLossOnInvestmentsByCategoryAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GainLossOnInvestmentsByCategoryAxis" xlink:to="us-gaap_GainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostCategoriesOfInvestmentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="GlobalDepositoryReceiptsMember" xlink:href="itus-20161031.xsd#itus_GlobalDepositoryReceiptsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GainLossOnInvestmentsByCategoryAxis" xlink:to="GlobalDepositoryReceiptsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SummaryofthechangesinthefairvalueoftheCompanysLevel3financialliabilitiesonrecurringbasisTable">
    <loc xlink:type="locator" xlink:label="SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract" xlink:href="itus-20161031.xsd#itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:href="itus-20161031.xsd#itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract" xlink:to="AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20161031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract" xlink:to="PaymentToAcquireRoyaltyInterestInPatentRights" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable">
    <loc xlink:type="locator" xlink:label="WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:href="itus-20161031.xsd#itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ValuationAssumptionsAbstract" xlink:href="itus-20161031.xsd#itus_ValuationAssumptionsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:to="ValuationAssumptionsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAssumptionsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/AccountspayableandaccruedliabilitiesTable">
    <loc xlink:type="locator" xlink:label="AccountsPayableAndAccruedLiabilitiesAbstract" xlink:href="itus-20161031.xsd#itus_AccountsPayableAndAccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_NotesPayableCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/Informationregardingthe2003and2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="InformationRegardingThe2003And2010SharePlanAbstract" xlink:href="itus-20161031.xsd#itus_InformationRegardingThe2003And2010SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2003And2010SharePlanAbstract" xlink:to="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A2003SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2003SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2003SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="A2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2010SharePlanMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanTable" xlink:to="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFVDB3Xzjr8GYI25Uk9Vy6/qcRrEsuAZfUt5UQC5nlxkGiq5YLv5a+F+/7ledHhFpceslIpB8H2YAcKJFlbjmJJqGSqwhlfgWnh4//mUBfEtsjMP4KvhGoC6UUhvdS/TiTmVZyIgmtjh1] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/Stockoptionsoutstandingandexercisableunder2003shareplanTable">
    <loc xlink:type="locator" xlink:label="StockOptionsOutstandingAndExercisableUnder2003SharePlanAbstract" xlink:href="itus-20161031.xsd#itus_StockOptionsOutstandingAndExercisableUnder2003SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionsOutstandingAndExercisableUnder2003SharePlanAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices179To775Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices179To775Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices179To775Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices1475To1725Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices1475To1725Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices1475To1725Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices2050To2300Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices2050To2300Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices2050To2300Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices2925Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices2925Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices2925Member" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/Stockoptionsoutstandingunder2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="StockOptionsOutstandingUnder2010SharePlanAbstract" xlink:href="itus-20161031.xsd#itus_StockOptionsOutstandingUnder2010SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionsOutstandingUnder2010SharePlanAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_RangeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices258To925Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices258To925Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="RangeOfExercisePrices258To925Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2010SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/Informationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="InformationRegardingStockOptionsThatWereNotGrantedUnderThe2003SharePlanOrThe2010SharePlanAbstract" xlink:href="itus-20161031.xsd#itus_InformationRegardingStockOptionsThatWereNotGrantedUnderThe2003SharePlanOrThe2010SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingStockOptionsThatWereNotGrantedUnderThe2003SharePlanOrThe2010SharePlanAbstract" xlink:to="SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable" xlink:to="SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/Stockoptionsgrantednotunder2003SharePlanand2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="StockOptionsGrantedNotUnder2003SharePlanAnd2010SharePlanAbstract" xlink:href="itus-20161031.xsd#itus_StockOptionsGrantedNotUnder2003SharePlanAnd2010SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionsGrantedNotUnder2003SharePlanAnd2010SharePlanAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices258To556Member" xlink:href="itus-20161031.xsd#itus_RangeOfExercisePrices258To556Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices258To556Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="itus-20161031.xsd#itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/IncometaxprovisionbenefitTable">
    <loc xlink:type="locator" xlink:label="IncomeTaxProvisionBenefitAbstract" xlink:href="itus-20161031.xsd#itus_IncomeTaxProvisionBenefitAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable">
    <loc xlink:type="locator" xlink:label="TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:href="itus-20161031.xsd#itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract"/>
    <loc xlink:type="locator" xlink:label="LongTermDeferredTaxAssetsAbstract" xlink:href="itus-20161031.xsd#itus_LongTermDeferredTaxAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:to="LongTermDeferredTaxAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="FederalAndStateNOLAndTaxCreditCarryforwards" xlink:href="itus-20161031.xsd#itus_FederalAndStateNOLAndTaxCreditCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongTermDeferredTaxAssetsAbstract" xlink:to="FederalAndStateNOLAndTaxCreditCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongTermDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongTermDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongTermDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/ReconciliationofincometaxesattheFederalstatutorytaxrateTable">
    <loc xlink:type="locator" xlink:label="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:href="itus-20161031.xsd#itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" xlink:href="itus-20161031.xsd#itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/BUSINESSANDFUNDINGDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="BUSINESSANDFUNDINGDetailsTable" xlink:href="itus-20161031.xsd#itus_BUSINESSANDFUNDINGDetailsTable"/>
    <loc xlink:type="locator" xlink:label="BUSINESSANDFUNDINGDetailsLineItems" xlink:href="itus-20161031.xsd#itus_BUSINESSANDFUNDINGDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="BUSINESSANDFUNDINGDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AUOSettlementMember" xlink:href="itus-20161031.xsd#itus_AUOSettlementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="AUOSettlementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PatentAssignmentAgreementMember" xlink:href="itus-20161031.xsd#itus_PatentAssignmentAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="PatentAssignmentAgreementMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgreementMember" xlink:href="itus-20161031.xsd#itus_AgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="AgreementMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AUOMember" xlink:href="itus-20161031.xsd#itus_AUOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="AUOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NationalSecuritiesCorporationMember" xlink:href="itus-20161031.xsd#itus_NationalSecuritiesCorporationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="NationalSecuritiesCorporationMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsTable" xlink:to="BUSINESSANDFUNDINGDetailsLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromLegalSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_ProceedsFromLegalSettlements" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LegalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_LegalFees" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20161031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="PaymentToAcquireRoyaltyInterestInPatentRights" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_CashPeriodIncreaseDecrease" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SUBSEQUENTEVENTDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SUBSEQUENTEVENTDetailsTable" xlink:href="itus-20161031.xsd#itus_SUBSEQUENTEVENTDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SUBSEQUENTEVENTDetailsLineItems" xlink:href="itus-20161031.xsd#itus_SUBSEQUENTEVENTDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SUBSEQUENTEVENTDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SecuredDebentureDueJune12017Member" xlink:href="itus-20161031.xsd#itus_SecuredDebentureDueJune12017Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="SecuredDebentureDueJune12017Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTDetailsTable" xlink:to="SUBSEQUENTEVENTDetailsLineItems" order="5.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTDetailsLineItems" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConversionOfStockCashPaid" xlink:href="itus-20161031.xsd#itus_ConversionOfStockCashPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTDetailsLineItems" xlink:to="ConversionOfStockCashPaid" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTDetailsLineItems" xlink:to="us-gaap_ConversionOfStockAmountIssued1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConversionOfStockDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTDetailsLineItems" xlink:to="us-gaap_ConversionOfStockDescription" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="itus-20161031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="itus-20161031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RangeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PatentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_PatentsMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_SalesRevenueNetMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="5.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="6.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="StockOptionsGrantedToEmployeesAndDirectorsMember" xlink:href="itus-20161031.xsd#itus_StockOptionsGrantedToEmployeesAndDirectorsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="StockOptionsGrantedToEmployeesAndDirectorsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockAwardGrantedConsultantsMember" xlink:href="itus-20161031.xsd#itus_StockAwardGrantedConsultantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="StockAwardGrantedConsultantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="7.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AwardsOfOptionsWith10YearTermsMember" xlink:href="itus-20161031.xsd#itus_AwardsOfOptionsWith10YearTermsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="AwardsOfOptionsWith10YearTermsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="8.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="Licensees1Member" xlink:href="itus-20161031.xsd#itus_Licensees1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="Licensees1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Licensees2Member" xlink:href="itus-20161031.xsd#itus_Licensees2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="Licensees2Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Licensees3Member" xlink:href="itus-20161031.xsd#itus_Licensees3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="Licensees3Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" order="9.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaturityOfTimeDeposits" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaturityOfTimeDeposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_MaturityOfTimeDeposits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CertificatesOfDepositAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_CertificatesOfDepositAtCarryingValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfAcquisitionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfAcquisitionCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AmortizationOfAcquisitionCosts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AmortizationRelatedToCompensationCost" xlink:href="itus-20161031.xsd#itus_AmortizationRelatedToCompensationCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="AmortizationRelatedToCompensationCost" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" xlink:href="itus-20161031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/SHAREHOLDERSEQUITYDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsTable" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsLineItems" xlink:href="itus-20161031.xsd#itus_SHAREHOLDERSEQUITYDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="SHAREHOLDERSEQUITYDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="WarrantsWithExercisePrice925Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice925Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantsWithExercisePrice925Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsWithExercisePrice13875Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice13875Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantsWithExercisePrice13875Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsWithExercisePrice775Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice775Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantsWithExercisePrice775Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsWithExercisePrice6925Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice6925Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantsWithExercisePrice6925Member" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsWithExercisePrice1000Member" xlink:href="itus-20161031.xsd#itus_WarrantsWithExercisePrice1000Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantsWithExercisePrice1000Member" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_RangeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2010SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="A2003SharePlanMember" xlink:href="itus-20161031.xsd#itus_A2003SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2003SharePlanMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20161031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_PreferredStockMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="5.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="RePricedOptionsMember" xlink:href="itus-20161031.xsd#itus_RePricedOptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="RePricedOptionsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="6.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConsultantMember" xlink:href="itus-20161031.xsd#itus_ConsultantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="ConsultantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BoardOfDirectorsChairmanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BoardOfDirectorsChairmanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_BoardOfDirectorsChairmanMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="7.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="8.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_CommonStockMember_0" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="SHAREHOLDERSEQUITYDetailsLineItems" order="9.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConsultationFeesRelatedToOptions" xlink:href="itus-20161031.xsd#itus_ConsultationFeesRelatedToOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="ConsultationFeesRelatedToOptions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockRedemptionNoticePeriod" xlink:href="itus-20161031.xsd#itus_ConvertiblePreferredStockRedemptionNoticePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="ConvertiblePreferredStockRedemptionNoticePeriod" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockRedemptionPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockRedemptionPricePerShare" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionDate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockRedemptionDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockRedemptionDate" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockSharesConvertedStatedValue" xlink:href="itus-20161031.xsd#itus_ConvertiblePreferredStockSharesConvertedStatedValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="ConvertiblePreferredStockSharesConvertedStatedValue" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockConversionPrice" xlink:href="itus-20161031.xsd#itus_ConvertiblePreferredStockConversionPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="ConvertiblePreferredStockConversionPrice" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockOwnershipThresholdPercentage" xlink:href="itus-20161031.xsd#itus_ConvertiblePreferredStockOwnershipThresholdPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="ConvertiblePreferredStockOwnershipThresholdPercentage" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CommonStockAntidilutionThresholdPrice" xlink:href="itus-20161031.xsd#itus_CommonStockAntidilutionThresholdPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="CommonStockAntidilutionThresholdPrice" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConertiblePreferredStockObserverDesignationNoticePeriod" xlink:href="itus-20161031.xsd#itus_ConertiblePreferredStockObserverDesignationNoticePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="ConertiblePreferredStockObserverDesignationNoticePeriod" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/COMMITMENTSANDCONTINGENCIESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:href="itus-20161031.xsd#itus_COMMITMENTSANDCONTINGENCIESDetailsTable"/>
    <loc xlink:type="locator" xlink:label="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:href="itus-20161031.xsd#itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="COMMITMENTSANDCONTINGENCIESDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OfficeSpaceInLosAngelesCaliforniaMember" xlink:href="itus-20161031.xsd#itus_OfficeSpaceInLosAngelesCaliforniaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="OfficeSpaceInLosAngelesCaliforniaMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:to="COMMITMENTSANDCONTINGENCIESDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="PatentAcquisitionObligationsDiscountedPresentValue" xlink:href="itus-20161031.xsd#itus_PatentAcquisitionObligationsDiscountedPresentValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="PatentAcquisitionObligationsDiscountedPresentValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="InterestExpensePatentAcquisitionObligations" xlink:href="itus-20161031.xsd#itus_InterestExpensePatentAcquisitionObligations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="InterestExpensePatentAcquisitionObligations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PatentAcquisitionObligationPaymentDueDateExtensionPeriod" xlink:href="itus-20161031.xsd#itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="PatentAcquisitionObligationPaymentDueDateExtensionPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AreaOfLand" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AreaOfLand"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_AreaOfLand" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="LeaseBaseRentAnnualIncrease" xlink:href="itus-20161031.xsd#itus_LeaseBaseRentAnnualIncrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="LeaseBaseRentAnnualIncrease" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/INCOMETAXESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="INCOMETAXESDetailsTable" xlink:href="itus-20161031.xsd#itus_INCOMETAXESDetailsTable"/>
    <loc xlink:type="locator" xlink:label="INCOMETAXESDetailsLineItems" xlink:href="itus-20161031.xsd#itus_INCOMETAXESDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="INCOMETAXESDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FederalCorporateTaxableMember" xlink:href="itus-20161031.xsd#itus_FederalCorporateTaxableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="FederalCorporateTaxableMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NewYorkStateMember" xlink:href="itus-20161031.xsd#itus_NewYorkStateMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="NewYorkStateMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CaliforniaStateMember" xlink:href="itus-20161031.xsd#itus_CaliforniaStateMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="CaliforniaStateMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PennsylvaniaStateMember" xlink:href="itus-20161031.xsd#itus_PennsylvaniaStateMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="PennsylvaniaStateMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsTable" xlink:to="INCOMETAXESDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange" xlink:href="itus-20161031.xsd#itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsLineItems" xlink:to="OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.copytele.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="itus-20161031.xsd#itus_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_TradingSymbol" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType" order="3.0"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="4.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityPublicFloat" order="6.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag" order="7.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentDescription" order="8.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey" order="9.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityVoluntaryFilers" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFilerCategory" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate" order="14.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="15.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="16.0"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6802367584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Nov. 30, 2016</div></th>
<th class="th"><div>Apr. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ITUS CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--10-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,752,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,608,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000715446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 31,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808303168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,488,323<span></span>
</td>
<td class="nump">$ 4,369,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short&#8211;term investments in certificates of deposit</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">162,069<span></span>
</td>
<td class="nump">126,528<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,400,392<span></span>
</td>
<td class="nump">6,895,747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_FiniteLivedPatentsNet', window );">Patents, net of accumulated amortization of $965,040 and $639,744, respectively</a></td>
<td class="nump">2,071,071<span></span>
</td>
<td class="nump">2,396,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation of $46,950 and $13,617, respectively</a></td>
<td class="nump">156,644<span></span>
</td>
<td class="nump">43,456<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">5,628,107<span></span>
</td>
<td class="nump">9,335,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">468,756<span></span>
</td>
<td class="nump">380,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_RoyaltiesAndContingentLegalFeesPayable', window );">Royalties and contingent legal fees payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213,017<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">468,756<span></span>
</td>
<td class="nump">593,782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PatentAcquisitionObligation', window );">Patent acquisition obligation (Note 6)</a></td>
<td class="nump">4,171,876<span></span>
</td>
<td class="nump">3,688,187<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">4,640,632<span></span>
</td>
<td class="nump">4,281,969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Notes 6 and 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding Series A convertible preferred stock, par value $100 per share; 140 shares authorized, issued and outstanding</a></td>
<td class="nump">14,000<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $.01 per share; 24,000,000 shares authorized; 8,752,387 and 8,724,878 shares issued and outstanding, respectively</a></td>
<td class="nump">87,524<span></span>
</td>
<td class="nump">87,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">152,051,144<span></span>
</td>
<td class="nump">151,101,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(151,165,193)<span></span>
</td>
<td class="num">(146,148,765)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">987,475<span></span>
</td>
<td class="nump">5,053,601<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">5,628,107<span></span>
</td>
<td class="nump">9,335,570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding Series A convertible preferred stock, par value $100 per share; 140 shares authorized, issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding Series A convertible preferred stock, par value $100 per share; 140 shares authorized, issued and outstanding</a></td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_FiniteLivedPatentsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net carrying amount after accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_FiniteLivedPatentsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PatentAcquisitionObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligation related to patent acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PatentAcquisitionObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_RoyaltiesAndContingentLegalFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalties and contingent legal fees payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_RoyaltiesAndContingentLegalFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808950224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Patents, accumulated amortization (in Dollars)</a></td>
<td class="nump">$ 965,040<span></span>
</td>
<td class="nump">$ 639,744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation (in Dollars)</a></td>
<td class="nump">$ 46,950<span></span>
</td>
<td class="nump">$ 13,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">19,860<span></span>
</td>
<td class="nump">19,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in Dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">24,000,000<span></span>
</td>
<td class="nump">24,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">8,752,387<span></span>
</td>
<td class="nump">8,724,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">8,752,387<span></span>
</td>
<td class="nump">8,724,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value (in Dollars per share)</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value (in Dollars per share)</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member] | Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6787552928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_RevenueFromPatentAssertionActivities', window );">Revenue from licensing activities</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 255,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Settlement with AU Optronics Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Total revenue</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">9,255,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Inventor royalties and contingent legal fees</a></td>
<td class="nump">111,192<span></span>
</td>
<td class="nump">147,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_LitigationAndLicensingExpenses', window );">Litigation and licensing expenses</a></td>
<td class="nump">106,224<span></span>
</td>
<td class="nump">3,500,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of patents</a></td>
<td class="nump">325,296<span></span>
</td>
<td class="nump">325,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses (including non-cash stock option compensation expenses of $259,930 and $306,584, respectively)</a></td>
<td class="nump">1,556,459<span></span>
</td>
<td class="nump">711,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Marketing, general and administrative expenses (including non-cash stock option compensation expense of $613,631 and $2,369,806, respectively)</a></td>
<td class="nump">2,709,841<span></span>
</td>
<td class="nump">5,514,555<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">4,809,012<span></span>
</td>
<td class="nump">10,199,759<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(4,509,012)<span></span>
</td>
<td class="num">(944,759)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense (Note 6)</a></td>
<td class="num">(519,946)<span></span>
</td>
<td class="num">(451,906)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">12,530<span></span>
</td>
<td class="nump">17,622<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="num">(5,016,428)<span></span>
</td>
<td class="num">(1,379,043)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (5,016,428)<span></span>
</td>
<td class="num">$ (1,379,043)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted (in Dollars per share)</a></td>
<td class="num">$ (0.57)<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted (in Shares)</a></td>
<td class="nump">8,739,453<span></span>
</td>
<td class="nump">8,760,126<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_LitigationAndLicensingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation and licensing expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_LitigationAndLicensingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_RevenueFromPatentAssertionActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from patent assertion activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_RevenueFromPatentAssertionActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Related Parties<br> -URI http://asc.fasb.org/extlink&amp;oid=16382449<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488393&amp;loc=d3e606610-122999<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6637463248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash Stock Option Compensation Expenses</a></td>
<td class="nump">$ 259,930<span></span>
</td>
<td class="nump">$ 306,584<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and Marketing Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash Stock Option Compensation Expenses</a></td>
<td class="nump">$ 613,631<span></span>
</td>
<td class="nump">$ 2,369,806<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6806440864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Series A Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Oct. 31, 2014</a></td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="nump">$ 87,882<span></span>
</td>
<td class="nump">$ 148,677,413<span></span>
</td>
<td class="num">$ (144,769,722)<span></span>
</td>
<td class="nump">$ 4,009,573<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Oct. 31, 2014</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">8,788,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock option compensation to employees and consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,676,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,676,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">44,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued upon exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common stock issued to consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116<span></span>
</td>
<td class="nump">45,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued to consultants (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants', window );">Repurchase 92,232 shares of common stock and cancellation of warrants to purchase 16,000 shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(343,973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(343,973)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Retire common stock repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (922)<span></span>
</td>
<td class="nump">922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Retire common stock repurchased (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(92,232)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,379,043)<span></span>
</td>
<td class="num">(1,379,043)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Oct. 31, 2015</a></td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="nump">$ 87,249<span></span>
</td>
<td class="nump">151,101,117<span></span>
</td>
<td class="num">(146,148,765)<span></span>
</td>
<td class="nump">5,053,601<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Oct. 31, 2015</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">8,724,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock option compensation to employees and consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">873,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">873,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
<td class="nump">33,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued upon exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common stock issued to consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
<td class="nump">31,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued to consultants (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_StockIssuedDuringPeriodValuePatentLicense', window );">Common stock issued to acquire patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">11,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_StockIssuedDuringPeriodSharesPatentLicense', window );">Common stock issued to acquire patents (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,016,428)<span></span>
</td>
<td class="num">(5,016,428)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Oct. 31, 2016</a></td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="nump">$ 87,524<span></span>
</td>
<td class="nump">$ 152,051,144<span></span>
</td>
<td class="num">$ (151,165,193)<span></span>
</td>
<td class="nump">$ 987,475<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Oct. 31, 2016</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">8,752,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_AdjustmentToAdditionalPaidInCapitalTrasuryStockValueAcquiredAndCancellationOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_StockIssuedDuringPeriodSharesPatentLicense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued to acquire patent license.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_StockIssuedDuringPeriodSharesPatentLicense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_StockIssuedDuringPeriodValuePatentLicense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued to acquire patent license.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_StockIssuedDuringPeriodValuePatentLicense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of recognized equity-based compensation related to stock options during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6603952448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (Parentheticals)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2015 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="nump">92,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="nump">16,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808938096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (5,016,428)<span></span>
</td>
<td class="num">$ (1,379,043)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option compensation to employees and consultants</a></td>
<td class="nump">873,561<span></span>
</td>
<td class="nump">2,676,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Common stock issued to consultants</a></td>
<td class="nump">31,360<span></span>
</td>
<td class="nump">46,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of patents</a></td>
<td class="nump">325,296<span></span>
</td>
<td class="nump">325,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense', window );">Accretion of interest on patent acquisition obligations to interest expense</a></td>
<td class="nump">519,946<span></span>
</td>
<td class="nump">451,906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants', window );">Loss on acquisition of common stock and warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Common stock issued to acquire patent license</a></td>
<td class="nump">11,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of property and equipment</a></td>
<td class="nump">33,333<span></span>
</td>
<td class="nump">12,515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ChangeInOperatingAssetsAndLiabilitiesAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(35,541)<span></span>
</td>
<td class="num">(65,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">87,991<span></span>
</td>
<td class="num">(868,661)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable', window );">Royalties and contingent legal fees payable</a></td>
<td class="num">(213,017)<span></span>
</td>
<td class="num">(347,059)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="num">(3,381,699)<span></span>
</td>
<td class="nump">1,363,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Disbursements to acquire short-term investments in certificates of deposit</a></td>
<td class="num">(1,900,000)<span></span>
</td>
<td class="num">(2,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from maturities of short-term investments in certificates of deposit</a></td>
<td class="nump">3,550,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(146,521)<span></span>
</td>
<td class="num">(54,776)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">1,503,479<span></span>
</td>
<td class="nump">45,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of employee stock options</a></td>
<td class="nump">33,581<span></span>
</td>
<td class="nump">44,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PaymentToAcquireRoyaltyInterestInPatentRights', window );">Royalty payment applied to patent acquisition obligation</a></td>
<td class="num">(36,257)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant', window );">Payments to acquire 92,232 shares of common stock and cancellation of warrants to purchase 16,000 shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(445,253)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(2,676)<span></span>
</td>
<td class="num">(400,618)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(1,880,896)<span></span>
</td>
<td class="nump">1,007,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">4,369,219<span></span>
</td>
<td class="nump">3,361,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">$ 2,488,323<span></span>
</td>
<td class="nump">$ 4,369,219<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accretion of interest on patent acquisition obligations to interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ChangeInOperatingAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ChangeInOperatingAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains and losses resulting from the acquisition of common stock and cancellatio n of warrants to purchase common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_GainLossOnSaleOnAcquisitionOfCommonStockAndCancellationOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred for royalties and legal fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PaymentToAcquireRoyaltyInterestInPatentRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the purchase of royalty interests in patent rights is the amount of cash the patent user pays the owner of the patent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PaymentToAcquireRoyaltyInterestInPatentRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock and cancellation of warrant during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PaymentsForRepurchaseOfCommonStockAndCancellationOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6603118416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2015 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of Common Stock Acquired</a></td>
<td class="nump">92,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number Of Warrants Cancelled</a></td>
<td class="nump">16,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6771575360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS AND FUNDING<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 11pt;"><font style="text-decoration: underline;"><font style="font-size: 11pt; color: black;">1.&#160; BUSINESS&#160;AND&#160;FUNDING</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Description of Business</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">As used herein, &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; the &#x201c;Company&#x201d; or &#x201c;ITUS&#x201d; means ITUS Corporation and its wholly-owned subsidiaries. &#160;From inception through October 2012, our primary operations involved the development of patented technologies in the areas of thin-film displays and encryption. &#160;Beginning in October of 2012 under the leadership of a new management team, we recapitalized the Company, unencumbered the Company&#x2019;s assets, changed the Company&#x2019;s name and ticker symbol, relocated the Company&#x2019;s headquarters, and modernized its systems. &#160;In July of 2015, the Company&#x2019;s stock was accepted for listing and began trading on the NASDAQ Capital Market.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">In June of 2015, the Company announced the formation of a new subsidiary, Anixa Diagnostics Corporation (&#x201c;Anixa&#x201d;), to develop a platform for non-invasive blood tests for the early detection of cancer. &#160;That platform is called Cchek<font style="font-size: 11pt;"><sup>TM</sup></font></font><font style="font-size: 11pt; color: black;">. &#160;In July of 2015, ITUS announced a collaborative research agreement with The Wistar Institute (&#x201c;Wistar&#x201d;), the nation&#x2019;s first independent biomedical research institute and a leading National Cancer Institute designated cancer research center, for the purpose of validating our cancer detection methodologies and establishing protocols for identifying certain biomarkers in the blood which we identified and which are known to be associated with malignancies. &#160;In August of 2016 ITUS announced the renewal and expansion of our relationship with Wistar. &#160;In October of 2015, ITUS and Wistar announced favorable results from initial testing of a small group of Breast Cancer patients and healthy controls. &#160;One hundred percent (100%) of the blood samples tested from patients with varying stages of Breast Cancer showed the presence of the biomarkers we identified, and none of the healthy patient blood samples contained the biomarkers. Breast Cancer is the second most common cancer in the United States and throughout the world.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">In April of 2016, ITUS announced that we had demonstrated the efficacy of our Cchek<sup>TM </sup></font><font style="font-size: 11pt; color: black;">early cancer detection platform with Lung Cancer. &#160;Lung cancer is the leading cause of death among cancers in the U.S. and throughout the world, accounting for approximately 27 percent of all cancer related deaths in the U.S. and 19 percent worldwide. In September of 2016, ITUS announced that we had demonstrated the efficacy of our Cchek<sup>TM </sup></font><font style="font-size: 11pt; color: black;">early cancer detection platform with Colon Cancer. Colon Cancer is the third most common cancer in men and the second most common cancer in woman worldwide, with approximately 1.4 million new cases diagnosed each year, and approximately 700,000 deaths. At the end of September 2016 through the end of October 2016, the Company made similar announcements with respect to the efficacy of our Cchek<sup>TM</sup> </font><font style="font-size: 11pt; color: black;">early cancer detection platform for Melanoma, Ovarian Cancer, Liver Cancer, Thyroid Cancer, and Pancreatic Cancer. On November 15, 2016, ITUS announced that we had demonstrated the efficacy of our Cchek<sup>TM</sup> </font><font style="font-size: 11pt; color: black;">early cancer detection platform with six additional cancer types including Appendiceal Cancer (cancer of the appendix), Uterine Cancer, Osteosarcoma (cancer of the bone), Leiomyosarcoma (cancer of the soft tissue), Liposarcoma (cancer of the connective tissue), and Vulvar Cancer (cancer of the vulva), bringing the number of cancer types for which the efficacy of Cchek<sup>TM</sup> </font><font style="font-size: 11pt; color: black;">has been validated thus far to fourteen.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Over the next several quarters, we expect Cchek&#x2122; to be the primary focus of the Company. &#160;As part of our legacy operations, the Company remains engaged in limited patent licensing activities in the area of encrypted audio/video conference calling. &#160;We do not expect these activities to be a significant part of the Company&#x2019;s ongoing operations.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">During years ended October 31, 2016 and 2015, our revenue has been derived from technology licensing and the sale of patented technologies, including in connection with the settlement of litigation. &#160;In addition to Anixa, the Company may make investments in and form new companies to develop additional emerging technologies.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline"><font style="COLOR:black">AUO Lawsuit and Settlement</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; BACKGROUND:white; COLOR:black">On December 29, 2014, the Company and AUO Optronics Corporation (&#x201c;AUO&#x201d;) entered into a Settlement Agreement (the &#x201c;Settlement Agreement&#x201d;) and a Patent Assignment Agreement (the &#x201c;Patent Assignment Agreement&#x201d; and together with the Settlement Agreement, the &#x201c;Agreements&#x201d;) pursuant to which the Company received an aggregate of $9,000,000 from AUO. &#160;The Agreements were entered into to resolve a lawsuit filed by the Company against AUO, relating to the Company&#x2019;s patented ePaper&#xae; Electrophoretic Display, and Nano Field Emission Display (&#x201c;nFED&#x201d;) technologies. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><i><font style="FONT-SIZE:11pt; BACKGROUND:white; COLOR:black">Background</font></i></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; BACKGROUND:white; COLOR:black">In May 2011, the Company entered into an Exclusive License Agreement (the &#x201c;EPD License Agreement&#x201d;) and a License Agreement (the &#x201c;Nano Display License Agreement&#x201d;) with AUO (together the &#x201c;AUO License Agreements&#x201d;). &#160;Under the EPD License Agreement, the Company provided AUO with an exclusive, non-transferable, worldwide license to its ePaper&#xae; Electrophoretic Display (&#x201c;EPD&#x201d;) patents and technology, in connection with AUO jointly developing EPD products with the Company. &#160;Under the Nano Display License Agreement, the Company provided AUO with a non-exclusive, non-transferable, worldwide license to its Nano Field Emission Display patents and technology, in connection with AUO jointly developing nFED products with the Company. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; BACKGROUND:white; COLOR:black">On January 28, 2013, the Company terminated the AUO License Agreements due to numerous alleged material and continual breaches of the agreements by AUO. &#160;On January 28, 2013, the Company also filed a lawsuit in the United States District Court for the Northern District of California against AUO and E Ink Corporation in connection with the AUO License Agreements, alleging breach of contract, breach of the implied covenant of good faith and fair dealing, fraudulent inducement, unjust enrichment, unfair business practices, and other charges (the &#x201c;AUO/E Ink Lawsuit&#x201d;). &#160;In June 2013, the Company and AUO agreed to arbitrate the charges (the case against E Ink Corporation had been dismissed without prejudice) (the &#x201c;AUO/E Ink Arbitration&#x201d;).</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><i><font style="FONT-SIZE:11pt; BACKGROUND:white; COLOR:black">The Agreements</font></i></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; BACKGROUND:white; COLOR:black">Pursuant to the Settlement Agreement, AUO paid the Company $2,000,000 in U.S. currency, net of any Taiwanese withholding taxes. The Settlement Agreement further provides that: </font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;"><font style="font-size: 11pt; font-family: Symbol; background: white; color: black;">&#x2022; </font><font style="font-size: 11pt; background: white; color: black;">the Company will dismiss the AUO/E Ink Lawsuit and AUO/E Ink Arbitration, with prejudice;</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;"><font style="font-size: 11pt; font-family: Symbol; background: white; color: black;">&#x2022; </font><font style="font-size: 11pt; background: white; color: black;">the AUO License Agreements are terminated; </font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;"><font style="font-size: 11pt; font-family: Symbol; background: white; color: black;">&#x2022; </font><font style="font-size: 11pt; background: white; color: black;">AUO gives up all rights to the nFED Technology;</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;"><font style="font-size: 11pt; font-family: Symbol; background: white; color: black;">&#x2022; </font><font style="font-size: 11pt; background: white; color: black;">for a period of two years, the Company agrees not to initiate (whether on its own or through a third party) any patent infringement lawsuits against AUO or its affiliates alleging infringement by AUO&#x2019;s or AUO&#x2019;s affiliates products or services, for patents owned or controlled by the Company as of the date of the Settlement Agreement. &#160;Any potential damages for patent infringement will toll uninterrupted during this two-year period. The prohibition does not apply to patents acquired by the Company after the date of the Settlement Agreement; and &#160;</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;"><font style="font-size: 11pt; font-family: Symbol; background: white; color: black;">&#x2022; </font><font style="font-size: 11pt; background: white; color: black;">each of AUO and the Company mutually released each other from all claims that either may have against the other in connection with the AUO License Agreements, including any claims relating to the ePaper&#xae; Electrophoretic Display and nFED patents and technologies.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; BACKGROUND:white; COLOR:black">&#160;Pursuant to the Patent Assignment Agreement, AUO paid the Company $7,000,000 in U.S. currency, net of any Taiwanese withholding taxes in exchange for the Company&#x2019;s ePaper&#xae; Electrophoretic Display patent portfolio for which AUO was previously the exclusive licensee, consisting of: </font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;"><font style="font-size: 11pt; font-family: Symbol; background: white; color: black;">&#x2022; </font><font style="font-size: 11pt; background: white; color: black;">10 active U.S. patents and 1 U.S. pending patent application; and</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt 1.5pt; text-indent: 0.5in;"><font style="font-size: 11pt; font-family: Symbol; background: white; color: black;">&#x2022; </font><font style="font-size: 11pt; background: white; color: black;">103 expired and/or abandoned U.S. and foreign patents and/or patent applications. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; BACKGROUND:white; COLOR:black">In connection with the lawsuit and settlement, the Company incurred a total of approximately $3,604,000 of legal fees and litigation costs.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Funding </font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In October 2015, the &#x201c;Company entered into an At Market Issuance Sales Agreement (the &#x201c;Agreement&#x201d;) with National Securities Corporation (&#x201c;National&#x201d;) to create an at-the-market equity program under which it may sell up to $10,000,000 worth of its common stock (the &#x201c;Shares&#x201d;) from time to time through National, as sales agent. The Company has no obligation to sell any of the Shares, and may at any time suspend offers under the Agreement or terminate the Agreement. The Shares will be issued pursuant to the Company&#x2019;s previously filed registration statement that was declared effective by the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on September 18, 2015. As of October 31, 2016, no Shares have been sold under the Agreement.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; BACKGROUND:white; COLOR:black">During the year ended October 31, 2016, cash used in operating activities was approximately $3,382,000.&#160; Cash provided by investing activities was approximately $1,503,000, which resulted from the proceeds on maturity&#160;of certificates of deposit totaling $3,550,000 which was offset by the purchase of certificates of deposit totaling $1,900,000 and the purchase of property and equipment of approximately $147,000.&#160; Our cash used in financing activities was approximately $3,000, which resulted from a royalty payment of approximately $36,000 applied to the patent acquisition obligation liability, offset by the proceeds from exercise of stock options of approximately $34,000. &#160;As a result, our cash, cash equivalents, and short-term investments at October 31, 2016 decreased approximately $3,531,000 to approximately $3,238,000 from approximately $6,769,000 at the end of fiscal year 2015.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; background: white; color: black;">Based on currently available information as of December 7, 2016, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows from operations will not be sufficient to fund our activities and debt obligations (Note 2) for the next 12 months. To date, we have relied primarily upon cash from the public and private sale of equity and debt securities, as well as net proceeds from the December 2014 AUO settlement, to generate the working capital needed to finance our operations. If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, we will be required to obtain more working capital. We may seek to obtain working capital through sales of our equity securities or through bank credit facilities or public or private debt from various financial institutions where possible and as permitted pursuant to our existing indebtedness. We cannot be certain that additional funding will be available on acceptable terms, or at all. If we do identify sources for additional funding, the sale of additional equity securities or convertible debt could result in dilution to our stockholders. Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities. We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all. If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition. Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; background: white; color: black;">The accompanying financial statements have been prepared assuming that we will continue as a going concern. In order for us to have sufficient capital to execute our business plan, fund our operations and meet our debt obligations over the next 12 months, we will need to raise additional capital. Although we have been successful in the past in raising capital, we cannot provide any assurance that we will be successful in doing so in the future to the extent necessary to be able to fund our operating activities and debt obligations over the next 12 months, which raises substantial doubt about our ability to continue as a going concern. Our financial statements do not include any adjustments that might result from the outcome of this uncertainty.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6798554752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 11pt;"><font style="text-decoration: underline;"><font style="font-size: 11pt; color: black;">2.&#160; SUBSEQUENT EVENT</font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">On November 11, 2016, the holder of all our outstanding Series A Preferred Stock (the &#x201c;Series A Preferred&#x201d;) with an aggregate stated value of $3,500,000 exercised its right of redemption to receive such amount from proceeds from the sale of the Company&#x2019;s equity securities. On December 6, 2016, we entered into an agreement with the holder of the Series A Preferred setting forth the terms under which such redemption would take place (the &#x201c;Series A Redemption Terms&#x201d;). Pursuant to the Series A Redemption Terms, at closing the holder of the Series A Preferred will receive (i) $500,000 in cash, (ii) a 12% secured debenture evidencing the remaining $3,000,000 amount to be redeemed, $1,000,000 of which is due on or before June 1, 2017 and the remainder of which is due November 11, 2017 (the &#x201c;Redemption Debenture&#x201d;), and (iii) a 5 year warrant to purchase 500,000 shares of the Company&#x2019;s common stock at an exercise price equal to 10% below the thirty (30) day volume weighted average closing price of our common stock at closing. The Redemption Debenture is secured by a lien on the Company&#x2019;s assets and prohibits the Company from incurring any senior indebtedness other than equipment financing in connection with the Company&#x2019;s business.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6798573280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 11pt;"><font style="text-decoration: underline;"><font style="font-size: 11pt; color: black;">3.&#160; SUMMARY&#160;OF&#160;SIGNIFICANT&#160;ACCOUNTING&#160;POLICIES</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Basis of Presentation</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The consolidated financial statements include the accounts of ITUS Corporation and its wholly owned subsidiaries. &#160;All intercompany transactions have been eliminated.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:11pt; COLOR:black">&#160;<font style="text-decoration:underline">Revenue Recognition</font> </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Patent Licensing</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In certain instances, our past revenue arrangements have provided for the payment of contractually determined fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&#160;&#160;These arrangements typically include some combination of the following:&#160;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&#160;&#160;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&#160;&#160;Pursuant to the terms of these agreements, we had no further obligations. &#160;&#160;As such, the earnings process was complete and revenue has been recognized upon the execution of the agreement, when collectability was reasonably assured, and when all other revenue recognition criteria were met.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Inventor Royalties and Contingent Legal Fees</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Inventor royalties and contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Research and Development Expenses</font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 11pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">Research and development expenses, consisting primarily of salaries and other direct costs associated with developing a platform for non-invasive blood tests for early detection of cancer, are expensed in the consolidated financial statements in the year incurred.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Fair Value Measurements</font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">Accounting Standards Codification (&#x201c;ASC&#x201d;) 820 &#x201c;Fair Value Measurements and Disclosures&#x201d; (&#x201c;ASC 820&#x201d;) defines fair value, establishes a framework for measuring fair value under GAAP, and expands disclosures about fair value measurements. &#160;In accordance with ASC 820, we have categorized our financial assets and liabilities, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. &#160;If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:11pt; COLOR:black">Level 1 - Financial instruments whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market which we have the ability to access at the measurement date.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:11pt; COLOR:black">Level 2 - Financial instruments whose values are based on quoted market prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:11pt; COLOR:black">Level 3 &#x2013; Financial instruments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. &#160;These inputs reflect management&#x2019;s own assumptions about the assumptions a market participant would use in pricing the instrument. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2016:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">&#160;&#160;</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Money market funds &#x2013; Cash&#160; and cash equivalents</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,899,136 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,899,136 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Certificates of deposit - Short term investments</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">750,000 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">750,000 </font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 46%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Total financial assets</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,899,136 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">750,000 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,649,136 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2015:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160; </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160; </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160; </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Money market funds &#x2013; Cash and cash equivalents</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">467,967 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">467,967 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Certificates of deposit - Short term investments</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,400,000 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,400,000 </font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 46%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Total financial assets</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">467,967 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,400,000 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,867,967 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2016:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Patent acquisition obligation</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">4,171,876 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">4,171,876 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2015:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Patent acquisition obligation</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,688,187 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,688,187 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following table sets forth a summary of the changes in the fair value of the Company&#x2019;s Level 3 financial liabilities that are measured at fair value on a recurring basis:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="text-decoration:underline"><font style="font-size: 11pt; color: black;">Patent acquisition obligation:</font></font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap; width: 12%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Balance October 31, 2014</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,236,281 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Accretion of interest on patent obligation</font></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">451,906 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Balance October 31, 2015</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,688,187 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Accretion of interest on patent obligation</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">519,946 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Royalty payment applied to patent acquisition obligation</font></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(36,257)</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Balance October 31, 2016</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">4,171,876 </font></p>
</td>
</tr>
</table><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">Our non-financial assets that are measured on a non-recurring basis include our patents and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists. &#160;The estimated fair value of prepaid expenses, accounts payable and accrued expenses approximates their individual carrying amounts due to the short term nature of these measurements.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Cash and Cash Equivalents</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:40.5pt"><font style="FONT-SIZE:11pt; COLOR:black">Cash equivalents consists of highly liquid, short term investments with original maturities of three months or less when purchased.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Short-term Investments</font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">At October 31, 2016 and 2015, we had certificates of deposit with maturities greater than 90 days and less than 12 months when acquired of $750,000 and $2,400,000, respectively, that were classified as short-term investments and reported at fair value. &#160;&#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Patents</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Our only identifiable intangible assets are patents and patent rights. &#160;We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life. &#160;No patent acquisition costs were capitalized during the years ended October 31, 2016 and 2015. &#160;We recorded patent amortization expense of approximately $325,000 and $325,000 during the years ended October 31, 2016 and 2015, respectively.<a name="_DV_M82"></a></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="COLOR:black">Impairment</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="COLOR:black">Long-lived assets, including intangible assets that are amortized, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates potential impairment by comparing the carrying amount of the assets with the estimated undiscounted future cash flows associated with them. Should the analysis indicate that an asset is not recoverable, the carrying value of the asset would be reduced to fair value and a corresponding charge would be recognized.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="COLOR:black">Intangible assets that are not amortized are reviewed for impairment at least annually. The Company evaluates potential impairment by comparing the carrying amount of the asset with its estimated fair value. Should the carrying amount exceed the estimated fair value, a corresponding charge would be recognized for the difference.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Income Taxes</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We recognize deferred tax assets and liabilities for the estimated future tax effects of events that have been recognized in our financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. &#160;A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Stock-Based Compensation</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We maintain stock equity incentive plans under which we may grant non-qualified stock options, incentive stock options, stock appreciation rights, stock awards, performance and performance-based awards, or stock units to employees, non-employee directors and consultants.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Stock Option Compensation Expense </font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We account for stock options granted to employees and directors using the accounting guidance in ASC 718 &#x201c;Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;). &#160;In accordance with ASC 718, we estimate the fair value of service based options and performance based options on the date of grant, using the Black-Scholes pricing model. &#160;For options vesting if the trading price of the Company&#x2019;s common stock achieves a defined target, we use a Monte Carlo simulation in estimating the fair value at grant date. We recognize compensation expense for stock option awards over the requisite or implied service period of the grant. &#160;With respect to performance based awards, compensation expense is recognized when the performance target is deemed probable. &#160;We recorded stock-based compensation expense, related to stock options granted to employees and directors, of approximately $874,000 and $2,192,000, during the years ended October 31, 2016 and 2015, respectively. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Included in stock-based compensation cost for employees and directors during the years ended October 31, 2016 and 2015 was approximately $393,000 and $2,093,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but not yet vested. &#160;As of October 31, 2016, there was unrecognized compensation cost related to non-vested stock options granted to employees and directors, related to service based options of approximately $1,139,000 which will be recognized over a weighted-average period of 2.3 years. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We account for stock options granted to consultants using the accounting guidance included in ASC 505-50 &#x201c;Equity-Based Payments to Non-Employees&#x201d; (&#x201c;ASC 505-50&#x201d;). &#160;In accordance with ASC 505-50, we estimate the fair value of service based stock options and performance based options at each reporting period, using the Black-Scholes pricing model. &#160;For options vesting if the trading price of the Company&#x2019;s common stock achieves a defined target we estimate the fair value at each reporting period using a Monte Carlo simulation. &#160;We recognize compensation expense for service based stock options and options subject to market conditions over the requisite or implied service period of the grant. &#160;For performance based awards, compensation expense is recognized when the performance target is achieved.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We recorded consulting expense, related to stock options granted to consultants, during the years ended October 31, 2016 and 2015 of approximately $-0- and $484,000, respectively. &#160;Stock-based consulting expense for the years ended October 31, 2016 and 2015 includes approximately $-0- and $484,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but vested in the current period. As of October 31, 2016, there was no unrecognized consulting expense related to non-vested stock options granted to consultants. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Fair Value Determination &#160;</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We use the Black-Scholes pricing model in estimating the fair value of stock options which vest over a specific period of time or upon achieving performance targets. &#160;To determine the weighted average fair value of stock options on the date of grant, employees and directors are included in a single group. &#160;The fair value of stock options granted to consultants is determined on an individual basis. &#160;The stock options we granted during the year ended October 31, 2015 consisted of awards with 10-year terms that vest over one year, options with 10-year terms that vest over 36 months. The stock options we granted during the year ended October 31, 2014 consisted of awards with 10-year terms that vest over one year and options with 10-year terms that vest over 36 months, options with 5-year terms which vest immediately and options with 10-year terms which vest upon achievement of performance milestones. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following weighted average assumptions were used in estimating the fair value of stock options granted during the years ended October 31, 2016 and 2015:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="5" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">For the Year </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="font-size: 11pt; color: black;">Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2016</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2015</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Weighted average fair value at grant date</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2.84 </font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">3.09 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Valuation assumptions:</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Expected life (years) </font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">5.70</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">5.75</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Expected volatility</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">181.1%</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">117.8%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Risk-free interest rate</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">1.26%</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2.01%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Expected dividend yield</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0%</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0%</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding. &#160;We use the simplified method to determine expected term. &#160;The simplified method was adopted since we do not believe that historical experience is representative of future performance because of the impact of the changes in our operations and the change in terms from historical options which vested immediately to terms including vesting periods of up to three years. &#160;Under the Black-Scholes pricing model, we estimated the expected volatility of our shares of common stock based upon the historical volatility of our share price over a period of time equal to the expected term of the options. &#160;We estimated the risk-free interest rate based on the implied yield available on the applicable grant date of a U.S. Treasury note with a term equal to the expected term of the underlying grants. &#160;We made the dividend yield assumption based on our history of not paying dividends and our expectation not to pay dividends in the future. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Under ASC 718, the amount of stock-based compensation expense recognized is based on the portion of the awards that are ultimately expected to vest. &#160;Accordingly, if deemed necessary, we reduce the fair value of the stock option awards for expected forfeitures, which are forfeitures of the unvested portion of surrendered options. &#160;Based on our historical experience and future expectations, we have not reduced the amount of stock-based compensation expenses for anticipated forfeitures.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We will reconsider use of the Black-Scholes pricing model if additional information becomes available in the future that indicates another model would be more appropriate. &#160;If factors change and we employ different assumptions in the application of ASC 718 in future periods, the compensation expense that we record under ASC 718 may differ significantly from what we have recorded in the current period.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Net&#160;Loss&#160;Per&#160;Share of Common Stock </font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In accordance with ASC 260, &#x201c;Earnings Per Share&#x201d;, basic net loss per common share (&#x201c;Basic EPS&#x201d;) is computed by dividing net loss by the weighted average number of common shares outstanding. &#160;Diluted net loss per common share (&#x201c;Diluted EPS&#x201d;) is computed by dividing net loss by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding. &#160;Diluted EPS for all years presented is the same as Basic EPS, as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive. &#160;For this reason, excluded from the calculation of Diluted EPS for the years ended October 31, 2016 and 2015, were options to purchase 3,086,472 and 2,672,471 shares, respectively, warrants to purchase 707,379 shares and 1,028,931 shares, respectively, preferred stock convertible into 739,958 shares.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Use of Estimates </font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. &#160;Estimates and assumptions are used for, but not limited to, determining stock-based compensation, asset impairment evaluations, tax assets and liabilities, license fee revenue, the allowance for doubtful accounts, depreciation lives and other contingencies. &#160;Actual results could differ from those estimates.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Effect of Recently Issued Pronouncements</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2014-09 (&#x201c;ASU 2014-09&#x201d;), Revenue from Contracts with Customers. &#160;This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &#160;This standard update is effective for&#160;interim and annual&#160;reporting periods beginning after December 15,&#160;2016, and are to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. &#160;In July 2015, a one-year deferral of the effective date of the new guidance was approved. &#160;We are currently evaluating the impact ASU 2014-09 will have on our consolidated financial statements&#160;and related disclosures.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In June 2014, the FASB issued Accounting Standards Update 2014-12 (&#x201c;ASU 2014-12&#x201d;), Compensation &#x2013; Stock Compensation. &#160;This amendment requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. &#160;&#160;We do not expect this update to have a significant impact on our consolidated financial statements and related disclosures.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">In August 2014, the FASB issued Accounting Standards Update 2014-15 (&#x201c;ASU 2014-15&#x201d;). &#160;This amendment requires management to assess an entity&#x2019;s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods ending after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption. We do not expect this update to have a significant impact on our consolidated financial statements and related disclosures.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">In April 2015, the FASB issued Accounting Standards Update 2015-03 (&#x201c;ASU 2015-03&#x201d;) to simplify the presentation of debt issuance costs. This amendment requires debt issuance costs be presented on the balance sheet as a direct reduction from the carrying amount of the debt liability, consistent with debt discounts or premiums. Adoption of this standard is required for interim and annual periods beginning after December 15, 2015 and is to be applied retrospectively. &#160;The adoption of this amendment on November 1, 2016 did not have an impact on our consolidated financial statements&#160;and related disclosures.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In November 2015, the FASB issued Accounting Standards Update 2015-17 (&#x201c;ASU 2015-17&#x201d;) to simplify the presentation of deferred taxes. This amendment requires that all deferred tax assets and liabilities, along with any related valuation allowances, be classified as noncurrent on the balance sheet. &#160;Adoption of this standard is required for annual periods beginning after December 15, 2016. &#160;We are currently evaluating the impact ASU 2015-17 will have on our consolidated financial statements&#160;and related disclosures.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In February 2016, the FASB issued Accounting Standards Update 2016-02 (&#x201c;ASU 2016-02&#x201d;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. &#160;The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. &#160;The requirements of this standard include a significant increase in required disclosures. &#160;We are currently evaluating the impact ASU 2016-02 will have on our consolidated financial statements&#160;and related disclosures.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In March 2016, the FASB issued Accounting Standards Update 2016-09 (&#x201c;ASU 2016-09&#x201d;) that changes the accounting for certain aspects of share-based payments to employees. &#160;The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee&#x2019;s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. &#160;The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. Early adoption is permitted. &#160;We are currently evaluating the impact ASU 2016-09 will have on our consolidated financial statements&#160;and related disclosures.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Concentration of Credit Risks</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Financial instruments that potentially subject us to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable. &#160;Cash equivalents are primarily highly rated money market funds. Short-term investments are certificates of deposit within federally insured limits. &#160;Where applicable, management reviews our accounts receivable and other receivables for potential doubtful accounts and maintains an allowance for estimated uncollectible amounts. &#160;Our policy is to write-off uncollectable amounts at the time it is determined that collection will not occur. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Two licensees accounted for 67% and 33%, respectively, of revenues from patent licensing activities during fiscal year 2016. &#160;Three licensees accounted for 53%, 37% and 10%, respectively, of revenues from patent licensing activities during fiscal year 2015. </font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6798542784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 11pt;"><font style="text-decoration: underline;"><font style="font-size: 11pt; color: black;">4.&#160; ACCOUNTS PAYABLE AND ACCRUED EXPENSES</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Accounts payable and accrued liabilities consist of the following as of:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">October 31,</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2016</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2015</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Accounts payable</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">373,224 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">374,703 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Payroll and related expenses</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">49,901 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Accrued other</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">45,631 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">6,062 </font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom"><font style="font-family: times new roman,times,serif; font-size: 12pt; display: none;">Total</font></td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">468,756 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">380,765 </font></p>
</td>
</tr>
</table><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6798606064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 11pt;"><font style="text-decoration: underline;"><font style="font-size: 11pt; color: black;">5.&#160; SHAREHOLDERS&#x2019; EQUITY</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; BACKGROUND:white; COLOR:black">Reverse Stock Split</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:40.5pt"><font style="FONT-SIZE:11pt; BACKGROUND:white; COLOR:black">On June 26, 2015, we effected a 1-for-25 reverse stock split (the &#x201c;Stock Split&#x201d;) of our issued common stock and preferred stock. &#160;Each shareholders&#x2019; percentage ownership and proportional voting power remained unchanged as a result of the Stock Split. &#160;All applicable share data, per share amounts and related information in the consolidated financial statements and notes thereto have been adjusted retroactively to give effect to the Stock Split. &#160;As a result of the Stock Split, the number of shares of our common stock and preferred stock authorized was also decreased by the same proportion as the outstanding shares.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Common Stock Issuances</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">During the years ended October 31, 2016 and 2015, we issued 10,833 shares and 11,600 shares, respectively, of common stock to consultants for services rendered, pursuant to the 2010 Share Plan. &#160;We recorded consulting expense for the years ended October 31, 2016 and 2015 of approximately $31,000 and $46,000, respectively, for shares of common stock issued to consultants. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt 4.5pt; TEXT-INDENT:-4.5pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Stock&#160;Option&#160;Plans</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">As of October 31, 2016, we have two stock option plans: the ITUS Corporation 2003 Share Incentive Plan (the &#x201c;2003 Share Plan&#x201d;) and the ITUS Corporation 2010 Share Incentive Plan (the &#x201c;2010 Share Plan&#x201d;) which were adopted by our Board of Directors on April 21, 2003 and July 14, 2010, respectively.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:11pt; COLOR:black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The 2003 Share Plan provided for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to key employees and consultants. &#160;The maximum number of shares of common stock in the 2003 Share Plan was 2,800,000 shares. The 2003 Share Plan was administered by the Stock Option Committee through June 2004, from June 2004 through July 2010, by the Board of Directors, from July 2010 through August 2012, by the Stock Option Committee, from August 2012 through November 2012, by the Executive Committee of the Board of Directors, from November 2012 to July 2015, by the Board of Directors and since July 2015 by the Compensation Committee, which determined the option price, term and provisions of each option. &#160;The exercise price with respect to all of the options granted under the 2003 Share Plan since its inception was equal to the fair market value of the underlying common stock at the grant date. &#160;In accordance with the provisions of the 2003 Share Plan, the plan terminated with respect to the grant of future options on April 21, 2013. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Information regarding the 2003 Share Plan for the two years ended October 31, 2016 is as follows:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average Exercise</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Price Per Share</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" colspan="2" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Aggregate</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Intrinsic Value</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Shares</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding at October 31, 2014</font></p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">493,991 </font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$18.00</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Exercised</font></p>
</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(4,000)</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.58</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Forfeited</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(123,791)</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$14.71</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding at October 31, 2015</font></p>
</td>
<td style="height: 15.75pt; width: 15%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">366,200 </font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$17.86</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Exercised</font></p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(11,080)</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.58</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Forfeited</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(129,520)</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$17.72</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding and Exercisable at <br />October 31, 2016</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">225,600 </font></p>
</td>
<td style="height: 16.5pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$18.69</font></p>
</td>
<td style="height: 16.5pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 16.5pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">142,470 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following table summarizes information about stock options outstanding and exercisable under the 2003 Share Plan as of October 31, 2016:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" rowspan="4" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Remaining</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Contractual Life</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">(in years)</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Price</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 25%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Range of</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Prices</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Number</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Outstanding</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$&#160; 1.79 - $&#160; 7.75</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">41,200</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">1.77</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.91 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$14.75 - $17.50</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">50,400</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">.43</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$16.98 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$20.50 - $23.00</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">94,000</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">.83</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$22.04 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$29.25 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">40,000</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">.81</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$29.25 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The 2010 Share Plan provides for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to key employees and consultants. &#160;The maximum number of shares of common stock in the 2010 Share Plan was initially 600,000 shares. On July 6, 2011, the 2010 Share Plan was amended by our Board of Directors to increase the maximum number of shares of common stock in the plan to 1,080,000 shares and on August 29, 2012, the maximum number of shares in the plan was further increased to 1,200,000 shares. &#160;On November 8, 2013, the Board of Directors approved an amendment to provide that effective November 8, 2013, the maximum aggregate number of shares available for future issuance will be 800,000 shares and that on the first business day in 2014 and on the first business day of each calendar year thereafter the maximum aggregate number of shares available for future issuance shall be replenished such that 800,000 shares will be available. Accordingly, on November 8, 2013, January 2, 2014 and January 2, 2015, the number of shares in the 2010 Share Plan was increased to 1,957,000 shares, 2,225,400 shares and 2,569,400 shares, respectively. &#160;In addition, on November 8, 2013, the 2010 Share Plan was amended to provide that on the first business day of each year commencing on January 2, 2014, each non-employee director of the Company at that time shall automatically be granted a 10-year stock option to purchase 12,000 shares of common stock (16,000 for the Chairman) that will vest in four equal quarterly installments. The 2010 Share Plan was administered by the Stock Option Committee through August 2012, from August 2012 through November 2012, by the Executive Committee of the Board of Directors, from November 2012 through July 2015, by the Board of Directors and since July 2015, by the Compensation Committee, which determines the option price, term and provisions of each option. The exercise price with respect to all of the options granted under the 2010 Share Plan was equal to the fair market value of the underlying common stock at the grant date. &#160;As of October 31, 2016, the 2010 Share Plan had 431,956 shares available for future grants. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Information regarding the 2010 Share Plan as of October 31, 2016 is as follows: </font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">&#160;Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average Exercise</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Price Per Share</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" colspan="2" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Aggregate&#160; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Intrinsic</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Value</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Shares</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding at October 31, 2014</font></p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">728,561 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$5.75 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Granted</font></p>
</td>
<td style="height: 15.75pt; width: 15%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">60,400 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.91 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Exercised</font></p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(13,334)</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.58 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">&#160;&#160;&#160; </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Forfeited</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(249,355)</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$6.24 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding at October 31, 2015</font></p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">526,272 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$3.33 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Granted</font></p>
</td>
<td style="height: 15.75pt; width: 15%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">557,000 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.92 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Exercised</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(2,400)</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$4.25 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding at October 31, 2016</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 15%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,080,872 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$3.12 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 16.5pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,569,079 </font></p>
</td>
</tr>
<tr style="height: 11.7pt;">
<td style="height: 11.7pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Exercisable at October 31, 2016</font></p>
</td>
<td style="border-top: 0px; height: 11.7pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">659,439 </font></p>
</td>
<td style="height: 11.7pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 11.7pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$3.16 </font></p>
</td>
<td style="height: 11.7pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 11.7pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 11.7pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,126,338 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following table summarizes information about stock options outstanding under the 2010 Share Plan as of October 31, 2016:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 42%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 42%;" colspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Options Outstanding</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 42%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 42%;" colspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Options Exercisable</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Remaining</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Contractual Life</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">(in years)</font></p>
</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Remaining</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Contractual Life </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">(in years)</font></p>
</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Price</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Price</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Range of</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Prices</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Number</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Outstanding</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Number</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercisable</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.58 - $9.25</font></p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">1,080,872</font></p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">7.71</font></p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$3.12 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">659,439</font></p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">6.71</font></p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$3.16 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black; display: none;">0</font></p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In addition to options granted under the 2003 Share Plan and the 2010 Share Plan, during the years ended October 31, 2012 and 2013, the Board of Directors approved the grant of stock options to purchase 1,660,000 shares and 120,000 shares, respectively. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan for the two years ended October 31, 2016 is as follows:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 60%; padding: 0in; width: 60%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap; width: 12%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average Exercise</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Price Per Share</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 11%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 11%;" colspan="2" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Aggregate</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Intrinsic</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Value</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 60%; padding: 0in; width: 60%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap; width: 12%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 60%; padding: 0in; width: 60%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Shares</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 60%; padding: 0in; width: 60%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; width: 12%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160; </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1%; padding: 0in; width: 1%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 11%; padding: 0in; white-space: nowrap; width: 11%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 60%; background: #cceeff; padding: 0in; white-space: nowrap; width: 60%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding at October 31, 2014, 2015 and 2016</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,780,000</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.70 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 1%; background: #cceeff; padding: 0in; width: 1%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 11%; background: #cceeff; padding: 0in; white-space: nowrap; width: 11%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 60%; padding: 0in; width: 60%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding and exercisable at October 31, 2016</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,780,000</font></p>
</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 12%; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.70 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 1%; padding: 0in; width: 1%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 16.5pt; width: 11%; padding: 0in; width: 11%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">6,494,275 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following table summarizes information about stock options outstanding and exercisable that were not granted under the 2003 Share Plan or the 2010 Share Plan as of October 31, 2016:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 24%; padding: 0in; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 24%; padding: 0in; white-space: nowrap; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 23%;" rowspan="4" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Remaining</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Contractual Life</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">(in years)</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 23%; padding: 0in; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 24%; padding: 0in; white-space: nowrap; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 24%; padding: 0in; white-space: nowrap; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 23%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Price</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 24%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 24%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Range of</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Prices</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 24%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 24%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Number</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Outstanding</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 24%; padding: 0in; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 24%; padding: 0in; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 23%; padding: 0in; width: 23%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 23%; padding: 0in; width: 23%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$ 2.58 - $ 5.56</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,780,000</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">5.76</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.70 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black; display: none;">0</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;" valign="bottom">&#160;</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Re-Priced Stock Options</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="COLOR:black">On January 28, 2015, the Board of Directors authorized management of the Company to re-price issued and outstanding stock options for all of the officers, directors and employees of the Company, at any time prior to February 16, 2015. &#160;On February 5, 2015, management acted to re-price 2,184,125 issued and outstanding stock options (the &#x201c;Re-Priced Options&#x201d;) pursuant to the authority granted by the Board of Directors. The new exercise price of the Re-Priced Options is $2.575, the closing sales price of the Company&#x2019;s common stock on February 5, 2015. &#160;All other terms of the previously granted Re-Priced Options remain the same. &#160;The Company recorded additional stock-based compensation of approximately $297,000, as of February 5, 2015, related to this re-pricing. &#160;This amount was determined to be the incremental value of the fair value of the Re-Priced Options compared to the fair value of the original option immediately before the re-pricing.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Preferred Stock</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In May 1986, our shareholders authorized 200,000 shares of preferred stock with a par value of $100 per share. &#160;The shares of preferred stock may be issued in series at the direction of the Board of Directors, and the relative rights, preferences and limitations of such shares will all be determined by the Board of Directors. &#160;As of October 31, 2016, 140 shares of preferred stock had been designated and issued as Series A Preferred Stock. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Series A Convertible Preferred&#160;Stock</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">On September 9, 2014, the Company designated 140 shares of the preferred stock as Series A Convertible Preferred Stock, par value $100 per share, in accordance with the Certificate of Designation of Series A Convertible Preferred Stock filed with the Secretary of State of the State of Delaware on September 9, 2014 (the &#x201c;Series A Convertible Preferred Stock&#x201d;). &#160;On September 9, 2014, 140 shares of Series A Convertible Preferred Stock with a stated value of $25,000 per share were issued in connection with the conversion of a Convertible Debenture due November 2016.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><i><font style="FONT-SIZE:11pt; COLOR:black">Ranking&#160;</font></i></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The Series A Convertible Preferred Stock ranked senior to the Company&#x2019;s common stock, to all series of any other classes of equity which may be issued and to any indebtedness, unless the Company obtained the prior written consent of the Series A Convertible Preferred Stock holder.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">&#160;<i>Redemption</i></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">At any time on or after November 11, 2016 (the &#x201c;Redemption Date&#x201d;), and upon at least 60 days prior written notice to the Company (a &#x201c;Redemption Notice&#x201d;), any holder of the Series A Convertible Preferred Stock had a one-time right to require the Company to redeem all or some of its shares of Series A Convertible Preferred Stock (a &#x201c;Redemption&#x201d;) for cash generated from a subsequent sale of the Company&#x2019;s equity securities. The redemption price being equal to the stated value ($25,000 per share) of the shares of Series A Convertible Preferred Stock being converted, (the &#x201c;Redemption Purchase Price&#x201d;). Upon receipt of a Redemption Notice, the Company shall complete a sale or sales of its equity securities for the purpose of accumulating net proceeds sufficient to pay the Redemption Purchase Price. </font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">On September 9, 2016, the holder of 140 shares of the Series A Convertible Preferred Stock delivered a Redemption Notice to the Company requesting a redemption date of November 11, 2016 (it being understood by the holder of the Series A Convertible Preferred Stock that the Company may only redeem shares of Series A Convertible Preferred Stock with the proceeds from the sale of the Company&#x2019;s equity securities). On December 6, 2016, we entered into an agreement with the holder of the Series A Preferred Stock to exchange the Series A Preferred Stock for a secured debenture, cash and warrants. See Note 2, Subsequent Event.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><i><font style="FONT-SIZE:11pt; COLOR:black">Optional Conversion</font></i></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Holders of the Series A Convertible Preferred Stock had the right at any time convert their shares of Series A Convertible Preferred Stock into such number of shares of the Company&#x2019;s common stock in such an amount equal to (a) the stated value of $25,000 per share of the shares of Series A Convertible Preferred Stock being converted, divided by the conversion price of $4.73, multiplied by (b) the number of shares of Series A Preferred Stock being converted. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The holder did not have the right to convert any portion of the Series A Convertible Preferred Stock if after giving effect to such conversion, the holder, together with any affiliate thereof, would beneficially own in excess of 4.99% of the number of shares of common stock outstanding immediately after giving effect to such conversion.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The embedded conversion option had certain anti-dilution protection provisions which would be triggered if the Company issues its common stock, or certain common stock equivalents, (as defined) at a price below $3.55 per share. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><i><font style="FONT-SIZE:11pt; COLOR:black">Board and Observer Rights</font></i></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Each holder of Series A Convertible Preferred Stock shall have the right, upon 10 days' prior written notice, to designate one representative, reasonably acceptable to the Company, who shall be entitled to attend and observe meetings of the Company&#x2019;s Board of Directors in a non-voting observer capacity (the &#x201c;Observer&#x201d;).</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><i><font style="FONT-SIZE:11pt; COLOR:black">Accounting for the Series A Convertible Preferred Stock</font></i></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The Company determined that the economic characteristics and risks of the conversion feature and the preferred stock instrument were clearly and closely related as equity instruments and accordingly, the conversion feature would not require separate accounting. &#160;&#160;In addition, the redemption feature was contingent upon Series A Convertible Preferred Stock not being converted into common stock and upon the holder delivering a redemption notice to the Company. &#160;&#160;Further, the redemption purchase price may only be paid from the proceeds of a subsequent sale of equity securities. Accordingly, the Series A Convertible Preferred Stock was accounted for as an equity instrument. Further, because the conversion rate of the Series A Convertible Preferred Stock of $4.73 per share was less than the Company&#x2019;s closing stock price on the date of this transaction, the Company determined that the Series A Convertible Preferred Stock contained a beneficial conversion feature. The beneficial conversion feature was recorded in additional paid-in-capital as a result of the Company&#x2019;s accumulated deficit</font><font style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Calibri&quot;,&quot;sans-serif&quot;; COLOR:black">. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Common Stock Purchase Warrants</font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 40.5pt;"><font style="font-size: 11pt; color: black;">As of October 31, 2016, we had warrants to purchase 10,000 shares and 10,000 shares of common stock at $9.25 and $13.875 per share, respectively, expiring on August 19, 2019, warrants to purchase 369,979 shares of common stock at $7.75 per share expiring on November 11, 2016, warrants to purchase 8,000 shares of common stock at $6.925 per share expiring on June 2, 2017 and warrants to purchase 309,400 shares of common stock at $10.00 per share expiring on July 15, 2019.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74567-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Preferred Stock<br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6798554752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 11pt;"><font style="text-decoration: underline;"><font style="font-size: 11pt; color: black;">6.&#160; COMMITMENTS AND CONTINGENCIES</font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 12pt;"><font style="text-decoration:underline">Patent Acquisition Obligations</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 12pt; ; text-indent: 0.5in;"><font style="text-decoration: none; color: black;">As of October 31, 2016, we have incurred obligations due no later than November 2017 related to the acquisition of patents, which have a discounted present value of approximately $4,172,000, and which amount will be reduced by royalties paid during the period, if any.&#160; The payment due in November 2017 is payable at the option of the Company in cash or common stock.&#160; We recorded interest expense of approximately $520,000 and $452,000, respectively, for the years ended October 31, 2016 and 2015, for the accretion of interest on patent acquisition obligations. The payment due date of November 2017 may be extended for up to two years if any patent infringement lawsuit initiated by the Company is stayed because of any re-exam or similar proceeding in the United States Patent and Trademark Office.</font></p><br/><p><font style="font-family: times new roman,times,serif; font-size: 12pt;"><font style="text-decoration:underline"><font style="color: black;">Leases</font></font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 12pt; ; text-indent: 0.5in;"><font style="color: black;">We lease approximately 3,000 square feet of office space in Los Angeles, California pursuant to a lease that expires May 31, 2019.&#160; The lease contains base rentals of approximately $11,000 per month with annual increases of approximately 3% and an escalation clause for increases in certain operating expenses.&#160; </font>As of October 31, 2016, our non-cancelable operating lease commitments for the years ending October 31, 2017, 2018 and 2019 were approximately $129,000, 134,000 and $80,000, respectively.&#160; Rent expense for the years ended October 31, 2016 and 2015, was approximately $104,000 and $100,000, respectively.&#160;</p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 12pt;"><font style="text-decoration:underline">Litigation Matters</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin-left: 0in; ; margin-right: 0in; text-indent: 0.5in;"><font style="color: black;">On December 29, 2014, we settled our lawsuit against AUO which had been filed on January 28, 2013. For a more detailed description of the settlement with AUO see Note 1, &#x201c;Business and Funding - Description of Business - AUO Lawsuit and Settlement&#x201d;.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin-left: 0in; ; margin-right: 0in; text-indent: 0.5in;"><font style="color: black;">Other than suits we bring to enforce our patent rights we are not a party to any material pending legal proceedings other than that which arise in the ordinary course of business. &#160;We believe that any liability that may ultimately result from the resolution of these matters will not, individually or in the aggregate, have a material adverse effect on our financial position or results of operations.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25287-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6796693072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 11pt;"><font style="text-decoration: underline;"><font style="font-size: 11pt; color: black;">7.&#160; INCOME TAXES</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="FONT-SIZE:11pt; COLOR:black">Income tax provision (benefit) consists of the following:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 30%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Year Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2016</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2015</font></p>
</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Federal:</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Current</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Deferred</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(1,631,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(487,000)</font></p>
</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">State:</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Current</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">- <br /></font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Deferred</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(134,000) </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(120,000)</font></p>
</td>
</tr>
<tr style="height: 15.1pt; page-break-inside: avoid;">
<td style="height: 15.1pt; width: 70%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Adjustment to valuation</font><font style="font-size: 11pt; color: black;"> allowance related to net deferred tax assets</font></p>
</td>
<td style="border-top: 0px; height: 15.1pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.1pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">1,765,000&#160; <br /></font></p>
</td>
<td style="height: 15.1pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.1pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.1pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">607,000 </font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="height: 15.75pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom"><font style="font-family: times new roman,times,serif; font-size: 12pt; display: none;"><font style="font-size: 12pt; color: black;">Income Tax Provision (Benefit)</font></font></td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The tax effects of temporary differences that give rise to significant portions of the deferred tax asset, net, at October 31, 2016 and 2015, are as follows:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2016</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2015</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Long-term deferred tax assets:</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Federal and state NOL and tax credit carryforwards</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; font-family: times new roman,times,serif; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">33,079,000 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; font-family: times new roman,times,serif; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">31,261,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Deferred compensation</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">6,232,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">6,522,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Intangibles</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">713,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">483,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Other</font></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">289,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">282,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 20pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Subtotal</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">40,313,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">38,548,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Less: valuation allowance</font></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(40,313,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(38,548,000)</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Deferred tax asset, net</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; font-family: times new roman,times,serif; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; font-family: times new roman,times,serif; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">As of October 31, 2016, we had tax net operating loss and tax credit carryforwards of approximately $79,428,000 and $1,110,000, respectively, available within statutory limits (expiring at various dates between 2020 and 2035), to offset any future regular Federal corporate taxable income and taxes payable. &#160;If the tax benefits relating to deductions of option holders&#x2019; income are ultimately realized, those benefits will be credited directly to additional paid-in capital. &#160;Certain changes in stock ownership can result in a limitation on the amount of net operating loss and tax credit carryovers that can be utilized each year. As of October 31, 2016, management has not determined the extent of any such limitations, if any.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 11pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">We had New York, California and Pennsylvania tax net operating loss carryforwards of approximately $76,847,000, $4,849,000 and $841,000, respectively, as of October 31, 2016, available within statutory limits (expiring at various dates between 2020 and 2035), to offset future corporate taxable income and taxes payable, if any, under certain computations of such taxes. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We have provided a valuation allowance against our deferred tax asset due to our current and historical pre-tax losses and the uncertainty regarding their realizability. &#160;The primary differences from the Federal statutory rate of 34% and the effective rate of 0% is attributable to certain permanent differences and a change in the valuation allowance. &#160;The following is a reconciliation of income taxes at the Federal statutory tax rate to income tax expense (benefit):</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 1%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="11" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Year Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 1%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2016</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 1%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2015</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Income tax benefit at U.S. </font></p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Federal statutory income&#160; Tax rate</font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(1,706,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(34.0)</font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(469,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(34.0)</font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">State income taxes</font></p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(411,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(8.2)</font></p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(117,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(8.5)</font></p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Permanent differences</font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0.1 </font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">1,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0.1 </font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Expiring net operating&#160; losses, credits and other</font></p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">350,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">7.0 </font></p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(22,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(1.6)</font></p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Change in valuation allowance</font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">1,765,000</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">35.1</font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">607,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">44.0 </font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Income tax provision</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 1%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0.0 </font></p>
</td>
<td style="height: 15.75pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 1%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0.0 </font></p>
</td>
<td style="height: 15.75pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">During the two fiscal years ended October 31, 2016, we incurred no Federal and no State income taxes. &#160;We have no unrecognized tax benefits as of October 31, 2016 and 2015 and we account for interest and penalties related to income tax matters in marketing, general and administrative expenses. &#160;Tax years to which our net operating losses relate remain open to examination by Federal authorities and other jurisdictions to the extent which the net operating losses have yet to be utilized.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808709360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AccountingPoliciesbyPolicyPoliciesLineItems', window );"><strong>Accounting Policies, by Policy (Policies) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Basis of Presentation</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The consolidated financial statements include the accounts of ITUS Corporation and its wholly owned subsidiaries. &#160;All intercompany transactions have been eliminated.</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:11pt; COLOR:black"><font style="text-decoration:underline">Revenue Recognition</font> </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Patent Licensing</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In certain instances, our past revenue arrangements have provided for the payment of contractually determined fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&#160;&#160;These arrangements typically include some combination of the following:&#160;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&#160;&#160;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&#160;&#160;Pursuant to the terms of these agreements, we had no further obligations. &#160;&#160;As such, the earnings process was complete and revenue has been recognized upon the execution of the agreement, when collectability was reasonably assured, and when all other revenue recognition criteria were met.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Inventor Royalties and Contingent Legal Fees</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Inventor royalties and contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expense, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Research and Development Expenses</font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 11pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">Research and development expenses, consisting primarily of salaries and other direct costs associated with developing a platform for non-invasive blood tests for early detection of cancer, are expensed in the consolidated financial statements in the year incurred.</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Fair Value Measurements</font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">Accounting Standards Codification (&#x201c;ASC&#x201d;) 820 &#x201c;Fair Value Measurements and Disclosures&#x201d; (&#x201c;ASC 820&#x201d;) defines fair value, establishes a framework for measuring fair value under GAAP, and expands disclosures about fair value measurements. &#160;In accordance with ASC 820, we have categorized our financial assets and liabilities, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. &#160;If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:11pt; COLOR:black">Level 1 - Financial instruments whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market which we have the ability to access at the measurement date.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:11pt; COLOR:black">Level 2 - Financial instruments whose values are based on quoted market prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:11pt; COLOR:black">Level 3 &#x2013; Financial instruments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. &#160;These inputs reflect management&#x2019;s own assumptions about the assumptions a market participant would use in pricing the instrument. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2016:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">&#160;&#160;</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Money market funds &#x2013; Cash&#160; and cash equivalents</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,899,136 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,899,136 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Certificates of deposit - Short term investments</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">750,000 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">750,000 </font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 46%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Total financial assets</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,899,136 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">750,000 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,649,136 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2015:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160; </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160; </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160; </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Money market funds &#x2013; Cash and cash equivalents</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">467,967 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">467,967 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Certificates of deposit - Short term investments</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,400,000 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,400,000 </font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 46%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Total financial assets</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">467,967 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,400,000 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,867,967 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2016:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Patent acquisition obligation</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">4,171,876 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">4,171,876 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2015:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Patent acquisition obligation</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,688,187 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,688,187 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following table sets forth a summary of the changes in the fair value of the Company&#x2019;s Level 3 financial liabilities that are measured at fair value on a recurring basis:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="text-decoration:underline"><font style="font-size: 11pt; color: black;">Patent acquisition obligation:</font></font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap; width: 12%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Balance October 31, 2014</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,236,281 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Accretion of interest on patent obligation</font></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">451,906 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Balance October 31, 2015</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,688,187 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Accretion of interest on patent obligation</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">519,946 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Royalty payment applied to patent acquisition obligation</font></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(36,257)</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Balance October 31, 2016</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">4,171,876 </font></p>
</td>
</tr>
</table><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">Our non-financial assets that are measured on a non-recurring basis include our patents and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists. &#160;The estimated fair value of prepaid expenses, accounts payable and accrued expenses approximates their individual carrying amounts due to the short term nature of these measurements.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Cash and Cash Equivalents</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:40.5pt"><font style="FONT-SIZE:11pt; COLOR:black">Cash equivalents consists of highly liquid, short term investments with original maturities of three months or less when purchased</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Short-term Investments</font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">At October 31, 2016 and 2015, we had certificates of deposit with maturities greater than 90 days and less than 12 months when acquired of $750,000 and $2,400,000, respectively, that were classified as short-term investments and reported at fair value.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="COLOR:black">Impairment</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="COLOR:black">Long-lived assets, including intangible assets that are amortized, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates potential impairment by comparing the carrying amount of the assets with the estimated undiscounted future cash flows associated with them. Should the analysis indicate that an asset is not recoverable, the carrying value of the asset would be reduced to fair value and a corresponding charge would be recognized.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="COLOR:black">Intangible assets that are not amortized are reviewed for impairment at least annually. The Company evaluates potential impairment by comparing the carrying amount of the asset with its estimated fair value. Should the carrying amount exceed the estimated fair value, a corresponding charge would be recognized for the difference.</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Income Taxes</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We recognize deferred tax assets and liabilities for the estimated future tax effects of events that have been recognized in our financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. &#160;A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Stock-Based Compensation</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We maintain stock equity incentive plans under which we may grant non-qualified stock options, incentive stock options, stock appreciation rights, stock awards, performance and performance-based awards, or stock units to employees, non-employee directors and consultants.</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Compensation Related Costs, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Stock Option Compensation Expense </font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We account for stock options granted to employees and directors using the accounting guidance in ASC 718 &#x201c;Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;). &#160;In accordance with ASC 718, we estimate the fair value of service based options and performance based options on the date of grant, using the Black-Scholes pricing model. &#160;For options vesting if the trading price of the Company&#x2019;s common stock achieves a defined target, we use a Monte Carlo simulation in estimating the fair value at grant date. We recognize compensation expense for stock option awards over the requisite or implied service period of the grant. &#160;With respect to performance based awards, compensation expense is recognized when the performance target is deemed probable. &#160;We recorded stock-based compensation expense, related to stock options granted to employees and directors, of approximately $874,000 and $2,192,000, during the years ended October 31, 2016 and 2015, respectively. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Included in stock-based compensation cost for employees and directors during the years ended October 31, 2016 and 2015 was approximately $393,000 and $2,093,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but not yet vested. &#160;As of October 31, 2016, there was unrecognized compensation cost related to non-vested stock options granted to employees and directors, related to service based options of approximately $1,139,000 which will be recognized over a weighted-average period of 2.3 years. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We account for stock options granted to consultants using the accounting guidance included in ASC 505-50 &#x201c;Equity-Based Payments to Non-Employees&#x201d; (&#x201c;ASC 505-50&#x201d;). &#160;In accordance with ASC 505-50, we estimate the fair value of service based stock options and performance based options at each reporting period, using the Black-Scholes pricing model. &#160;For options vesting if the trading price of the Company&#x2019;s common stock achieves a defined target we estimate the fair value at each reporting period using a Monte Carlo simulation. &#160;We recognize compensation expense for service based stock options and options subject to market conditions over the requisite or implied service period of the grant. &#160;For performance based awards, compensation expense is recognized when the performance target is achieved.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We recorded consulting expense, related to stock options granted to consultants, during the years ended October 31, 2016 and 2015 of approximately $-0- and $484,000, respectively. &#160;Stock-based consulting expense for the years ended October 31, 2016 and 2015 includes approximately $-0- and $484,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but vested in the current period. As of October 31, 2016, there was no unrecognized consulting expense related to non-vested stock options granted to consultants.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Fair Value Determination &#160;</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We use the Black-Scholes pricing model in estimating the fair value of stock options which vest over a specific period of time or upon achieving performance targets. &#160;To determine the weighted average fair value of stock options on the date of grant, employees and directors are included in a single group. &#160;The fair value of stock options granted to consultants is determined on an individual basis. &#160;The stock options we granted during the year ended October 31, 2015 consisted of awards with 10-year terms that vest over one year, options with 10-year terms that vest over 36 months. The stock options we granted during the year ended October 31, 2014 consisted of awards with 10-year terms that vest over one year and options with 10-year terms that vest over 36 months, options with 5-year terms which vest immediately and options with 10-year terms which vest upon achievement of performance milestones. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The following weighted average assumptions were used in estimating the fair value of stock options granted during the years ended October 31, 2016 and 2015:</font></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="5" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">For the Year </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="font-size: 11pt; color: black;">Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2016</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2015</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Weighted average fair value at grant date</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2.84 </font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">3.09 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Valuation assumptions:</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Expected life (years) </font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">5.70</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">5.75</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Expected volatility</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">181.1%</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">117.8%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Risk-free interest rate</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">1.26%</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2.01%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Expected dividend yield</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0%</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0%</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding. &#160;We use the simplified method to determine expected term. &#160;The simplified method was adopted since we do not believe that historical experience is representative of future performance because of the impact of the changes in our operations and the change in terms from historical options which vested immediately to terms including vesting periods of up to three years. &#160;Under the Black-Scholes pricing model, we estimated the expected volatility of our shares of common stock based upon the historical volatility of our share price over a period of time equal to the expected term of the options. &#160;We estimated the risk-free interest rate based on the implied yield available on the applicable grant date of a U.S. Treasury note with a term equal to the expected term of the underlying grants. &#160;We made the dividend yield assumption based on our history of not paying dividends and our expectation not to pay dividends in the future. &#160;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Under ASC 718, the amount of stock-based compensation expense recognized is based on the portion of the awards that are ultimately expected to vest. &#160;Accordingly, if deemed necessary, we reduce the fair value of the stock option awards for expected forfeitures, which are forfeitures of the unvested portion of surrendered options. &#160;Based on our historical experience and future expectations, we have not reduced the amount of stock-based compensation expenses for anticipated forfeitures.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">We will reconsider use of the Black-Scholes pricing model if additional information becomes available in the future that indicates another model would be more appropriate. &#160;If factors change and we employ different assumptions in the application of ASC 718 in future periods, the compensation expense that we record under ASC 718 may differ significantly from what we have recorded in the current period</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Net&#160;Loss&#160;Per&#160;Share of Common Stock </font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In accordance with ASC 260, &#x201c;Earnings Per Share&#x201d;, basic net loss per common share (&#x201c;Basic EPS&#x201d;) is computed by dividing net loss by the weighted average number of common shares outstanding. &#160;Diluted net loss per common share (&#x201c;Diluted EPS&#x201d;) is computed by dividing net loss by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding. &#160;Diluted EPS for all years presented is the same as Basic EPS, as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive. &#160;For this reason, excluded from the calculation of Diluted EPS for the years ended October 31, 2016 and 2015, were options to purchase 3,086,472 and 2,672,471 shares, respectively, warrants to purchase 707,379 shares and 1,028,931 shares, respectively, preferred stock convertible into 739,958 shares.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Use of Estimates </font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. &#160;Estimates and assumptions are used for, but not limited to, determining stock-based compensation, asset impairment evaluations, tax assets and liabilities, license fee revenue, the allowance for doubtful accounts, depreciation lives and other contingencies. &#160;Actual results could differ from those estimates</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Effect of Recently Issued Pronouncements</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2014-09 (&#x201c;ASU 2014-09&#x201d;), Revenue from Contracts with Customers. &#160;This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &#160;This standard update is effective for&#160;interim and annual&#160;reporting periods beginning after December 15,&#160;2016, and are to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. &#160;In July 2015, a one-year deferral of the effective date of the new guidance was approved. &#160;We are currently evaluating the impact ASU 2014-09 will have on our consolidated financial statements&#160;and related disclosures.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In June 2014, the FASB issued Accounting Standards Update 2014-12 (&#x201c;ASU 2014-12&#x201d;), Compensation &#x2013; Stock Compensation. &#160;This amendment requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. &#160;&#160;We do not expect this update to have a significant impact on our consolidated financial statements and related disclosures.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">In August 2014, the FASB issued Accounting Standards Update 2014-15 (&#x201c;ASU 2014-15&#x201d;). &#160;This amendment requires management to assess an entity&#x2019;s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods ending after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption. We do not expect this update to have a significant impact on our consolidated financial statements and related disclosures.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="font-size: 11pt; color: black;">In April 2015, the FASB issued Accounting Standards Update 2015-03 (&#x201c;ASU 2015-03&#x201d;) to simplify the presentation of debt issuance costs. This amendment requires debt issuance costs be presented on the balance sheet as a direct reduction from the carrying amount of the debt liability, consistent with debt discounts or premiums. Adoption of this standard is required for interim and annual periods beginning after December 15, 2015 and is to be applied retrospectively. &#160;The adoption of this amendment on November 1, 2016 did not have an impact on our consolidated financial statements&#160;and related disclosures.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In November 2015, the FASB issued Accounting Standards Update 2015-17 (&#x201c;ASU 2015-17&#x201d;) to simplify the presentation of deferred taxes. This amendment requires that all deferred tax assets and liabilities, along with any related valuation allowances, be classified as noncurrent on the balance sheet. &#160;Adoption of this standard is required for annual periods beginning after December 15, 2016. &#160;We are currently evaluating the impact ASU 2015-17 will have on our consolidated financial statements&#160;and related disclosures.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In February 2016, the FASB issued Accounting Standards Update 2016-02 (&#x201c;ASU 2016-02&#x201d;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. &#160;The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. &#160;The requirements of this standard include a significant increase in required disclosures. &#160;We are currently evaluating the impact ASU 2016-02 will have on our consolidated financial statements&#160;and related disclosures.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In March 2016, the FASB issued Accounting Standards Update 2016-09 (&#x201c;ASU 2016-09&#x201d;) that changes the accounting for certain aspects of share-based payments to employees. &#160;The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee&#x2019;s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. &#160;The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. Early adoption is permitted. &#160;We are currently evaluating the impact ASU 2016-09 will have on our consolidated financial statements&#160;and related disclosures.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration Risk, Credit Risk, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 11pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Concentration of Credit Risks</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Financial instruments that potentially subject us to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable. &#160;Cash equivalents are primarily highly rated money market funds. Short-term investments are certificates of deposit within federally insured limits. &#160;Where applicable, management reviews our accounts receivable and other receivables for potential doubtful accounts and maintains an allowance for estimated uncollectible amounts. &#160;Our policy is to write-off uncollectable amounts at the time it is determined that collection will not occur. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Two licensees accounted for 67% and 33%, respectively, of revenues from patent licensing activities during fiscal year 2016. &#160;Three licensees accounted for 53%, 37% and 10%, respectively, of revenues from patent licensing activities during fiscal year 2015.</font></p></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AccountingPoliciesbyPolicyPoliciesLineItems', window );"><strong>Accounting Policies, by Policy (Policies) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline"><font style="FONT-SIZE:11pt; COLOR:black">Patents</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">Our only identifiable intangible assets are patents and patent rights. &#160;We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life. &#160;No patent acquisition costs were capitalized during the years ended October 31, 2016 and 2015. &#160;We recorded patent amortization expense of approximately $325,000 and $325,000 during the years ended October 31, 2016 and 2015, respectively.</font></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_AccountingPoliciesbyPolicyPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_AccountingPoliciesbyPolicyPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6875567&amp;loc=d3e14489-108613<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68064133&amp;loc=d3e61082-112788<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28088331&amp;loc=SL29635902-196195<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13531-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68064133&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13279-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64802544&amp;loc=d3e202-110218<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investments in financial assets, including marketable securities (debt and equity securities with readily determinable fair values), investments accounted for under the equity method and cost method, securities borrowed and loaned, and repurchase and resale agreements. For marketable securities, the disclosure may include the entity's accounting treatment for transfers between investment categories and how the fair values for such securities are determined. Also, for all investments, an entity may describe its policy for assessing, recognizing and measuring impairment of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66011266&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2,12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.M)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877573&amp;loc=d3e87990-122713<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6872867&amp;loc=d3e40691-111596<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Research and Development<br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6782472416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text"><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">&#160;&#160;</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Money market funds &#x2013; Cash&#160; and cash equivalents</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,899,136 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,899,136 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Certificates of deposit - Short term investments</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">750,000 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">750,000 </font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 46%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Total financial assets</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,899,136 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">750,000 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,649,136 </font></p>
</td>
</tr>
</table><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160; </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160; </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160; </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Money market funds &#x2013; Cash and cash equivalents</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">467,967 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">467,967 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Certificates of deposit - Short term investments</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,400,000 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,400,000 </font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 46%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Total financial assets</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">467,967 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,400,000 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,867,967 </font></p>
</td>
</tr>
</table><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Patent acquisition obligation</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">4,171,876 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">4,171,876 </font></p>
</td>
</tr>
</table><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 10%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 10%; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap; width: 46%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Patent acquisition obligation</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,688,187 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in; white-space: nowrap; width: 10%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,688,187 </font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text"><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="text-decoration:underline"><font style="font-size: 11pt; color: black;">Patent acquisition obligation:</font></font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap; width: 12%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Balance October 31, 2014</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,236,281 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Accretion of interest on patent obligation</font></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">451,906 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Balance October 31, 2015</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,688,187 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Accretion of interest on patent obligation</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">519,946 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 86%; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Royalty payment applied to patent acquisition obligation</font></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(36,257)</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 86%; background: #cceeff; padding: 0in; white-space: nowrap; width: 86%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Balance October 31, 2016</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">4,171,876 </font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text"><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="5" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">For the Year </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="font-size: 11pt; color: black;">Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2016</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2015</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Weighted average fair value at grant date</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2.84 </font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">3.09 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Valuation assumptions:</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Expected life (years) </font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">5.70</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">5.75</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Expected volatility</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">181.1%</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">117.8%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Risk-free interest rate</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">1.26%</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2.01%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Expected dividend yield</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0%</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0%</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19279-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6630986704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</a></td>
<td class="text"><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">October 31,</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2016</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2015</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Accounts payable</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">373,224 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">374,703 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Payroll and related expenses</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">49,901 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-align: right;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Accrued other</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">45,631 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">6,062 </font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom"><font style="font-family: times new roman,times,serif; font-size: 12pt; display: none;">Total</font></td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">468,756 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">380,765 </font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6806461088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYTablesLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Tables) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</a></td>
<td class="text"><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average Exercise</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Price Per Share</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" colspan="2" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Aggregate</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Intrinsic Value</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Shares</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding at October 31, 2014</font></p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">493,991 </font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$18.00</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Exercised</font></p>
</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(4,000)</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.58</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Forfeited</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(123,791)</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$14.71</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding at October 31, 2015</font></p>
</td>
<td style="height: 15.75pt; width: 15%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">366,200 </font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$17.86</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Exercised</font></p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(11,080)</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.58</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Forfeited</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(129,520)</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$17.72</font></p>
</td>
<td style="height: 15.75pt; width: 1.62%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding and Exercisable at <br />October 31, 2016</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">225,600 </font></p>
</td>
<td style="height: 16.5pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$18.69</font></p>
</td>
<td style="height: 16.5pt; width: 1.62%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 16.5pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 16.5pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">142,470 </font></p>
</td>
</tr>
</table><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">&#160;Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average Exercise</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Price Per Share</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" colspan="2" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Aggregate&#160; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Intrinsic</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Value</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Shares</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding at October 31, 2014</font></p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">728,561 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$5.75 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Granted</font></p>
</td>
<td style="height: 15.75pt; width: 15%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">60,400 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.91 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Exercised</font></p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(13,334)</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.58 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">&#160;&#160;&#160; </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Forfeited</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(249,355)</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$6.24 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding at October 31, 2015</font></p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">526,272 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$3.33 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Granted</font></p>
</td>
<td style="height: 15.75pt; width: 15%; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">557,000 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.92 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 49%; background: #cceeff; padding: 0in 0in 0in 10pt; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Exercised</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">(2,400)</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$4.25 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 49%; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding at October 31, 2016</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 15%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,080,872 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$3.12 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 16.5pt; width: 15%; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">3,569,079 </font></p>
</td>
</tr>
<tr style="height: 11.7pt;">
<td style="height: 11.7pt; width: 49%; background: #cceeff; padding: 0in; white-space: nowrap; width: 49%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Exercisable at October 31, 2016</font></p>
</td>
<td style="border-top: 0px; height: 11.7pt; border-right: 0px; width: 15%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">659,439 </font></p>
</td>
<td style="height: 11.7pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;">&#160;</p>
</td>
<td style="height: 11.7pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$3.16 </font></p>
</td>
<td style="height: 11.7pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 11.7pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 11.7pt; width: 15%; background: #cceeff; padding: 0in; white-space: nowrap; width: 15%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">2,126,338 </font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2003SharePlanMember', window );">2003 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYTablesLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Tables) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]</a></td>
<td class="text"><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" rowspan="4" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Remaining</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Contractual Life</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">(in years)</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Price</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 25%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Range of</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Prices</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Number</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Outstanding</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$&#160; 1.79 - $&#160; 7.75</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">41,200</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">1.77</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.91 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$14.75 - $17.50</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">50,400</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">.43</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$16.98 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$20.50 - $23.00</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">94,000</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">.83</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 23%; background: #cceeff; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$22.04 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 25%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 25%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$29.25 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">40,000</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">.81</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 23%; padding: 0in 5.4pt 0in 5.4pt; white-space: nowrap; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$29.25 </font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember', window );">2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYTablesLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Tables) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]</a></td>
<td class="text"><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 42%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 42%;" colspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Options Outstanding</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 42%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 42%;" colspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Options Exercisable</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Remaining</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Contractual Life</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">(in years)</font></p>
</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Remaining</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Contractual Life </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">(in years)</font></p>
</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Price</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Price</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Range of</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Prices</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Number</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Outstanding</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 14%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Number</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercisable</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.58 - $9.25</font></p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">1,080,872</font></p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">7.71</font></p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$3.12 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">659,439</font></p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">6.71</font></p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$3.16 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black; display: none;">0</font></p>
</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 14%; background: #cceeff; padding: 0in; white-space: nowrap; width: 14%;" valign="bottom">&#160;</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember', window );">Stock Options Not Granted Under 2003 Share Plan Or 2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYTablesLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Tables) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</a></td>
<td class="text"><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 60%; padding: 0in; width: 60%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap; width: 12%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average Exercise</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Price Per Share</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 11%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 11%;" colspan="2" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Aggregate</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Intrinsic</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Value</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 60%; padding: 0in; width: 60%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; white-space: nowrap; width: 12%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 60%; padding: 0in; width: 60%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Shares</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 60%; padding: 0in; width: 60%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; width: 12%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160; </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1%; padding: 0in; width: 1%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 11%; padding: 0in; white-space: nowrap; width: 11%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 60%; background: #cceeff; padding: 0in; white-space: nowrap; width: 60%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding at October 31, 2014, 2015 and 2016</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,780,000</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.70 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 1%; background: #cceeff; padding: 0in; width: 1%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 11%; background: #cceeff; padding: 0in; white-space: nowrap; width: 11%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 60%; padding: 0in; width: 60%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Options Outstanding and exercisable at October 31, 2016</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,780,000</font></p>
</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 12%; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.70 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 16.5pt; width: 1%; padding: 0in; width: 1%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 16.5pt; width: 11%; padding: 0in; width: 11%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">6,494,275 </font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]</a></td>
<td class="text"><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 24%; padding: 0in; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 24%; padding: 0in; white-space: nowrap; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 23%;" rowspan="4" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Remaining</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Contractual Life</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">(in years)</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 23%; padding: 0in; white-space: nowrap; width: 23%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 24%; padding: 0in; white-space: nowrap; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 24%; padding: 0in; white-space: nowrap; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 23%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 23%;" rowspan="3" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Weighted</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Average</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Price</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 24%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 24%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Range of</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Exercise Prices</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 24%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 24%;" rowspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">Number</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-align: center;"><font style="font-size: 11pt; color: black;">Outstanding</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 24%; padding: 0in; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 24%; padding: 0in; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 23%; padding: 0in; width: 23%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 23%; padding: 0in; width: 23%;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$ 2.58 - $ 5.56</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="font-size: 11pt; color: black;">1,780,000</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">5.76</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;">&#160;</p>
</td>
<td style="height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black;">$2.70 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="font-size: 11pt; color: black; display: none;">0</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 24%; background: #cceeff; padding: 0in; width: 24%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 23%; background: #cceeff; padding: 0in; width: 23%;" valign="bottom">&#160;</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SHAREHOLDERSEQUITYTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SHAREHOLDERSEQUITYTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2003SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2003SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6798608464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</a></td>
<td class="text"><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 30%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Year Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2016</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2015</font></p>
</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Federal:</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Current</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Deferred</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(1,631,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(487,000)</font></p>
</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">State:</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Current</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">- <br /></font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
</tr>
<tr style="height: 15pt; page-break-inside: avoid;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Deferred</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(134,000) </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(120,000)</font></p>
</td>
</tr>
<tr style="height: 15.1pt; page-break-inside: avoid;">
<td style="height: 15.1pt; width: 70%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Adjustment to valuation</font><font style="font-size: 11pt; color: black;"> allowance related to net deferred tax assets</font></p>
</td>
<td style="border-top: 0px; height: 15.1pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.1pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">1,765,000&#160; <br /></font></p>
</td>
<td style="height: 15.1pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.1pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.1pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">607,000 </font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="height: 15.75pt; width: 70%; padding: 0in; white-space: nowrap;" valign="bottom"><font style="font-family: times new roman,times,serif; font-size: 12pt; display: none;"><font style="font-size: 12pt; color: black;">Income Tax Provision (Benefit)</font></font></td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</a></td>
<td class="text"><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2016</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2015</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Long-term deferred tax assets:</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; padding: 0in 0in 0in 10pt; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Federal and state NOL and tax credit carryforwards</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; font-family: times new roman,times,serif; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">33,079,000 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; font-family: times new roman,times,serif; color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">31,261,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Deferred compensation</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">6,232,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">6,522,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Intangibles</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">713,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">483,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Other</font></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">289,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">282,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in 0in 0in 20pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Subtotal</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">40,313,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">38,548,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Less: valuation allowance</font></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(40,313,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(38,548,000)</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #cceeff; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Deferred tax asset, net</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; font-family: times new roman,times,serif; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; font-family: times new roman,times,serif; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</a></td>
<td class="text"><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 1%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="11" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Year Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 1%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2016</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 1%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; white-space: nowrap;" colspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2015</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Income tax benefit at U.S. </font></p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Federal statutory income&#160; Tax rate</font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(1,706,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(34.0)</font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1%; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(469,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(34.0)</font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">State income taxes</font></p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(411,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(8.2)</font></p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(117,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(8.5)</font></p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Permanent differences</font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">2,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0.1 </font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">1,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0.1 </font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Expiring net operating&#160; losses, credits and other</font></p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">350,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">7.0 </font></p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(22,000)</font></p>
</td>
<td style="height: 15pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">(1.6)</font></p>
</td>
<td style="height: 15pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 46%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Change in valuation allowance</font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">1,765,000</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">35.1</font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1%; padding: 0in; white-space: nowrap;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">607,000 </font></p>
</td>
<td style="height: 15pt; width: 2%; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">44.0 </font></p>
</td>
<td style="height: 15pt; width: 1%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">Income tax provision</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 1%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0.0 </font></p>
</td>
<td style="height: 15.75pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 1%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; white-space: nowrap;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 10%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">0.0 </font></p>
</td>
<td style="height: 15.75pt; width: 1%; background: #cceeff; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="font-size: 11pt; color: black;">%</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808679728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS AND FUNDING (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2014</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_BUSINESSANDFUNDINGDetailsLineItems', window );"><strong>BUSINESS AND FUNDING (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by (Used in) Operating Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,381,699)<span></span>
</td>
<td class="nump">$ 1,363,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Provided by (Used in) Investing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,503,479<span></span>
</td>
<td class="nump">45,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from Sale of Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,550,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Payments to Acquire Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payments to Acquire Property, Plant, and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,521<span></span>
</td>
<td class="nump">54,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by (Used in) Financing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,676)<span></span>
</td>
<td class="num">(400,618)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PaymentToAcquireRoyaltyInterestInPatentRights', window );">Payment to Acquire Royalty Interest in Patent Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from Stock Options Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,581<span></span>
</td>
<td class="nump">44,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashPeriodIncreaseDecrease', window );">Cash, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,531,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, Cash Equivalents, and Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,238,000<span></span>
</td>
<td class="nump">6,769,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=itus_AUOSettlementMember', window );">AUO Settlement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_BUSINESSANDFUNDINGDetailsLineItems', window );"><strong>BUSINESS AND FUNDING (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Proceeds from Legal Settlements</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,604,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=itus_AUOSettlementMember', window );">AUO Settlement [Member] | AUO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_BUSINESSANDFUNDINGDetailsLineItems', window );"><strong>BUSINESS AND FUNDING (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Proceeds from Legal Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=itus_PatentAssignmentAgreementMember', window );">Patent Assignment Agreement [Member] | AUO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_BUSINESSANDFUNDINGDetailsLineItems', window );"><strong>BUSINESS AND FUNDING (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Proceeds from Legal Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=itus_AgreementMember', window );">Agreement [Member] | National Securities Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_BUSINESSANDFUNDINGDetailsLineItems', window );"><strong>BUSINESS AND FUNDING (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_BUSINESSANDFUNDINGDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_BUSINESSANDFUNDINGDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PaymentToAcquireRoyaltyInterestInPatentRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the purchase of royalty interests in patent rights is the amount of cash the patent user pays the owner of the patent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PaymentToAcquireRoyaltyInterestInPatentRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=itus_AUOSettlementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=itus_AUOSettlementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_AUOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_AUOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=itus_PatentAssignmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=itus_PatentAssignmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=itus_AgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=itus_AgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_NationalSecuritiesCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_NationalSecuritiesCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6787678192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENT (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 06, 2016</div></th>
<th class="th"><div>Nov. 11, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUBSEQUENTEVENTDetailsLineItems', window );"><strong>SUBSEQUENT EVENT (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUBSEQUENTEVENTDetailsLineItems', window );"><strong>SUBSEQUENT EVENT (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ConversionOfStockCashPaid', window );">Conversion of Stock, Cash Paid</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion of Stock, Amount Issued</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUBSEQUENTEVENTDetailsLineItems', window );"><strong>SUBSEQUENT EVENT (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockDescription', window );">Conversion of Stock, Description</a></td>
<td class="text">exercise price equal to 10% below the thirty (30) day volume weighted average closing price of our common stock at closing<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUBSEQUENTEVENTDetailsLineItems', window );"><strong>SUBSEQUENT EVENT (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of Stock, Amount Converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=itus_SecuredDebentureDueJune12017Member', window );">Secured Debenture Due June 1,2017 [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUBSEQUENTEVENTDetailsLineItems', window );"><strong>SUBSEQUENT EVENT (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ConversionOfStockCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid in part noncash conversion of stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ConversionOfStockCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SUBSEQUENTEVENTDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SUBSEQUENTEVENTDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=itus_SecuredDebentureDueJune12017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=itus_SecuredDebentureDueJune12017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6809284080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
<th class="th"><div>Oct. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CertificatesOfDepositAtCarryingValue', window );">Certificates of Deposit, at Carrying Value</a></td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=itus_AwardsOfOptionsWith10YearTermsMember', window );">Awards Of Options With 10 Year Terms [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription', window );">Share Based Compensation Arrangement By Share Based Payment Award, Award Vesting Period, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The stock options we granted during the year ended October 31, 2015 consisted of awards with 10-year terms that vest over one year, options with 10-year terms that vest over 36 months.<span></span>
</td>
<td class="text">The stock options we granted during the year ended October 31, 2014 consisted of awards with 10-year terms that vest over one year and options with 10-year terms that vest over 36 months, options with 5-year terms which vest immediately and options with 10-year terms which vest upon achievement of performance milestones.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</a></td>
<td class="nump">3,086,472<span></span>
</td>
<td class="nump">2,672,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=itus_StockOptionsGrantedToEmployeesAndDirectorsMember', window );">Stock Options Granted To Employees And Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="nump">$ 874,000<span></span>
</td>
<td class="nump">$ 2,192,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AmortizationRelatedToCompensationCost', window );">Amortization Related To Compensation Cost</a></td>
<td class="nump">393,000<span></span>
</td>
<td class="nump">2,093,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</a></td>
<td class="nump">$ 1,139,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years 109 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=itus_StockAwardGrantedConsultantsMember', window );">Stock Award Granted Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">484,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AmortizationRelatedToCompensationCost', window );">Amortization Related To Compensation Cost</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 484,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</a></td>
<td class="nump">707,379<span></span>
</td>
<td class="nump">1,028,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</a></td>
<td class="nump">739,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Licensees 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="nump">53.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Licensees 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Licensees 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfAcquisitionCosts', window );">Amortization of Acquisition Costs</a></td>
<td class="nump">$ 325,000<span></span>
</td>
<td class="nump">$ 325,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturityOfTimeDeposits', window );">Maturity of Time Deposits</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturityOfTimeDeposits', window );">Maturity of Time Deposits</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_AmortizationRelatedToCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization related to compensation cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_AmortizationRelatedToCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of vesting period related to the share based compensation arrangement by share based payment award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Antidilution<br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Diluted Earnings Per Share<br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Contingent Stock Agreement<br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CertificatesOfDepositAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A savings certificate entitling the Entity (that is, bearer) to receive interest at an established maturity date, based upon a fixed interest rate.  A certificate of deposit may be issued in any denomination. Certificates of deposit are generally issued by commercial banks and, therefore, insured by the FDIC (up to the prescribed limit).  Certificates of deposit generally restrict holders from withdrawing funds on demand without the incurrence of penalties.  Generally, only certificates of deposit with original maturities of three months or less qualify as cash equivalents. Original maturity means original maturity to the entity holding the investment. As a related example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CertificatesOfDepositAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6351-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturityOfTimeDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of customer deposits, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Industry Guide<br> -Number 3<br> -Section V<br> -Paragraph D-E<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturityOfTimeDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=itus_AwardsOfOptionsWith10YearTermsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=itus_AwardsOfOptionsWith10YearTermsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=itus_StockOptionsGrantedToEmployeesAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=itus_StockOptionsGrantedToEmployeesAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=itus_StockAwardGrantedConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=itus_StockAwardGrantedConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_Licensees1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_Licensees1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_Licensees2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_Licensees2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_Licensees3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_Licensees3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6802619072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">$ 2,649,136<span></span>
</td>
<td class="nump">$ 2,867,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Patent acquisition obligation</a></td>
<td class="nump">4,171,876<span></span>
</td>
<td class="nump">3,688,187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsByCategoryAxis=itus_GlobalDepositoryReceiptsMember', window );">Global Depository Receipts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds &#8211; Cash and cash equivalents</a></td>
<td class="nump">1,899,136<span></span>
</td>
<td class="nump">467,967<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">1,899,136<span></span>
</td>
<td class="nump">467,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Patent acquisition obligation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Global Depository Receipts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds &#8211; Cash and cash equivalents</a></td>
<td class="nump">1,899,136<span></span>
</td>
<td class="nump">467,967<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Certificates of Deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Patent acquisition obligation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Global Depository Receipts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds &#8211; Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Certificates of Deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Patent acquisition obligation</a></td>
<td class="nump">4,171,876<span></span>
</td>
<td class="nump">3,688,187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Global Depository Receipts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds &#8211; Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Certificates of Deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Trading Securities<br> -URI http://asc.fasb.org/extlink&amp;oid=6526789<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27723805&amp;loc=d3e24584-111560<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884222&amp;loc=d3e22054-111558<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Available-for-Sale Securities<br> -URI http://asc.fasb.org/extlink&amp;oid=6505594<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsByCategoryAxis=itus_GlobalDepositoryReceiptsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsByCategoryAxis=itus_GlobalDepositoryReceiptsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6776198016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Summary of the changes in the fair value of the Company's Level 3 financial liabilities on recurring basis - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract', window );"><strong>Summary of the changes in the fair value of the Company's Level 3 financial liabilities on recurring basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance October 31, 2014</a></td>
<td class="nump">$ 3,688,187<span></span>
</td>
<td class="nump">$ 3,236,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense', window );">Accretion of interest on patent obligation</a></td>
<td class="nump">519,946<span></span>
</td>
<td class="nump">451,906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PaymentToAcquireRoyaltyInterestInPatentRights', window );">Royalty payment applied to patent acquisition obligation</a></td>
<td class="num">(36,257)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance</a></td>
<td class="nump">$ 4,171,876<span></span>
</td>
<td class="nump">$ 3,688,187<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accretion of interest on patent acquisition obligations to interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PaymentToAcquireRoyaltyInterestInPatentRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the purchase of royalty interests in patent rights is the amount of cash the patent user pays the owner of the patent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PaymentToAcquireRoyaltyInterestInPatentRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SummaryOfTheChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesOnRecurringBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6631416464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Weighted average assumptions used in estimating the fair value of stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract', window );"><strong>Weighted average assumptions used in estimating the fair value of stock options [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value at grant date (in Dollars per share)</a></td>
<td class="nump">$ 2.84<span></span>
</td>
<td class="nump">$ 3.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ValuationAssumptionsAbstract', window );"><strong>Valuation assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (years)</a></td>
<td class="text">5 years 255 days<span></span>
</td>
<td class="text">5 years 9 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">181.10%<span></span>
</td>
<td class="nump">117.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.26%<span></span>
</td>
<td class="nump">2.01%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ValuationAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ValuationAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6797042976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - Accounts payable and accrued liabilities - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AccountsPayableAndAccruedLiabilitiesAbstract', window );"><strong>Accounts payable and accrued liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 373,224<span></span>
</td>
<td class="nump">$ 374,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related expenses</a></td>
<td class="nump">49,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other</a></td>
<td class="nump">45,631<span></span>
</td>
<td class="nump">6,062<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Total</a></td>
<td class="nump">$ 468,756<span></span>
</td>
<td class="nump">$ 380,765<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_AccountsPayableAndAccruedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_AccountsPayableAndAccruedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6817171344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 05, 2015</div></th>
<th class="th"><div>Jan. 02, 2014</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
<th class="th"><div>Oct. 31, 2013</div></th>
<th class="th"><div>Oct. 31, 2012</div></th>
<th class="th"><div>Jan. 02, 2015</div></th>
<th class="th"><div>Oct. 31, 2014</div></th>
<th class="th"><div>Sep. 09, 2014</div></th>
<th class="th"><div>Nov. 08, 2013</div></th>
<th class="th"><div>Aug. 29, 2012</div></th>
<th class="th"><div>Jul. 06, 2011</div></th>
<th class="th"><div>Oct. 31, 2010</div></th>
<th class="th"><div>May 31, 1986</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,860<span></span>
</td>
<td class="nump">19,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=itus_RePricedOptionsMember', window );">Re-Priced Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">2,184,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 2.575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation (in Dollars)</a></td>
<td class="nump">$ 297,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,833<span></span>
</td>
<td class="nump">11,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible Preferred Stock, Shares Issued upon Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ConvertiblePreferredStockRedemptionNoticePeriod', window );">Convertible Preferred Stock Redemption, Notice Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionPricePerShare', window );">Preferred Stock, Redemption Price Per Share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionDate', window );">Preferred Stock, Redemption Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 11,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ConvertiblePreferredStockSharesConvertedStatedValue', window );">Convertible Preferred Stock, Shares Converted, Stated Value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ConvertiblePreferredStockConversionPrice', window );">Convertible Preferred Stock, Conversion Price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ConvertiblePreferredStockOwnershipThresholdPercentage', window );">Convertible Preferred Stock, Ownership Threshold, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_CommonStockAntidilutionThresholdPrice', window );">Common Stock, Anti-dilution Threshold Price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ConertiblePreferredStockObserverDesignationNoticePeriod', window );">Conertible Preferred Stock, Observer Designation, Notice Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member] | Series A Preferred Stock [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ConvertiblePreferredStockConversionPrice', window );">Convertible Preferred Stock, Conversion Price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember', window );">2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557,000<span></span>
</td>
<td class="nump">60,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,080,872<span></span>
</td>
<td class="nump">526,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">728,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.12<span></span>
</td>
<td class="nump">$ 3.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember', window );">2010 Share Plan [Member] | Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,225,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,569,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,957,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">1,080,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">431,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember', window );">2010 Share Plan [Member] | Employee Stock Option [Member] | Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,833<span></span>
</td>
<td class="nump">11,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ConsultationFeesRelatedToOptions', window );">Consultation Fees Related To Options (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">$ 46,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember', window );">2010 Share Plan [Member] | Common Stock [Member] | Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember', window );">2010 Share Plan [Member] | Common Stock [Member] | Employee Stock Option [Member] | Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2003SharePlanMember', window );">2003 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">366,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2003SharePlanMember', window );">2003 Share Plan [Member] | Common Stock [Member] | Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember', window );">Stock Options Not Granted Under 2003 Share Plan Or 2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="nump">1,660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,780,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member] | 2010 Share Plan [Member] | Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice925Member', window );">Warrants With Exercise Price $9.25 [Member] | Warrant [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice13875Member', window );">Warrants With Exercise Price $13.875 [Member] | Warrant [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice775Member', window );">Warrants With Exercise Price $7.75 [Member] | Warrant [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">369,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice6925Member', window );">Warrants With Exercise Price $6.925 [Member] | Warrant [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice1000Member', window );">Warrants With Exercise Price $10.00 [Member] | Warrant [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">309,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_CommonStockAntidilutionThresholdPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share, below which certain anti-dilution protection provision will be triggered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_CommonStockAntidilutionThresholdPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ConertiblePreferredStockObserverDesignationNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notice period the holder is required to deliver before it can designate an observer to observe meetings of the company's board, in 'PnYnMnDTnHnMnS' format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ConertiblePreferredStockObserverDesignationNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ConsultationFeesRelatedToOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consultation fees related to options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ConsultationFeesRelatedToOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ConvertiblePreferredStockConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The conversion price of the convertible preferred stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ConvertiblePreferredStockConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ConvertiblePreferredStockOwnershipThresholdPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The threshold percentage of ownership of an affiliate beneficially own thorough convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ConvertiblePreferredStockOwnershipThresholdPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ConvertiblePreferredStockRedemptionNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notice period the entity is required to deliver before it can redeem Convertible Preferred Stock, in 'PnYnMnDTnHnMnS' format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ConvertiblePreferredStockRedemptionNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ConvertiblePreferredStockSharesConvertedStatedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The stated value per share of convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ConvertiblePreferredStockSharesConvertedStatedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SHAREHOLDERSEQUITYDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SHAREHOLDERSEQUITYDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the preferred stock has been redeemed, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=itus_RePricedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=itus_RePricedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2003SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2003SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice925Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice925Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice13875Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice13875Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice775Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice775Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice6925Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice6925Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice1000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantsWithExercisePrice1000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6787675840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - Information regarding the 2003 and 2010 Share Plan - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2003SharePlanMember', window );">2003 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) - Information regarding the 2003 and 2010 Share Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Shares</a></td>
<td class="nump">366,200<span></span>
</td>
<td class="nump">493,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 17.86<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options Exercised, Shares</a></td>
<td class="num">(11,080)<span></span>
</td>
<td class="num">(4,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options Exercised, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 2.58<span></span>
</td>
<td class="nump">$ 2.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options Forfeited, Shares</a></td>
<td class="num">(129,520)<span></span>
</td>
<td class="num">(123,791)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options Forfeited, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 17.72<span></span>
</td>
<td class="nump">$ 14.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber', window );">Options Outstanding and Exercisable, Shares</a></td>
<td class="nump">225,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Options Outstanding and Exercisable, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 18.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue', window );">Options Outstanding and Exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 142,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">366,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding, Weighted Average Exercise Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember', window );">2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) - Information regarding the 2003 and 2010 Share Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Shares</a></td>
<td class="nump">526,272<span></span>
</td>
<td class="nump">728,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 3.33<span></span>
</td>
<td class="nump">$ 5.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options Granted, Shares</a></td>
<td class="nump">557,000<span></span>
</td>
<td class="nump">60,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options Granted, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 2.92<span></span>
</td>
<td class="nump">$ 2.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options Exercised, Shares</a></td>
<td class="num">(2,400)<span></span>
</td>
<td class="num">(13,334)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options Exercised, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="nump">$ 2.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options Forfeited, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(249,355)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options Forfeited, Weighted Average Exercise Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Shares</a></td>
<td class="nump">1,080,872<span></span>
</td>
<td class="nump">526,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 3.12<span></span>
</td>
<td class="nump">$ 3.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 3,569,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options Exercisable, Shares</a></td>
<td class="nump">659,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options Exercisable, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 3.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options Exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 2,126,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003and2010SharePlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding and exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding and exercisable, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price per share at which the shares are outstanding and exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2003SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2003SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6809658352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - Stock options outstanding and exercisable under 2003 share plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2016 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices179To775Member', window );">Range Of Exercise Prices $1.79 To $7.75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number | shares</a></td>
<td class="nump">41,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding,Weighted Average Remaining Contractual Life</a></td>
<td class="text">1 year 281 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 2.91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices1475To1725Member', window );">Range Of Exercise Prices $14.75 To $17.25 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number | shares</a></td>
<td class="nump">50,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding,Weighted Average Remaining Contractual Life</a></td>
<td class="text">156 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 16.98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices2050To2300Member', window );">Range Of Exercise Prices $20.50 To $23.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number | shares</a></td>
<td class="nump">94,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding,Weighted Average Remaining Contractual Life</a></td>
<td class="text">302 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 22.04<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices2925Member', window );">Range Of Exercise Prices $29.25 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number | shares</a></td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding,Weighted Average Remaining Contractual Life</a></td>
<td class="text">295 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 29.25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices179To775Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices179To775Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices1475To1725Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices1475To1725Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices2050To2300Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices2050To2300Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices2925Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices2925Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6634094080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - Stock options outstanding under 2010 Share Plan - Range Of Exercise Prices $2.58 To $9.25 [Member] - 2010 Share Plan [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2016 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number | shares</a></td>
<td class="nump">1,080,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding,Weighted Average Remaining Contractual Life</a></td>
<td class="text">7 years 259 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable, Number | shares</a></td>
<td class="nump">659,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable,Weighted Average Remaining Contractual Life</a></td>
<td class="text">6 years 259 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted Average Exercise Price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=itus_RangeOfExercisePrices258To925Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=itus_RangeOfExercisePrices258To925Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6790362336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan - Stock Options Not Granted Under 2003 Share Plan Or 2010 Share Plan [Member]<br></strong></div></th>
<th class="th">
<div>Oct. 31, 2016 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) - Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding at October 31, 2014, 2015 and 2016 | shares</a></td>
<td class="nump">1,780,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding at October 31, 2014, 2015 and 2016 | $ / shares</a></td>
<td class="nump">$ 2.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber', window );">Options Outstanding and exercisable at October 31, 2016 | shares</a></td>
<td class="nump">1,780,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Options Outstanding and exercisable at October 31, 2016 | $ / shares</a></td>
<td class="nump">$ 2.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue', window );">Options Outstanding and exercisable at October 31, 2016 | $</a></td>
<td class="nump">$ 6,494,275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SHAREHOLDERSEQUITYDetailsInformationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding and exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding and exercisable, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price per share at which the shares are outstanding and exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6634560400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - Stock options granted not under 2003 Share Plan and 2010 Share Plan - Range Of Exercise Prices $2.58 To $5.56 [Member] - Stock Options Not Granted Under 2003 Share Plan Or 2010 Share Plan [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2016 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable', window );">Options Outstanding and Exercisable, Number | shares</a></td>
<td class="nump">1,780,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding and Exercisable, Weighted Average Remaining Contractual Life</a></td>
<td class="text">5 years 277 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice', window );">Options Outstanding and Exercisable, Weighted Average Exercise Price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 2.70<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance or issued but not exercised pertaining to the outstanding and exercisable stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding and exercisable stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding and exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices258To556Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices258To556Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6797807504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2016 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Oct. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PatentAcquisitionObligationsDiscountedPresentValue', window );">Patent Acquisition Obligations Discounted, Present Value</a></td>
<td class="nump">$ 4,172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_InterestExpensePatentAcquisitionObligations', window );">Interest Expense, Patent Acquisition Obligations</a></td>
<td class="nump">$ 520,000<span></span>
</td>
<td class="nump">$ 452,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod', window );">Patent Acquisition Obligation, Payment Due Date Extension Period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Operating Leases, Future Minimum Payments Due, Next Twelve Months</a></td>
<td class="nump">$ 129,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Operating Leases, Future Minimum Payments, Due in Two Years</a></td>
<td class="nump">134,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">Operating Leases, Future Minimum Payments, Due in Three Years</a></td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
<td class="nump">$ 104,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=itus_OfficeSpaceInLosAngelesCaliforniaMember', window );">Office Space in Los Angeles, California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of Land (in Square Feet) | ft&#178;</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals', window );">Operating Leases, Rent Expense, Minimum Rentals</a></td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_LeaseBaseRentAnnualIncrease', window );">Lease, Base Rent, Annual Increase</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_InterestExpensePatentAcquisitionObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense recorded during the period for the accretion of interest on patent acquisition obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_InterestExpensePatentAcquisitionObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_LeaseBaseRentAnnualIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage annual increase of base rent of lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_LeaseBaseRentAnnualIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The extension period of the payment due date of patent acquisition obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PatentAcquisitionObligationPaymentDueDateExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PatentAcquisitionObligationsDiscountedPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discounted present value of patent acquisition obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PatentAcquisitionObligationsDiscountedPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=7661868&amp;loc=d3e34039-112682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseMinimumRentals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=itus_OfficeSpaceInLosAngelesCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=itus_OfficeSpaceInLosAngelesCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6791818384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_INCOMETAXESDetailsLineItems', window );"><strong>INCOME TAXES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange', window );">Operating Loss Carryforward and Tax Credit Carryforward Expiration, Date Range</a></td>
<td class="text">expiring at various dates between 2020 and 2035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=itus_FederalCorporateTaxableMember', window );">Federal Corporate Taxable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_INCOMETAXESDetailsLineItems', window );"><strong>INCOME TAXES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 79,428,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credit Carryforward, Amount</a></td>
<td class="nump">1,110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=itus_NewYorkStateMember', window );">New York State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_INCOMETAXESDetailsLineItems', window );"><strong>INCOME TAXES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">76,847,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=itus_CaliforniaStateMember', window );">California State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_INCOMETAXESDetailsLineItems', window );"><strong>INCOME TAXES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">4,849,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=itus_PennsylvaniaStateMember', window );">Pennsylvania State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_INCOMETAXESDetailsLineItems', window );"><strong>INCOME TAXES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 841,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_INCOMETAXESDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_INCOMETAXESDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date range of operating loss carryforward and tax credit carryforward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_OperatingLossCarryforwardAndTaxCreditCarryforwardExpirationDateRange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Carryforwards<br> -URI http://asc.fasb.org/extlink&amp;oid=6506874<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=itus_FederalCorporateTaxableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=itus_FederalCorporateTaxableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=itus_NewYorkStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=itus_NewYorkStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=itus_CaliforniaStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=itus_CaliforniaStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=itus_PennsylvaniaStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=itus_PennsylvaniaStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6777109312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - Income tax provision (benefit) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Federal:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(1,631,000)<span></span>
</td>
<td class="num">(487,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>State:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(134,000)<span></span>
</td>
<td class="num">(120,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability', window );">Adjustment to valuation allowance related to net deferred tax assets</a></td>
<td class="nump">1,765,000<span></span>
</td>
<td class="nump">607,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Provision (Benefit)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779214832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Details) - The tax effects of temporary differences of the deferred tax - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_LongTermDeferredTaxAssetsAbstract', window );"><strong>Long-term deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_FederalAndStateNOLAndTaxCreditCarryforwards', window );">Federal and state NOL and tax credit carryforwards</a></td>
<td class="nump">$ 33,079,000<span></span>
</td>
<td class="nump">$ 31,261,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Deferred compensation</a></td>
<td class="nump">6,232,000<span></span>
</td>
<td class="nump">6,522,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="nump">713,000<span></span>
</td>
<td class="nump">483,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">289,000<span></span>
</td>
<td class="nump">282,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Subtotal</a></td>
<td class="nump">40,313,000<span></span>
</td>
<td class="nump">38,548,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(40,313,000)<span></span>
</td>
<td class="num">(38,548,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax asset, net</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_FederalAndStateNOLAndTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss and tax carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_FederalAndStateNOLAndTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_LongTermDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_LongTermDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Asset<br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.6.0.2</span><table class="report" border="0" cellspacing="2" id="idp6797994224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - Reconciliation of income taxes at the Federal statutory tax rate - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract', window );"><strong>Reconciliation of income taxes at the Federal statutory tax rate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Federal statutory income Tax rate</a></td>
<td class="num">$ (1,706,000)<span></span>
</td>
<td class="num">$ (469,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory income Tax rate</a></td>
<td class="num">(34.00%)<span></span>
</td>
<td class="num">(34.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes</a></td>
<td class="num">$ (411,000)<span></span>
</td>
<td class="num">$ (117,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes</a></td>
<td class="num">(8.20%)<span></span>
</td>
<td class="num">(8.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Permanent differences</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Permanent differences</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther', window );">Expiring net operating losses, credits and other</a></td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="num">$ (22,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Expiring net operating losses, credits and other</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">$ 1,765,000<span></span>
</td>
<td class="nump">$ 607,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">35.10%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax provision</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to expiring net operating losses, credits and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>50
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M'WXW8=<;N[?_V/@JV#;PZR[:+U!+ P04    " !YBCM*F5R<(Q &  "<)P
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MJX5Y>L>KD*P9K*BM-.2]?U>M>=_[+W$TT& "'@AX).#T4T(T$**1@.)/"?%
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M^OMV.B)/#WUSGH__R?5_$)O_ 5!+ P04    " !YBCM*1SY3X\$"  !3"P
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MWDP#.05.]_-;(\N#+_\"4$L#!!0    ( 'F*.THI19GJ+00   ,2   8
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M0NV#>8>V'==L=+SIIA?$YF=<_ 502P,$%     @ >8H[2O[0Q6VU 0  T@,
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MXWL\VWG,9L.;8?E!;/W&Y1]02P,$%     @ >8H[2EY?UT.W 0  T@,  !D
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MX-F.8S8:WG33#V+S-\X_ %!+ P04    " !YBCM*K>IBQ+@!  #2 P  &0
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M^[,9QVPT'';3#V+S-R[^ E!+ P04    " !YBCM*@,37IK4!  #2 P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6QU4]MNG# 0_17+'Q O+$FC%2!E
M4U6MU$JK5&V?O3" %5^H;9;T[SLV+"$I?;$]XSEGSHS'^6CLL^L /'E14KN"
M=M[W!\9<U8'B[L;TH/&F,59QCZ9MF>LM\#J"E&3I;G?'%!>:EGGTG6R9F\%+
MH>%DB1N4XO;/$:09"YK0J^-)M)T/#E;F/6_A._@?_<FBQ1:66BC03AA-+#0%
M?4@.QRS$QX"? D:W.I-0R=F8YV!\J0NZ"X) 0N4# \?M H\@92!"&;]G3KJD
M#,#U^<K^*=:.M9RY@T<C?XG:=P6]IZ2&A@_2/YGQ,\SUW%(R%_\5+B Q/"C!
M')61+JZD&IPW:F9!*8J_3+O0<1^GF]LK;!N0SH!T =Q' )L21>4?N>=E;LU(
M[-3[GH<G3@XI]J8*SMB*>(?B'7HO97*7Y.P2B.:8XQ23KF.6"(;L2XIT*\4Q
M_0>>;L/WFPKW$;Y_H_ _!-DF018)LC<$^W<E;L5D[Y*P54\5V#9.DR.5&72<
MY)5W&=B'-+[):_@T[=^X;85VY&P\OFSL?V.,!Y2RN\$1ZO"#+8:$QH?C!SS;
M:<PFPYM^_D%L^<;E7U!+ P04    " !YBCM*.PR*6;<!  #2 P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q-2YX;6QM4]MNVS ,_15!'U ECI,&@6V@Z3!L
MP 8$';8]*S9M"]7%D^2X^_M1LNNZG5\DD>(Y/*2H;##VV;4 GKPHJ5U.6^^[
M$V.N;$%Q=V<ZT'A3&ZNX1],VS'46>!5!2K)DLSDPQ86F119]%UMDIO=2:+A8
MXGJEN/U[!FF&G&[IJ^-)-*T/#E9D'6_@!_B?W<6BQ6:62BC03AA-+-0Y?=B>
MSFF(CP&_! QN<2:ADJLQS\'X6N5T$P2!A-('!H[;#1Y!RD"$,OY,G'1.&8#+
M\RO[YU@[UG+E#AZ-_"TJW^;T2$D%->^E?S+#%YCJV5,R%?\-;B Q/"C!'*61
M+JZD[)TW:F)!*8J_C+O0<1_&FWTZP=8!R01(9L QYF%CHJC\$_>\R*P9B!U[
MW_'PQ-M3@KTI@S.V(MZA>(?>6[$][#-V"T13S'F,298Q<P1#]CE%LI;BG/P'
M3];ANU6%NPC?O5-X6"=(5PG22)"^([C_4.):S/%#$K;HJ0+;Q&ERI#2]CI.\
M\,X#^Y#$-WD+'Z?].[>-T(Y<C<>7C?VOC?& 4C9W.$(M?K#9D%#[<+S'LQW'
M;#2\Z:8?Q.9O7/P#4$L#!!0    ( 'F*.THW4VEXM@$  -(#   9    >&PO
M=V]R:W-H965T<R]S:&5E=#$V+GAM;&U3VV[<(!#]%<0'!-N[N71E6\HFBEJI
ME5:IFCZS]MA& <8%O$[_OH =UTW] LPPY\R98<A'-*^V W#D34EM"]HYUQ\8
MLU4'BMLK[$'[FP:-XLZ;IF6V-\#K"%*294ERPQ07FI9Y])U,F>/@I-!P,L0.
M2G'S^P@2QX*F]-WQ+-K.!0<K\YZW\!W<C_YDO,46EEHHT%:@)@::@MZGA^,^
MQ,> %P&C79U)J.2,^!J,+W5!DR ()%0N,'"_7> !I Q$7L:OF9,N*0-P?7YG
M?XJU^UK.W,(#RI^B=EU![RBIH>&#=,\X?H:YGFM*YN*_P@6D#P]*?(X*I8TK
MJ0;K4,TL7HKB;],N=-S'Z69W/<.V =D,R!; 7<S#ID11^2-WO,P-CL1,O>]Y
M>.+TD/G>5,$96Q'OO'CKO9<RO?F4LTL@FF..4TRVCEDBF&=?4F1;*8[9?_!L
M&[[;5+B+\-TZ^VVR3;#?)-A'@OT_!.F'$K=B/JIDJYXJ,&V<)DLJ''2<Y)5W
M&=C[++[)W_!IVK]QTPIMR1F=?]G8_P;1@9>27/D1ZOP'6PP)C0O'6W\VTYA-
MAL-^_D%L^<;E'U!+ P04    " !YBCM*S!>GU9("  !B"@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970Q-RYX;6R-5NV.FS 0?!7$ QS8^2!$"5)R5=5*K11=
MU>MO)W$".L#4=I+KV]<80G-F+/5/L)W9F5UVU^SJ)N2;RCG7P7M5UFH=YEHW
MRRA2AYQ73#V)AM?FGY.0%=-F*\^1:B1G1VM4E1&-XWE4L:(.LY4]V\EL)2ZZ
M+&J^DX&Z5!63?[:\%+=U2,+[P4MQSG5[$&6KAIWY#ZY_-CMI=M' <BPJ7JM"
MU('DIW6X(<LMM086\5KPFWI8!VTH>R'>VLW7XSJ,6X]XR0^ZI6#F<>7/O"Q;
M)N/'[YXT'#1;P\?UG?VS#=X$LV>*/XOR5W'4^3I<A,&1G]BEU"_B]H7W <W"
MH(_^&[_RTL!;3XS&093*_@:'B]*BZEF,*Q5[[YY%;9^WGO]NA@UH;T =@Z@3
MLIY_8IIE*REN@>Q>?L/:'),E->_FT![:5V'_,\XK<WK-2#)91=>6J,=L.PQ]
MQ R(R+ /$A1);.G(G&+S"?1P8LTG'SR<8H(I))A:@ND'@ID3(L+,L<@,BLP
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M)$_NQA7N(>H7 D[63Q=NKMMNW"ZLJKN7AO3/7?8'4$L#!!0    ( 'F*.TK
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M/![-&O9@TWF 4C)!,>%;_/P:P;"=L ]DD8Z]#X%F$SJPZS!@NV0J5=A1./Q
MM;"G< 1D@<>[6'2_CA[^7]A^&/!?,K$#8-A9./E Q;!O,&"<9+P+X'OG8- Y
MZ.I$,7>"[T0<RUHZ6Z[TX62/D /GBFI2[T5/8Z&O(4.'T8,RS42W17<6=QW%
MF_Z>@8;+3OX/4$L#!!0    ( 'F*.TI=D,]%U ,  !D3   9    >&PO=V]R
M:W-H965T<R]S:&5E=#(T+GAM;)58VV[;.!3\%4$?4)$\U"VP#20.BEU@%PBZ
MV.VS8M,75!)=28[;OZ]N\5KD,+7R$$GT<#CGD',H<7'1U;?ZH%3C_2CRLE[Z
MAZ8Y/01!O3FH(JL_Z9,JVU]VNBJRIGVL]D%]JE2V[3L5>2 8BX(B.Y;^:M&W
MO52KA3XW^;%4+Y57GXLBJWX^J5Q?EC[WWQN^'/>'IFL(5HM3ME?_J.;?TTO5
M/@57ENVQ4&5]U*57J=W2?^0/SU)V'7K$?T=UJ6_NO2Z45ZV_=0]_;I<^ZQ2I
M7&V:CB)K+V]JK?*\8VIU?!])_>N87<?;^W?VSWWP;3"O6:W6.O]ZW#:'I9_X
MWE;MLG/>?-&7/]084.A[8_1_J3>5M_!.23O&1N=U_]_;G.M&%R-+*Z7(?@S7
M8]E?+R/_>S?<08P=Q+4#CS_L0&,'NG<$.7:01H=@"*7/S7/69*M%I2]>-4SO
M*>M6$7^0;?8W76.?[/ZW-CUUV_JV$K%<!&\=T8AY&C#B!L.OB*!EOPXAT!!/
MPNHNI@.L;02Q*>09D,0A5D$P4.H):$(080()"61/("<$L9&I 1/WF++'Q"%K
M_XQX;9B0;(*;Z FAGA#H23!!! FB^S,20X(8*$B-4 $F,><681PK+(%"$D @
M,$$*"=+[4\$9]A$#&L@TT@"*;B:>6!+)V#0$ (HH%C)VI(4[S,V!*.F@@.9]
MY&)&:K#S. $5H9D:LCR1Q-*V#L )G@JG=S@V,P=N3B)3D[2G*R6@R<8)-@5.
M-6%#<^#HQ*PP(^@V?LXI=8^%O<\C,%9BCH5 J6,<7"(X\';JDHK-S9,9*Q#;
MFZ?WK,#4RJPUT:DUT3*1SMP+7"H$*A7FVAM!'ZD!D _5X!HA0(U(7?L[KA%B
M1HT0N$8(5"/,\CF";M,?LYBL/0?@.&M7+KG"PC5"@!J1.K85@2TMPAF9P4X5
MR(169B([,Y2FH>-]0&"S"F16<E!@LXH99A78K *8-35?22$H--<! CG$$/8J
M :^FL8,"&XSX_2DA;# 2=Z0$@HR2OH8@1TDGQXNT;55RU1S"SB(Y(R78600V
M2S,E:P BYB@"A.U'P'[,]>&!;47QC&BQK<A^PR4FS 606/L!B=!^7?D];BH)
MVY1L<Q%S% N)S279C&\R;"YI[U[$3&= D&,.)7:@M'U#S"45^T;.^0)U?(+:
M.Q*(%H',DA7<G \4JMKW9R^UM]'GLND^LV]:K^<[CZ([7S#:G_C#\W!*\S_-
M<&CT=U;MCV7MO>JFT45_QK#3NE&M1O:I->9!9=OK0ZYV37<;M_?5<%@S/#3Z
M-!Y$!=?3L-4O4$L#!!0    ( 'F*.TJ?ITC7O0,  !\5   9    >&PO=V]R
M:W-H965T<R]S:&5E=#(U+GAM;)68:V^;,!2&_PKB!PQ\X9(JB;1FFC9IDZI.
MVS[3Q$E0 6?@-MV_G[DT2NS7#/JA7/*>XW/,>0[8R[.LGYNC$,I[*XNJ6?E'
MI4YW0=!LCZ+,F@_R)"K]RU[69:;T97T(FE,MLEUG5!8!#<,X*+.\\M?+[MY#
MO5[*%U7DE7BHO>:E++/Z[[THY'GE$__]QF-^.*KV1K!>GK*#^"'4S]-#K:^"
MBY==7HJJR67EU6*_\C^2NTU$6X-.\2L7Y^;JW&M3>9+RN;WXNEOY81N1*,16
MM2XR?7@5&U$4K2<=QY_!J7\9LS6\/G_W_KE+7B?SE#5B(XO?^4X=5W[J>SNQ
MSUX*]2C/7\204.1[0_;?Q*LHM+R-1(^QE473_?>V+XV2Y>!%AU)F;_TQK[KC
M>?#_;H8-Z&! +P:$CQJPP8 9!D$?69?JITQEZV4MSU[=/ZU3UA8%N6-Z,K?M
MS6[NNM]TMHV^^[IF8;H,7EM'@^:^U] K#;U5;&P%"R^20 =PB8+"*&AGSV[L
M%]@!@PY8YX!?.R"AD4:O23I-U:<1\P5AL9$,T*5QLH@3'!"' 7$0$#$"ZC7Q
MU4"<)"1-S(!L'8O35 MQ0!$,* (!4>P@A@[BZ<\H@0X2$ $S4DVL5"D/VS\\
M4 H'2L% '#M80 >+Z:F2$&,5@A@BDZO0RI:D"U"10,A'*I(X4"<@IMCA G-*
M9H!*,*D$H<K,F6%6PDGD+@."&20(0M><86I(-"-AS V))_2F032A%&SA:"E@
M% EBT6Q/0,2M<$8UMZ%@6 FB-76XP+B2&;Q2S"M%O)K-"8A<R5*,($4(NB)U
MO"IG($@Q@A0A:#8G:B.(*Q((QRJ28E8I8)6ZOB$PJW0&JQ2S2A&K9G,"(F<9
M8/PHP(\2APN,#4UG)(NQH8L)C6D0C73BH0ILW>B;FV$.&>+0;$Q 9#6F<<UM
M*)A5!EBECB\FAEEE<[YK'1^V$UZ7&V8C.#[YF$&&&&0.%YA!-H-!AAEDB$&S
M.P&170+3.6684X8X=7Q),LPIF\$IPYPRQ*G9E-A_.;U=M&#\.,"/1@X7&!M.
MIB?,,3:<3FA,0&15P+CF-A2,'T?X6>LX\ ;$"SE;.+J2XXZU)>+4E1?FE,_@
ME&-.^81WY0:(G$\ ,\@1@Z[YP@SR&0QRS"!'#)I-"8CLDAS5W*[C,:,18M3Q
MP1QA1J,9C$:8T0@Q:C8E(+*2#:YVJMJMP^]9?<BKQGN22LFRVYK:2ZF$]A=^
MT%5[%-GN<E&(O6I/$WU>]UMV_862IV$[,KCLB:[_ 5!+ P04    " !YBCM*
M>;4^.BD"  #R!0  &0   'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q]5%V/
MFS 0_"N(]YX!$T@B@G2DJEJIE:*KKGUVR":@,YC:3KC^^_J#<!SX^@+V,CL[
ML\:;]8R_B I >J\-;<7.KZ3LM@B)LH*&B ?60:N^G!EOB%1;?D&BXT!.)JFA
M* J"!#6D;OT\,[$#SS-VE;1NX< ]<6T:PO\60%F_\T/_'GBJ+Y74 91G';G
M3Y#/W8&K'1I93G4#K:A9ZW$X[_S'<+M/-=X ?M70B\G:TTZ.C+WHS;?3S@^T
M(*!02LU U.L&>Z!4$RD9?P9.?RRI$Z?K._L7XUUY.1(!>T9_UR=9[?RU[YW@
M3*Y4/K'^*PQ^5KXWF/\.-Z *KI6H&B6CPCR]\BHD:P86):4AK_9=M^;=#_SW
M-'="-"1$8T*8_#<!#PGX+2$VYJTR8_4SD23/..L];@^K(_J?"+=8-;/40=,[
M\TVY%2IZRW&TR=!-$PV8PF*B"28<$4BQCR4B5XDB6J1'[POLEP@<N"M@IPEL
M\O$T_R."V$D0&X+X'4$XZX+%I ;36DRR7H?K=&;&@8MP$JT_Z-G**6CE$#3K
M6F$QR:30*MQLXF2F9PF+%2Y(W'(2IYQD(2?$,]]%LJCS2=E>I>XZJ;-.ZK"-
M9W7217_C,%7',/>]Q,W/RPI"DZO2 +^8J2*\DEU;J7_*270<7(^1OFJS>*$&
MFIT_;S1V&OX@_%*WPCLRJ2ZRN6YGQB0HF<&#.I]*#>!Q0^$L]3)5:V['D-U(
MU@T3%HUC/O\'4$L#!!0    ( 'F*.THA6#[\+0(  ,D&   9    >&PO=V]R
M:W-H965T<R]S:&5E=#(W+GAM;'U5[8[:,!!\E2@/@/,!)* 0Z4AU:J560E?U
M^MN$A43GQ#G;D.O;UW9""F9[?["]F9V=L<TZZ[EXDQ6 \CX:ULJ-7RG5K0F1
M904-E3/>0:N_'+EHJ-)+<2*R$T /-JEA) J")6EHW?IY9F,[D6?\K%C=PDYX
M\MPT5/S9 N/]Q@_]:^"E/E7*!$B>=?0$/T']ZG9"K\C$<J@;:&7-6T_ <>,_
MA>MB9? 6\%I#+V_FGG&RY_S-++X=-GY@! &#4AD&JH<+%,"8(=(RWD=.?RII
M$F_G5_9GZUU[V5,)!6>_ZX.J-G[J>P<XTC-3+[S_"J.?A>^-YK_#!9B&&R6Z
M1LF9M+]>>9:*-R.+EM+0CV&L6SOV(_\U#4^(QH1H2@B33Q/B,2%V$LB@S%K]
M0A7-,\%[3PR'U5%S)\)UK#>S-$&[=_:;=BMU])+'\3PC%T,T8K8#)KK!A!."
M:/:I1(25V$8/Z=%]@>(1$0=XA1@U$=O\^,[$ B>8HP1S2S"_(U@ZNS!@4HMI
M!QNSU-FJXA$4SX(5+F6!2ED@7A*<8(D2+!$OJ>,%PZP<*PAF_I]325 A"4(0
M.D(PC'L[,$R,"TE1(2E"X-YQ#+-PA&"8)2YDA0I9(02)(P3#.,=7?(X9A)";
M#M" .-EF*;V2GUME_FLWT:D?/T6F@SCQK>[30UO]1S,T^1]4G.I6>GNN='^R
M7>3(N0(M,9CI>USI=V5:,#@J,TWT7 S==5@HWHT/!YE>K_PO4$L#!!0    (
M 'F*.TI9O&"H^P$  %<%   9    >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM
M;'U4T8Z;,!#\%<0'G &#22*"=,FI:J56BJYJ^^R$): SF-I.N/Y];4,0!VY?
ML'>9F9U=C+.>BS=9 2COO6&MW/N54MT.(7FIH*'RB7?0ZC<E%PU5.A17)#L!
MM+"DAJ$H" AJ:-WZ>69S)Y%G_*98W<))>/+6-%3\.0#C_=X/_4?BM;Y6RB10
MGG7T"M]!_>A.0D=H4BGJ!EI9\]834.[]YW!W) 9O 3]KZ.5L[YE.SIR_F>!+
ML?<#8P@87)11H'JYPQ$8,T+:QN]1TY]*&N)\_U#_9'O7O9RIA"-GO^I"57M_
MXWL%E/3&U"OO/\/83^)[8_-?X0Y,PXT37>/"F;1/[W*3BC>CBK;2T/=AK5N[
M]J/^@^8F1",AF@AA_%\"'@EX04"#,]OJ"U4TSP3O/3%\K(Z:,Q'NL![FQ23M
M[.P[W:W4V7N.XVV&[D9HQ!P&3#3#1!\1QS4"!Q,$:0.3B\CI(K)\/.<G_Q#
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M_8]#]Q_*?'N^_^'K_/CKVXO_ 5!+ P04    " !YBCM*B-TU(.$#   2$0
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M' [B4=6,+TL[.%L!82LX=G+G#4E37B29YVT,.#0!@28XB]#=7_&T8-23BN)
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MF9Z+Z7><%HH/\TF#E^.N_ U02P,$%     @ >8H[2F*W<'O? 0  H@0  !D
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M)&Y PO&"@Z-NI_/V'1-B=<I%!'(D7!Q.C,O#Q>BA:9^/@,JX)-C(/0MH[D)
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M!U^ +0/ATSN_ BJ=%<"SX=2JK]T!/857/L9 'Y^;'BJR!=P=&<WPV63=]"!
M=\J^4_,XGON?-DNXJX:5/^*/\. =+/H>-TOBC58_G1-! &!>7CUY?>H/$?I
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M PG)/('9- 50:-3P0B, *F<4N<T JO:Y8WV%L#0#Z>*I)=S1%#3TT4%<Y5^
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M]VQW-R$)L@52_!5H("M2X%!L,$BO,-@F5Y/E= =H_<<K=X$RM[ZEXY:D%80
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M\QY)_H4QLR>L7T6@YJR]%@J7Q[ &<;&2_L?"LQ4%MXK2S0*/,X^5.Y2<6CI
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M(V#$[XJ56@=@UY5>5Z&Q5V_KRF0'7Q(E2<BKD#PF\PTYXG,NBZ3,KY+O213
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M+ 0 K55ST6XK)HW=_,!^(\J$E<^:9EI@9H?G[%V2% = \R,).B#W9U:NMZ[
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MTZDI0RON+D[9V<"]SX&6W>>QI FIR1L.HK;YS%0*V?H@*8R\.DPS44PN9.I
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MNX"KP C'7V9/P9M^>S"PM5K6")&@7%&G=_CEAIM%4EZ H6M[P0?S7A?N0A8
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MCV-^=*S6KI>"[#>J]3&W[KY^2#6#"9V4F'8!<'E%"VJ=1!"APR+XV-6$2;K
MBV%[PC)Z*C98#( "Q2T_J=$-4)]]QA],XPZVZQS'OT<KLG,EJV09Y4I.X.I\
M-(I;7UE0!,_H<QZ!'!+EOP57Y)K&ZCY40.F76$H<N3?$W1L+#-VDXK[$>]BK
M'5!".\[X,0,\@YTM,2SE% /YLSQ-(L<Y',GP'**-- LF1:^>7.&$#YX?$A[+
MW1<P,[3$=/TZ^'2[6L&GYD%*[:0Z2"I0V/-B_ZW4;@MB+#<@;<:6=,Q<X$V]
M:E4LE*8H)M$48.4CW!X##NP%%(^\<&Q+/>U8>=+59,B!J:X_NL=M O7Z<J6I
MA;C;V%64U2(:^EQ+*N):,R#&1/0@Z%2S/'&0E2<TYBN<I% FI*ZNM?]>12?C
MD7S8L!9]C.XM>T#]U#&-\U%M -ZYU?.(_M,.KMB3CI03'Z/N4W>Y% Z.,00&
MY34LI,&@R?Y/?"I2?=/1/\?E*MEVB*H.5;?B!2[C>_RD(;]0WGN6&#%01AI@
M)(7NX4"2,9XE4.*<44K%9A/I<MKMX+2FU Y]A4AO-?D0:4S+Z_ Y$\, 7P%6
M!!*P4'4]0JO+&%>>5#T>5,Q3J#B&WG,TY^( JE1^M3\YU5I)V(FC:F,CFNHN
M/C51X.(2F.IY\'GZGW7.;[JP[\?F&Y[?PM-'H.%9"U!]W[$&DK:B!$<L.9?O
M5%4+K=GJZ*H?6CO;7WW@RC,_M$ZY5E#K3>N8_CL3J;YUU,4B%9P1=W0R'O%?
M1#G-6\?N&WW)H#N2F+QWK2F5%%#Y*+YFZ':[0""CG@J%&.TT))-E:]CA"%KK
M;*_-R;R7DU&;(<I9J8-5@K:9Y0CK=@-W@N)[CC@H8JZ[:*J8B:'0U#RMK3'$
MM8>^F#B+ U,=!RONS]S&QRR]YP)"GNW_H"Y+\K:0[5Y>?62K!3PE!9&H\B<0
M$$KQPF#@/D8"<S!>"U;3&])EZNMR FQ:P[#7[_$1AX->3PZYC-)[5/:*UJA+
M'*]U,N9_B9"U>F.>H#?F-VXW=R65,SGIA'UYHS\.!R>D(K2P8-X//B   -,O
M /285]Z9Y;IGK:]XAYJ&;R%8&29%74.VG9V'G\(YGO3&1B+KAEU6[*HRF8FJ
MEPI/>%T;:N;$E9V"(ZV78)L_H,+9I@BX2OU=7#XAA^MU>AT!F_[@'5D&0;+
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M?]:RF.N@/0Q]=WHY$WDDD+"_U9<6Y0!LR1I7PM&T&_9O2_9T#3==.R1;.24
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MVWO7FTP*R5'4&PS=A3KLG-_1Z;XJ,P.HF45))6XDRQ&&,W8!8 [G?6R_J:W
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M3=U.M9;BG9R*S,Z&-I7*$,QE#0';_,;'V6)AWHBL-Q1KI>":I*Q$<#)-EGD
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M(O91XLE?-TB!/L1QB:C4".5;5QGJG>.WT=*3)1SA4YC'18^@:XL:/JC,YYH
M[@NL<6N@[ X8:7A^.\O7^\3>NJ=6!0TB6%B@0>J:.[]1>01! 0)[XB'5T6-5
M1 '3HR+ ADT1</?#N[A\BN,4B$BO(URI7XLWV;=Z!27OJ1H3M[K&1.4E[9NL
MG?V)[_#WG[QA6+4@E75-(Q#W;^9\C9=1@["&BPD;4C8Q9_O7+/^-'<O-!GF#
M4=L?O([3M'A>/D:['VV$8E]1B^#H3E7IV1(7Q;5W:HOGHCK5KU7YE'H,!Y;B
MJ1&,5RBX4V=!VZKM['U>F =9Z: !.(VPE3_;-4U,@RUK98VGN;WP3A-0[U^'
MI^DZG.(['J:MZN[4D,0;8B=5=^ITN*'<3N.JW!H[>]]-I9P.Q0>;^C2J^'^]
M#DXI!7":[^>K1VZ.@-Q9EJ?ZPA&32D\X5+4B3^W-<;OG>1%K\WB^]I;JJ3[4
M\<7+'EJVIV;R\;$"K.'C6>76DCXU)C/P+??$RWI\A-$\\WU1E#_]_U!+ P04
M    " !YBCM*$X M-C8"  !_"@  #0   'AL+W-T>6QE<RYX;6S55MMJVT 0
M_95E74H")9*<VJ&-)&@#@4); O%#W\):&DD+>U%7*U?.UW<ONM@NZ<6D$+]H
M9\[LG#E[0;-QH[<,[BL C3K.1)/@2NOZ?1 T606<-!>R!F$BA52<:..J,FAJ
M!21O;!)GP3P,EP$G5. T%BV_Y;I!F6R%3O#E""&??R-S2/##V>OOK=37KY ?
M9V]FL_#A_/H0/W.!<XP\QZ<\P='R+0[^GO0B?)K7Q ZH%_](_5ON0_*E)0_Z
M#4KC0HK]?;* J4XXH UA";XAC*X5M5D%X91M/3RW0":95$B; S+J(HLTCSX<
M><^>7<_#J9#*U?85_'?=3S\(#)X52!D;!<ZQ!]*X)EJ#$K?&<9,=^$L(]?9J
M6QN%I2+;:+[ 4X(;3)&U5#FHL4R$!RB-&116CJ)E94<MZ\ &M9;<&#DEI13$
M:1@R>L/09L#8O;W8WXH][JY ?HX]DA CJV(PS:I[<SJUT$G>9?/<N[3A4;RH
MIANI/[9F.<+Y]O+ G8*"=L[OBE& 82=US;8?&"T%![^8/Q:,CBR8QF2H@RJI
MZ*/ALU<E,P HC#:@-,UVD1^*U"OH]'"=NN)8S?,3U/S<^UR" $78KFAS]U_R
M+I^>8O=3.=3[C!(OKUZ^1MM)3T#DXA1$+O^SR*!O.CN=;:^OC2A:MY1I*GJY
M%<US\'KLPR+!7^VKANUUEZF]&7I-UN8UN,=O<G,H2,OTG5VB"R9XLC];X=%R
MG+4:*1(\V5\@IRU_YPI.3\[T)U!+ P04    " !YBCM*]=TL$SD#  #M&0
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M,G8G;N!Q B I DF[A&0 DB&0S#CD.YH,=3'E02C)[)K,YGP!(/L(9+]+R &
M'""0@TZF^X@+((<(Y+!+R%, >8I GG8VW9XK;P'D&0)YUB7D.8 \1R#/S4*.
MEU($7$KB!CZY7@:^"&[@"M[#EO">63:Y'$O^<ZD?&N%W^A=RH6HQ[!:YG$[=
MQ4,SD5+<!.):>*YF=#UOM@Q" 3$QN3B&[?*'1Y*Y^^".)WP_Q;IQL=3_1WX/
M,3&].(;](F_=!;^=37R^D%^(GF\1/D VS"J.<:U,IR(\A&WS]'1(ASI >. )
M+B$D9A7'L%9$H#$Y"=W[CTR81!S#%G'CN'C66\/\D<R+-(D357TCJ[=#Y0UN
MOQQ,(XYACZ"1[)Q!3$PDCF&3H)'L0),XF$H<PRYIBV1RHM.45%5?X8X;DPHU
M+!48+:UPF%FH8;.TV9B<^*J.DO0C)9JU&!;+WUYN)\2<0DT[!8MKVH>8F%ZH
M8;W@F#!KH9A@J&'!X)A#B(DYAQIV#HX),Q>*.8<:=@ZZF%/H'(HYAQIV3OMB
MWA;HF')H)\HY4L)]!L.DPTQG,A@F<R FIA]F.K%!,2G$Q/S#3/L'Q?SPV@Q]
M;]9!8O.."27$, FQ+G,<<@(Q,0FQ_YCEM*Y##',/,^R>=CKRG8@\+C(%,3'W
M,,/N^10SW"I21Q 3<P\S[)Y/,1<J+O(88F+R87OYV,<O(FNU27*U#O0M*MT>
M1VD\+TE3'%[5] =-]K1Y3E-/M\WR21'MOV$T8QP_OUS]!E!+ P04    " !Y
MBCM*@TE%A9X!  !*&   &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
MQ=D];L) $(;AJR ?(.N9X3<"JC2T22Y@F<5&^$^[&P5N'\=-C 0[*=!'8V09
MS;S5P\JLWVV5A6/;^/+8^<FYKAJ_2<H0NE=C?%[:.O,O;6>;_LFA=746^EM7
MF"[+3UEA#:?IW+CQC&2['L^<[/:;Q.WVE$P^,U?8L$G,N3+?K3OYTMK@S?!!
M+_V"_BN7SOYG?7LX''/[UN9?M6W"C8J_!8FY'<3Q((8'23Q(X$'3>- 4'C2+
M!\W@0?-XT!P>M(@'+>!!RWC0$AZTB@>MX$&4*C*F^"0-:[S6I'!->*]) 9OP
M8I-"-N'-)@5MPJM-"MN$=YL4N DO-RET$]YN4O FO-ZLZ,UXO5G1FY]PUM8.
MVWB]6=&;\7JSHC?C]69%;\;KS8K>C->;%;T9KS<K>C->;U;T9KS>HN@M>+U%
MT5OP>HNBMSSA78GVL@2OMRAZ"UYO4?06O-ZBZ"UXO4716_!ZBZ*WX/4616_!
MZST=Z>W+S-G]1W#'IO"/+KD:?K=F!+</E\H^/F.8>G?_2.G0;[%FN#[\YV*8
M^AMAKOXZV/X 4$L#!!0    ( 'F*.TIFK-&@I0$  *48   3    6T-O;G1E
M;G1?5'EP97-=+GAM;,V9WV["(!2'7\7T=K$(;.Y/U)MMMYO)]@*L/;7$MA!
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( 'F*.TH?FX<'[@   "L"   1
M          "  9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( 'F*
M.TJ97)PC$ 8  )PG   3              "  ;8"  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ >8H[2G8JO=.; @  GPD  !@
M ( !]P@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( 'F*
M.TJN<5?#N@,  (\0   8              "  <@+  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " !YBCM*1SY3X\$"  !3"P  &
M        @ &X#P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ >8H[2H&T]>9S P  '0X  !@              ( !KQ(  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( 'F*.TK8<-33  (  #0%   8
M              "  5@6  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    " !YBCM*F%MW#Q,$  !&$@  &               @ &.&   >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ >8H[2HUF$#S% 0
M_ ,  !@              ( !UQP  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( 'F*.THI19GJ+00   ,2   8              "  =(>
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !YBCM*)X6H
M4,4!  #\ P  &               @ $U(P  >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ >8H[2IC */ZS 0  T@,  !D
M ( !,"4  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " !Y
MBCM*_M#%;;4!  #2 P  &0              @ $:)P  >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( 'F*.TI>7]=#MP$  -(#   9
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M970Q-BYX;6Q02P$"% ,4    " !YBCM*S!>GU9("  !B"@  &0
M    @ &J,@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M 'F*.TK H70HT $  )P$   9              "  7,U  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ >8H[2G_>*5FW 0  T@,  !D
M             ( !>C<  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    " !YBCM*-_.Y1!8"  #Z!@  &0              @ %H.0  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( 'F*.TK 3^:'TP$
M )P$   9              "  ;4[  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ >8H[2B@S[48F P  3@T  !D              ( !
MOST  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " !YBCM*
M,-=G0V,"  #X"   &0              @ $<00  >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( 'F*.TI=D,]%U ,  !D3   9
M      "  ;9#  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ >8H[2I^G2->] P  'Q4  !D              ( !P4<  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " !YBCM*>;4^.BD"  #R!0
M&0              @ &U2P  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( 'F*.THA6#[\+0(  ,D&   9              "  15.  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ >8H[2EF\8*C[
M 0  5P4  !D              ( !>5   'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    " !YBCM*/[R&3@0'  ")*P  &0
M@ &K4@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( 'F*
M.TJ(W34@X0,  !(1   9              "  >99  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ >8H[2BEC\4>3 @  )0H  !D
M         ( !_ET  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    " !YBCM*V4L^+@X"  #6!0  &0              @ '(8   >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( 'F*.TK8'J%OX $  /H$
M   9              "  0UC  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ >8H[2F*W<'O? 0  H@0  !D              ( !)&4
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " !YBCM*<C22
M-XL"   ("0  &0              @ $Z9P  >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( 'F*.TKKA9*ZD (  '\)   9
M  "  ?QI  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
M>8H[2B5]T^9- @  1 <  !D              ( !PVP  'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    " !YBCM*B+8(%#@"   X!P  &0
M            @ %';P  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( 'F*.TH'@_K1LP(  'P*   9              "  ;9Q  !X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ >8H[2H@T&!DI;
MV;\! !0              ( !H'0  'AL+W-H87)E9%-T<FEN9W,N>&UL4$L!
M A0#%     @ >8H[2A. +38V @  ?PH   T              ( !^^   'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " !YBCM*]=TL$SD#  #M&0  #P
M        @ %<XP  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ >8H[2H-)
M186> 0  2A@  !H              ( !PN8  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ >8H[2F:LT:"E 0  I1@  !,
M     ( !F.@  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #  ,  "#0
&;NH

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.6.0.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>147</ContextCount>
  <ElementCount>235</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>58</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Disclosure - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/ConsolidatedIncomeStatement_Parentheticals</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/ShareholdersEquityType2or3_Parentheticals</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/ConsolidatedCashFlow</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/ConsolidatedCashFlow_Parentheticals</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - BUSINESS AND FUNDING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/BUSINESSANDFUNDING</Role>
      <ShortName>BUSINESS AND FUNDING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - SUBSEQUENT EVENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/SUBSEQUENTEVENT</Role>
      <ShortName>SUBSEQUENT EVENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/SHAREHOLDERSEQUITY</Role>
      <ShortName>SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/SHAREHOLDERSEQUITYTables</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.copytele.com/role/SHAREHOLDERSEQUITY</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.copytele.com/role/INCOMETAXES</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - BUSINESS AND FUNDING (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/BUSINESSANDFUNDINGDetails</Role>
      <ShortName>BUSINESS AND FUNDING (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/BUSINESSANDFUNDING</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - SUBSEQUENT EVENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/SUBSEQUENTEVENTDetails</Role>
      <ShortName>SUBSEQUENT EVENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/SUBSEQUENTEVENT</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Summary of the changes in the fair value of the Company's Level 3 financial liabilities on recurring basis</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/SummaryofthechangesinthefairvalueoftheCompanysLevel3financialliabilitiesonrecurringbasisTable</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Summary of the changes in the fair value of the Company's Level 3 financial liabilities on recurring basis</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Weighted average assumptions used in estimating the fair value of stock options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Weighted average assumptions used in estimating the fair value of stock options</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - Accounts payable and accrued liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/AccountspayableandaccruedliabilitiesTable</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - Accounts payable and accrued liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - SHAREHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/SHAREHOLDERSEQUITYDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/SHAREHOLDERSEQUITYTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Information regarding the 2003 and 2010 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/Informationregardingthe2003and2010SharePlanTable</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details) - Information regarding the 2003 and 2010 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/SHAREHOLDERSEQUITYTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Stock options outstanding and exercisable under 2003 share plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/Stockoptionsoutstandingandexercisableunder2003shareplanTable</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details) - Stock options outstanding and exercisable under 2003 share plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/SHAREHOLDERSEQUITYTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Stock options outstanding under 2010 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/Stockoptionsoutstandingunder2010SharePlanTable</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details) - Stock options outstanding under 2010 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/SHAREHOLDERSEQUITYTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/Informationregardingstockoptionsthatwerenotgrantedunderthe2003SharePlanorthe2010SharePlanTable</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details) - Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/SHAREHOLDERSEQUITYTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Stock options granted not under 2003 Share Plan and 2010 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/Stockoptionsgrantednotunder2003SharePlanand2010SharePlanTable</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details) - Stock options granted not under 2003 Share Plan and 2010 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/SHAREHOLDERSEQUITYTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/INCOMETAXESTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - INCOME TAXES (Details) - Income tax provision (benefit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/IncometaxprovisionbenefitTable</Role>
      <ShortName>INCOME TAXES (Details) - Income tax provision (benefit)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/INCOMETAXESTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - INCOME TAXES (Details) - The tax effects of temporary differences of the deferred tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable</Role>
      <ShortName>INCOME TAXES (Details) - The tax effects of temporary differences of the deferred tax</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/INCOMETAXESTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="itus-20161031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - INCOME TAXES (Details) - Reconciliation of income taxes at the Federal statutory tax rate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.copytele.com/role/ReconciliationofincometaxesattheFederalstatutorytaxrateTable</Role>
      <ShortName>INCOME TAXES (Details) - Reconciliation of income taxes at the Federal statutory tax rate</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.copytele.com/role/INCOMETAXESTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>itus-20161031.xml</File>
    <File>itus-20161031.xsd</File>
    <File>itus-20161031_cal.xml</File>
    <File>itus-20161031_def.xml</File>
    <File>itus-20161031_lab.xml</File>
    <File>itus-20161031_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>56
<FILENAME>0001513162-17-000027-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001513162-17-000027-xbrl.zip
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MP<99KY]#1\%$.;6Q(2A5,7(V[O4R""F$1 8DOKFS1EGK U5ZDKK/39'#Q 8
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MFMNIV:'V=TN0ED\7%!6X;HNG;@XH:=NE!#NCX6BD#P=E&-H!01O!TN:0=#9
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M<6I>/+@VS[ZN(=D@VXUA-V"*6"*])+?&PT3Y/$#Q3 7RLQ$T6]>:E(&3/5,
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MXQ!]0KH#[C%=$F*>GECGD8ZWQ0U$P#$$&RQVE9:G:&6.4,E'D8H0#&SP@%X
MSDV(,[W(L80=0K-LV4X4AP.(A$"Z%Q/\V61X9Y&=N' V.P[@R-G("&G,TD%T
M]V]Q&#O&I7@(8A2:EELCD!<:$E]+H:4]+>_1?31\(*:%U7ZQ'\ SP;&%CE=.
M[CQP#H>)Q%9J'IN"%Y.9ML#173=@*3ZM)3X>3:1-](0D;9*B%2!.(O#N2/0"
M$-$ :$K'*VW F84+%?+&)1\W,6$=B GQGGP DX0$S0+MT\2L@<8X9H<@PIXQ
M02IM@C2>3S3 ^F0D>98I?>E;0C?W=HD#LN3 [9Z)4($MY.:TI0LQ\S(O3V 6
M23M(+)I7%$8@VMXP-YF!EH-#("8XM_)-*ZG.UD+*4MFH@76L;DZSQ:UFD.*2
MEL2$9*(IL!6"S0\-?N+%8JCQQ/1HXV,<<\ZU7=J/Y::1.XOBY,[<H[-(=%*0
M@?)!_L%V,, ^7"@BK&@%5IF+]D2I3>'DQ>%!U('3HH"/B06M4AC#^(U80>P4
M<\I))UT=#.]];ND2^\ -9:91W8[G7$_,<\.,!/8IH6P#=2I)F"/))\CQ^ASO
M*:/<*M!VQN-223,D!A>96N,'B^$[4'(N-2GQ?-1MJ-,YF6G@C!81QM-#-69&
M.7N-C0_<5NJ?Y1A[QAAGSB5'S<N<*$\<M-3^NZ(JV3=0<V:Z*0BK?^%@B?']
M-''E>/XB K,6!)/(B=7>W*#F7C22).8TE3"A(K36> 5&H8HE(R$/;1$N V]9
MNW*=3Z&=R_ -K)\71\%)07E+",O&GX6N;3G&>$R*> JHJ5UHB#H0+X(QC#NL
MP\YIB)5L@4%R(=>)T^Y\GUU@*[%V8E=_AO59L6U,/%T  6^2%QTG,4\GS&RX
MJ"CTKRW[ ?].^]WOM1OQN](K3N@6L[1J9>5M#]TNM3'NC,'3YQ</)'_^ >Y^
M.DKA!>'C59<DY<&H">!>6=_E(GCQNT+(.YM!ONK6FXV@[Y="+^[G3<H0DKSF
MFI4,-UR)O(SDOKN5,)=VNJ[ (=U!NY>!+IER@PMXP2S2+ZO!++U!XX\\*N/,
MOW3#>KK/4;@,O9W'<B5X"VY$WVF)HW)*[+S$S=>F+=^$LK]+6[K]KIXA0/ET
MR^**S^9O'7&M3:^.:V=N.UD"L-,=+0%8;=*"*V5VAU;/0+MTN^QP,*X'VANP
MYQ YP2\?'_#GQK?+?YF]\COR)L/-C_<W'__OCX]?;[6/_X1_[[P1?Q0A3@EF
M,KW>DJTQ] E%7D4T6\PG06X8-DK7+C1PX_@5S-I-R;[TTI,%V^^9_ACDTEK8
M["OBS3*ZK;[8<&+)I76X(4Z'#? )&)3-YG%&2G3=$#F.&?J0HE/K4HHW3DR5
M5R#F,U;4'B_)# ^DA'R^1"'7%#F+4[ZGO(1#3#"+_I?B%9XND2L&:%G2BGED
M'V)3(@CW(# J)\'W]"W4:_F6 <LG\TK>:V'RQG2\(-YH7;LP"M)BPOQL_Z+]
MU$^K2/F&Q<\V?&V "/V-HYMZ>MX!_C!N8Q@ \IU G(%W%1.[FW&QA" U#^40
M08!]JX7[E?$3 )^HNN 'LSTZN'#'L.2,G\3E(C!,=C;Y1&)MF7?S8C-<QKN$
MM@_Q2C(HY_MVL'!:>9]ODCV*.P*Q9C_>5XV1Q>^K6LFQF2H1JL5(,YP\IPD\
MS5,&>OMON(WD/7).F]JX;?MSM_V+9AD+[<%S(H@)'QE*&68PL*W</4OHGDF0
MYF<5#_$2CB(\(!IC,M\M\'BZS=RX?_Z*ZP3$-@\_Z1!DZMA$DVC<4XFKS"'"
MM#'%+.7F15(4HF%7VIY.-YI+JMH+08KS+%L'R:7^0^ZRNB0M?3WAMSD2J_.O
M85WZ2L=YS+T/X7X,;KWDSS^XI%XD<DJ#"R\Z!UMQA-//109K(96N?%]ZEKQ:
M+#A?L9I>FU8SX'$Z+";^JQ*\,;BKY\]?K 1,&V+;>)_N8(KO!OT.5HJZ)UC?
M>(-A%(X$<A!=E@>=>Z75 >Y 8'*N=U+L5@<D[U47DX6'.2NY9S=\+UTDO1J0
MY> EN^)/8-[X"RM![N3PS-5,HGH^1 QUO8Y*>P->U_-K*8,MSSZ7#JBNY,+5
M:Y\ND_U*W58!"6F,2I=&O%^(YP+Q8+#FML*-N8JN,%R2V]U@+(@Z\X26;U3*
M+J!;QF%BEI4T>O=\QFT%5TN+S7/#3;H%HZY;.YX0LIL-(;]\N?C^+ZD3SZ?T
M[YNKW[Y>?;JZO(#0,BWDNKR\_O'U%B]A2P]C77^^NKSZ>'-$E>#/73Q/>P<H
MEO+NP9'A;T^E]+>\&;C89V%6\1Y1O#D4BGW,R.5;WFLN2=-67Y)VX>">&W@C
M9MP;"WN=&2;?&DMW_QBV?J86#LVO5ZZ#)MDSTMN(RG?1,/D[/'7OVDOL_A).
M0!6B-D:,C6>("3=XXQL5A6!Z8<XPE4'G.T7J@%<^ 6.C3R&.VE/Q5A"G'C#-
M)>WHRIO6R:XMB (,C06:!8<01&F+Z-R6SM.*0_P9ES<LO9O83[S9 -Y20,<?
MJ"T@SP<\_,*;?&$/ C.,-X81?C$"K1JOU(6WQ)[X,<C4X3I(5^(A<?KY<]QK
M_(@,R5Z/9,4U=E@8B:46@;CA$BLUX@[N$GL+44D.0"27IJ7U]G$//]Z#(&9Y
M?);Q\^!EW=FY'7+YT6Q+5*\D,]S[HN]?"G'(2&8P"$A.(HBF-&G#C?RUF^L[
M?TC>7_K7+;]00,9$N)CCM73.(K&T 196@%V\L]WDAD,J2(%IO$?@NC?I@*BY
M,NM::B3J,X!/G(:FVC1>UB+U$ 6.BB:(:I_%1V?IQ%;2_P3[)8JLV[;82)*U
M<>_%,]<+ST+O#*+X6-GQ["DUFXB7')^TYYFZF&:\$T1.]8G>7N(P*O9/$4>\
MI<;]122Y<GE^7&)=ZA6YBB\(V\R2J[:8/V?T+,#GXJD;6!;5#!$,&+,YHHYH
M;OL9LL;748G3RX5 YO/LLMT(Y)Z?K?B&'==+NM-))DIVP3)G1A %?.',\#%-
M'O"]CX ?GD$OS6'BIL2E*QDD<TK%]J)&UHSD91IIFPBRN3E3A;,L&ZA66KA)
MQI;6$\_OIQZ.!K$S56WRSN>S+>].;9*[N%<[AOO3;@@"^YU..L4U:I=4179/
M)HZ.;&/EB;)Q,L+\#,+,%&'R&7>?Q=6T5EQ-F FTI/ J6SP<5SCR/EM4?R>K
M",'Y?(94ZAK.Z\^= OB>7#H+%/L@U2I_%!7/S=[/YRO;WX9^!CUR*7=:$"ZU
MN4G/5>'Q1,.AR%[J<6S9/IZ[H+X.2U?*2FW%-[E6N?1*Y=9Z42O)::2'?>->
M%DJ(5C>AP/;65-*F?0$S'?EE[8J;)#I[+H5)L_'8%-VU#-_"'A 6/PR]?"'.
M3>YT_ZC3SNS^E^"8ZRT[P$V$*->Q86D&'#0[B\4FN.7,6YM3B4PKO6 :91?;
MG,\8'IHA:9O1U%13DKPARDE^N[CXUDKO=+;P5LX$+%&8+KTTDQ:1OS0+4.=;
M5)7/+Q_@D*?'./$T^;WGDU/I9>K7I5W]^$0UG<Z\BX_(\B/5MN>+% AWY^=1
MVF44P1/=*3",L?]"G(AKB<(I^*EG#FHJ>2U3&XPT:$GJZ(AGMWG!#>T79=:6
MF8].I6.(Q3'!P[C,,4*^%8C4 ?\644&'Y29T2QTZ%0!&DB!*8.">>H(BT3<_
MR*(   ,R\R$X/-RAP#(*Z?HZ@9)BLJ7HBR%MN)K<GP?X:0T#DC_F6ZD9RASZ
MR=BD.S";R/D@?DPD]V1VSU!Q+>.BE16I@>!-XXE3!R4^$T?KVIGVJ5"4'J=>
MP%$E/.4$H9'+C[? )QR-'Q./S\#R@[%F2F#/S]"7[NR+^\J)-CWBI)S0643U
M]$R.0:>+XN8&LE0A&S1?D.JC56<+6@D""40+.N&)<?HB/G8=^OPR<<\$+RZ@
MMKA\Q]^ADZEKAQ?C8K\D&2I^Z:^XZCD,??LN"@4+R/3/YE->#CV[DMO2?;LQ
M:6.D^\7ZC*R4.+N<Z#\Z"(^#0)@!<NS=84=F(SYP7V#0/+K3UBDQ;+F[\X)D
M(I]-,"V%25'C/M?[BWI&/[K\9*;HR<*='I)\^=N$;PV?'\K%HEXJNXUH+L)!
M7)LJ6==CXJ<];DLGJ6Z-]S.8\\W[(.L&D=HN= X%I2U4OA(#X.X VFE1[WE'
MM0%&83.MBJ:4@R>O\=&VPND;K=\G#-W1>=PS3'8:\P "BOBOMUH<KH"O.8'(
MQ(A"+_F*\LSB.SZL1N.*.8;=KOC69(X3S UD)?%;6_IECL=L\[_0)C"5Y(1^
M!O(IX[/J_?-A/U-!(QZW5CZNB97W!G][JXF9*11[RT](GR&<@ '7>_2->>9Q
M 3)>UGWOBN%!T$-OEH?A68)')(, 'F^1O@?PIV=T/Y=MUA5+%N7E2U@PK:EZ
M'5K2(9T<?03KA=X<UC1_>JLM$4P\(9B-GA%$T3M_2W[FA'@#/[F6]QC28>5Y
MJ)$[FSS$>9B&J$YZG"7F5@_9.*9]IQ)#'*"RC),?@0#)I>,:6_-)T5@U\8YP
MB$O993VOE,ER9R-1[E23Y!R#QW!IBHT5&T.LH-A8L?'QLW%7L;%BXV-FXUOL
MWKJA!_HZ]&6N/J;PHD0,CDP\RT#3VQO!AH\KI#48-$5/14]%S^:"]@ST/)CM
ME5L?_F_39&PRV4N^[\03?E\\ERWB;0+> 32SJ8)'RZ4#A$GC9JG+\YY"C!T)
M7%'0GN5DZ&%)_%,9@;:G#RF6'0E45=L<-A*B@+&>0(@/51,1]=9H/&[IW4'9
MP;E*R?@7(F^'(FC6#B8QJ:*#TGM*[]5#Q%3&SE9D@93$*<W7*#HHS:<TWXY$
M5/JN0814^D[I.Z7OFACA'O%FWXE+Y67)A9QGVDWAK7"[)#9V*0@X2#U DY1U
MXXWF3N4=[8.4=RC5W@A7]HCKD)3:46I'J9U]JIVAN#V\_NA J1ZE>I3J4:KG
M6;<ME )2"D@I(*6 ZO)]JF72!N>Y1-K:HD3^QF;%>VG;,<)D/95\A^4,[/!A
M3Q;/G86C Q1+1]/WDVL3E%ZC]XMH7ZX].N<=&)0N'7;8P0S":6=F=]@OV8'X
MY5LJ!Z%^9?NAS$?MY899$W#8O<]3(><>7#NEKY6^5OJZ*0+>D%2GTM5*5RM=
MK72UTM7-W@U7>EKI::6GE9Y6>GI/>KK3&O1V+DA]3:TYX_=4Q]1]=TSMJXZI
M#:MRWJ#[AVKK]5+:>JE>H8J-3X:-5:]0Q<8GP,:J5ZABXZ-F8]4K] C%\\"]
MZU1F(TNAC?]:D0PY;CMQA* I&5$RT@A&;#!H2D:4C#2"$1L,FNH3K/H$KQ'U
M*GV"57?@(R2LZIUT H:X-QBVQH/AGDZZGY"L-;ZPZ(700>D\I?.:449YVG*F
M]%TSZ*#TG=)W2M^=#B&5OE/Z3NF[IL6T1[R9?^(2J7H!GZRB+C*%JM_42]/6
MJLV=TB9*FRAM4H\VZ;1Z[=4-+91645I%:16E592/HK2)TB9*FQR-CZ*Z[*HN
MNZK#S&$8Y6AW(52'F1=A0FHLVU/=P%0W,*6KE:Y6NKI9[K[2UTI?*WVM]+72
MU\>9[%5Z6NEII:>5GE9Z>F]^]6A-%D1UV:VMRZYC&W>V8X<V6]5J%T<)?<,-
M##.TX;-EA(S.=L,/KF98F'.']W!X?#2([@+V5P0 :(9I^HS>\2::C;V]6!"V
MBCOU#DZ\4Z^V9HNGD67(AVK6>^C]3-573S7K56RLV%@UZU5L?!)LK)KU*C8^
M:C96S7J/4#P;U$#N^)'68- 4/14]%3V;"YIJV*D:=J[QK[X9(<_(_A79@<US
MLG> #P/_K&=O]+1;F#1^=U2U*FG*'I9JS=0@0JK63"=*!Z77E%Y3\J3T6B/=
M;=5RKB%BL@L1>RU]J+=&PPUO_'Z9\J;T7C/HH/2>TGO/H_=4#>:QUV#V50WF
M46\5JW*)EU(NH6HP%1N?#!NK&DS%QB? QJH&4['Q4;.QJL$\0O%L4$W0\2.M
MP: I>BIZ*GHV%S15@ZEJ,%4-YFELGJA:I4:00=4JG0@AU9[]B=)!Z36EUY0\
M*;W62'=;U2(U1$QV(6*W-1B-6OIHPWYP+U/>E-YK!AV4WE-Z[WGTGJK!E&HP
M\<XE+(D,IYJA!=$,B+S JD>LD#2GAGL/Z[%Y;:5<;<D?N/1F<\-=<%WWU&GK
MX[>!)C;Z2\HWPZD1:H;/5M1Q&IK/S,CW$<@[(["#$Z^X7)V9SJ:EUZDD21^-
M:LA*CU[F%68T@,5,SZ>T\QM '_,=VV6'2'(7<'OU4H,JC'$X1Z)LUZ@RJ'H-
ML.KU;'$=8B-IM%D11V7I/"'1K"IB[PT'K _+5^_WZI*G ^RY*B]\&R\\3PJM
M<SZ>A_$"ZU$5)Q6H[N:!=[J#5F>D[^-"5^7Z-%B_7A0=F4+O?<Y]FRJ;]NNE
M?$5=[>JBVBWN,CGXO=U'RC6%B:T]DK+<!ZR!EONR#LHXA&][?;TU;I<?D'TN
MP[ 7&W"DPKP'%[N_IY"U?A5\I#3;4@&7!]C[5XA*'=:4K5:^\A$JRL/XRB\C
MU[<GATTIJ/!M7Q^WQCWEKYVJ&OKN+0PG7  ^%S/:?IC/'9M96NC%BFC#JOM]
MQ^^-"=6/E%F>)U+?^TEF%89O)/8_8X:V/_RE=K7.[Y0MRHI7NQGZH)[GD8KP
M'N+SP6[QN;I@^@7ONNURP?2^J:\V^DZDW>&!1 W8#'Q>^ 7+Z^K"TW7D Z^Y
M9VGQFQ%0B=URW1M5NN&SN6HWS79-)[(8]4#DCGE ;0SGOC=G/CCP^(&!ISXG
M-Q[XW)QFAXX"'$VJJ@N9.77MOR+ V>.4N>P!S '\"T?V?+G.S[1],YH%(1H.
M_,*R3>JB".N%OY,<QFP.8]/L[,D.PN!<2YU-K#)D8 !G!G5;S!0-SGT&;P+T
M3W/F!BQH8>M%4 < !T0E5+^'B\-^C!%+'\-0Q?>>:$CJ%@EC(FP/MA4!BDW#
M]Q>X8F/&Q[)PR1[O\CCU_!#6[\\TUP@!.Z)V,4C0A<L(SDO8>B6C'K0F= V#
M;ENR5JEP]-((ID08^N,CL!Y0%-&VC+4FHS!;5MMKH\FJ#3TLQ0H*2X!B@;PV
M!37L+#0'I,^V6C(_VNX#R FQ']BE< JB:(.N H:>(:?R>EGB5I\!MP)H4Q)7
MAP5<C+5YY(/L!LQJ./LB[IZ3?V\0Z6>$]*L4Z3LS[S$;JHMP*2X@"<<-O);V
MR+2I86DFF!M[0B: .-%B *L=<FZ5F/3>9_ (MM4U7&W<UBQCP4T6L2I]JW=B
M#B;.I4P36<&)]M.PWVZUVVUZXZ=.J]>FCRW-9\&<F:']P)Q%BUO01P8:W'3
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M!8"T#G?:E8)9G1\*/?//L_?$:&AX( 8IJ7QI- KWIVQF!KJU,$V F*)<9[A
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MS05!""XH<B7Y6H9$ AV]'C[#%D(A2U2A$E^6&KVE=\>$7>$HVHZ32Y"0AC)
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MYT%OVIX:O#)X8XZ.X3US0;4YV)#.--E<:G/ZP[7QTTT8WU1\0;E"@W<31J$
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M(./YES2#,\.+U1QF8(Z\F$%)BC )(A5*@=.'6X7PK!?&]RH2OQ>)4%YU8TJ
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M07Y,$#Y,XE.  E/(Y:R\M 5":Q,D-8_W] KF7-8]UO9WJ(4PF4&9#%L4F4Y
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MH51[(US9(ZY#4FI'J1VE=O:I=H;]=JO=;I?ZDTKU*-6C5(]2/4>Z;:$4D%)
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M#]V*6^(NM-Q'CS\-ONF#P=L40FJ!Z3AKSV8+7/ODPV%67I4:VO:JWZ.MI,_
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M9?KEWF@.E4Q=U<S&J(WV4T4"[334@[1B%;*I1%I#9%M<>AY,ZQQJ/GSM1EO
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M[G;H;@^E/(E"RI(9S#83H?D!QXDH.U&=![VCZ<-.KY?=]")'!/(SG80:WB?
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MX)*U]=;#T;&5]U^<JUVU/YGL6ONV1:PA(LI<7=B^&1Y^6MTH!,'QO%.TZ!P
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MJF(!GEW%?S!L!10"U89X]TAQ"?XT4WP'?B6*$2,$O&Q)R>-UL'Y[^L!>8V
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M@CM9X.6:-K(6^/HN<]#N.(6[RDJ3@8F](Y9)'KD51  LT[@S+1,APJ_0F0S
MK>>:$E0B_*7,P8FB+X*_'2N(\2:\;,&4!HL18(G@^,-2'LT96#YX!+5AS \.
M!R!VPN@D6KTQ>R0(.)G/00.CL" 2Y[ H>TJQXX3^L<MAHF:-6RQTEO/QY\\
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M[;<J1EW'2VDZZE]?_WC<OC@E_P-02P,$%     @ >8H[2H]^.Y::$P  #,4
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MM2<8-NMT3-=9C G=N]@05'!W%N21&91YW6,-O7%RSWM#[JBN!3/?=!9<D&*
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MRN\DXS?G/_,1U>%%#E#B VX,"Y82#;*T(/.UZ*I/-*(O;86F4 ;"- _AW1]
M6$D=5F*8TBTN:%I6$'XY/_R*@O KF?"[8BAL#/CW6^+[+G]FP6-U.,H#,VU^
M=,G3O46_*A97$E"E%N1ZTREH=,#OK&_S"Q]JD.T;(((@-*G#5EZH$D<=7+BD
MSTRQP:Q>\I8%,7V^W1'39"OC$:N7Z:1!2[]R5!R-G49.N[+2JXOJT"I=E*OJ
M<)8/J/3^ND0*%Y=#Z^)">4:C,-/<9&+?<K%:'%KE2K&H.),QH%MKLUQ],[2J
MU=>J,QJ%N9TV>=]+Y6?F!LSM6/P)V+N,NIR4"Q1%8_^[1(582@0F.2O',S8R
M:9 Q/(._&@[YZ)BD5"Z6+M3A*@=*V1&O>.^N]2BZE=1G-!&JC%MQLH"7>[Q+
MZ]?E!87L- ?*+!ZC5_,/K>9B:5@K(NX*:^B4:+!(5XWC;3#+;UCT*&W\=,/&
M[S8H6I3?CX%T9^;?F\>KFQ&G7BJJE"'E@9GZPT^I?2MO5$IU<^'<09.OE4H@
M\L#<6I-*+5ERH)3XZ=3>/X<6-S+!9!YE/W>JSMWWN5!R4Q6_*^K^MJ*8G?\/
M4$L#!!0    ( 'F*.TH[S RKJ L   B    5    :71U<RTR,#$V,3 S,5]C
M86PN>&UL[5UK<]JZ%OW>7^'+^7+O="B!-$V32<X90D)*2DL*(4UZYDQ'V"*H
M$98CF5=^_97\X&D;V<@8>N^G)([1VEI+VMI;+\[^&O>Q-H24(6*>YXKO#G(:
M-'5B(//I/-=NY<NM2JV6^^M/37MS]J]\7KN&)J3 AH;6F6BH\F^[_Q\MKU5(
MWVKI2*N9-O^O;J,AY,],7B[_F_^_9]O6::$P&HW>Z?Q5IB,*&1E0'3+Q0,OG
M.8#F8U0H% BGVG<.<P-,K72DE0Y/#S^>'I6TJ]:=5CHH'KN?>7.&D?G< 0QJ
MO"(F.\_-08T[%+\C]*E0.C@X+/@OYMPW3\?BP<+[HT/G[>+)R4G!^>_T58:"
M7N3%%@L/7^HMO0?[((],9@-3%P ,G3+G89WHP':H76N7%OJ&^"OOOY87C_+%
M4OZP^&[,C)Q#W!M-.Z,$PR;L:H[EI_;$@N<YAOH6%@8YSWH4=L]SR!XP7DCQ
M0_' +>(/\>0G_<D%8P0C0W!_ ;"H2JL'H9W31-'M9FVA$CJQ)C;$4.A7$"\4
M0C]?\,15;62--]0^;-G\]SXT$]FY7 0W5;F9%<!Z54Q&2>R;?E9PJ,2RLJZ3
M@6DS"TQ !T-@&D#7Z0 :&($.PLA&D-V)_\B:*U]@05U;=76SP=BB9(B$\^IP
MQ]1%=BS3UY2BC/.[G@"!W2[4;4:ZO*U9A (Z,1!_1+F_A>)I#QJ0_TFAP5^.
M58_$Y<\4T0'6!]CQ575>HX6ZPK$-30,:?FT%9E)?X -R2$ST!1@L?"6A/@H&
M'8C/<YS2)P"LGV7&H,TJ VZ_Z.KSO'N6.$ZS"UC'\9S>YPI"CP+$-O.?. KE
M#XJ> _TC&&#FLV);*OILV72Z[M7+  T!Y@6RLET!E$[XN'H/\ "F40,Y8*=F
M;KWF1"_3Q2H"JOLF\E]7%%\<H+PW"FS0[SNEY1%O@_[GNY3TU^AHD]CT$6I
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M03GF5WE1G!"4#<-Q!@#?\CRY9E: A6R 4XG90J R#PCDI AE*BP;2")'$]H
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MC@TT\I@*C4@5"9+2O=V!.%G'AE&5C^XO-/*N,#5*B.,1+A\8DY'WA>GI"Q,
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M\T#_]R\WUM,?VU]^^>MV\=>7C;5:?[(WWYV?;Q^O5V//G5Q</5Y\^N'JW>7
M^<OY=?C^RV3ZO#)G[VX^WNY^]=__[]EP,7_]6MV]5D6\W(XYF!M0]U./39WQ
ME)..:"B1U]:=0DAB_27&,(VK/S;@XDNL1N$FLNRG%[EVP4U4<_L"SR::T'%L
ME2579XWB=R;PKIQC_$7^BXXOX9-_82I%E[[U+ED4(W,)"&\<![ZW<;#Y-S(>
M*=G$!235FYN:Y'.JD(PJX3U^;4Y%G8^^089O430><;ZN]UG.<@IN),D/EF.H
MO52F8J<9RTTY(6!=RZCJ:7KRY[T.5'40!)N <5UEF5&S/J0ZXJNI<) J)JFS
M&ZX4"H)-Y3TW =V")&,L5C%,>1< JS U8E#VJ+#,K+O6"%?R%A"9K5*$W3?O
MWB^==^_><A1KL8RCM'8+<!DXW.8P"5,RF&$)X>_>O5TZ;]Y=UM?CZ4@JN\2I
M4V1&G@U.R<N+MQ=+Y_+JXJ*N,C,C?9/*S,H3IC]@/O'W]>=D8HSF+T#4J^]]
M9A8V=*<A^'+A#<QLE;@/C0X66Q^\E;"NYDY#P;E-4Z8 "#6;.?L69#_+]LF5
MS1Q1S9&OAXX=X$GYFD6!G"^;NPQI_M5>3FPK<(NBP)*@H.&:?<'4(]=H;=IV
MT,*%#*<W>7FHZ/WZ2:/ IAC#)<67E='U9!YF7QO"N?Y^LK^?[.\GNW,_"7JK
MF+X+_,8N GFN[\15EW=:(E%YP <I3'=EI7<**2& 7),F*,!<*)T(6NE-$*NL
M6>]=>B34%GJF7(14>6?UIV1ZE-1<<?0HJ2\0);4'])2-DII_R_'VAZ4CXZXH
M/8Y2D>>$<Q57/2=":'^26'_7T_G3NOZNI[_KZ>]ZVB'N_JZG$_.EO^MIG<R[
ME1J3J+#K6KB4PWH?+DDVA6KX6N5K0);M%Q,NU7BUWO,W:TG5.+Y=F"JI1]H?
M'O&^CP+ H)<^)4XMIAK]5W5W2C>1^^)M-.\+PLAVO#4%=4=&D (301T<#B&=
M\)/<O!C8MHY2F"W(FY'1"%(R?Z*GX\WS#-184R)OC67,*+>:TQ-M9=90.].F
MO]*6V-Q3_CROT0JTO^7N;[G[6^[*=3S1)&7J>+?A5'V,49,.LW*&<R^)65;C
M6A34%?U57)K7%!S+[;IJI-KVHF-VLU\F7! &J/P.]'7M&I3F2VNOV2F[KMF,
MLSTX]GVOC_;8::.=0>0UZ>Q;@W2V-4A7;;EN[\[VF'??1^2;->*"%@\MQ$6.
M1$F$ZF=VIJ>XTGWE<4U.^\KCOO+X6ZT\EOPZ/3)RV\L.013>_J*7'AFY1T;N
MD9%[9.27@(S\C>4S]"7Z??)"G[SPDI(7B@NIW[[]7DHU^7&<EY/>SP5 ?"),
M"%3W/@7EA:2@E!RZUBR4RE8(I@]D:YR^0W/V8F#G><_9P57.L*:(62] 76N:
M]UI5<V76W3K.7W3]3XOE#M3F0:I,.5]65OZ "F[[1:!)TV#(DVFT(H[\B3SM
MZPX[SR;=7#TAFU#P!!O1!M(.!UUJ7Q_B0:_#00=/;N )F"9(]2@U3B-N$-&"
M9AUHC+]2JT 1!>JQ3-L/5G?RLW"!S^5=SA:Z!C<*LRF8U9S<?=<1/,@%S-#'
M&-E>Q%>&(PAU5Y%4MZ>K/RV2NJX4+<RAUPBM$"%LE+\,A&(9*:N%)9&K8U9A
M@V7J>YJ'R#)\1W[5%G=>FR<%&Q-QCUY? S @?)'W2;'7I'NO(*PTZI8T:7*<
M?96X90.WGOHAEE>#=/U,]%4>/ "HGD_VE;-=1/T\;V+\X;L>S3.;K6+.R8,#
MUT7>G:D]F9;I[2%,1#J/ZBI;A!8*^3IB.$>2:$P-VD3GMG55L[WXN*/!PX[E
MAIYTH-4*Z9[KK#RTW3E8PWO#)!^1Q4M']-,-B61#BR,_%DT[#R1)Z%&)A/1F
MJV5,;W2D1S[=H*2%\YR0U!E?J%SESK'7] CW=$H61-,%;%>/HM#Z)>CL<.K(
M("X0'/MH+T96XF!%GL[NR)^$^)#P0/RMAO%^Y6!:2\(& <4SGD+5,5OG04%<
M@I*<77 :/!VX)7_$GT7.-%4@9!N1;P7)AJO!35<T+T/P(#%LAJ%;QS&^F!:U
MSXGM:?;:)(M1^%4CNB^CK^J(0HZJ2R5;'55*T>Z,1!H@^"4%E)25#LM1620N
MZ67FQ3:"';>A>1904GD@5&Z<Y5,I%!/L4?Z!&JUI#=VQ93E?*,)Z(QK*(:MN
M\RTI1.62,=3Q?8;X%($>SZ7H*,V:Y3#M4FT% F.+39O:9\^1[MBZ:9G!ZSAD
MZ"C) )%0BCB6*.QV2<SM$]/8DV\P";_KI!RD2<Y6A_,(Y Z\Y8'D(B9)OIG3
MPTJ>?6M=&C46IP.I- \%IRX#[Y25X_.$(=!S+"D,*@M5))E1[LF8'-6!0?.%
MZXGYC%($TTPK,"P9;+TD<Y*B)K BKP)CS[\80B#1-2\++\DXN,4O/1&7QTR;
MM(I:_*@+]14YD$J#J<A>E>4W;AR,S+6=XC3>Y7BF9C7H/RI9>5%&(JR/:HPT
M,'>BPEBD\*7PX%R1?V&VHV+0,O&D]#0K)/PV,4441EZ4?F"O[QRRLW;#2R!:
MV)5S4EN5LRY*1-6QND1#D"1MALY!8*[D< 6H+!9)<* (/%R1:TB*/C*!=[)-
MH, XAQM:W3.Q%1TZ2^#JY9B*#!5%YO.#"@^BV)9DL_@"EB4P[45F]E[NS=>W
MG8,(Z5&*\I$E7UWFVUE>LFMS#B"7^DLZ .,1>JSWTB2>IJ[,KA\7D^EXL1A,
M1S>/T]%D>ALA4PO>AQ6.=\?5_)%A&*%$TL)QV?LH5@P!=QR3W_"07>"'/5*5
M$"3 Y8HXKCFRR)PQ'C3L[9=8LUTRUZCH@/#WRL@I;B_(9J5)_U,J.Z $T@*:
M<#A[Y035PNXQ&"^#OF!!^4J)PF#T5:M,*62?3*V!@I$64':O]\EO&G:5>=1?
MBN?,E:QD;*T\%IKQGFT!PN8WZR+5,7M..0J"]Y;MP(:6K2!6)\D=V \>9QS0
ME\=?*ZR(+I[VAT@]\59R0X)@]&FP(R4;7:3[F+PY<H<.IBF]]&,.:;*,HS3E
ME4'23+* P%8D*EX@SPNW5GPFG'FN)<9<N!E(VG7VI2%0=!\(4[8W<%US;0>-
MK-88\4JZ:@QUJ$E\0J^4!0P<M8C(<T3<#N_!8-H%4BU-=1."6,>.CI#AWA!F
M[]":NJYX1L'T*RBCI_#(GN\ C$UZ,,!  9T;!)-H>!Q<U9V9F"(20@%"U0B
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MU5-) ]Z,'M=X>]I$P+&#,QMHCY9+$$I-L#XM7W;5\'-"I?II6G">+9\0?&3
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M+@_U <?>>HY]9(%CIK&,U)'0@T<V<3:,W!1:8B;Y5O+D(DP,:(1<<VUKHIL
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M/V>_;?TG+R#HDFEZXL7QCFP;/WC!EK^4>ZJA&N*O]B1F5!.52!*H(@Q"7KA
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MH5V2+8N5@B ^]&6^/V>0U5R5%A!V=A(%2@2*40ZB"E'Z**Y+5'603^&?*'!
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MK8A&J8#=1%_5Q0[<T0Y>7H1SR-+'IYC]]X+X!_-H2[;]&SS'_I/W$!CJ4*.
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MPA[' 5L@R)8C-H\_&ADQ8@Q'!V\.[J*CUP<'?16L 6D,"K9/5&<%.SIX]>:
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M<%,[WJINUT++QL6I'9VYW3XD^+<MP7[V!/;#Z!H5([/K8@GI$!<@S;Y';(!
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MC</Z!>7C1Q-]Z"KIVGU.%Y9H7^] 8MYLF665S^(;?_5H[*V1&)E=91/2(?*
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M&B)1YH@UBWV%/_X4Q;\J>.3D2P2?CL@?;Q+?Y+A@?O8:W<R62[(0;S?>'%]
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M+(,L+Y5D&&1G\K'>VYEU9*81E('B.!5]]D#;LP=JY(L\84"(>,?#4F5%Y*K
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MI"E[=2%GQ^NXZU4#7"X'UDUM7D$\]K)!7AV>?3TE'E;R;NQZH!TUS@BHR3"
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MT4E"L%PX-DY"F*^/H**:OFM@@[7I-7E#T*.C].U%V=>(B^RMN!9&$5R$;5$
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M,?!P#YL(-Q,$H=/C'\AS#S2%NNI,>8HS6RM",CC+Y9"XM9Q'S8I4'=K- NC
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M3"A)*2X%4%39+@0RGNXXEJ=/EO#\=)<[9KP4EM*\BW+)*Z=_Q0!R.MV"DP*
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M=3#5:C]26:YF5Y:,N70NML0AS0+N CP!&S=!DIE?6@A(Y3N&A2TEY!+R7"_
M1V8:?!6X9Z;H<CGR/PC6<7+SY*O M4ZS5:5I5])-C#X;^J[G[ #,@9*GV>I
MMDS'53*HCGI"%%V?K"I*UY'EL+[EL,/[#-8^@[7UA"?*8&4)97OX&=Q4K4,=
MR$Z=A5KZ\7OA7OP<)D$Q,(+93._ZV4S"8A!MF<V4[,MTB]4G,%;.>+>WG ,
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M<: P]9)>M'NV7X8HR<;(7-K\,["L?]K.-WL)-->Q@1$T8JX8I$-']K+EN\>
M4D(E.QLSLB+&*JPC%/80+5ZV0VJFA"[)[L(L:B9>]O2XO4&?"-#K90MWYT(M
M)4VR_2_;79I>.F2I%+HGE^Z,S5Y!G62/WM"0+(X2_'R.5WS47(#_]7]02P$"
M% ,4    " !YBCM*PA,9NF/J  !-#0\ $0              @ $     :71U
M<RTR,#$V,3 S,2YX;6Q02P$"% ,4    " !YBCM*CWX[EIH3   ,Q0  $0
M            @ &2Z@  :71U<RTR,#$V,3 S,2YX<V102P$"% ,4    " !Y
MBCM*.\P,JZ@+   (@   %0              @ %;_@  :71U<RTR,#$V,3 S
M,5]C86PN>&UL4$L! A0#%     @ >8H[2AR&:Q%3/0  7R\$ !4
M     ( !-@H! &ET=7,M,C Q-C$P,S%?9&5F+GAM;%!+ 0(4 Q0    ( 'F*
M.THA?$LD&FD  #Y7!0 5              "  ;Q' 0!I='5S+3(P,38Q,#,Q
M7VQA8BYX;6Q02P$"% ,4    " !YBCM*"&[JUL ]  !A* 0 %0
M    @ $)L0$ :71U<RTR,#$V,3 S,5]P<F4N>&UL4$L%!@     &  8 B@$
' /SN 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
